id	sid	tid	token	lemma	pos
10_1101-2021_01_05_425508	1	1	Human	human	JJ
10_1101-2021_01_05_425508	1	2	cell	cell	NN
10_1101-2021_01_05_425508	1	3	-	-	HYPH
10_1101-2021_01_05_425508	1	4	dependent	dependent	JJ
10_1101-2021_01_05_425508	1	5	,	,	,
10_1101-2021_01_05_425508	1	6	directional	directional	JJ
10_1101-2021_01_05_425508	1	7	,	,	,
10_1101-2021_01_05_425508	1	8	time	time	NN
10_1101-2021_01_05_425508	1	9	-	-	HYPH
10_1101-2021_01_05_425508	1	10	dependent	dependent	JJ
10_1101-2021_01_05_425508	1	11	changes	change	NNS
10_1101-2021_01_05_425508	1	12	in	in	IN
10_1101-2021_01_05_425508	1	13	the	the	DT
10_1101-2021_01_05_425508	1	14	mono-	mono-	NN
10_1101-2021_01_05_425508	1	15	and	and	CC
10_1101-2021_01_05_425508	1	16	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	1	17	compositions	composition	NNS
10_1101-2021_01_05_425508	1	18	of	of	IN
10_1101-2021_01_05_425508	1	19	SARS	SARS	NNP
10_1101-2021_01_05_425508	1	20	-	-	HYPH
10_1101-2021_01_05_425508	1	21	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	1	22	genomes	genome	VBZ
10_1101-2021_01_05_425508	1	23	1	1	CD
10_1101-2021_01_05_425508	1	24	Human	human	JJ
10_1101-2021_01_05_425508	1	25	cell	cell	NN
10_1101-2021_01_05_425508	1	26	-	-	HYPH
10_1101-2021_01_05_425508	1	27	dependent	dependent	JJ
10_1101-2021_01_05_425508	1	28	,	,	,
10_1101-2021_01_05_425508	1	29	directional	directional	JJ
10_1101-2021_01_05_425508	1	30	,	,	,
10_1101-2021_01_05_425508	1	31	time	time	NN
10_1101-2021_01_05_425508	1	32	-	-	HYPH
10_1101-2021_01_05_425508	1	33	dependent	dependent	JJ
10_1101-2021_01_05_425508	1	34	changes	change	NNS
10_1101-2021_01_05_425508	1	35	in	in	IN
10_1101-2021_01_05_425508	1	36	the	the	DT
10_1101-2021_01_05_425508	1	37	mono-	mono-	NN
10_1101-2021_01_05_425508	1	38	and	and	CC
10_1101-2021_01_05_425508	1	39	1	1	CD
10_1101-2021_01_05_425508	1	40	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	1	41	compositions	composition	NNS
10_1101-2021_01_05_425508	1	42	of	of	IN
10_1101-2021_01_05_425508	1	43	SARS	SARS	NNP
10_1101-2021_01_05_425508	1	44	-	-	HYPH
10_1101-2021_01_05_425508	1	45	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	1	46	genomes	genome	NNS
10_1101-2021_01_05_425508	1	47	2	2	CD
10_1101-2021_01_05_425508	1	48	3	3	CD
10_1101-2021_01_05_425508	1	49	Yuki	Yuki	NNP
10_1101-2021_01_05_425508	1	50	Iwasaki1	Iwasaki1	NNP
10_1101-2021_01_05_425508	1	51	,	,	,
10_1101-2021_01_05_425508	1	52	Takashi	Takashi	NNP
10_1101-2021_01_05_425508	1	53	Abe2	Abe2	NNP
10_1101-2021_01_05_425508	1	54	,	,	,
10_1101-2021_01_05_425508	1	55	Toshimichi	Toshimichi	NNP
10_1101-2021_01_05_425508	1	56	Ikemura1	Ikemura1	NNP
10_1101-2021_01_05_425508	1	57	4	4	CD
10_1101-2021_01_05_425508	1	58	1	1	CD
10_1101-2021_01_05_425508	1	59	.	.	.
10_1101-2021_01_05_425508	2	1	Department	Department	NNP
10_1101-2021_01_05_425508	2	2	of	of	IN
10_1101-2021_01_05_425508	2	3	Bioscience	Bioscience	NNP
10_1101-2021_01_05_425508	2	4	,	,	,
10_1101-2021_01_05_425508	2	5	Nagahama	Nagahama	NNP
10_1101-2021_01_05_425508	2	6	Institute	Institute	NNP
10_1101-2021_01_05_425508	2	7	of	of	IN
10_1101-2021_01_05_425508	2	8	Bio	Bio	NNP
10_1101-2021_01_05_425508	2	9	-	-	HYPH
10_1101-2021_01_05_425508	2	10	Science	Science	NNP
10_1101-2021_01_05_425508	2	11	and	and	CC
10_1101-2021_01_05_425508	2	12	Technology	Technology	NNP
10_1101-2021_01_05_425508	2	13	.	.	.
10_1101-2021_01_05_425508	3	1	5	5	CD
10_1101-2021_01_05_425508	3	2	Shiga	Shiga	NNP
10_1101-2021_01_05_425508	3	3	,	,	,
10_1101-2021_01_05_425508	3	4	Japan	Japan	NNP
10_1101-2021_01_05_425508	3	5	6	6	CD
10_1101-2021_01_05_425508	3	6	2	2	CD
10_1101-2021_01_05_425508	3	7	.	.	.
10_1101-2021_01_05_425508	4	1	Graduate	Graduate	NNP
10_1101-2021_01_05_425508	4	2	School	School	NNP
10_1101-2021_01_05_425508	4	3	of	of	IN
10_1101-2021_01_05_425508	4	4	Science	Science	NNP
10_1101-2021_01_05_425508	4	5	and	and	CC
10_1101-2021_01_05_425508	4	6	Technology	Technology	NNP
10_1101-2021_01_05_425508	4	7	,	,	,
10_1101-2021_01_05_425508	4	8	Niigata	Niigata	NNP
10_1101-2021_01_05_425508	4	9	University	University	NNP
10_1101-2021_01_05_425508	4	10	,	,	,
10_1101-2021_01_05_425508	4	11	Niigata	Niigata	NNP
10_1101-2021_01_05_425508	4	12	,	,	,
10_1101-2021_01_05_425508	4	13	Japan	Japan	NNP
10_1101-2021_01_05_425508	4	14	7	7	CD
10_1101-2021_01_05_425508	4	15	8	8	CD
10_1101-2021_01_05_425508	4	16	Abstract	Abstract	NNP
10_1101-2021_01_05_425508	4	17	9	9	CD
10_1101-2021_01_05_425508	4	18	Background	background	NN
10_1101-2021_01_05_425508	4	19	10	10	CD
10_1101-2021_01_05_425508	4	20	When	when	WRB
10_1101-2021_01_05_425508	4	21	a	a	DT
10_1101-2021_01_05_425508	4	22	virus	virus	NN
10_1101-2021_01_05_425508	4	23	that	that	WDT
10_1101-2021_01_05_425508	4	24	has	have	VBZ
10_1101-2021_01_05_425508	4	25	grown	grow	VBN
10_1101-2021_01_05_425508	4	26	in	in	IN
10_1101-2021_01_05_425508	4	27	a	a	DT
10_1101-2021_01_05_425508	4	28	nonhuman	nonhuman	NNP
10_1101-2021_01_05_425508	4	29	host	host	NN
10_1101-2021_01_05_425508	4	30	starts	start	VBZ
10_1101-2021_01_05_425508	4	31	an	an	DT
10_1101-2021_01_05_425508	4	32	epidemic	epidemic	NN
10_1101-2021_01_05_425508	4	33	in	in	IN
10_1101-2021_01_05_425508	4	34	the	the	DT
10_1101-2021_01_05_425508	4	35	human	human	JJ
10_1101-2021_01_05_425508	4	36	11	11	CD
10_1101-2021_01_05_425508	4	37	population	population	NN
10_1101-2021_01_05_425508	4	38	,	,	,
10_1101-2021_01_05_425508	4	39	human	human	JJ
10_1101-2021_01_05_425508	4	40	cells	cell	NNS
10_1101-2021_01_05_425508	4	41	may	may	MD
10_1101-2021_01_05_425508	4	42	not	not	RB
10_1101-2021_01_05_425508	4	43	provide	provide	VB
10_1101-2021_01_05_425508	4	44	growth	growth	NN
10_1101-2021_01_05_425508	4	45	conditions	condition	NNS
10_1101-2021_01_05_425508	4	46	ideal	ideal	JJ
10_1101-2021_01_05_425508	4	47	for	for	IN
10_1101-2021_01_05_425508	4	48	the	the	DT
10_1101-2021_01_05_425508	4	49	virus	virus	NN
10_1101-2021_01_05_425508	4	50	.	.	.
10_1101-2021_01_05_425508	5	1	12	12	CD
10_1101-2021_01_05_425508	5	2	Therefore	therefore	RB
10_1101-2021_01_05_425508	5	3	,	,	,
10_1101-2021_01_05_425508	5	4	the	the	DT
10_1101-2021_01_05_425508	5	5	invasion	invasion	NN
10_1101-2021_01_05_425508	5	6	of	of	IN
10_1101-2021_01_05_425508	5	7	severe	severe	JJ
10_1101-2021_01_05_425508	5	8	acute	acute	JJ
10_1101-2021_01_05_425508	5	9	respiratory	respiratory	JJ
10_1101-2021_01_05_425508	5	10	syndrome	syndrome	NN
10_1101-2021_01_05_425508	5	11	coronavirus-2	coronavirus-2	NNP
10_1101-2021_01_05_425508	5	12	(	(	-LRB-
10_1101-2021_01_05_425508	5	13	SARS-13	SARS-13	,
10_1101-2021_01_05_425508	5	14	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	5	15	)	)	-RRB-
10_1101-2021_01_05_425508	5	16	,	,	,
10_1101-2021_01_05_425508	5	17	which	which	WDT
10_1101-2021_01_05_425508	5	18	is	be	VBZ
10_1101-2021_01_05_425508	5	19	usually	usually	RB
10_1101-2021_01_05_425508	5	20	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	5	21	in	in	IN
10_1101-2021_01_05_425508	5	22	the	the	DT
10_1101-2021_01_05_425508	5	23	bat	bat	NN
10_1101-2021_01_05_425508	5	24	population	population	NN
10_1101-2021_01_05_425508	5	25	,	,	,
10_1101-2021_01_05_425508	5	26	into	into	IN
10_1101-2021_01_05_425508	5	27	the	the	DT
10_1101-2021_01_05_425508	5	28	human	human	JJ
10_1101-2021_01_05_425508	5	29	population	population	NN
10_1101-2021_01_05_425508	5	30	is	be	VBZ
10_1101-2021_01_05_425508	5	31	14	14	CD
10_1101-2021_01_05_425508	5	32	thought	think	VBD
10_1101-2021_01_05_425508	5	33	to	to	TO
10_1101-2021_01_05_425508	5	34	have	have	VB
10_1101-2021_01_05_425508	5	35	necessitated	necessitate	VBN
10_1101-2021_01_05_425508	5	36	changes	change	NNS
10_1101-2021_01_05_425508	5	37	in	in	IN
10_1101-2021_01_05_425508	5	38	the	the	DT
10_1101-2021_01_05_425508	5	39	viral	viral	JJ
10_1101-2021_01_05_425508	5	40	genome	genome	NN
10_1101-2021_01_05_425508	5	41	for	for	IN
10_1101-2021_01_05_425508	5	42	efficient	efficient	JJ
10_1101-2021_01_05_425508	5	43	growth	growth	NN
10_1101-2021_01_05_425508	5	44	in	in	IN
10_1101-2021_01_05_425508	5	45	the	the	DT
10_1101-2021_01_05_425508	5	46	new	new	JJ
10_1101-2021_01_05_425508	5	47	15	15	CD
10_1101-2021_01_05_425508	5	48	environment	environment	NN
10_1101-2021_01_05_425508	5	49	.	.	.
10_1101-2021_01_05_425508	6	1	In	in	IN
10_1101-2021_01_05_425508	6	2	the	the	DT
10_1101-2021_01_05_425508	6	3	present	present	JJ
10_1101-2021_01_05_425508	6	4	study	study	NN
10_1101-2021_01_05_425508	6	5	,	,	,
10_1101-2021_01_05_425508	6	6	to	to	TO
10_1101-2021_01_05_425508	6	7	understand	understand	VB
10_1101-2021_01_05_425508	6	8	host	host	NN
10_1101-2021_01_05_425508	6	9	-	-	HYPH
10_1101-2021_01_05_425508	6	10	dependent	dependent	JJ
10_1101-2021_01_05_425508	6	11	changes	change	NNS
10_1101-2021_01_05_425508	6	12	in	in	IN
10_1101-2021_01_05_425508	6	13	coronavirus	coronavirus	NNP
10_1101-2021_01_05_425508	6	14	16	16	CD
10_1101-2021_01_05_425508	6	15	genomes	genome	NNS
10_1101-2021_01_05_425508	6	16	,	,	,
10_1101-2021_01_05_425508	6	17	we	-PRON-	PRP
10_1101-2021_01_05_425508	6	18	focused	focus	VBD
10_1101-2021_01_05_425508	6	19	on	on	IN
10_1101-2021_01_05_425508	6	20	the	the	DT
10_1101-2021_01_05_425508	6	21	mono-	mono-	NN
10_1101-2021_01_05_425508	6	22	and	and	CC
10_1101-2021_01_05_425508	6	23	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	6	24	compositions	composition	NNS
10_1101-2021_01_05_425508	6	25	of	of	IN
10_1101-2021_01_05_425508	6	26	SARS	SARS	NNP
10_1101-2021_01_05_425508	6	27	-	-	HYPH
10_1101-2021_01_05_425508	6	28	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	6	29	17	17	CD
10_1101-2021_01_05_425508	6	30	genomes	genome	NNS
10_1101-2021_01_05_425508	6	31	and	and	CC
10_1101-2021_01_05_425508	6	32	investigated	investigate	VBD
10_1101-2021_01_05_425508	6	33	how	how	WRB
10_1101-2021_01_05_425508	6	34	these	these	DT
10_1101-2021_01_05_425508	6	35	compositions	composition	NNS
10_1101-2021_01_05_425508	6	36	changed	change	VBD
10_1101-2021_01_05_425508	6	37	time	time	NN
10_1101-2021_01_05_425508	6	38	-	-	HYPH
10_1101-2021_01_05_425508	6	39	dependently	dependently	RB
10_1101-2021_01_05_425508	6	40	in	in	IN
10_1101-2021_01_05_425508	6	41	the	the	DT
10_1101-2021_01_05_425508	6	42	18	18	CD
10_1101-2021_01_05_425508	6	43	human	human	JJ
10_1101-2021_01_05_425508	6	44	cellular	cellular	JJ
10_1101-2021_01_05_425508	6	45	environment	environment	NN
10_1101-2021_01_05_425508	6	46	.	.	.
10_1101-2021_01_05_425508	7	1	We	-PRON-	PRP
10_1101-2021_01_05_425508	7	2	also	also	RB
10_1101-2021_01_05_425508	7	3	compared	compare	VBD
10_1101-2021_01_05_425508	7	4	the	the	DT
10_1101-2021_01_05_425508	7	5	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	7	6	compositions	composition	NNS
10_1101-2021_01_05_425508	7	7	of	of	IN
10_1101-2021_01_05_425508	7	8	19	19	CD
10_1101-2021_01_05_425508	7	9	SARS	SARS	NNP
10_1101-2021_01_05_425508	7	10	-	-	HYPH
10_1101-2021_01_05_425508	7	11	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	7	12	and	and	CC
10_1101-2021_01_05_425508	7	13	other	other	JJ
10_1101-2021_01_05_425508	7	14	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	7	15	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	7	16	in	in	IN
10_1101-2021_01_05_425508	7	17	humans	human	NNS
10_1101-2021_01_05_425508	7	18	or	or	CC
10_1101-2021_01_05_425508	7	19	bats	bat	NNS
10_1101-2021_01_05_425508	7	20	to	to	TO
10_1101-2021_01_05_425508	7	21	investigate	investigate	VB
10_1101-2021_01_05_425508	7	22	the	the	DT
10_1101-2021_01_05_425508	7	23	20	20	CD
10_1101-2021_01_05_425508	7	24	causes	cause	NNS
10_1101-2021_01_05_425508	7	25	of	of	IN
10_1101-2021_01_05_425508	7	26	changes	change	NNS
10_1101-2021_01_05_425508	7	27	in	in	IN
10_1101-2021_01_05_425508	7	28	the	the	DT
10_1101-2021_01_05_425508	7	29	host	host	NN
10_1101-2021_01_05_425508	7	30	environment	environment	NN
10_1101-2021_01_05_425508	7	31	.	.	.
10_1101-2021_01_05_425508	8	1	21	21	CD
10_1101-2021_01_05_425508	8	2	Results	result	NNS
10_1101-2021_01_05_425508	8	3	22	22	CD
10_1101-2021_01_05_425508	8	4	Time	Time	NNP
10_1101-2021_01_05_425508	8	5	-	-	HYPH
10_1101-2021_01_05_425508	8	6	series	series	NN
10_1101-2021_01_05_425508	8	7	analyses	analysis	NNS
10_1101-2021_01_05_425508	8	8	of	of	IN
10_1101-2021_01_05_425508	8	9	changes	change	NNS
10_1101-2021_01_05_425508	8	10	in	in	IN
10_1101-2021_01_05_425508	8	11	the	the	DT
10_1101-2021_01_05_425508	8	12	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	8	13	compositions	composition	NNS
10_1101-2021_01_05_425508	8	14	of	of	IN
10_1101-2021_01_05_425508	8	15	SARS	SARS	NNP
10_1101-2021_01_05_425508	8	16	-	-	HYPH
10_1101-2021_01_05_425508	8	17	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	8	18	23	23	CD
10_1101-2021_01_05_425508	8	19	genomes	genome	NNS
10_1101-2021_01_05_425508	8	20	revealed	reveal	VBD
10_1101-2021_01_05_425508	8	21	a	a	DT
10_1101-2021_01_05_425508	8	22	group	group	NN
10_1101-2021_01_05_425508	8	23	of	of	IN
10_1101-2021_01_05_425508	8	24	mono-	mono-	NN
10_1101-2021_01_05_425508	8	25	and	and	CC
10_1101-2021_01_05_425508	8	26	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	8	27	whose	whose	WP$
10_1101-2021_01_05_425508	8	28	compositions	composition	NNS
10_1101-2021_01_05_425508	8	29	changed	change	VBD
10_1101-2021_01_05_425508	8	30	24	24	CD
10_1101-2021_01_05_425508	8	31	in	in	IN
10_1101-2021_01_05_425508	8	32	a	a	DT
10_1101-2021_01_05_425508	8	33	common	common	JJ
10_1101-2021_01_05_425508	8	34	direction	direction	NN
10_1101-2021_01_05_425508	8	35	for	for	IN
10_1101-2021_01_05_425508	8	36	all	all	DT
10_1101-2021_01_05_425508	8	37	clades	clade	NNS
10_1101-2021_01_05_425508	8	38	,	,	,
10_1101-2021_01_05_425508	8	39	even	even	RB
10_1101-2021_01_05_425508	8	40	though	though	IN
10_1101-2021_01_05_425508	8	41	viruses	virus	NNS
10_1101-2021_01_05_425508	8	42	belonging	belong	VBG
10_1101-2021_01_05_425508	8	43	to	to	IN
10_1101-2021_01_05_425508	8	44	different	different	JJ
10_1101-2021_01_05_425508	8	45	clades	clade	NNS
10_1101-2021_01_05_425508	8	46	25	25	CD
10_1101-2021_01_05_425508	8	47	should	should	MD
10_1101-2021_01_05_425508	8	48	evolve	evolve	VB
10_1101-2021_01_05_425508	8	49	independently	independently	RB
10_1101-2021_01_05_425508	8	50	.	.	.
10_1101-2021_01_05_425508	9	1	Interestingly	interestingly	RB
10_1101-2021_01_05_425508	9	2	,	,	,
10_1101-2021_01_05_425508	9	3	the	the	DT
10_1101-2021_01_05_425508	9	4	compositions	composition	NNS
10_1101-2021_01_05_425508	9	5	of	of	IN
10_1101-2021_01_05_425508	9	6	these	these	DT
10_1101-2021_01_05_425508	9	7	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	9	8	26	26	CD
10_1101-2021_01_05_425508	9	9	.CC	.CC	:
10_1101-2021_01_05_425508	9	10	-	-	HYPH
10_1101-2021_01_05_425508	9	11	BY	BY	NNP
10_1101-2021_01_05_425508	9	12	-	-	HYPH
10_1101-2021_01_05_425508	9	13	NC	NC	NNP
10_1101-2021_01_05_425508	9	14	4.0	4.0	CD
10_1101-2021_01_05_425508	9	15	International	international	JJ
10_1101-2021_01_05_425508	9	16	licensemade	licensemade	NN
10_1101-2021_01_05_425508	9	17	available	available	JJ
10_1101-2021_01_05_425508	9	18	under	under	IN
10_1101-2021_01_05_425508	9	19	a	a	DT
10_1101-2021_01_05_425508	9	20	(	(	-LRB-
10_1101-2021_01_05_425508	9	21	which	which	WDT
10_1101-2021_01_05_425508	9	22	was	be	VBD
10_1101-2021_01_05_425508	9	23	not	not	RB
10_1101-2021_01_05_425508	9	24	certified	certify	VBN
10_1101-2021_01_05_425508	9	25	by	by	IN
10_1101-2021_01_05_425508	9	26	peer	peer	NN
10_1101-2021_01_05_425508	9	27	review	review	NN
10_1101-2021_01_05_425508	9	28	)	)	-RRB-
10_1101-2021_01_05_425508	9	29	is	be	VBZ
10_1101-2021_01_05_425508	9	30	the	the	DT
10_1101-2021_01_05_425508	9	31	author	author	NN
10_1101-2021_01_05_425508	9	32	/	/	SYM
10_1101-2021_01_05_425508	9	33	funder	funder	NN
10_1101-2021_01_05_425508	9	34	,	,	,
10_1101-2021_01_05_425508	9	35	who	who	WP
10_1101-2021_01_05_425508	9	36	has	have	VBZ
10_1101-2021_01_05_425508	9	37	granted	grant	VBN
10_1101-2021_01_05_425508	9	38	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	9	39	a	a	DT
10_1101-2021_01_05_425508	9	40	license	license	NN
10_1101-2021_01_05_425508	9	41	to	to	TO
10_1101-2021_01_05_425508	9	42	display	display	VB
10_1101-2021_01_05_425508	9	43	the	the	DT
10_1101-2021_01_05_425508	9	44	preprint	preprint	NN
10_1101-2021_01_05_425508	9	45	in	in	IN
10_1101-2021_01_05_425508	9	46	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	9	47	.	.	.
10_1101-2021_01_05_425508	10	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	10	2	is	be	VBZ
10_1101-2021_01_05_425508	10	3	The	the	DT
10_1101-2021_01_05_425508	10	4	copyright	copyright	NN
10_1101-2021_01_05_425508	10	5	holder	holder	NN
10_1101-2021_01_05_425508	10	6	for	for	IN
10_1101-2021_01_05_425508	10	7	this	this	DT
10_1101-2021_01_05_425508	10	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	10	9	version	version	NN
10_1101-2021_01_05_425508	10	10	posted	post	VBD
10_1101-2021_01_05_425508	10	11	January	January	NNP
10_1101-2021_01_05_425508	10	12	6	6	CD
10_1101-2021_01_05_425508	10	13	,	,	,
10_1101-2021_01_05_425508	10	14	2021	2021	CD
10_1101-2021_01_05_425508	10	15	.	.	.
10_1101-2021_01_05_425508	10	16	;	;	:
10_1101-2021_01_05_425508	10	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	10	18	:	:	:
10_1101-2021_01_05_425508	10	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	10	20	preprint	preprint	NN
10_1101-2021_01_05_425508	10	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	10	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	10	23	2	2	CD
10_1101-2021_01_05_425508	10	24	changed	change	VBD
10_1101-2021_01_05_425508	10	25	towards	towards	IN
10_1101-2021_01_05_425508	10	26	those	those	DT
10_1101-2021_01_05_425508	10	27	of	of	IN
10_1101-2021_01_05_425508	10	28	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	10	29	that	that	WDT
10_1101-2021_01_05_425508	10	30	have	have	VBP
10_1101-2021_01_05_425508	10	31	been	be	VBN
10_1101-2021_01_05_425508	10	32	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	10	33	in	in	IN
10_1101-2021_01_05_425508	10	34	humans	human	NNS
10_1101-2021_01_05_425508	10	35	for	for	IN
10_1101-2021_01_05_425508	10	36	a	a	DT
10_1101-2021_01_05_425508	10	37	long	long	JJ
10_1101-2021_01_05_425508	10	38	27	27	CD
10_1101-2021_01_05_425508	10	39	period	period	NN
10_1101-2021_01_05_425508	10	40	and	and	CC
10_1101-2021_01_05_425508	10	41	away	away	RB
10_1101-2021_01_05_425508	10	42	from	from	IN
10_1101-2021_01_05_425508	10	43	those	those	DT
10_1101-2021_01_05_425508	10	44	of	of	IN
10_1101-2021_01_05_425508	10	45	bat	bat	NN
10_1101-2021_01_05_425508	10	46	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	10	47	.	.	.
10_1101-2021_01_05_425508	11	1	28	28	CD
10_1101-2021_01_05_425508	11	2	Conclusions	Conclusions	NNPS
10_1101-2021_01_05_425508	11	3	29	29	CD
10_1101-2021_01_05_425508	11	4	Clade	Clade	NNP
10_1101-2021_01_05_425508	11	5	-	-	HYPH
10_1101-2021_01_05_425508	11	6	independent	independent	JJ
10_1101-2021_01_05_425508	11	7	,	,	,
10_1101-2021_01_05_425508	11	8	time	time	NN
10_1101-2021_01_05_425508	11	9	-	-	HYPH
10_1101-2021_01_05_425508	11	10	dependent	dependent	JJ
10_1101-2021_01_05_425508	11	11	changes	change	NNS
10_1101-2021_01_05_425508	11	12	are	be	VBP
10_1101-2021_01_05_425508	11	13	thought	think	VBN
10_1101-2021_01_05_425508	11	14	to	to	TO
10_1101-2021_01_05_425508	11	15	have	have	VB
10_1101-2021_01_05_425508	11	16	biological	biological	JJ
10_1101-2021_01_05_425508	11	17	significance	significance	NN
10_1101-2021_01_05_425508	11	18	30	30	CD
10_1101-2021_01_05_425508	11	19	and	and	CC
10_1101-2021_01_05_425508	11	20	should	should	MD
10_1101-2021_01_05_425508	11	21	relate	relate	VB
10_1101-2021_01_05_425508	11	22	to	to	IN
10_1101-2021_01_05_425508	11	23	viral	viral	JJ
10_1101-2021_01_05_425508	11	24	adaptation	adaptation	NN
10_1101-2021_01_05_425508	11	25	to	to	IN
10_1101-2021_01_05_425508	11	26	a	a	DT
10_1101-2021_01_05_425508	11	27	new	new	JJ
10_1101-2021_01_05_425508	11	28	host	host	NN
10_1101-2021_01_05_425508	11	29	environment	environment	NN
10_1101-2021_01_05_425508	11	30	,	,	,
10_1101-2021_01_05_425508	11	31	providing	provide	VBG
10_1101-2021_01_05_425508	11	32	important	important	JJ
10_1101-2021_01_05_425508	11	33	31	31	CD
10_1101-2021_01_05_425508	11	34	clues	clue	NNS
10_1101-2021_01_05_425508	11	35	for	for	IN
10_1101-2021_01_05_425508	11	36	understanding	understand	VBG
10_1101-2021_01_05_425508	11	37	viral	viral	JJ
10_1101-2021_01_05_425508	11	38	host	host	NN
10_1101-2021_01_05_425508	11	39	adaptation	adaptation	NN
10_1101-2021_01_05_425508	11	40	mechanisms	mechanism	NNS
10_1101-2021_01_05_425508	11	41	.	.	.
10_1101-2021_01_05_425508	12	1	32	32	CD
10_1101-2021_01_05_425508	12	2	33	33	CD
10_1101-2021_01_05_425508	12	3	Keyword	Keyword	NNP
10_1101-2021_01_05_425508	12	4	34	34	CD
10_1101-2021_01_05_425508	12	5	“	"	``
10_1101-2021_01_05_425508	12	6	COVID-19	covid-19	JJ
10_1101-2021_01_05_425508	12	7	”	"	''
10_1101-2021_01_05_425508	12	8	,	,	,
10_1101-2021_01_05_425508	12	9	“	"	``
10_1101-2021_01_05_425508	12	10	SARS	SARS	NNP
10_1101-2021_01_05_425508	12	11	-	-	HYPH
10_1101-2021_01_05_425508	12	12	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	12	13	”	"	''
10_1101-2021_01_05_425508	12	14	,	,	,
10_1101-2021_01_05_425508	12	15	“	"	``
10_1101-2021_01_05_425508	12	16	Oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	12	17	composition	composition	NN
10_1101-2021_01_05_425508	12	18	”	"	''
10_1101-2021_01_05_425508	12	19	,	,	,
10_1101-2021_01_05_425508	12	20	“	"	``
10_1101-2021_01_05_425508	12	21	Time	Time	NNP
10_1101-2021_01_05_425508	12	22	-	-	HYPH
10_1101-2021_01_05_425508	12	23	series	series	NNP
10_1101-2021_01_05_425508	12	24	analysis	analysis	NN
10_1101-2021_01_05_425508	12	25	”	"	''
10_1101-2021_01_05_425508	12	26	,	,	,
10_1101-2021_01_05_425508	12	27	35	35	CD
10_1101-2021_01_05_425508	12	28	“	"	``
10_1101-2021_01_05_425508	12	29	Big	big	JJ
10_1101-2021_01_05_425508	12	30	data	datum	NNS
10_1101-2021_01_05_425508	12	31	”	"	''
10_1101-2021_01_05_425508	12	32	,	,	,
10_1101-2021_01_05_425508	12	33	“	"	``
10_1101-2021_01_05_425508	12	34	Zoonotic	zoonotic	JJ
10_1101-2021_01_05_425508	12	35	virus	virus	NN
10_1101-2021_01_05_425508	12	36	”	"	''
10_1101-2021_01_05_425508	12	37	,	,	,
10_1101-2021_01_05_425508	12	38	“	"	``
10_1101-2021_01_05_425508	12	39	RNA	RNA	NNP
10_1101-2021_01_05_425508	12	40	virus	virus	NN
10_1101-2021_01_05_425508	12	41	”	"	''
10_1101-2021_01_05_425508	12	42	,	,	,
10_1101-2021_01_05_425508	12	43	“	"	``
10_1101-2021_01_05_425508	12	44	Viral	viral	JJ
10_1101-2021_01_05_425508	12	45	adaptation	adaptation	NN
10_1101-2021_01_05_425508	12	46	”	"	''
10_1101-2021_01_05_425508	12	47	,	,	,
10_1101-2021_01_05_425508	12	48	“	"	``
10_1101-2021_01_05_425508	12	49	Coronavirus	Coronavirus	NNP
10_1101-2021_01_05_425508	12	50	”	"	''
10_1101-2021_01_05_425508	12	51	36	36	CD
10_1101-2021_01_05_425508	12	52	37	37	CD
10_1101-2021_01_05_425508	12	53	Background	background	NN
10_1101-2021_01_05_425508	12	54	38	38	CD
10_1101-2021_01_05_425508	12	55	Severe	severe	JJ
10_1101-2021_01_05_425508	12	56	acute	acute	JJ
10_1101-2021_01_05_425508	12	57	respiratory	respiratory	JJ
10_1101-2021_01_05_425508	12	58	syndrome	syndrome	NN
10_1101-2021_01_05_425508	12	59	coronavirus-2	coronavirus-2	NNP
10_1101-2021_01_05_425508	12	60	(	(	-LRB-
10_1101-2021_01_05_425508	12	61	SARS	SARS	NNP
10_1101-2021_01_05_425508	12	62	-	-	HYPH
10_1101-2021_01_05_425508	12	63	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	12	64	)	)	-RRB-
10_1101-2021_01_05_425508	12	65	,	,	,
10_1101-2021_01_05_425508	12	66	an	an	DT
10_1101-2021_01_05_425508	12	67	RNA	RNA	NNP
10_1101-2021_01_05_425508	12	68	virus	virus	NN
10_1101-2021_01_05_425508	12	69	39	39	CD
10_1101-2021_01_05_425508	12	70	belonging	belong	VBG
10_1101-2021_01_05_425508	12	71	to	to	IN
10_1101-2021_01_05_425508	12	72	the	the	DT
10_1101-2021_01_05_425508	12	73	betacoronavirus	betacoronavirus	NNP
10_1101-2021_01_05_425508	12	74	genus	genus	NNP
10_1101-2021_01_05_425508	12	75	,	,	,
10_1101-2021_01_05_425508	12	76	began	begin	VBD
10_1101-2021_01_05_425508	12	77	to	to	TO
10_1101-2021_01_05_425508	12	78	spread	spread	VB
10_1101-2021_01_05_425508	12	79	in	in	IN
10_1101-2021_01_05_425508	12	80	the	the	DT
10_1101-2021_01_05_425508	12	81	human	human	JJ
10_1101-2021_01_05_425508	12	82	population	population	NN
10_1101-2021_01_05_425508	12	83	in	in	IN
10_1101-2021_01_05_425508	12	84	40	40	CD
10_1101-2021_01_05_425508	12	85	2019	2019	CD
10_1101-2021_01_05_425508	12	86	.	.	.
10_1101-2021_01_05_425508	13	1	This	this	DT
10_1101-2021_01_05_425508	13	2	viral	viral	JJ
10_1101-2021_01_05_425508	13	3	strain	strain	NN
10_1101-2021_01_05_425508	13	4	is	be	VBZ
10_1101-2021_01_05_425508	13	5	believed	believe	VBN
10_1101-2021_01_05_425508	13	6	to	to	TO
10_1101-2021_01_05_425508	13	7	have	have	VB
10_1101-2021_01_05_425508	13	8	been	be	VBN
10_1101-2021_01_05_425508	13	9	originally	originally	RB
10_1101-2021_01_05_425508	13	10	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	13	11	in	in	IN
10_1101-2021_01_05_425508	13	12	bats	bat	NNS
10_1101-2021_01_05_425508	13	13	and	and	CC
10_1101-2021_01_05_425508	13	14	41	41	CD
10_1101-2021_01_05_425508	13	15	transferred	transfer	VBN
10_1101-2021_01_05_425508	13	16	to	to	IN
10_1101-2021_01_05_425508	13	17	the	the	DT
10_1101-2021_01_05_425508	13	18	human	human	JJ
10_1101-2021_01_05_425508	13	19	population	population	NN
10_1101-2021_01_05_425508	13	20	through	through	IN
10_1101-2021_01_05_425508	13	21	intermediate	intermediate	JJ
10_1101-2021_01_05_425508	13	22	hosts	host	NNS
10_1101-2021_01_05_425508	13	23	[	[	-LRB-
10_1101-2021_01_05_425508	13	24	1	1	CD
10_1101-2021_01_05_425508	13	25	]	]	-RRB-
10_1101-2021_01_05_425508	13	26	.	.	.
10_1101-2021_01_05_425508	14	1	Viral	viral	JJ
10_1101-2021_01_05_425508	14	2	growth	growth	NN
10_1101-2021_01_05_425508	14	3	42	42	CD
10_1101-2021_01_05_425508	14	4	requires	require	VBZ
10_1101-2021_01_05_425508	14	5	a	a	DT
10_1101-2021_01_05_425508	14	6	wide	wide	JJ
10_1101-2021_01_05_425508	14	7	variety	variety	NN
10_1101-2021_01_05_425508	14	8	of	of	IN
10_1101-2021_01_05_425508	14	9	host	host	NN
10_1101-2021_01_05_425508	14	10	factors	factor	NNS
10_1101-2021_01_05_425508	14	11	(	(	-LRB-
10_1101-2021_01_05_425508	14	12	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	14	13	pools	pool	NNS
10_1101-2021_01_05_425508	14	14	,	,	,
10_1101-2021_01_05_425508	14	15	proteins	protein	NNS
10_1101-2021_01_05_425508	14	16	,	,	,
10_1101-2021_01_05_425508	14	17	RNA	RNA	NNP
10_1101-2021_01_05_425508	14	18	,	,	,
10_1101-2021_01_05_425508	14	19	etc	etc	FW
10_1101-2021_01_05_425508	14	20	.	.	.
10_1101-2021_01_05_425508	14	21	)	)	-RRB-
10_1101-2021_01_05_425508	15	1	and	and	CC
10_1101-2021_01_05_425508	15	2	43	43	CD
10_1101-2021_01_05_425508	15	3	should	should	MD
10_1101-2021_01_05_425508	15	4	evade	evade	VB
10_1101-2021_01_05_425508	15	5	the	the	DT
10_1101-2021_01_05_425508	15	6	diverse	diverse	JJ
10_1101-2021_01_05_425508	15	7	antiviral	antiviral	JJ
10_1101-2021_01_05_425508	15	8	mechanisms	mechanism	NNS
10_1101-2021_01_05_425508	15	9	of	of	IN
10_1101-2021_01_05_425508	15	10	host	host	NN
10_1101-2021_01_05_425508	15	11	cells	cell	NNS
10_1101-2021_01_05_425508	15	12	(	(	-LRB-
10_1101-2021_01_05_425508	15	13	antibodies	antibody	NNS
10_1101-2021_01_05_425508	15	14	,	,	,
10_1101-2021_01_05_425508	15	15	killer	killer	NN
10_1101-2021_01_05_425508	15	16	T	t	NN
10_1101-2021_01_05_425508	15	17	cells	cell	NNS
10_1101-2021_01_05_425508	15	18	,	,	,
10_1101-2021_01_05_425508	15	19	44	44	CD
10_1101-2021_01_05_425508	15	20	interferon	interferon	NN
10_1101-2021_01_05_425508	15	21	,	,	,
10_1101-2021_01_05_425508	15	22	RNA	RNA	NNP
10_1101-2021_01_05_425508	15	23	interference	interference	NN
10_1101-2021_01_05_425508	15	24	,	,	,
10_1101-2021_01_05_425508	15	25	etc	etc	FW
10_1101-2021_01_05_425508	15	26	.	.	.
10_1101-2021_01_05_425508	15	27	)	)	-RRB-
10_1101-2021_01_05_425508	16	1	[	[	-LRB-
10_1101-2021_01_05_425508	16	2	2	2	CD
10_1101-2021_01_05_425508	16	3	-	-	SYM
10_1101-2021_01_05_425508	16	4	4	4	CD
10_1101-2021_01_05_425508	16	5	]	]	-RRB-
10_1101-2021_01_05_425508	16	6	.	.	.
10_1101-2021_01_05_425508	17	1	Since	since	IN
10_1101-2021_01_05_425508	17	2	ancestral	ancestral	JJ
10_1101-2021_01_05_425508	17	3	SARS	SARS	NNP
10_1101-2021_01_05_425508	17	4	-	-	HYPH
10_1101-2021_01_05_425508	17	5	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	17	6	strains	strain	NNS
10_1101-2021_01_05_425508	17	7	are	be	VBP
10_1101-2021_01_05_425508	17	8	45	45	CD
10_1101-2021_01_05_425508	17	9	thought	think	VBD
10_1101-2021_01_05_425508	17	10	to	to	TO
10_1101-2021_01_05_425508	17	11	be	be	VB
10_1101-2021_01_05_425508	17	12	endemic	endemic	JJ
10_1101-2021_01_05_425508	17	13	in	in	IN
10_1101-2021_01_05_425508	17	14	bats	bat	NNS
10_1101-2021_01_05_425508	17	15	,	,	,
10_1101-2021_01_05_425508	17	16	they	-PRON-	PRP
10_1101-2021_01_05_425508	17	17	should	should	MD
10_1101-2021_01_05_425508	17	18	be	be	VB
10_1101-2021_01_05_425508	17	19	well	well	RB
10_1101-2021_01_05_425508	17	20	adapted	adapt	VBN
10_1101-2021_01_05_425508	17	21	to	to	IN
10_1101-2021_01_05_425508	17	22	their	-PRON-	PRP$
10_1101-2021_01_05_425508	17	23	host	host	NN
10_1101-2021_01_05_425508	17	24	environment	environment	NN
10_1101-2021_01_05_425508	17	25	;	;	:
10_1101-2021_01_05_425508	17	26	46	46	CD
10_1101-2021_01_05_425508	17	27	when	when	WRB
10_1101-2021_01_05_425508	17	28	the	the	DT
10_1101-2021_01_05_425508	17	29	virus	virus	NN
10_1101-2021_01_05_425508	17	30	invades	invade	VBZ
10_1101-2021_01_05_425508	17	31	the	the	DT
10_1101-2021_01_05_425508	17	32	human	human	JJ
10_1101-2021_01_05_425508	17	33	population	population	NN
10_1101-2021_01_05_425508	17	34	,	,	,
10_1101-2021_01_05_425508	17	35	human	human	JJ
10_1101-2021_01_05_425508	17	36	cells	cell	NNS
10_1101-2021_01_05_425508	17	37	may	may	MD
10_1101-2021_01_05_425508	17	38	not	not	RB
10_1101-2021_01_05_425508	17	39	provide	provide	VB
10_1101-2021_01_05_425508	17	40	growth	growth	NN
10_1101-2021_01_05_425508	17	41	47	47	CD
10_1101-2021_01_05_425508	17	42	conditions	condition	NNS
10_1101-2021_01_05_425508	17	43	ideal	ideal	JJ
10_1101-2021_01_05_425508	17	44	for	for	IN
10_1101-2021_01_05_425508	17	45	the	the	DT
10_1101-2021_01_05_425508	17	46	virus	virus	NN
10_1101-2021_01_05_425508	17	47	.	.	.
10_1101-2021_01_05_425508	18	1	For	for	IN
10_1101-2021_01_05_425508	18	2	efficient	efficient	JJ
10_1101-2021_01_05_425508	18	3	growth	growth	NN
10_1101-2021_01_05_425508	18	4	and	and	CC
10_1101-2021_01_05_425508	18	5	rapid	rapid	JJ
10_1101-2021_01_05_425508	18	6	spread	spread	NN
10_1101-2021_01_05_425508	18	7	of	of	IN
10_1101-2021_01_05_425508	18	8	the	the	DT
10_1101-2021_01_05_425508	18	9	infection	infection	NN
10_1101-2021_01_05_425508	18	10	,	,	,
10_1101-2021_01_05_425508	18	11	48	48	CD
10_1101-2021_01_05_425508	18	12	changes	change	NNS
10_1101-2021_01_05_425508	18	13	in	in	IN
10_1101-2021_01_05_425508	18	14	the	the	DT
10_1101-2021_01_05_425508	18	15	viral	viral	JJ
10_1101-2021_01_05_425508	18	16	genome	genome	NN
10_1101-2021_01_05_425508	18	17	should	should	MD
10_1101-2021_01_05_425508	18	18	be	be	VB
10_1101-2021_01_05_425508	18	19	required	require	VBN
10_1101-2021_01_05_425508	18	20	.	.	.
10_1101-2021_01_05_425508	19	1	Analyses	analysis	NNS
10_1101-2021_01_05_425508	19	2	of	of	IN
10_1101-2021_01_05_425508	19	3	time	time	NN
10_1101-2021_01_05_425508	19	4	-	-	HYPH
10_1101-2021_01_05_425508	19	5	dependent	dependent	JJ
10_1101-2021_01_05_425508	19	6	changes	change	NNS
10_1101-2021_01_05_425508	19	7	in	in	IN
10_1101-2021_01_05_425508	19	8	49	49	CD
10_1101-2021_01_05_425508	19	9	SARS	SARS	NNP
10_1101-2021_01_05_425508	19	10	-	-	HYPH
10_1101-2021_01_05_425508	19	11	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	19	12	in	in	IN
10_1101-2021_01_05_425508	19	13	the	the	DT
10_1101-2021_01_05_425508	19	14	human	human	JJ
10_1101-2021_01_05_425508	19	15	population	population	NN
10_1101-2021_01_05_425508	19	16	can	can	MD
10_1101-2021_01_05_425508	19	17	be	be	VB
10_1101-2021_01_05_425508	19	18	used	use	VBN
10_1101-2021_01_05_425508	19	19	to	to	TO
10_1101-2021_01_05_425508	19	20	characterize	characterize	VB
10_1101-2021_01_05_425508	19	21	how	how	WRB
10_1101-2021_01_05_425508	19	22	and	and	CC
10_1101-2021_01_05_425508	19	23	why	why	WRB
10_1101-2021_01_05_425508	19	24	viral	viral	JJ
10_1101-2021_01_05_425508	19	25	50	50	CD
10_1101-2021_01_05_425508	19	26	genomes	genome	NNS
10_1101-2021_01_05_425508	19	27	change	change	VBP
10_1101-2021_01_05_425508	19	28	to	to	TO
10_1101-2021_01_05_425508	19	29	adapt	adapt	VB
10_1101-2021_01_05_425508	19	30	to	to	IN
10_1101-2021_01_05_425508	19	31	a	a	DT
10_1101-2021_01_05_425508	19	32	new	new	JJ
10_1101-2021_01_05_425508	19	33	host	host	NN
10_1101-2021_01_05_425508	19	34	environment	environment	NN
10_1101-2021_01_05_425508	19	35	.	.	.
10_1101-2021_01_05_425508	20	1	51	51	CD
10_1101-2021_01_05_425508	20	2	Due	due	IN
10_1101-2021_01_05_425508	20	3	to	to	IN
10_1101-2021_01_05_425508	20	4	the	the	DT
10_1101-2021_01_05_425508	20	5	great	great	JJ
10_1101-2021_01_05_425508	20	6	threat	threat	NN
10_1101-2021_01_05_425508	20	7	of	of	IN
10_1101-2021_01_05_425508	20	8	COVID-19	COVID-19	,
10_1101-2021_01_05_425508	20	9	and	and	CC
10_1101-2021_01_05_425508	20	10	remarkable	remarkable	JJ
10_1101-2021_01_05_425508	20	11	development	development	NN
10_1101-2021_01_05_425508	20	12	of	of	IN
10_1101-2021_01_05_425508	20	13	52	52	CD
10_1101-2021_01_05_425508	20	14	sequencing	sequence	VBG
10_1101-2021_01_05_425508	20	15	technology	technology	NN
10_1101-2021_01_05_425508	20	16	,	,	,
10_1101-2021_01_05_425508	20	17	a	a	DT
10_1101-2021_01_05_425508	20	18	massive	massive	JJ
10_1101-2021_01_05_425508	20	19	number	number	NN
10_1101-2021_01_05_425508	20	20	of	of	IN
10_1101-2021_01_05_425508	20	21	SARS	SARS	NNP
10_1101-2021_01_05_425508	20	22	-	-	HYPH
10_1101-2021_01_05_425508	20	23	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	20	24	genome	genome	NNP
10_1101-2021_01_05_425508	20	25	sequences	sequence	NNS
10_1101-2021_01_05_425508	20	26	are	be	VBP
10_1101-2021_01_05_425508	20	27	53	53	CD
10_1101-2021_01_05_425508	20	28	.CC	.CC	:
10_1101-2021_01_05_425508	20	29	-	-	HYPH
10_1101-2021_01_05_425508	20	30	BY	BY	NNP
10_1101-2021_01_05_425508	20	31	-	-	HYPH
10_1101-2021_01_05_425508	20	32	NC	NC	NNP
10_1101-2021_01_05_425508	20	33	4.0	4.0	CD
10_1101-2021_01_05_425508	20	34	International	international	JJ
10_1101-2021_01_05_425508	20	35	licensemade	licensemade	NN
10_1101-2021_01_05_425508	20	36	available	available	JJ
10_1101-2021_01_05_425508	20	37	under	under	IN
10_1101-2021_01_05_425508	20	38	a	a	DT
10_1101-2021_01_05_425508	20	39	(	(	-LRB-
10_1101-2021_01_05_425508	20	40	which	which	WDT
10_1101-2021_01_05_425508	20	41	was	be	VBD
10_1101-2021_01_05_425508	20	42	not	not	RB
10_1101-2021_01_05_425508	20	43	certified	certify	VBN
10_1101-2021_01_05_425508	20	44	by	by	IN
10_1101-2021_01_05_425508	20	45	peer	peer	NN
10_1101-2021_01_05_425508	20	46	review	review	NN
10_1101-2021_01_05_425508	20	47	)	)	-RRB-
10_1101-2021_01_05_425508	20	48	is	be	VBZ
10_1101-2021_01_05_425508	20	49	the	the	DT
10_1101-2021_01_05_425508	20	50	author	author	NN
10_1101-2021_01_05_425508	20	51	/	/	SYM
10_1101-2021_01_05_425508	20	52	funder	funder	NN
10_1101-2021_01_05_425508	20	53	,	,	,
10_1101-2021_01_05_425508	20	54	who	who	WP
10_1101-2021_01_05_425508	20	55	has	have	VBZ
10_1101-2021_01_05_425508	20	56	granted	grant	VBN
10_1101-2021_01_05_425508	20	57	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	20	58	a	a	DT
10_1101-2021_01_05_425508	20	59	license	license	NN
10_1101-2021_01_05_425508	20	60	to	to	TO
10_1101-2021_01_05_425508	20	61	display	display	VB
10_1101-2021_01_05_425508	20	62	the	the	DT
10_1101-2021_01_05_425508	20	63	preprint	preprint	NN
10_1101-2021_01_05_425508	20	64	in	in	IN
10_1101-2021_01_05_425508	20	65	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	20	66	.	.	.
10_1101-2021_01_05_425508	21	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	21	2	is	be	VBZ
10_1101-2021_01_05_425508	21	3	The	the	DT
10_1101-2021_01_05_425508	21	4	copyright	copyright	NN
10_1101-2021_01_05_425508	21	5	holder	holder	NN
10_1101-2021_01_05_425508	21	6	for	for	IN
10_1101-2021_01_05_425508	21	7	this	this	DT
10_1101-2021_01_05_425508	21	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	21	9	version	version	NN
10_1101-2021_01_05_425508	21	10	posted	post	VBD
10_1101-2021_01_05_425508	21	11	January	January	NNP
10_1101-2021_01_05_425508	21	12	6	6	CD
10_1101-2021_01_05_425508	21	13	,	,	,
10_1101-2021_01_05_425508	21	14	2021	2021	CD
10_1101-2021_01_05_425508	21	15	.	.	.
10_1101-2021_01_05_425508	21	16	;	;	:
10_1101-2021_01_05_425508	21	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	21	18	:	:	:
10_1101-2021_01_05_425508	21	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	21	20	preprint	preprint	NN
10_1101-2021_01_05_425508	21	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	POS
10_1101-2021_01_05_425508	21	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NN
10_1101-2021_01_05_425508	21	23	3	3	CD
10_1101-2021_01_05_425508	21	24	available	available	JJ
10_1101-2021_01_05_425508	21	25	in	in	IN
10_1101-2021_01_05_425508	21	26	databases	database	NNS
10_1101-2021_01_05_425508	21	27	,	,	,
10_1101-2021_01_05_425508	21	28	even	even	RB
10_1101-2021_01_05_425508	21	29	though	though	IN
10_1101-2021_01_05_425508	21	30	the	the	DT
10_1101-2021_01_05_425508	21	31	epidemic	epidemic	NN
10_1101-2021_01_05_425508	21	32	has	have	VBZ
10_1101-2021_01_05_425508	21	33	lasted	last	VBN
10_1101-2021_01_05_425508	21	34	for	for	IN
10_1101-2021_01_05_425508	21	35	approximately	approximately	RB
10_1101-2021_01_05_425508	21	36	10	10	CD
10_1101-2021_01_05_425508	21	37	54	54	CD
10_1101-2021_01_05_425508	21	38	months	month	NNS
10_1101-2021_01_05_425508	21	39	.	.	.
10_1101-2021_01_05_425508	22	1	These	these	DT
10_1101-2021_01_05_425508	22	2	sequence	sequence	NN
10_1101-2021_01_05_425508	22	3	data	datum	NNS
10_1101-2021_01_05_425508	22	4	have	have	VBP
10_1101-2021_01_05_425508	22	5	provided	provide	VBN
10_1101-2021_01_05_425508	22	6	a	a	DT
10_1101-2021_01_05_425508	22	7	wide	wide	JJ
10_1101-2021_01_05_425508	22	8	range	range	NN
10_1101-2021_01_05_425508	22	9	of	of	IN
10_1101-2021_01_05_425508	22	10	insights	insight	NNS
10_1101-2021_01_05_425508	22	11	into	into	IN
10_1101-2021_01_05_425508	22	12	SARS	SARS	NNP
10_1101-2021_01_05_425508	22	13	-	-	HYPH
10_1101-2021_01_05_425508	22	14	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	22	15	55	55	CD
10_1101-2021_01_05_425508	22	16	[	[	-LRB-
10_1101-2021_01_05_425508	22	17	5,6	5,6	CD
10_1101-2021_01_05_425508	22	18	]	]	-RRB-
10_1101-2021_01_05_425508	22	19	.	.	.
10_1101-2021_01_05_425508	23	1	Phylogenetic	phylogenetic	JJ
10_1101-2021_01_05_425508	23	2	methods	method	NNS
10_1101-2021_01_05_425508	23	3	based	base	VBN
10_1101-2021_01_05_425508	23	4	on	on	IN
10_1101-2021_01_05_425508	23	5	sequence	sequence	NN
10_1101-2021_01_05_425508	23	6	alignment	alignment	NN
10_1101-2021_01_05_425508	23	7	have	have	VBP
10_1101-2021_01_05_425508	23	8	been	be	VBN
10_1101-2021_01_05_425508	23	9	widely	widely	RB
10_1101-2021_01_05_425508	23	10	used	use	VBN
10_1101-2021_01_05_425508	23	11	in	in	IN
10_1101-2021_01_05_425508	23	12	56	56	CD
10_1101-2021_01_05_425508	23	13	molecular	molecular	JJ
10_1101-2021_01_05_425508	23	14	evolution	evolution	NN
10_1101-2021_01_05_425508	23	15	studies	study	NNS
10_1101-2021_01_05_425508	23	16	[	[	-LRB-
10_1101-2021_01_05_425508	23	17	7,8	7,8	CD
10_1101-2021_01_05_425508	23	18	]	]	-RRB-
10_1101-2021_01_05_425508	23	19	,	,	,
10_1101-2021_01_05_425508	23	20	and	and	CC
10_1101-2021_01_05_425508	23	21	these	these	DT
10_1101-2021_01_05_425508	23	22	methods	method	NNS
10_1101-2021_01_05_425508	23	23	are	be	VBP
10_1101-2021_01_05_425508	23	24	well	well	RB
10_1101-2021_01_05_425508	23	25	refined	refined	JJ
10_1101-2021_01_05_425508	23	26	and	and	CC
10_1101-2021_01_05_425508	23	27	essential	essential	JJ
10_1101-2021_01_05_425508	23	28	for	for	IN
10_1101-2021_01_05_425508	23	29	57	57	CD
10_1101-2021_01_05_425508	23	30	studying	study	VBG
10_1101-2021_01_05_425508	23	31	phylogenetic	phylogenetic	JJ
10_1101-2021_01_05_425508	23	32	relationships	relationship	NNS
10_1101-2021_01_05_425508	23	33	between	between	IN
10_1101-2021_01_05_425508	23	34	different	different	JJ
10_1101-2021_01_05_425508	23	35	viral	viral	JJ
10_1101-2021_01_05_425508	23	36	species	specie	NNS
10_1101-2021_01_05_425508	23	37	and	and	CC
10_1101-2021_01_05_425508	23	38	variations	variation	NNS
10_1101-2021_01_05_425508	23	39	in	in	IN
10_1101-2021_01_05_425508	23	40	the	the	DT
10_1101-2021_01_05_425508	23	41	58	58	CD
10_1101-2021_01_05_425508	23	42	same	same	JJ
10_1101-2021_01_05_425508	23	43	viral	viral	JJ
10_1101-2021_01_05_425508	23	44	species	specie	NNS
10_1101-2021_01_05_425508	23	45	at	at	IN
10_1101-2021_01_05_425508	23	46	the	the	DT
10_1101-2021_01_05_425508	23	47	single	single	JJ
10_1101-2021_01_05_425508	23	48	-	-	HYPH
10_1101-2021_01_05_425508	23	49	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	23	50	level	level	NN
10_1101-2021_01_05_425508	23	51	.	.	.
10_1101-2021_01_05_425508	24	1	However	however	RB
10_1101-2021_01_05_425508	24	2	,	,	,
10_1101-2021_01_05_425508	24	3	when	when	WRB
10_1101-2021_01_05_425508	24	4	dealing	deal	VBG
10_1101-2021_01_05_425508	24	5	with	with	IN
10_1101-2021_01_05_425508	24	6	a	a	DT
10_1101-2021_01_05_425508	24	7	massive	massive	JJ
10_1101-2021_01_05_425508	24	8	59	59	CD
10_1101-2021_01_05_425508	24	9	number	number	NN
10_1101-2021_01_05_425508	24	10	of	of	IN
10_1101-2021_01_05_425508	24	11	genome	genome	JJ
10_1101-2021_01_05_425508	24	12	sequences	sequence	NNS
10_1101-2021_01_05_425508	24	13	,	,	,
10_1101-2021_01_05_425508	24	14	methods	method	NNS
10_1101-2021_01_05_425508	24	15	based	base	VBN
10_1101-2021_01_05_425508	24	16	on	on	IN
10_1101-2021_01_05_425508	24	17	sequence	sequence	NN
10_1101-2021_01_05_425508	24	18	alignment	alignment	NN
10_1101-2021_01_05_425508	24	19	become	become	VBN
10_1101-2021_01_05_425508	24	20	60	60	CD
10_1101-2021_01_05_425508	24	21	problematic	problematic	JJ
10_1101-2021_01_05_425508	24	22	because	because	IN
10_1101-2021_01_05_425508	24	23	they	-PRON-	PRP
10_1101-2021_01_05_425508	24	24	require	require	VBP
10_1101-2021_01_05_425508	24	25	a	a	DT
10_1101-2021_01_05_425508	24	26	large	large	JJ
10_1101-2021_01_05_425508	24	27	amount	amount	NN
10_1101-2021_01_05_425508	24	28	of	of	IN
10_1101-2021_01_05_425508	24	29	computational	computational	JJ
10_1101-2021_01_05_425508	24	30	resources	resource	NNS
10_1101-2021_01_05_425508	24	31	.	.	.
10_1101-2021_01_05_425508	25	1	61	61	CD
10_1101-2021_01_05_425508	25	2	We	-PRON-	PRP
10_1101-2021_01_05_425508	25	3	have	have	VBP
10_1101-2021_01_05_425508	25	4	continued	continue	VBN
10_1101-2021_01_05_425508	25	5	to	to	TO
10_1101-2021_01_05_425508	25	6	develop	develop	VB
10_1101-2021_01_05_425508	25	7	sequence	sequence	NN
10_1101-2021_01_05_425508	25	8	alignment	alignment	NN
10_1101-2021_01_05_425508	25	9	-	-	HYPH
10_1101-2021_01_05_425508	25	10	free	free	JJ
10_1101-2021_01_05_425508	25	11	methods	method	NNS
10_1101-2021_01_05_425508	25	12	focused	focus	VBN
10_1101-2021_01_05_425508	25	13	on	on	IN
10_1101-2021_01_05_425508	25	14	62	62	CD
10_1101-2021_01_05_425508	25	15	the	the	DT
10_1101-2021_01_05_425508	25	16	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	25	17	compositions	composition	NNS
10_1101-2021_01_05_425508	25	18	of	of	IN
10_1101-2021_01_05_425508	25	19	genome	genome	JJ
10_1101-2021_01_05_425508	25	20	sequences	sequence	NNS
10_1101-2021_01_05_425508	25	21	[	[	-LRB-
10_1101-2021_01_05_425508	25	22	9	9	CD
10_1101-2021_01_05_425508	25	23	-	-	SYM
10_1101-2021_01_05_425508	25	24	12	12	CD
10_1101-2021_01_05_425508	25	25	]	]	-RRB-
10_1101-2021_01_05_425508	25	26	.	.	.
10_1101-2021_01_05_425508	26	1	Notably	notably	RB
10_1101-2021_01_05_425508	26	2	,	,	,
10_1101-2021_01_05_425508	26	3	oligonucleotide	oligonucleotide	RB
10_1101-2021_01_05_425508	26	4	63	63	CD
10_1101-2021_01_05_425508	26	5	composition	composition	NN
10_1101-2021_01_05_425508	26	6	varies	vary	VBZ
10_1101-2021_01_05_425508	26	7	widely	widely	RB
10_1101-2021_01_05_425508	26	8	among	among	IN
10_1101-2021_01_05_425508	26	9	species	specie	NNS
10_1101-2021_01_05_425508	26	10	,	,	,
10_1101-2021_01_05_425508	26	11	including	include	VBG
10_1101-2021_01_05_425508	26	12	viruses	virus	NNS
10_1101-2021_01_05_425508	26	13	,	,	,
10_1101-2021_01_05_425508	26	14	and	and	CC
10_1101-2021_01_05_425508	26	15	is	be	VBZ
10_1101-2021_01_05_425508	26	16	designated	designate	VBN
10_1101-2021_01_05_425508	26	17	as	as	IN
10_1101-2021_01_05_425508	26	18	64	64	CD
10_1101-2021_01_05_425508	26	19	genome	genome	NN
10_1101-2021_01_05_425508	26	20	signatures	signature	NNS
10_1101-2021_01_05_425508	26	21	[	[	-LRB-
10_1101-2021_01_05_425508	26	22	13	13	CD
10_1101-2021_01_05_425508	26	23	]	]	-RRB-
10_1101-2021_01_05_425508	26	24	.	.	.
10_1101-2021_01_05_425508	27	1	These	these	DT
10_1101-2021_01_05_425508	27	2	compositions	composition	NNS
10_1101-2021_01_05_425508	27	3	can	can	MD
10_1101-2021_01_05_425508	27	4	be	be	VB
10_1101-2021_01_05_425508	27	5	treated	treat	VBN
10_1101-2021_01_05_425508	27	6	as	as	IN
10_1101-2021_01_05_425508	27	7	numerical	numerical	JJ
10_1101-2021_01_05_425508	27	8	data	datum	NNS
10_1101-2021_01_05_425508	27	9	,	,	,
10_1101-2021_01_05_425508	27	10	and	and	CC
10_1101-2021_01_05_425508	27	11	a	a	DT
10_1101-2021_01_05_425508	27	12	65	65	CD
10_1101-2021_01_05_425508	27	13	massive	massive	JJ
10_1101-2021_01_05_425508	27	14	amount	amount	NN
10_1101-2021_01_05_425508	27	15	of	of	IN
10_1101-2021_01_05_425508	27	16	sequence	sequence	NN
10_1101-2021_01_05_425508	27	17	data	datum	NNS
10_1101-2021_01_05_425508	27	18	can	can	MD
10_1101-2021_01_05_425508	27	19	easily	easily	RB
10_1101-2021_01_05_425508	27	20	be	be	VB
10_1101-2021_01_05_425508	27	21	subjected	subject	VBN
10_1101-2021_01_05_425508	27	22	to	to	IN
10_1101-2021_01_05_425508	27	23	various	various	JJ
10_1101-2021_01_05_425508	27	24	statistical	statistical	JJ
10_1101-2021_01_05_425508	27	25	analyses	analysis	NNS
10_1101-2021_01_05_425508	27	26	.	.	.
10_1101-2021_01_05_425508	28	1	66	66	CD
10_1101-2021_01_05_425508	28	2	Furthermore	furthermore	RB
10_1101-2021_01_05_425508	28	3	,	,	,
10_1101-2021_01_05_425508	28	4	even	even	RB
10_1101-2021_01_05_425508	28	5	genomic	genomic	JJ
10_1101-2021_01_05_425508	28	6	fragments	fragment	NNS
10_1101-2021_01_05_425508	28	7	without	without	IN
10_1101-2021_01_05_425508	28	8	orthologous	orthologous	JJ
10_1101-2021_01_05_425508	28	9	and/or	and/or	CC
10_1101-2021_01_05_425508	28	10	paralogous	paralogous	JJ
10_1101-2021_01_05_425508	28	11	pairs	pair	NNS
10_1101-2021_01_05_425508	28	12	can	can	MD
10_1101-2021_01_05_425508	28	13	67	67	CD
10_1101-2021_01_05_425508	28	14	be	be	VB
10_1101-2021_01_05_425508	28	15	compared	compare	VBN
10_1101-2021_01_05_425508	28	16	[	[	-LRB-
10_1101-2021_01_05_425508	28	17	11,12,14	11,12,14	CD
10_1101-2021_01_05_425508	28	18	-	-	SYM
10_1101-2021_01_05_425508	28	19	17	17	CD
10_1101-2021_01_05_425508	28	20	]	]	-RRB-
10_1101-2021_01_05_425508	28	21	.	.	.
10_1101-2021_01_05_425508	29	1	Specifically	specifically	RB
10_1101-2021_01_05_425508	29	2	,	,	,
10_1101-2021_01_05_425508	29	3	our	-PRON-	PRP$
10_1101-2021_01_05_425508	29	4	previous	previous	JJ
10_1101-2021_01_05_425508	29	5	work	work	NN
10_1101-2021_01_05_425508	29	6	on	on	IN
10_1101-2021_01_05_425508	29	7	influenza	influenza	FW
10_1101-2021_01_05_425508	29	8	A	a	NN
10_1101-2021_01_05_425508	29	9	-	-	HYPH
10_1101-2021_01_05_425508	29	10	type	type	NN
10_1101-2021_01_05_425508	29	11	virus	virus	NN
10_1101-2021_01_05_425508	29	12	68	68	CD
10_1101-2021_01_05_425508	29	13	genomes	genome	NNS
10_1101-2021_01_05_425508	29	14	found	find	VBD
10_1101-2021_01_05_425508	29	15	that	that	IN
10_1101-2021_01_05_425508	29	16	the	the	DT
10_1101-2021_01_05_425508	29	17	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	29	18	compositions	composition	NNS
10_1101-2021_01_05_425508	29	19	of	of	IN
10_1101-2021_01_05_425508	29	20	the	the	DT
10_1101-2021_01_05_425508	29	21	viral	viral	JJ
10_1101-2021_01_05_425508	29	22	genomes	genome	NNS
10_1101-2021_01_05_425508	29	23	differed	differ	VBD
10_1101-2021_01_05_425508	29	24	69	69	CD
10_1101-2021_01_05_425508	29	25	between	between	IN
10_1101-2021_01_05_425508	29	26	hosts	host	NNS
10_1101-2021_01_05_425508	29	27	(	(	-LRB-
10_1101-2021_01_05_425508	29	28	e.g.	e.g.	RB
10_1101-2021_01_05_425508	29	29	,	,	,
10_1101-2021_01_05_425508	29	30	humans	human	NNS
10_1101-2021_01_05_425508	29	31	and	and	CC
10_1101-2021_01_05_425508	29	32	birds	bird	NNS
10_1101-2021_01_05_425508	29	33	)	)	-RRB-
10_1101-2021_01_05_425508	29	34	,	,	,
10_1101-2021_01_05_425508	29	35	even	even	RB
10_1101-2021_01_05_425508	29	36	for	for	IN
10_1101-2021_01_05_425508	29	37	viruses	virus	NNS
10_1101-2021_01_05_425508	29	38	within	within	IN
10_1101-2021_01_05_425508	29	39	the	the	DT
10_1101-2021_01_05_425508	29	40	same	same	JJ
10_1101-2021_01_05_425508	29	41	subtype	subtype	NN
10_1101-2021_01_05_425508	29	42	(	(	-LRB-
10_1101-2021_01_05_425508	29	43	e.g.	e.g.	RB
10_1101-2021_01_05_425508	29	44	,	,	,
10_1101-2021_01_05_425508	29	45	70	70	CD
10_1101-2021_01_05_425508	29	46	H1N1	H1N1	NNP
10_1101-2021_01_05_425508	29	47	and	and	CC
10_1101-2021_01_05_425508	29	48	H3N2	H3N2	NNP
10_1101-2021_01_05_425508	29	49	of	of	IN
10_1101-2021_01_05_425508	29	50	type	type	NN
10_1101-2021_01_05_425508	29	51	A	a	NN
10_1101-2021_01_05_425508	29	52	)	)	-RRB-
10_1101-2021_01_05_425508	29	53	[	[	-LRB-
10_1101-2021_01_05_425508	29	54	11,12,14	11,12,14	CD
10_1101-2021_01_05_425508	29	55	]	]	-RRB-
10_1101-2021_01_05_425508	29	56	;	;	:
10_1101-2021_01_05_425508	29	57	we	-PRON-	PRP
10_1101-2021_01_05_425508	29	58	also	also	RB
10_1101-2021_01_05_425508	29	59	examined	examine	VBD
10_1101-2021_01_05_425508	29	60	changes	change	NNS
10_1101-2021_01_05_425508	29	61	in	in	IN
10_1101-2021_01_05_425508	29	62	the	the	DT
10_1101-2021_01_05_425508	29	63	71	71	CD
10_1101-2021_01_05_425508	29	64	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	29	65	compositions	composition	NNS
10_1101-2021_01_05_425508	29	66	of	of	IN
10_1101-2021_01_05_425508	29	67	influenza	influenza	NNP
10_1101-2021_01_05_425508	29	68	H1N1/09	H1N1/09	NNP
10_1101-2021_01_05_425508	29	69	,	,	,
10_1101-2021_01_05_425508	29	70	which	which	WDT
10_1101-2021_01_05_425508	29	71	have	have	VBP
10_1101-2021_01_05_425508	29	72	been	be	VBN
10_1101-2021_01_05_425508	29	73	epidemic	epidemic	NN
10_1101-2021_01_05_425508	29	74	in	in	IN
10_1101-2021_01_05_425508	29	75	72	72	CD
10_1101-2021_01_05_425508	29	76	humans	human	NNS
10_1101-2021_01_05_425508	29	77	beginning	begin	VBG
10_1101-2021_01_05_425508	29	78	in	in	IN
10_1101-2021_01_05_425508	29	79	2009	2009	CD
10_1101-2021_01_05_425508	29	80	,	,	,
10_1101-2021_01_05_425508	29	81	and	and	CC
10_1101-2021_01_05_425508	29	82	found	find	VBD
10_1101-2021_01_05_425508	29	83	that	that	IN
10_1101-2021_01_05_425508	29	84	their	-PRON-	PRP$
10_1101-2021_01_05_425508	29	85	compositions	composition	NNS
10_1101-2021_01_05_425508	29	86	changed	change	VBN
10_1101-2021_01_05_425508	29	87	to	to	TO
10_1101-2021_01_05_425508	29	88	approach	approach	VB
10_1101-2021_01_05_425508	29	89	73	73	CD
10_1101-2021_01_05_425508	29	90	those	those	DT
10_1101-2021_01_05_425508	29	91	of	of	IN
10_1101-2021_01_05_425508	29	92	the	the	DT
10_1101-2021_01_05_425508	29	93	seasonal	seasonal	JJ
10_1101-2021_01_05_425508	29	94	flu	flu	NN
10_1101-2021_01_05_425508	29	95	strains	strain	VBZ
10_1101-2021_01_05_425508	29	96	H1N1	H1N1	NNP
10_1101-2021_01_05_425508	29	97	and	and	CC
10_1101-2021_01_05_425508	29	98	H3N2	H3N2	NNP
10_1101-2021_01_05_425508	29	99	[	[	-LRB-
10_1101-2021_01_05_425508	29	100	11	11	CD
10_1101-2021_01_05_425508	29	101	]	]	-RRB-
10_1101-2021_01_05_425508	29	102	.	.	.
10_1101-2021_01_05_425508	30	1	Furthermore	furthermore	RB
10_1101-2021_01_05_425508	30	2	,	,	,
10_1101-2021_01_05_425508	30	3	although	although	IN
10_1101-2021_01_05_425508	30	4	epidemics	epidemic	NNS
10_1101-2021_01_05_425508	30	5	74	74	CD
10_1101-2021_01_05_425508	30	6	of	of	IN
10_1101-2021_01_05_425508	30	7	the	the	DT
10_1101-2021_01_05_425508	30	8	H1N1	H1N1	NNP
10_1101-2021_01_05_425508	30	9	and	and	CC
10_1101-2021_01_05_425508	30	10	H3N2	H3N2	NNP
10_1101-2021_01_05_425508	30	11	strains	strain	NNS
10_1101-2021_01_05_425508	30	12	began	begin	VBD
10_1101-2021_01_05_425508	30	13	several	several	JJ
10_1101-2021_01_05_425508	30	14	decades	decade	NNS
10_1101-2021_01_05_425508	30	15	apart	apart	RB
10_1101-2021_01_05_425508	30	16	,	,	,
10_1101-2021_01_05_425508	30	17	these	these	DT
10_1101-2021_01_05_425508	30	18	strains	strain	NNS
10_1101-2021_01_05_425508	30	19	showed	show	VBD
10_1101-2021_01_05_425508	30	20	highly	highly	RB
10_1101-2021_01_05_425508	30	21	75	75	CD
10_1101-2021_01_05_425508	30	22	similar	similar	JJ
10_1101-2021_01_05_425508	30	23	chronological	chronological	JJ
10_1101-2021_01_05_425508	30	24	changes	change	NNS
10_1101-2021_01_05_425508	30	25	from	from	IN
10_1101-2021_01_05_425508	30	26	the	the	DT
10_1101-2021_01_05_425508	30	27	start	start	NN
10_1101-2021_01_05_425508	30	28	of	of	IN
10_1101-2021_01_05_425508	30	29	these	these	DT
10_1101-2021_01_05_425508	30	30	epidemics	epidemic	NNS
10_1101-2021_01_05_425508	30	31	.	.	.
10_1101-2021_01_05_425508	31	1	These	these	DT
10_1101-2021_01_05_425508	31	2	evolutionary	evolutionary	JJ
10_1101-2021_01_05_425508	31	3	yet	yet	RB
10_1101-2021_01_05_425508	31	4	76	76	CD
10_1101-2021_01_05_425508	31	5	reproducible	reproducible	NN
10_1101-2021_01_05_425508	31	6	changes	change	NNS
10_1101-2021_01_05_425508	31	7	suggest	suggest	VBP
10_1101-2021_01_05_425508	31	8	that	that	IN
10_1101-2021_01_05_425508	31	9	mutations	mutation	NNS
10_1101-2021_01_05_425508	31	10	to	to	TO
10_1101-2021_01_05_425508	31	11	adapt	adapt	VB
10_1101-2021_01_05_425508	31	12	to	to	IN
10_1101-2021_01_05_425508	31	13	a	a	DT
10_1101-2021_01_05_425508	31	14	new	new	JJ
10_1101-2021_01_05_425508	31	15	host	host	NN
10_1101-2021_01_05_425508	31	16	environment	environment	NN
10_1101-2021_01_05_425508	31	17	77	77	CD
10_1101-2021_01_05_425508	31	18	inevitably	inevitably	RB
10_1101-2021_01_05_425508	31	19	accumulate	accumulate	VBP
10_1101-2021_01_05_425508	31	20	when	when	WRB
10_1101-2021_01_05_425508	31	21	the	the	DT
10_1101-2021_01_05_425508	31	22	host	host	NN
10_1101-2021_01_05_425508	31	23	species	specie	NNS
10_1101-2021_01_05_425508	31	24	of	of	IN
10_1101-2021_01_05_425508	31	25	a	a	DT
10_1101-2021_01_05_425508	31	26	virus	virus	NN
10_1101-2021_01_05_425508	31	27	changes	change	NNS
10_1101-2021_01_05_425508	31	28	,	,	,
10_1101-2021_01_05_425508	31	29	and	and	CC
10_1101-2021_01_05_425508	31	30	these	these	DT
10_1101-2021_01_05_425508	31	31	changes	change	NNS
10_1101-2021_01_05_425508	31	32	can	can	MD
10_1101-2021_01_05_425508	31	33	78	78	CD
10_1101-2021_01_05_425508	31	34	be	be	VB
10_1101-2021_01_05_425508	31	35	efficiently	efficiently	RB
10_1101-2021_01_05_425508	31	36	detected	detect	VBN
10_1101-2021_01_05_425508	31	37	by	by	IN
10_1101-2021_01_05_425508	31	38	analyzing	analyze	VBG
10_1101-2021_01_05_425508	31	39	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	31	40	compositions	composition	NNS
10_1101-2021_01_05_425508	31	41	.	.	.
10_1101-2021_01_05_425508	32	1	79	79	CD
10_1101-2021_01_05_425508	32	2	.CC	.CC	:
10_1101-2021_01_05_425508	32	3	-	-	HYPH
10_1101-2021_01_05_425508	32	4	BY	BY	NNP
10_1101-2021_01_05_425508	32	5	-	-	HYPH
10_1101-2021_01_05_425508	32	6	NC	NC	NNP
10_1101-2021_01_05_425508	32	7	4.0	4.0	CD
10_1101-2021_01_05_425508	32	8	International	international	JJ
10_1101-2021_01_05_425508	32	9	licensemade	licensemade	NN
10_1101-2021_01_05_425508	32	10	available	available	JJ
10_1101-2021_01_05_425508	32	11	under	under	IN
10_1101-2021_01_05_425508	32	12	a	a	DT
10_1101-2021_01_05_425508	32	13	(	(	-LRB-
10_1101-2021_01_05_425508	32	14	which	which	WDT
10_1101-2021_01_05_425508	32	15	was	be	VBD
10_1101-2021_01_05_425508	32	16	not	not	RB
10_1101-2021_01_05_425508	32	17	certified	certify	VBN
10_1101-2021_01_05_425508	32	18	by	by	IN
10_1101-2021_01_05_425508	32	19	peer	peer	NN
10_1101-2021_01_05_425508	32	20	review	review	NN
10_1101-2021_01_05_425508	32	21	)	)	-RRB-
10_1101-2021_01_05_425508	32	22	is	be	VBZ
10_1101-2021_01_05_425508	32	23	the	the	DT
10_1101-2021_01_05_425508	32	24	author	author	NN
10_1101-2021_01_05_425508	32	25	/	/	SYM
10_1101-2021_01_05_425508	32	26	funder	funder	NN
10_1101-2021_01_05_425508	32	27	,	,	,
10_1101-2021_01_05_425508	32	28	who	who	WP
10_1101-2021_01_05_425508	32	29	has	have	VBZ
10_1101-2021_01_05_425508	32	30	granted	grant	VBN
10_1101-2021_01_05_425508	32	31	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	32	32	a	a	DT
10_1101-2021_01_05_425508	32	33	license	license	NN
10_1101-2021_01_05_425508	32	34	to	to	TO
10_1101-2021_01_05_425508	32	35	display	display	VB
10_1101-2021_01_05_425508	32	36	the	the	DT
10_1101-2021_01_05_425508	32	37	preprint	preprint	NN
10_1101-2021_01_05_425508	32	38	in	in	IN
10_1101-2021_01_05_425508	32	39	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	32	40	.	.	.
10_1101-2021_01_05_425508	33	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	33	2	is	be	VBZ
10_1101-2021_01_05_425508	33	3	The	the	DT
10_1101-2021_01_05_425508	33	4	copyright	copyright	NN
10_1101-2021_01_05_425508	33	5	holder	holder	NN
10_1101-2021_01_05_425508	33	6	for	for	IN
10_1101-2021_01_05_425508	33	7	this	this	DT
10_1101-2021_01_05_425508	33	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	33	9	version	version	NN
10_1101-2021_01_05_425508	33	10	posted	post	VBD
10_1101-2021_01_05_425508	33	11	January	January	NNP
10_1101-2021_01_05_425508	33	12	6	6	CD
10_1101-2021_01_05_425508	33	13	,	,	,
10_1101-2021_01_05_425508	33	14	2021	2021	CD
10_1101-2021_01_05_425508	33	15	.	.	.
10_1101-2021_01_05_425508	33	16	;	;	:
10_1101-2021_01_05_425508	33	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	33	18	:	:	:
10_1101-2021_01_05_425508	33	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	33	20	preprint	preprint	NN
10_1101-2021_01_05_425508	33	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	POS
10_1101-2021_01_05_425508	33	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NN
10_1101-2021_01_05_425508	33	23	4	4	CD
10_1101-2021_01_05_425508	33	24	Several	several	JJ
10_1101-2021_01_05_425508	33	25	groups	group	NNS
10_1101-2021_01_05_425508	33	26	,	,	,
10_1101-2021_01_05_425508	33	27	including	include	VBG
10_1101-2021_01_05_425508	33	28	ours	our	NNS
10_1101-2021_01_05_425508	33	29	,	,	,
10_1101-2021_01_05_425508	33	30	have	have	VBP
10_1101-2021_01_05_425508	33	31	examined	examine	VBN
10_1101-2021_01_05_425508	33	32	changes	change	NNS
10_1101-2021_01_05_425508	33	33	in	in	IN
10_1101-2021_01_05_425508	33	34	SARS	SARS	NNP
10_1101-2021_01_05_425508	33	35	-	-	HYPH
10_1101-2021_01_05_425508	33	36	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	33	37	80	80	CD
10_1101-2021_01_05_425508	33	38	genomes	genome	NNS
10_1101-2021_01_05_425508	33	39	during	during	IN
10_1101-2021_01_05_425508	33	40	the	the	DT
10_1101-2021_01_05_425508	33	41	early	early	JJ
10_1101-2021_01_05_425508	33	42	stages	stage	NNS
10_1101-2021_01_05_425508	33	43	of	of	IN
10_1101-2021_01_05_425508	33	44	the	the	DT
10_1101-2021_01_05_425508	33	45	SARS	SARS	NNP
10_1101-2021_01_05_425508	33	46	-	-	HYPH
10_1101-2021_01_05_425508	33	47	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	33	48	epidemic	epidemic	NN
10_1101-2021_01_05_425508	33	49	and	and	CC
10_1101-2021_01_05_425508	33	50	found	find	VBD
10_1101-2021_01_05_425508	33	51	clear	clear	JJ
10_1101-2021_01_05_425508	33	52	81	81	CD
10_1101-2021_01_05_425508	33	53	directional	directional	JJ
10_1101-2021_01_05_425508	33	54	changes	change	NNS
10_1101-2021_01_05_425508	33	55	in	in	IN
10_1101-2021_01_05_425508	33	56	a	a	DT
10_1101-2021_01_05_425508	33	57	group	group	NN
10_1101-2021_01_05_425508	33	58	of	of	IN
10_1101-2021_01_05_425508	33	59	mono-	mono-	NN
10_1101-2021_01_05_425508	33	60	and	and	CC
10_1101-2021_01_05_425508	33	61	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	33	62	detectable	detectable	JJ
10_1101-2021_01_05_425508	33	63	on	on	IN
10_1101-2021_01_05_425508	33	64	even	even	RB
10_1101-2021_01_05_425508	33	65	a	a	DT
10_1101-2021_01_05_425508	33	66	82	82	CD
10_1101-2021_01_05_425508	33	67	monthly	monthly	JJ
10_1101-2021_01_05_425508	33	68	basis	basis	NN
10_1101-2021_01_05_425508	33	69	[	[	-LRB-
10_1101-2021_01_05_425508	33	70	15,18,19	15,18,19	CD
10_1101-2021_01_05_425508	33	71	]	]	-RRB-
10_1101-2021_01_05_425508	33	72	.	.	.
10_1101-2021_01_05_425508	34	1	These	these	DT
10_1101-2021_01_05_425508	34	2	directional	directional	JJ
10_1101-2021_01_05_425508	34	3	changes	change	NNS
10_1101-2021_01_05_425508	34	4	will	will	MD
10_1101-2021_01_05_425508	34	5	allow	allow	VB
10_1101-2021_01_05_425508	34	6	us	-PRON-	PRP
10_1101-2021_01_05_425508	34	7	to	to	TO
10_1101-2021_01_05_425508	34	8	predict	predict	VB
10_1101-2021_01_05_425508	34	9	changes	change	NNS
10_1101-2021_01_05_425508	34	10	in	in	IN
10_1101-2021_01_05_425508	34	11	83	83	CD
10_1101-2021_01_05_425508	34	12	the	the	DT
10_1101-2021_01_05_425508	34	13	near	near	JJ
10_1101-2021_01_05_425508	34	14	future	future	NN
10_1101-2021_01_05_425508	34	15	.	.	.
10_1101-2021_01_05_425508	35	1	Notably	notably	RB
10_1101-2021_01_05_425508	35	2	,	,	,
10_1101-2021_01_05_425508	35	3	near	near	JJ
10_1101-2021_01_05_425508	35	4	-	-	HYPH
10_1101-2021_01_05_425508	35	5	future	future	NN
10_1101-2021_01_05_425508	35	6	prediction	prediction	NN
10_1101-2021_01_05_425508	35	7	and	and	CC
10_1101-2021_01_05_425508	35	8	verification	verification	NN
10_1101-2021_01_05_425508	35	9	should	should	MD
10_1101-2021_01_05_425508	35	10	be	be	VB
10_1101-2021_01_05_425508	35	11	the	the	DT
10_1101-2021_01_05_425508	35	12	most	most	RBS
10_1101-2021_01_05_425508	35	13	84	84	CD
10_1101-2021_01_05_425508	35	14	direct	direct	JJ
10_1101-2021_01_05_425508	35	15	ways	way	NNS
10_1101-2021_01_05_425508	35	16	to	to	TO
10_1101-2021_01_05_425508	35	17	test	test	VB
10_1101-2021_01_05_425508	35	18	the	the	DT
10_1101-2021_01_05_425508	35	19	reliability	reliability	NN
10_1101-2021_01_05_425508	35	20	of	of	IN
10_1101-2021_01_05_425508	35	21	the	the	DT
10_1101-2021_01_05_425508	35	22	obtained	obtain	VBN
10_1101-2021_01_05_425508	35	23	results	result	NNS
10_1101-2021_01_05_425508	35	24	,	,	,
10_1101-2021_01_05_425508	35	25	models	model	NNS
10_1101-2021_01_05_425508	35	26	and	and	CC
10_1101-2021_01_05_425508	35	27	ideas	idea	NNS
10_1101-2021_01_05_425508	35	28	(	(	-LRB-
10_1101-2021_01_05_425508	35	29	e.g.	e.g.	RB
10_1101-2021_01_05_425508	35	30	,	,	,
10_1101-2021_01_05_425508	35	31	those	those	DT
10_1101-2021_01_05_425508	35	32	85	85	CD
10_1101-2021_01_05_425508	35	33	discovered	discover	VBD
10_1101-2021_01_05_425508	35	34	for	for	IN
10_1101-2021_01_05_425508	35	35	influenza	influenza	NN
10_1101-2021_01_05_425508	35	36	viruses	virus	NNS
10_1101-2021_01_05_425508	35	37	)	)	-RRB-
10_1101-2021_01_05_425508	35	38	,	,	,
10_1101-2021_01_05_425508	35	39	providing	provide	VBG
10_1101-2021_01_05_425508	35	40	a	a	DT
10_1101-2021_01_05_425508	35	41	new	new	JJ
10_1101-2021_01_05_425508	35	42	paradigm	paradigm	NN
10_1101-2021_01_05_425508	35	43	for	for	IN
10_1101-2021_01_05_425508	35	44	molecular	molecular	JJ
10_1101-2021_01_05_425508	35	45	evolutionary	evolutionary	JJ
10_1101-2021_01_05_425508	35	46	86	86	CD
10_1101-2021_01_05_425508	35	47	studies	study	NNS
10_1101-2021_01_05_425508	35	48	.	.	.
10_1101-2021_01_05_425508	36	1	In	in	IN
10_1101-2021_01_05_425508	36	2	this	this	DT
10_1101-2021_01_05_425508	36	3	context	context	NN
10_1101-2021_01_05_425508	36	4	,	,	,
10_1101-2021_01_05_425508	36	5	the	the	DT
10_1101-2021_01_05_425508	36	6	present	present	JJ
10_1101-2021_01_05_425508	36	7	study	study	NN
10_1101-2021_01_05_425508	36	8	analyzed	analyze	VBD
10_1101-2021_01_05_425508	36	9	the	the	DT
10_1101-2021_01_05_425508	36	10	genome	genome	JJ
10_1101-2021_01_05_425508	36	11	sequences	sequence	NNS
10_1101-2021_01_05_425508	36	12	of	of	IN
10_1101-2021_01_05_425508	36	13	over	over	IN
10_1101-2021_01_05_425508	36	14	87	87	CD
10_1101-2021_01_05_425508	36	15	seventy	seventy	CD
10_1101-2021_01_05_425508	36	16	thousand	thousand	CD
10_1101-2021_01_05_425508	36	17	SARS	SARS	NNP
10_1101-2021_01_05_425508	36	18	-	-	HYPH
10_1101-2021_01_05_425508	36	19	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	36	20	strains	strain	NNS
10_1101-2021_01_05_425508	36	21	isolated	isolate	VBN
10_1101-2021_01_05_425508	36	22	from	from	IN
10_1101-2021_01_05_425508	36	23	December	December	NNP
10_1101-2021_01_05_425508	36	24	2019	2019	CD
10_1101-2021_01_05_425508	36	25	to	to	IN
10_1101-2021_01_05_425508	36	26	September	September	NNP
10_1101-2021_01_05_425508	36	27	88	88	CD
10_1101-2021_01_05_425508	36	28	2020	2020	CD
10_1101-2021_01_05_425508	36	29	.	.	.
10_1101-2021_01_05_425508	37	1	89	89	CD
10_1101-2021_01_05_425508	37	2	90	90	CD
10_1101-2021_01_05_425508	37	3	91	91	CD
10_1101-2021_01_05_425508	37	4	Results	result	NNS
10_1101-2021_01_05_425508	37	5	92	92	CD
10_1101-2021_01_05_425508	37	6	Directional	directional	JJ
10_1101-2021_01_05_425508	37	7	changes	change	NNS
10_1101-2021_01_05_425508	37	8	in	in	IN
10_1101-2021_01_05_425508	37	9	the	the	DT
10_1101-2021_01_05_425508	37	10	mononucleotide	mononucleotide	NN
10_1101-2021_01_05_425508	37	11	compositions	composition	NNS
10_1101-2021_01_05_425508	37	12	(	(	-LRB-
10_1101-2021_01_05_425508	37	13	%	%	NN
10_1101-2021_01_05_425508	37	14	)	)	-RRB-
10_1101-2021_01_05_425508	37	15	of	of	IN
10_1101-2021_01_05_425508	37	16	SARS	SARS	NNP
10_1101-2021_01_05_425508	37	17	-	-	HYPH
10_1101-2021_01_05_425508	37	18	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	37	19	93	93	CD
10_1101-2021_01_05_425508	37	20	For	for	IN
10_1101-2021_01_05_425508	37	21	fast	fast	RB
10_1101-2021_01_05_425508	37	22	-	-	HYPH
10_1101-2021_01_05_425508	37	23	evolving	evolve	VBG
10_1101-2021_01_05_425508	37	24	RNA	RNA	NNP
10_1101-2021_01_05_425508	37	25	viruses	virus	NNS
10_1101-2021_01_05_425508	37	26	,	,	,
10_1101-2021_01_05_425508	37	27	diversity	diversity	NN
10_1101-2021_01_05_425508	37	28	within	within	IN
10_1101-2021_01_05_425508	37	29	the	the	DT
10_1101-2021_01_05_425508	37	30	viral	viral	JJ
10_1101-2021_01_05_425508	37	31	population	population	NN
10_1101-2021_01_05_425508	37	32	arises	arise	VBZ
10_1101-2021_01_05_425508	37	33	rapidly	rapidly	RB
10_1101-2021_01_05_425508	37	34	as	as	IN
10_1101-2021_01_05_425508	37	35	94	94	CD
10_1101-2021_01_05_425508	37	36	the	the	DT
10_1101-2021_01_05_425508	37	37	epidemic	epidemic	NN
10_1101-2021_01_05_425508	37	38	progresses	progress	NNS
10_1101-2021_01_05_425508	37	39	and	and	CC
10_1101-2021_01_05_425508	37	40	subpopulation	subpopulation	NN
10_1101-2021_01_05_425508	37	41	structure	structure	NN
10_1101-2021_01_05_425508	37	42	forms	form	NNS
10_1101-2021_01_05_425508	37	43	;	;	:
10_1101-2021_01_05_425508	37	44	the	the	DT
10_1101-2021_01_05_425508	37	45	GISAID	GISAID	NNP
10_1101-2021_01_05_425508	37	46	consortium	consortium	NN
10_1101-2021_01_05_425508	37	47	has	have	VBZ
10_1101-2021_01_05_425508	37	48	95	95	CD
10_1101-2021_01_05_425508	37	49	defined	define	VBN
10_1101-2021_01_05_425508	37	50	at	at	IN
10_1101-2021_01_05_425508	37	51	least	least	JJS
10_1101-2021_01_05_425508	37	52	seven	seven	CD
10_1101-2021_01_05_425508	37	53	main	main	JJ
10_1101-2021_01_05_425508	37	54	clades	clade	NNS
10_1101-2021_01_05_425508	37	55	(	(	-LRB-
10_1101-2021_01_05_425508	37	56	G	G	NNP
10_1101-2021_01_05_425508	37	57	,	,	,
10_1101-2021_01_05_425508	37	58	GH	GH	NNP
10_1101-2021_01_05_425508	37	59	,	,	,
10_1101-2021_01_05_425508	37	60	GR	GR	NNP
10_1101-2021_01_05_425508	37	61	,	,	,
10_1101-2021_01_05_425508	37	62	L	L	NNP
10_1101-2021_01_05_425508	37	63	,	,	,
10_1101-2021_01_05_425508	37	64	V	V	NNP
10_1101-2021_01_05_425508	37	65	,	,	,
10_1101-2021_01_05_425508	37	66	S	S	NNP
10_1101-2021_01_05_425508	37	67	and	and	CC
10_1101-2021_01_05_425508	37	68	Others	Others	NNPS
10_1101-2021_01_05_425508	37	69	)	)	-RRB-
10_1101-2021_01_05_425508	37	70	.	.	.
10_1101-2021_01_05_425508	38	1	Notably	notably	RB
10_1101-2021_01_05_425508	38	2	,	,	,
10_1101-2021_01_05_425508	38	3	the	the	DT
10_1101-2021_01_05_425508	38	4	96	96	CD
10_1101-2021_01_05_425508	38	5	elementary	elementary	JJ
10_1101-2021_01_05_425508	38	6	processes	process	NNS
10_1101-2021_01_05_425508	38	7	of	of	IN
10_1101-2021_01_05_425508	38	8	molecular	molecular	JJ
10_1101-2021_01_05_425508	38	9	evolution	evolution	NN
10_1101-2021_01_05_425508	38	10	are	be	VBP
10_1101-2021_01_05_425508	38	11	based	base	VBN
10_1101-2021_01_05_425508	38	12	on	on	IN
10_1101-2021_01_05_425508	38	13	random	random	JJ
10_1101-2021_01_05_425508	38	14	mutations	mutation	NNS
10_1101-2021_01_05_425508	38	15	,	,	,
10_1101-2021_01_05_425508	38	16	and	and	CC
10_1101-2021_01_05_425508	38	17	97	97	CD
10_1101-2021_01_05_425508	38	18	strains	strain	NNS
10_1101-2021_01_05_425508	38	19	belonging	belong	VBG
10_1101-2021_01_05_425508	38	20	to	to	IN
10_1101-2021_01_05_425508	38	21	different	different	JJ
10_1101-2021_01_05_425508	38	22	clades	clade	NNS
10_1101-2021_01_05_425508	38	23	are	be	VBP
10_1101-2021_01_05_425508	38	24	thought	think	VBN
10_1101-2021_01_05_425508	38	25	to	to	TO
10_1101-2021_01_05_425508	38	26	have	have	VB
10_1101-2021_01_05_425508	38	27	evolved	evolve	VBN
10_1101-2021_01_05_425508	38	28	independently	independently	RB
10_1101-2021_01_05_425508	38	29	.	.	.
10_1101-2021_01_05_425508	39	1	98	98	CD
10_1101-2021_01_05_425508	39	2	Therefore	therefore	RB
10_1101-2021_01_05_425508	39	3	,	,	,
10_1101-2021_01_05_425508	39	4	the	the	DT
10_1101-2021_01_05_425508	39	5	observation	observation	NN
10_1101-2021_01_05_425508	39	6	of	of	IN
10_1101-2021_01_05_425508	39	7	highly	highly	RB
10_1101-2021_01_05_425508	39	8	similar	similar	JJ
10_1101-2021_01_05_425508	39	9	time	time	NN
10_1101-2021_01_05_425508	39	10	-	-	HYPH
10_1101-2021_01_05_425508	39	11	dependent	dependent	JJ
10_1101-2021_01_05_425508	39	12	changes	change	NNS
10_1101-2021_01_05_425508	39	13	independent	independent	JJ
10_1101-2021_01_05_425508	39	14	of	of	IN
10_1101-2021_01_05_425508	39	15	99	99	CD
10_1101-2021_01_05_425508	39	16	clade	clade	NN
10_1101-2021_01_05_425508	39	17	has	have	VBZ
10_1101-2021_01_05_425508	39	18	certain	certain	JJ
10_1101-2021_01_05_425508	39	19	biological	biological	JJ
10_1101-2021_01_05_425508	39	20	meanings	meaning	NNS
10_1101-2021_01_05_425508	39	21	and	and	CC
10_1101-2021_01_05_425508	39	22	may	may	MD
10_1101-2021_01_05_425508	39	23	be	be	VB
10_1101-2021_01_05_425508	39	24	inevitable	inevitable	JJ
10_1101-2021_01_05_425508	39	25	for	for	IN
10_1101-2021_01_05_425508	39	26	efficient	efficient	JJ
10_1101-2021_01_05_425508	39	27	growth	growth	NN
10_1101-2021_01_05_425508	39	28	in	in	IN
10_1101-2021_01_05_425508	39	29	100	100	CD
10_1101-2021_01_05_425508	39	30	human	human	JJ
10_1101-2021_01_05_425508	39	31	cells	cell	NNS
10_1101-2021_01_05_425508	39	32	.	.	.
10_1101-2021_01_05_425508	40	1	From	from	IN
10_1101-2021_01_05_425508	40	2	this	this	DT
10_1101-2021_01_05_425508	40	3	perspective	perspective	NN
10_1101-2021_01_05_425508	40	4	,	,	,
10_1101-2021_01_05_425508	40	5	we	-PRON-	PRP
10_1101-2021_01_05_425508	40	6	first	first	RB
10_1101-2021_01_05_425508	40	7	examined	examine	VBD
10_1101-2021_01_05_425508	40	8	time	time	NN
10_1101-2021_01_05_425508	40	9	-	-	HYPH
10_1101-2021_01_05_425508	40	10	dependent	dependent	JJ
10_1101-2021_01_05_425508	40	11	changes	change	NNS
10_1101-2021_01_05_425508	40	12	in	in	IN
10_1101-2021_01_05_425508	40	13	the	the	DT
10_1101-2021_01_05_425508	40	14	101	101	CD
10_1101-2021_01_05_425508	40	15	mononucleotide	mononucleotide	NN
10_1101-2021_01_05_425508	40	16	compositions	composition	NNS
10_1101-2021_01_05_425508	40	17	(	(	-LRB-
10_1101-2021_01_05_425508	40	18	%	%	NN
10_1101-2021_01_05_425508	40	19	)	)	-RRB-
10_1101-2021_01_05_425508	40	20	of	of	IN
10_1101-2021_01_05_425508	40	21	SARS	SARS	NNP
10_1101-2021_01_05_425508	40	22	-	-	HYPH
10_1101-2021_01_05_425508	40	23	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	40	24	strains	strain	NNS
10_1101-2021_01_05_425508	40	25	isolated	isolate	VBN
10_1101-2021_01_05_425508	40	26	from	from	IN
10_1101-2021_01_05_425508	40	27	December	December	NNP
10_1101-2021_01_05_425508	40	28	102	102	CD
10_1101-2021_01_05_425508	40	29	2019	2019	CD
10_1101-2021_01_05_425508	40	30	to	to	IN
10_1101-2021_01_05_425508	40	31	September	September	NNP
10_1101-2021_01_05_425508	40	32	2020	2020	CD
10_1101-2021_01_05_425508	40	33	.	.	.
10_1101-2021_01_05_425508	41	1	103	103	CD
10_1101-2021_01_05_425508	41	2	Among	among	IN
10_1101-2021_01_05_425508	41	3	the	the	DT
10_1101-2021_01_05_425508	41	4	seven	seven	CD
10_1101-2021_01_05_425508	41	5	clades	clade	NNS
10_1101-2021_01_05_425508	41	6	(	(	-LRB-
10_1101-2021_01_05_425508	41	7	G	G	NNP
10_1101-2021_01_05_425508	41	8	,	,	,
10_1101-2021_01_05_425508	41	9	GH	GH	NNP
10_1101-2021_01_05_425508	41	10	,	,	,
10_1101-2021_01_05_425508	41	11	GR	GR	NNP
10_1101-2021_01_05_425508	41	12	,	,	,
10_1101-2021_01_05_425508	41	13	L	L	NNP
10_1101-2021_01_05_425508	41	14	,	,	,
10_1101-2021_01_05_425508	41	15	V	V	NNP
10_1101-2021_01_05_425508	41	16	,	,	,
10_1101-2021_01_05_425508	41	17	S	S	NNP
10_1101-2021_01_05_425508	41	18	and	and	CC
10_1101-2021_01_05_425508	41	19	Others	Others	NNP
10_1101-2021_01_05_425508	41	20	)	)	-RRB-
10_1101-2021_01_05_425508	41	21	reported	report	VBN
10_1101-2021_01_05_425508	41	22	by	by	IN
10_1101-2021_01_05_425508	41	23	the	the	DT
10_1101-2021_01_05_425508	41	24	104	104	CD
10_1101-2021_01_05_425508	41	25	GISAID	GISAID	NNP
10_1101-2021_01_05_425508	41	26	consortium	consortium	NN
10_1101-2021_01_05_425508	41	27	,	,	,
10_1101-2021_01_05_425508	41	28	we	-PRON-	PRP
10_1101-2021_01_05_425508	41	29	used	use	VBD
10_1101-2021_01_05_425508	41	30	six	six	CD
10_1101-2021_01_05_425508	41	31	clades	clade	NNS
10_1101-2021_01_05_425508	41	32	(	(	-LRB-
10_1101-2021_01_05_425508	41	33	G	G	NNP
10_1101-2021_01_05_425508	41	34	,	,	,
10_1101-2021_01_05_425508	41	35	GH	GH	NNP
10_1101-2021_01_05_425508	41	36	,	,	,
10_1101-2021_01_05_425508	41	37	GR	GR	NNP
10_1101-2021_01_05_425508	41	38	,	,	,
10_1101-2021_01_05_425508	41	39	L	L	NNP
10_1101-2021_01_05_425508	41	40	,	,	,
10_1101-2021_01_05_425508	41	41	V	V	NNP
10_1101-2021_01_05_425508	41	42	and	and	CC
10_1101-2021_01_05_425508	41	43	S	S	NNP
10_1101-2021_01_05_425508	41	44	)	)	-RRB-
10_1101-2021_01_05_425508	41	45	,	,	,
10_1101-2021_01_05_425508	41	46	excluding	exclude	VBG
10_1101-2021_01_05_425508	41	47	Others	Others	NNPS
10_1101-2021_01_05_425508	41	48	,	,	,
10_1101-2021_01_05_425508	41	49	in	in	IN
10_1101-2021_01_05_425508	41	50	105	105	CD
10_1101-2021_01_05_425508	41	51	the	the	DT
10_1101-2021_01_05_425508	41	52	analysis	analysis	NN
10_1101-2021_01_05_425508	41	53	.	.	.
10_1101-2021_01_05_425508	42	1	For	for	IN
10_1101-2021_01_05_425508	42	2	the	the	DT
10_1101-2021_01_05_425508	42	3	time	time	NN
10_1101-2021_01_05_425508	42	4	-	-	HYPH
10_1101-2021_01_05_425508	42	5	series	series	NN
10_1101-2021_01_05_425508	42	6	analysis	analysis	NN
10_1101-2021_01_05_425508	42	7	,	,	,
10_1101-2021_01_05_425508	42	8	we	-PRON-	PRP
10_1101-2021_01_05_425508	42	9	calculated	calculate	VBD
10_1101-2021_01_05_425508	42	10	the	the	DT
10_1101-2021_01_05_425508	42	11	average	average	JJ
10_1101-2021_01_05_425508	42	12	mononucleotide	mononucleotide	NN
10_1101-2021_01_05_425508	42	13	106	106	CD
10_1101-2021_01_05_425508	42	14	.CC	.CC	NFP
10_1101-2021_01_05_425508	42	15	-	-	HYPH
10_1101-2021_01_05_425508	42	16	BY	BY	NNP
10_1101-2021_01_05_425508	42	17	-	-	HYPH
10_1101-2021_01_05_425508	42	18	NC	NC	NNP
10_1101-2021_01_05_425508	42	19	4.0	4.0	CD
10_1101-2021_01_05_425508	42	20	International	international	JJ
10_1101-2021_01_05_425508	42	21	licensemade	licensemade	NN
10_1101-2021_01_05_425508	42	22	available	available	JJ
10_1101-2021_01_05_425508	42	23	under	under	IN
10_1101-2021_01_05_425508	42	24	a	a	DT
10_1101-2021_01_05_425508	42	25	(	(	-LRB-
10_1101-2021_01_05_425508	42	26	which	which	WDT
10_1101-2021_01_05_425508	42	27	was	be	VBD
10_1101-2021_01_05_425508	42	28	not	not	RB
10_1101-2021_01_05_425508	42	29	certified	certify	VBN
10_1101-2021_01_05_425508	42	30	by	by	IN
10_1101-2021_01_05_425508	42	31	peer	peer	NN
10_1101-2021_01_05_425508	42	32	review	review	NN
10_1101-2021_01_05_425508	42	33	)	)	-RRB-
10_1101-2021_01_05_425508	42	34	is	be	VBZ
10_1101-2021_01_05_425508	42	35	the	the	DT
10_1101-2021_01_05_425508	42	36	author	author	NN
10_1101-2021_01_05_425508	42	37	/	/	SYM
10_1101-2021_01_05_425508	42	38	funder	funder	NN
10_1101-2021_01_05_425508	42	39	,	,	,
10_1101-2021_01_05_425508	42	40	who	who	WP
10_1101-2021_01_05_425508	42	41	has	have	VBZ
10_1101-2021_01_05_425508	42	42	granted	grant	VBN
10_1101-2021_01_05_425508	42	43	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	42	44	a	a	DT
10_1101-2021_01_05_425508	42	45	license	license	NN
10_1101-2021_01_05_425508	42	46	to	to	TO
10_1101-2021_01_05_425508	42	47	display	display	VB
10_1101-2021_01_05_425508	42	48	the	the	DT
10_1101-2021_01_05_425508	42	49	preprint	preprint	NN
10_1101-2021_01_05_425508	42	50	in	in	IN
10_1101-2021_01_05_425508	42	51	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	42	52	.	.	.
10_1101-2021_01_05_425508	43	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	43	2	is	be	VBZ
10_1101-2021_01_05_425508	43	3	The	the	DT
10_1101-2021_01_05_425508	43	4	copyright	copyright	NN
10_1101-2021_01_05_425508	43	5	holder	holder	NN
10_1101-2021_01_05_425508	43	6	for	for	IN
10_1101-2021_01_05_425508	43	7	this	this	DT
10_1101-2021_01_05_425508	43	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	43	9	version	version	NN
10_1101-2021_01_05_425508	43	10	posted	post	VBD
10_1101-2021_01_05_425508	43	11	January	January	NNP
10_1101-2021_01_05_425508	43	12	6	6	CD
10_1101-2021_01_05_425508	43	13	,	,	,
10_1101-2021_01_05_425508	43	14	2021	2021	CD
10_1101-2021_01_05_425508	43	15	.	.	.
10_1101-2021_01_05_425508	43	16	;	;	:
10_1101-2021_01_05_425508	43	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	43	18	:	:	:
10_1101-2021_01_05_425508	43	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	43	20	preprint	preprint	NN
10_1101-2021_01_05_425508	43	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	CD
10_1101-2021_01_05_425508	43	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	43	23	5	5	CD
10_1101-2021_01_05_425508	43	24	compositions	composition	NNS
10_1101-2021_01_05_425508	43	25	(	(	-LRB-
10_1101-2021_01_05_425508	43	26	%	%	NN
10_1101-2021_01_05_425508	43	27	)	)	-RRB-
10_1101-2021_01_05_425508	43	28	of	of	IN
10_1101-2021_01_05_425508	43	29	the	the	DT
10_1101-2021_01_05_425508	43	30	genomes	genome	NNS
10_1101-2021_01_05_425508	43	31	in	in	IN
10_1101-2021_01_05_425508	43	32	each	each	DT
10_1101-2021_01_05_425508	43	33	clade	clade	NN
10_1101-2021_01_05_425508	43	34	collected	collect	VBN
10_1101-2021_01_05_425508	43	35	monthly	monthly	RB
10_1101-2021_01_05_425508	43	36	;	;	:
10_1101-2021_01_05_425508	43	37	in	in	IN
10_1101-2021_01_05_425508	43	38	Fig	Fig	NNP
10_1101-2021_01_05_425508	43	39	.	.	.
10_1101-2021_01_05_425508	44	1	1A	1a	CD
10_1101-2021_01_05_425508	44	2	,	,	,
10_1101-2021_01_05_425508	44	3	the	the	DT
10_1101-2021_01_05_425508	44	4	107	107	CD
10_1101-2021_01_05_425508	44	5	mononucleotide	mononucleotide	NN
10_1101-2021_01_05_425508	44	6	composition	composition	NN
10_1101-2021_01_05_425508	44	7	of	of	IN
10_1101-2021_01_05_425508	44	8	each	each	DT
10_1101-2021_01_05_425508	44	9	clade	clade	NN
10_1101-2021_01_05_425508	44	10	is	be	VBZ
10_1101-2021_01_05_425508	44	11	shown	show	VBN
10_1101-2021_01_05_425508	44	12	as	as	IN
10_1101-2021_01_05_425508	44	13	a	a	DT
10_1101-2021_01_05_425508	44	14	colored	colored	JJ
10_1101-2021_01_05_425508	44	15	line	line	NN
10_1101-2021_01_05_425508	44	16	,	,	,
10_1101-2021_01_05_425508	44	17	while	while	IN
10_1101-2021_01_05_425508	44	18	that	that	IN
10_1101-2021_01_05_425508	44	19	for	for	IN
10_1101-2021_01_05_425508	44	20	the	the	DT
10_1101-2021_01_05_425508	44	21	108	108	CD
10_1101-2021_01_05_425508	44	22	monthly	monthly	JJ
10_1101-2021_01_05_425508	44	23	collected	collect	VBN
10_1101-2021_01_05_425508	44	24	genomes	genome	NNS
10_1101-2021_01_05_425508	44	25	belonging	belong	VBG
10_1101-2021_01_05_425508	44	26	to	to	IN
10_1101-2021_01_05_425508	44	27	all	all	DT
10_1101-2021_01_05_425508	44	28	clades	clade	NNS
10_1101-2021_01_05_425508	44	29	is	be	VBZ
10_1101-2021_01_05_425508	44	30	shown	show	VBN
10_1101-2021_01_05_425508	44	31	as	as	IN
10_1101-2021_01_05_425508	44	32	a	a	DT
10_1101-2021_01_05_425508	44	33	dashed	dash	VBN
10_1101-2021_01_05_425508	44	34	line	line	NN
10_1101-2021_01_05_425508	44	35	.	.	.
10_1101-2021_01_05_425508	45	1	109	109	CD
10_1101-2021_01_05_425508	45	2	Regardless	regardless	RB
10_1101-2021_01_05_425508	45	3	of	of	IN
10_1101-2021_01_05_425508	45	4	clade	clade	NN
10_1101-2021_01_05_425508	45	5	,	,	,
10_1101-2021_01_05_425508	45	6	the	the	DT
10_1101-2021_01_05_425508	45	7	composition	composition	NN
10_1101-2021_01_05_425508	45	8	of	of	IN
10_1101-2021_01_05_425508	45	9	C	C	NNP
10_1101-2021_01_05_425508	45	10	decreased	decrease	VBD
10_1101-2021_01_05_425508	45	11	,	,	,
10_1101-2021_01_05_425508	45	12	while	while	IN
10_1101-2021_01_05_425508	45	13	that	that	DT
10_1101-2021_01_05_425508	45	14	of	of	IN
10_1101-2021_01_05_425508	45	15	U	u	NN
10_1101-2021_01_05_425508	45	16	increased	increase	VBD
10_1101-2021_01_05_425508	45	17	110	110	CD
10_1101-2021_01_05_425508	45	18	in	in	IN
10_1101-2021_01_05_425508	45	19	a	a	DT
10_1101-2021_01_05_425508	45	20	time	time	NN
10_1101-2021_01_05_425508	45	21	-	-	HYPH
10_1101-2021_01_05_425508	45	22	dependent	dependent	JJ
10_1101-2021_01_05_425508	45	23	manner	manner	NN
10_1101-2021_01_05_425508	45	24	,	,	,
10_1101-2021_01_05_425508	45	25	but	but	CC
10_1101-2021_01_05_425508	45	26	the	the	DT
10_1101-2021_01_05_425508	45	27	changes	change	NNS
10_1101-2021_01_05_425508	45	28	in	in	IN
10_1101-2021_01_05_425508	45	29	A	a	NN
10_1101-2021_01_05_425508	45	30	and	and	CC
10_1101-2021_01_05_425508	45	31	G	g	NN
10_1101-2021_01_05_425508	45	32	composition	composition	NN
10_1101-2021_01_05_425508	45	33	were	be	VBD
10_1101-2021_01_05_425508	45	34	less	less	RBR
10_1101-2021_01_05_425508	45	35	clear	clear	JJ
10_1101-2021_01_05_425508	45	36	111	111	CD
10_1101-2021_01_05_425508	45	37	(	(	-LRB-
10_1101-2021_01_05_425508	45	38	Fig	fig	NN
10_1101-2021_01_05_425508	45	39	.	.	.
10_1101-2021_01_05_425508	46	1	1A	1a	LS
10_1101-2021_01_05_425508	46	2	)	)	-RRB-
10_1101-2021_01_05_425508	46	3	.	.	.
10_1101-2021_01_05_425508	47	1	Correlation	correlation	NN
10_1101-2021_01_05_425508	47	2	coefficients	coefficient	NNS
10_1101-2021_01_05_425508	47	3	between	between	IN
10_1101-2021_01_05_425508	47	4	the	the	DT
10_1101-2021_01_05_425508	47	5	mononucleotide	mononucleotide	NNP
10_1101-2021_01_05_425508	47	6	composition	composition	NN
10_1101-2021_01_05_425508	47	7	and	and	CC
10_1101-2021_01_05_425508	47	8	month	month	NN
10_1101-2021_01_05_425508	47	9	112	112	CD
10_1101-2021_01_05_425508	47	10	from	from	IN
10_1101-2021_01_05_425508	47	11	the	the	DT
10_1101-2021_01_05_425508	47	12	start	start	NN
10_1101-2021_01_05_425508	47	13	of	of	IN
10_1101-2021_01_05_425508	47	14	the	the	DT
10_1101-2021_01_05_425508	47	15	epidemic	epidemic	NN
10_1101-2021_01_05_425508	47	16	showed	show	VBD
10_1101-2021_01_05_425508	47	17	a	a	DT
10_1101-2021_01_05_425508	47	18	high	high	JJ
10_1101-2021_01_05_425508	47	19	negative	negative	JJ
10_1101-2021_01_05_425508	47	20	correlation	correlation	NN
10_1101-2021_01_05_425508	47	21	for	for	IN
10_1101-2021_01_05_425508	47	22	C	c	NN
10_1101-2021_01_05_425508	47	23	and	and	CC
10_1101-2021_01_05_425508	47	24	a	a	DT
10_1101-2021_01_05_425508	47	25	high	high	JJ
10_1101-2021_01_05_425508	47	26	113	113	CD
10_1101-2021_01_05_425508	47	27	positive	positive	JJ
10_1101-2021_01_05_425508	47	28	correlation	correlation	NN
10_1101-2021_01_05_425508	47	29	for	for	IN
10_1101-2021_01_05_425508	47	30	U	u	NN
10_1101-2021_01_05_425508	47	31	for	for	IN
10_1101-2021_01_05_425508	47	32	all	all	DT
10_1101-2021_01_05_425508	47	33	clades	clade	NNS
10_1101-2021_01_05_425508	47	34	,	,	,
10_1101-2021_01_05_425508	47	35	but	but	CC
10_1101-2021_01_05_425508	47	36	there	there	EX
10_1101-2021_01_05_425508	47	37	was	be	VBD
10_1101-2021_01_05_425508	47	38	no	no	DT
10_1101-2021_01_05_425508	47	39	clear	clear	JJ
10_1101-2021_01_05_425508	47	40	directionality	directionality	NN
10_1101-2021_01_05_425508	47	41	for	for	IN
10_1101-2021_01_05_425508	47	42	A	a	NN
10_1101-2021_01_05_425508	47	43	and	and	CC
10_1101-2021_01_05_425508	47	44	114	114	CD
10_1101-2021_01_05_425508	47	45	G	g	NN
10_1101-2021_01_05_425508	47	46	(	(	-LRB-
10_1101-2021_01_05_425508	47	47	Fig	fig	NN
10_1101-2021_01_05_425508	47	48	.	.	.
10_1101-2021_01_05_425508	48	1	1A	1a	CD
10_1101-2021_01_05_425508	48	2	and	and	CC
10_1101-2021_01_05_425508	48	3	Tables	Tables	NNP
10_1101-2021_01_05_425508	48	4	1	1	CD
10_1101-2021_01_05_425508	48	5	,	,	,
10_1101-2021_01_05_425508	48	6	2	2	CD
10_1101-2021_01_05_425508	48	7	)	)	-RRB-
10_1101-2021_01_05_425508	48	8	.	.	.
10_1101-2021_01_05_425508	49	1	These	these	DT
10_1101-2021_01_05_425508	49	2	results	result	NNS
10_1101-2021_01_05_425508	49	3	indicate	indicate	VBP
10_1101-2021_01_05_425508	49	4	that	that	IN
10_1101-2021_01_05_425508	49	5	the	the	DT
10_1101-2021_01_05_425508	49	6	mononucleotide	mononucleotide	NNP
10_1101-2021_01_05_425508	49	7	composition	composition	NN
10_1101-2021_01_05_425508	49	8	115	115	CD
10_1101-2021_01_05_425508	49	9	of	of	IN
10_1101-2021_01_05_425508	49	10	this	this	DT
10_1101-2021_01_05_425508	49	11	virus	virus	NN
10_1101-2021_01_05_425508	49	12	may	may	MD
10_1101-2021_01_05_425508	49	13	be	be	VB
10_1101-2021_01_05_425508	49	14	prone	prone	JJ
10_1101-2021_01_05_425508	49	15	to	to	IN
10_1101-2021_01_05_425508	49	16	biased	biased	JJ
10_1101-2021_01_05_425508	49	17	mutations	mutation	NNS
10_1101-2021_01_05_425508	49	18	that	that	WDT
10_1101-2021_01_05_425508	49	19	reduce	reduce	VBP
10_1101-2021_01_05_425508	49	20	C	c	NN
10_1101-2021_01_05_425508	49	21	and	and	CC
10_1101-2021_01_05_425508	49	22	increase	increase	VB
10_1101-2021_01_05_425508	49	23	U	u	NN
10_1101-2021_01_05_425508	49	24	or	or	CC
10_1101-2021_01_05_425508	49	25	the	the	DT
10_1101-2021_01_05_425508	49	26	116	116	CD
10_1101-2021_01_05_425508	49	27	mutated	mutate	VBN
10_1101-2021_01_05_425508	49	28	strains	strain	NNS
10_1101-2021_01_05_425508	49	29	tend	tend	VBP
10_1101-2021_01_05_425508	49	30	to	to	TO
10_1101-2021_01_05_425508	49	31	be	be	VB
10_1101-2021_01_05_425508	49	32	more	more	RBR
10_1101-2021_01_05_425508	49	33	favorable	favorable	JJ
10_1101-2021_01_05_425508	49	34	for	for	IN
10_1101-2021_01_05_425508	49	35	growth	growth	NN
10_1101-2021_01_05_425508	49	36	in	in	IN
10_1101-2021_01_05_425508	49	37	human	human	JJ
10_1101-2021_01_05_425508	49	38	cells	cell	NNS
10_1101-2021_01_05_425508	49	39	.	.	.
10_1101-2021_01_05_425508	50	1	117	117	CD
10_1101-2021_01_05_425508	50	2	118	118	CD
10_1101-2021_01_05_425508	50	3	Directional	directional	JJ
10_1101-2021_01_05_425508	50	4	changes	change	NNS
10_1101-2021_01_05_425508	50	5	in	in	IN
10_1101-2021_01_05_425508	50	6	short	short	JJ
10_1101-2021_01_05_425508	50	7	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	50	8	compositions	composition	NNS
10_1101-2021_01_05_425508	50	9	119	119	CD
10_1101-2021_01_05_425508	50	10	Oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	50	11	are	be	VBP
10_1101-2021_01_05_425508	50	12	known	know	VBN
10_1101-2021_01_05_425508	50	13	to	to	TO
10_1101-2021_01_05_425508	50	14	act	act	VB
10_1101-2021_01_05_425508	50	15	as	as	IN
10_1101-2021_01_05_425508	50	16	functional	functional	JJ
10_1101-2021_01_05_425508	50	17	motifs	motif	NNS
10_1101-2021_01_05_425508	50	18	,	,	,
10_1101-2021_01_05_425508	50	19	such	such	JJ
10_1101-2021_01_05_425508	50	20	as	as	IN
10_1101-2021_01_05_425508	50	21	binding	bind	VBG
10_1101-2021_01_05_425508	50	22	sites	site	NNS
10_1101-2021_01_05_425508	50	23	for	for	IN
10_1101-2021_01_05_425508	50	24	a	a	DT
10_1101-2021_01_05_425508	50	25	wide	wide	JJ
10_1101-2021_01_05_425508	50	26	120	120	CD
10_1101-2021_01_05_425508	50	27	variety	variety	NN
10_1101-2021_01_05_425508	50	28	of	of	IN
10_1101-2021_01_05_425508	50	29	proteins	protein	NNS
10_1101-2021_01_05_425508	50	30	and	and	CC
10_1101-2021_01_05_425508	50	31	target	target	VB
10_1101-2021_01_05_425508	50	32	sites	site	NNS
10_1101-2021_01_05_425508	50	33	for	for	IN
10_1101-2021_01_05_425508	50	34	RNA	RNA	NNP
10_1101-2021_01_05_425508	50	35	modifications	modification	NNS
10_1101-2021_01_05_425508	50	36	.	.	.
10_1101-2021_01_05_425508	51	1	Therefore	therefore	RB
10_1101-2021_01_05_425508	51	2	,	,	,
10_1101-2021_01_05_425508	51	3	directional	directional	JJ
10_1101-2021_01_05_425508	51	4	121	121	CD
10_1101-2021_01_05_425508	51	5	changes	change	NNS
10_1101-2021_01_05_425508	51	6	in	in	IN
10_1101-2021_01_05_425508	51	7	some	some	DT
10_1101-2021_01_05_425508	51	8	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	51	9	independent	independent	JJ
10_1101-2021_01_05_425508	51	10	of	of	IN
10_1101-2021_01_05_425508	51	11	clade	clade	NN
10_1101-2021_01_05_425508	51	12	may	may	MD
10_1101-2021_01_05_425508	51	13	relate	relate	VB
10_1101-2021_01_05_425508	51	14	to	to	IN
10_1101-2021_01_05_425508	51	15	certain	certain	JJ
10_1101-2021_01_05_425508	51	16	processes	process	NNS
10_1101-2021_01_05_425508	51	17	122	122	CD
10_1101-2021_01_05_425508	51	18	for	for	IN
10_1101-2021_01_05_425508	51	19	adaptation	adaptation	NN
10_1101-2021_01_05_425508	51	20	to	to	IN
10_1101-2021_01_05_425508	51	21	the	the	DT
10_1101-2021_01_05_425508	51	22	new	new	JJ
10_1101-2021_01_05_425508	51	23	host	host	NN
10_1101-2021_01_05_425508	51	24	environment	environment	NN
10_1101-2021_01_05_425508	51	25	.	.	.
10_1101-2021_01_05_425508	52	1	Our	-PRON-	PRP$
10_1101-2021_01_05_425508	52	2	previous	previous	JJ
10_1101-2021_01_05_425508	52	3	work	work	NN
10_1101-2021_01_05_425508	52	4	on	on	IN
10_1101-2021_01_05_425508	52	5	influenza	influenza	NN
10_1101-2021_01_05_425508	52	6	A	a	DT
10_1101-2021_01_05_425508	52	7	viruses	virus	NNS
10_1101-2021_01_05_425508	52	8	123	123	CD
10_1101-2021_01_05_425508	52	9	found	find	VBD
10_1101-2021_01_05_425508	52	10	that	that	IN
10_1101-2021_01_05_425508	52	11	their	-PRON-	PRP$
10_1101-2021_01_05_425508	52	12	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	52	13	compositions	composition	NNS
10_1101-2021_01_05_425508	52	14	varied	varied	JJ
10_1101-2021_01_05_425508	52	15	among	among	IN
10_1101-2021_01_05_425508	52	16	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	52	17	hosts	host	NNS
10_1101-2021_01_05_425508	52	18	[	[	-LRB-
10_1101-2021_01_05_425508	52	19	11,12	11,12	CD
10_1101-2021_01_05_425508	52	20	]	]	-RRB-
10_1101-2021_01_05_425508	52	21	;	;	:
10_1101-2021_01_05_425508	52	22	124	124	CD
10_1101-2021_01_05_425508	52	23	notably	notably	RB
10_1101-2021_01_05_425508	52	24	,	,	,
10_1101-2021_01_05_425508	52	25	although	although	IN
10_1101-2021_01_05_425508	52	26	influenza	influenza	NN
10_1101-2021_01_05_425508	52	27	virus	virus	NN
10_1101-2021_01_05_425508	52	28	isolated	isolate	VBN
10_1101-2021_01_05_425508	52	29	from	from	IN
10_1101-2021_01_05_425508	52	30	humans	human	NNS
10_1101-2021_01_05_425508	52	31	tended	tend	VBD
10_1101-2021_01_05_425508	52	32	to	to	TO
10_1101-2021_01_05_425508	52	33	prefer	prefer	VB
10_1101-2021_01_05_425508	52	34	A	a	NN
10_1101-2021_01_05_425508	52	35	and	and	CC
10_1101-2021_01_05_425508	52	36	U	u	NN
10_1101-2021_01_05_425508	52	37	(	(	-LRB-
10_1101-2021_01_05_425508	52	38	but	but	CC
10_1101-2021_01_05_425508	52	39	125	125	CD
10_1101-2021_01_05_425508	52	40	not	not	RB
10_1101-2021_01_05_425508	52	41	G	g	NN
10_1101-2021_01_05_425508	52	42	and	and	CC
10_1101-2021_01_05_425508	52	43	C	C	NNP
10_1101-2021_01_05_425508	52	44	)	)	-RRB-
10_1101-2021_01_05_425508	52	45	more	more	JJR
10_1101-2021_01_05_425508	52	46	than	than	IN
10_1101-2021_01_05_425508	52	47	viruses	virus	NNS
10_1101-2021_01_05_425508	52	48	isolated	isolate	VBN
10_1101-2021_01_05_425508	52	49	from	from	IN
10_1101-2021_01_05_425508	52	50	birds	bird	NNS
10_1101-2021_01_05_425508	52	51	,	,	,
10_1101-2021_01_05_425508	52	52	the	the	DT
10_1101-2021_01_05_425508	52	53	human	human	JJ
10_1101-2021_01_05_425508	52	54	viruses	virus	NNS
10_1101-2021_01_05_425508	52	55	showed	show	VBD
10_1101-2021_01_05_425508	52	56	a	a	DT
10_1101-2021_01_05_425508	52	57	126	126	CD
10_1101-2021_01_05_425508	52	58	preference	preference	NN
10_1101-2021_01_05_425508	52	59	for	for	IN
10_1101-2021_01_05_425508	52	60	GGCG	GGCG	NNP
10_1101-2021_01_05_425508	52	61	and	and	CC
10_1101-2021_01_05_425508	52	62	GGGG	GGGG	NNP
10_1101-2021_01_05_425508	52	63	,	,	,
10_1101-2021_01_05_425508	52	64	which	which	WDT
10_1101-2021_01_05_425508	52	65	are	be	VBP
10_1101-2021_01_05_425508	52	66	G-	G-	NNP
10_1101-2021_01_05_425508	52	67	or	or	CC
10_1101-2021_01_05_425508	52	68	C	C	NNP
10_1101-2021_01_05_425508	52	69	-	-	HYPH
10_1101-2021_01_05_425508	52	70	rich	rich	JJ
10_1101-2021_01_05_425508	52	71	.	.	.
10_1101-2021_01_05_425508	53	1	Importantly	importantly	RB
10_1101-2021_01_05_425508	53	2	,	,	,
10_1101-2021_01_05_425508	53	3	there	there	EX
10_1101-2021_01_05_425508	53	4	are	be	VBP
10_1101-2021_01_05_425508	53	5	127	127	CD
10_1101-2021_01_05_425508	53	6	various	various	JJ
10_1101-2021_01_05_425508	53	7	examples	example	NNS
10_1101-2021_01_05_425508	53	8	of	of	IN
10_1101-2021_01_05_425508	53	9	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	53	10	whose	whose	WP$
10_1101-2021_01_05_425508	53	11	changes	change	NNS
10_1101-2021_01_05_425508	53	12	in	in	IN
10_1101-2021_01_05_425508	53	13	composition	composition	NN
10_1101-2021_01_05_425508	53	14	can	can	MD
10_1101-2021_01_05_425508	53	15	not	not	RB
10_1101-2021_01_05_425508	53	16	be	be	VB
10_1101-2021_01_05_425508	53	17	128	128	CD
10_1101-2021_01_05_425508	53	18	explained	explain	VBN
10_1101-2021_01_05_425508	53	19	by	by	IN
10_1101-2021_01_05_425508	53	20	changes	change	NNS
10_1101-2021_01_05_425508	53	21	in	in	IN
10_1101-2021_01_05_425508	53	22	mononucleotide	mononucleotide	NNP
10_1101-2021_01_05_425508	53	23	composition	composition	NN
10_1101-2021_01_05_425508	53	24	alone	alone	RB
10_1101-2021_01_05_425508	53	25	,	,	,
10_1101-2021_01_05_425508	53	26	and	and	CC
10_1101-2021_01_05_425508	53	27	these	these	DT
10_1101-2021_01_05_425508	53	28	changes	change	NNS
10_1101-2021_01_05_425508	53	29	may	may	MD
10_1101-2021_01_05_425508	53	30	129	129	CD
10_1101-2021_01_05_425508	53	31	relate	relate	VB
10_1101-2021_01_05_425508	53	32	to	to	IN
10_1101-2021_01_05_425508	53	33	the	the	DT
10_1101-2021_01_05_425508	53	34	molecular	molecular	JJ
10_1101-2021_01_05_425508	53	35	mechanisms	mechanism	NNS
10_1101-2021_01_05_425508	53	36	of	of	IN
10_1101-2021_01_05_425508	53	37	viral	viral	JJ
10_1101-2021_01_05_425508	53	38	adaptation	adaptation	NN
10_1101-2021_01_05_425508	53	39	to	to	IN
10_1101-2021_01_05_425508	53	40	a	a	DT
10_1101-2021_01_05_425508	53	41	new	new	JJ
10_1101-2021_01_05_425508	53	42	host	host	NN
10_1101-2021_01_05_425508	53	43	.	.	.
10_1101-2021_01_05_425508	54	1	130	130	CD
10_1101-2021_01_05_425508	54	2	From	from	IN
10_1101-2021_01_05_425508	54	3	this	this	DT
10_1101-2021_01_05_425508	54	4	perspective	perspective	NN
10_1101-2021_01_05_425508	54	5	,	,	,
10_1101-2021_01_05_425508	54	6	we	-PRON-	PRP
10_1101-2021_01_05_425508	54	7	next	next	RB
10_1101-2021_01_05_425508	54	8	analyzed	analyze	VBN
10_1101-2021_01_05_425508	54	9	time	time	NN
10_1101-2021_01_05_425508	54	10	-	-	HYPH
10_1101-2021_01_05_425508	54	11	dependent	dependent	JJ
10_1101-2021_01_05_425508	54	12	changes	change	NNS
10_1101-2021_01_05_425508	54	13	in	in	IN
10_1101-2021_01_05_425508	54	14	di-	di-	NNS
10_1101-2021_01_05_425508	54	15	and	and	CC
10_1101-2021_01_05_425508	54	16	131	131	CD
10_1101-2021_01_05_425508	54	17	trinucleotide	trinucleotide	NN
10_1101-2021_01_05_425508	54	18	compositions	composition	NNS
10_1101-2021_01_05_425508	54	19	and	and	CC
10_1101-2021_01_05_425508	54	20	found	find	VBD
10_1101-2021_01_05_425508	54	21	that	that	IN
10_1101-2021_01_05_425508	54	22	a	a	DT
10_1101-2021_01_05_425508	54	23	group	group	NN
10_1101-2021_01_05_425508	54	24	of	of	IN
10_1101-2021_01_05_425508	54	25	di-	di-	PRP
10_1101-2021_01_05_425508	54	26	and	and	CC
10_1101-2021_01_05_425508	54	27	trinucleotides	trinucleotide	NNS
10_1101-2021_01_05_425508	54	28	showed	show	VBD
10_1101-2021_01_05_425508	54	29	a	a	DT
10_1101-2021_01_05_425508	54	30	132	132	CD
10_1101-2021_01_05_425508	54	31	highly	highly	RB
10_1101-2021_01_05_425508	54	32	positive	positive	JJ
10_1101-2021_01_05_425508	54	33	or	or	CC
10_1101-2021_01_05_425508	54	34	negative	negative	JJ
10_1101-2021_01_05_425508	54	35	correlation	correlation	NN
10_1101-2021_01_05_425508	54	36	(	(	-LRB-
10_1101-2021_01_05_425508	54	37	Figs	fig	NNS
10_1101-2021_01_05_425508	54	38	.	.	.
10_1101-2021_01_05_425508	55	1	1B	1B	NNP
10_1101-2021_01_05_425508	55	2	,	,	,
10_1101-2021_01_05_425508	55	3	S1	S1	NNS
10_1101-2021_01_05_425508	55	4	and	and	CC
10_1101-2021_01_05_425508	55	5	Tables	Tables	NNP
10_1101-2021_01_05_425508	55	6	1	1	CD
10_1101-2021_01_05_425508	55	7	,	,	,
10_1101-2021_01_05_425508	55	8	2	2	CD
10_1101-2021_01_05_425508	55	9	)	)	-RRB-
10_1101-2021_01_05_425508	55	10	.	.	.
10_1101-2021_01_05_425508	56	1	Interestingly	interestingly	RB
10_1101-2021_01_05_425508	56	2	,	,	,
10_1101-2021_01_05_425508	56	3	a	a	DT
10_1101-2021_01_05_425508	56	4	133	133	CD
10_1101-2021_01_05_425508	56	5	.CC	.cc	SYM
10_1101-2021_01_05_425508	56	6	-	-	HYPH
10_1101-2021_01_05_425508	56	7	BY	BY	NNP
10_1101-2021_01_05_425508	56	8	-	-	HYPH
10_1101-2021_01_05_425508	56	9	NC	NC	NNP
10_1101-2021_01_05_425508	56	10	4.0	4.0	CD
10_1101-2021_01_05_425508	56	11	International	international	JJ
10_1101-2021_01_05_425508	56	12	licensemade	licensemade	NN
10_1101-2021_01_05_425508	56	13	available	available	JJ
10_1101-2021_01_05_425508	56	14	under	under	IN
10_1101-2021_01_05_425508	56	15	a	a	DT
10_1101-2021_01_05_425508	56	16	(	(	-LRB-
10_1101-2021_01_05_425508	56	17	which	which	WDT
10_1101-2021_01_05_425508	56	18	was	be	VBD
10_1101-2021_01_05_425508	56	19	not	not	RB
10_1101-2021_01_05_425508	56	20	certified	certify	VBN
10_1101-2021_01_05_425508	56	21	by	by	IN
10_1101-2021_01_05_425508	56	22	peer	peer	NN
10_1101-2021_01_05_425508	56	23	review	review	NN
10_1101-2021_01_05_425508	56	24	)	)	-RRB-
10_1101-2021_01_05_425508	56	25	is	be	VBZ
10_1101-2021_01_05_425508	56	26	the	the	DT
10_1101-2021_01_05_425508	56	27	author	author	NN
10_1101-2021_01_05_425508	56	28	/	/	SYM
10_1101-2021_01_05_425508	56	29	funder	funder	NN
10_1101-2021_01_05_425508	56	30	,	,	,
10_1101-2021_01_05_425508	56	31	who	who	WP
10_1101-2021_01_05_425508	56	32	has	have	VBZ
10_1101-2021_01_05_425508	56	33	granted	grant	VBN
10_1101-2021_01_05_425508	56	34	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	56	35	a	a	DT
10_1101-2021_01_05_425508	56	36	license	license	NN
10_1101-2021_01_05_425508	56	37	to	to	TO
10_1101-2021_01_05_425508	56	38	display	display	VB
10_1101-2021_01_05_425508	56	39	the	the	DT
10_1101-2021_01_05_425508	56	40	preprint	preprint	NN
10_1101-2021_01_05_425508	56	41	in	in	IN
10_1101-2021_01_05_425508	56	42	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	56	43	.	.	.
10_1101-2021_01_05_425508	57	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	57	2	is	be	VBZ
10_1101-2021_01_05_425508	57	3	The	the	DT
10_1101-2021_01_05_425508	57	4	copyright	copyright	NN
10_1101-2021_01_05_425508	57	5	holder	holder	NN
10_1101-2021_01_05_425508	57	6	for	for	IN
10_1101-2021_01_05_425508	57	7	this	this	DT
10_1101-2021_01_05_425508	57	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	57	9	version	version	NN
10_1101-2021_01_05_425508	57	10	posted	post	VBD
10_1101-2021_01_05_425508	57	11	January	January	NNP
10_1101-2021_01_05_425508	57	12	6	6	CD
10_1101-2021_01_05_425508	57	13	,	,	,
10_1101-2021_01_05_425508	57	14	2021	2021	CD
10_1101-2021_01_05_425508	57	15	.	.	.
10_1101-2021_01_05_425508	57	16	;	;	:
10_1101-2021_01_05_425508	57	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	57	18	:	:	:
10_1101-2021_01_05_425508	57	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	57	20	preprint	preprint	NN
10_1101-2021_01_05_425508	57	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	57	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	57	23	6	6	CD
10_1101-2021_01_05_425508	57	24	group	group	NN
10_1101-2021_01_05_425508	57	25	of	of	IN
10_1101-2021_01_05_425508	57	26	A-	A-	NNP
10_1101-2021_01_05_425508	57	27	or	or	CC
10_1101-2021_01_05_425508	57	28	G	G	NNP
10_1101-2021_01_05_425508	57	29	-	-	HYPH
10_1101-2021_01_05_425508	57	30	rich	rich	JJ
10_1101-2021_01_05_425508	57	31	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	57	32	,	,	,
10_1101-2021_01_05_425508	57	33	such	such	JJ
10_1101-2021_01_05_425508	57	34	as	as	IN
10_1101-2021_01_05_425508	57	35	GAG	GAG	NNP
10_1101-2021_01_05_425508	57	36	and	and	CC
10_1101-2021_01_05_425508	57	37	GGA	GGA	NNP
10_1101-2021_01_05_425508	57	38	,	,	,
10_1101-2021_01_05_425508	57	39	showed	show	VBD
10_1101-2021_01_05_425508	57	40	a	a	DT
10_1101-2021_01_05_425508	57	41	high	high	JJ
10_1101-2021_01_05_425508	57	42	positive	positive	JJ
10_1101-2021_01_05_425508	57	43	134	134	CD
10_1101-2021_01_05_425508	57	44	correlation	correlation	NN
10_1101-2021_01_05_425508	57	45	independent	independent	JJ
10_1101-2021_01_05_425508	57	46	of	of	IN
10_1101-2021_01_05_425508	57	47	clade	clade	NN
10_1101-2021_01_05_425508	57	48	,	,	,
10_1101-2021_01_05_425508	57	49	which	which	WDT
10_1101-2021_01_05_425508	57	50	was	be	VBD
10_1101-2021_01_05_425508	57	51	not	not	RB
10_1101-2021_01_05_425508	57	52	expected	expect	VBN
10_1101-2021_01_05_425508	57	53	from	from	IN
10_1101-2021_01_05_425508	57	54	the	the	DT
10_1101-2021_01_05_425508	57	55	changes	change	NNS
10_1101-2021_01_05_425508	57	56	in	in	IN
10_1101-2021_01_05_425508	57	57	135	135	CD
10_1101-2021_01_05_425508	57	58	mononucleotide	mononucleotide	NN
10_1101-2021_01_05_425508	57	59	compositions	composition	NNS
10_1101-2021_01_05_425508	57	60	alone	alone	RB
10_1101-2021_01_05_425508	57	61	.	.	.
10_1101-2021_01_05_425508	58	1	To	to	TO
10_1101-2021_01_05_425508	58	2	confirm	confirm	VB
10_1101-2021_01_05_425508	58	3	the	the	DT
10_1101-2021_01_05_425508	58	4	extent	extent	NN
10_1101-2021_01_05_425508	58	5	of	of	IN
10_1101-2021_01_05_425508	58	6	these	these	DT
10_1101-2021_01_05_425508	58	7	changes	change	NNS
10_1101-2021_01_05_425508	58	8	,	,	,
10_1101-2021_01_05_425508	58	9	we	-PRON-	PRP
10_1101-2021_01_05_425508	58	10	also	also	RB
10_1101-2021_01_05_425508	58	11	136	136	CD
10_1101-2021_01_05_425508	58	12	calculated	calculate	VBD
10_1101-2021_01_05_425508	58	13	the	the	DT
10_1101-2021_01_05_425508	58	14	fold	fold	JJ
10_1101-2021_01_05_425508	58	15	change	change	NN
10_1101-2021_01_05_425508	58	16	in	in	IN
10_1101-2021_01_05_425508	58	17	composition	composition	NN
10_1101-2021_01_05_425508	58	18	for	for	IN
10_1101-2021_01_05_425508	58	19	the	the	DT
10_1101-2021_01_05_425508	58	20	first	first	JJ
10_1101-2021_01_05_425508	58	21	isolated	isolated	JJ
10_1101-2021_01_05_425508	58	22	month	month	NN
10_1101-2021_01_05_425508	58	23	and	and	CC
10_1101-2021_01_05_425508	58	24	the	the	DT
10_1101-2021_01_05_425508	58	25	last	last	JJ
10_1101-2021_01_05_425508	58	26	137	137	CD
10_1101-2021_01_05_425508	58	27	examined	examine	VBN
10_1101-2021_01_05_425508	58	28	month	month	NN
10_1101-2021_01_05_425508	58	29	(	(	-LRB-
10_1101-2021_01_05_425508	58	30	Fig	fig	NN
10_1101-2021_01_05_425508	58	31	.	.	.
10_1101-2021_01_05_425508	59	1	2	2	LS
10_1101-2021_01_05_425508	59	2	)	)	-RRB-
10_1101-2021_01_05_425508	59	3	and	and	CC
10_1101-2021_01_05_425508	59	4	found	find	VBD
10_1101-2021_01_05_425508	59	5	clear	clear	JJ
10_1101-2021_01_05_425508	59	6	increases	increase	NNS
10_1101-2021_01_05_425508	59	7	and	and	CC
10_1101-2021_01_05_425508	59	8	decreases	decrease	NNS
10_1101-2021_01_05_425508	59	9	in	in	IN
10_1101-2021_01_05_425508	59	10	mono-	mono-	NN
10_1101-2021_01_05_425508	59	11	and	and	CC
10_1101-2021_01_05_425508	59	12	138	138	CD
10_1101-2021_01_05_425508	59	13	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	59	14	compositions	composition	NNS
10_1101-2021_01_05_425508	59	15	common	common	JJ
10_1101-2021_01_05_425508	59	16	among	among	IN
10_1101-2021_01_05_425508	59	17	the	the	DT
10_1101-2021_01_05_425508	59	18	six	six	CD
10_1101-2021_01_05_425508	59	19	clades	clade	NNS
10_1101-2021_01_05_425508	59	20	,	,	,
10_1101-2021_01_05_425508	59	21	which	which	WDT
10_1101-2021_01_05_425508	59	22	supports	support	VBZ
10_1101-2021_01_05_425508	59	23	the	the	DT
10_1101-2021_01_05_425508	59	24	result	result	NN
10_1101-2021_01_05_425508	59	25	139	139	CD
10_1101-2021_01_05_425508	59	26	presented	present	VBN
10_1101-2021_01_05_425508	59	27	in	in	IN
10_1101-2021_01_05_425508	59	28	Fig	Fig	NNP
10_1101-2021_01_05_425508	59	29	.	.	.
10_1101-2021_01_05_425508	60	1	1	1	LS
10_1101-2021_01_05_425508	60	2	and	and	CC
10_1101-2021_01_05_425508	60	3	Tables	Tables	NNP
10_1101-2021_01_05_425508	60	4	1	1	CD
10_1101-2021_01_05_425508	60	5	and	and	CC
10_1101-2021_01_05_425508	60	6	2	2	CD
10_1101-2021_01_05_425508	60	7	.	.	.
10_1101-2021_01_05_425508	61	1	140	140	CD
10_1101-2021_01_05_425508	61	2	141	141	CD
10_1101-2021_01_05_425508	61	3	Changes	change	NNS
10_1101-2021_01_05_425508	61	4	towards	towards	IN
10_1101-2021_01_05_425508	61	5	the	the	DT
10_1101-2021_01_05_425508	61	6	sequences	sequence	NNS
10_1101-2021_01_05_425508	61	7	of	of	IN
10_1101-2021_01_05_425508	61	8	other	other	JJ
10_1101-2021_01_05_425508	61	9	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	61	10	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	61	11	in	in	IN
10_1101-2021_01_05_425508	61	12	humans	human	NNS
10_1101-2021_01_05_425508	61	13	142	142	CD
10_1101-2021_01_05_425508	61	14	In	in	IN
10_1101-2021_01_05_425508	61	15	a	a	DT
10_1101-2021_01_05_425508	61	16	previous	previous	JJ
10_1101-2021_01_05_425508	61	17	study	study	NN
10_1101-2021_01_05_425508	61	18	of	of	IN
10_1101-2021_01_05_425508	61	19	SARS	SARS	NNP
10_1101-2021_01_05_425508	61	20	-	-	HYPH
10_1101-2021_01_05_425508	61	21	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	61	22	[	[	-LRB-
10_1101-2021_01_05_425508	61	23	16	16	CD
10_1101-2021_01_05_425508	61	24	]	]	-RRB-
10_1101-2021_01_05_425508	61	25	,	,	,
10_1101-2021_01_05_425508	61	26	we	-PRON-	PRP
10_1101-2021_01_05_425508	61	27	analyzed	analyze	VBD
10_1101-2021_01_05_425508	61	28	mono-	mono-	NN
10_1101-2021_01_05_425508	61	29	and	and	CC
10_1101-2021_01_05_425508	61	30	dinucleotide	dinucleotide	VB
10_1101-2021_01_05_425508	61	31	143	143	CD
10_1101-2021_01_05_425508	61	32	compositions	composition	NNS
10_1101-2021_01_05_425508	61	33	for	for	IN
10_1101-2021_01_05_425508	61	34	the	the	DT
10_1101-2021_01_05_425508	61	35	first	first	JJ
10_1101-2021_01_05_425508	61	36	four	four	CD
10_1101-2021_01_05_425508	61	37	epidemic	epidemic	NN
10_1101-2021_01_05_425508	61	38	months	month	NNS
10_1101-2021_01_05_425508	61	39	without	without	IN
10_1101-2021_01_05_425508	61	40	separating	separate	VBG
10_1101-2021_01_05_425508	61	41	the	the	DT
10_1101-2021_01_05_425508	61	42	sequences	sequence	NNS
10_1101-2021_01_05_425508	61	43	by	by	IN
10_1101-2021_01_05_425508	61	44	144	144	CD
10_1101-2021_01_05_425508	61	45	clade	clade	NN
10_1101-2021_01_05_425508	61	46	.	.	.
10_1101-2021_01_05_425508	62	1	Notably	notably	RB
10_1101-2021_01_05_425508	62	2	,	,	,
10_1101-2021_01_05_425508	62	3	the	the	DT
10_1101-2021_01_05_425508	62	4	directional	directional	JJ
10_1101-2021_01_05_425508	62	5	changes	change	NNS
10_1101-2021_01_05_425508	62	6	shown	show	VBN
10_1101-2021_01_05_425508	62	7	in	in	IN
10_1101-2021_01_05_425508	62	8	Figs	Figs	NNP
10_1101-2021_01_05_425508	62	9	.	.	.
10_1101-2021_01_05_425508	63	1	1	1	CD
10_1101-2021_01_05_425508	63	2	and	and	CC
10_1101-2021_01_05_425508	63	3	2	2	CD
10_1101-2021_01_05_425508	63	4	and	and	CC
10_1101-2021_01_05_425508	63	5	Tables	Tables	NNP
10_1101-2021_01_05_425508	63	6	1	1	CD
10_1101-2021_01_05_425508	63	7	and	and	CC
10_1101-2021_01_05_425508	63	8	2	2	CD
10_1101-2021_01_05_425508	63	9	were	be	VBD
10_1101-2021_01_05_425508	63	10	145	145	CD
10_1101-2021_01_05_425508	63	11	absolutely	absolutely	RB
10_1101-2021_01_05_425508	63	12	consistent	consistent	JJ
10_1101-2021_01_05_425508	63	13	with	with	IN
10_1101-2021_01_05_425508	63	14	the	the	DT
10_1101-2021_01_05_425508	63	15	previous	previous	JJ
10_1101-2021_01_05_425508	63	16	results	result	NNS
10_1101-2021_01_05_425508	63	17	,	,	,
10_1101-2021_01_05_425508	63	18	even	even	RB
10_1101-2021_01_05_425508	63	19	when	when	WRB
10_1101-2021_01_05_425508	63	20	the	the	DT
10_1101-2021_01_05_425508	63	21	six	six	CD
10_1101-2021_01_05_425508	63	22	clades	clade	NNS
10_1101-2021_01_05_425508	63	23	were	be	VBD
10_1101-2021_01_05_425508	63	24	separately	separately	RB
10_1101-2021_01_05_425508	63	25	146	146	CD
10_1101-2021_01_05_425508	63	26	analyzed	analyze	VBN
10_1101-2021_01_05_425508	63	27	.	.	.
10_1101-2021_01_05_425508	64	1	In	in	IN
10_1101-2021_01_05_425508	64	2	the	the	DT
10_1101-2021_01_05_425508	64	3	previous	previous	JJ
10_1101-2021_01_05_425508	64	4	study	study	NN
10_1101-2021_01_05_425508	64	5	,	,	,
10_1101-2021_01_05_425508	64	6	time	time	NN
10_1101-2021_01_05_425508	64	7	-	-	HYPH
10_1101-2021_01_05_425508	64	8	series	series	NN
10_1101-2021_01_05_425508	64	9	analysis	analysis	NN
10_1101-2021_01_05_425508	64	10	of	of	IN
10_1101-2021_01_05_425508	64	11	ebolavirus	ebolavirus	NNP
10_1101-2021_01_05_425508	64	12	at	at	IN
10_1101-2021_01_05_425508	64	13	the	the	DT
10_1101-2021_01_05_425508	64	14	beginning	beginning	NN
10_1101-2021_01_05_425508	64	15	of	of	IN
10_1101-2021_01_05_425508	64	16	147	147	CD
10_1101-2021_01_05_425508	64	17	the	the	DT
10_1101-2021_01_05_425508	64	18	epidemic	epidemic	NN
10_1101-2021_01_05_425508	64	19	in	in	IN
10_1101-2021_01_05_425508	64	20	West	West	NNP
10_1101-2021_01_05_425508	64	21	Africa	Africa	NNP
10_1101-2021_01_05_425508	64	22	in	in	IN
10_1101-2021_01_05_425508	64	23	2014	2014	CD
10_1101-2021_01_05_425508	64	24	also	also	RB
10_1101-2021_01_05_425508	64	25	showed	show	VBD
10_1101-2021_01_05_425508	64	26	directional	directional	JJ
10_1101-2021_01_05_425508	64	27	changes	change	NNS
10_1101-2021_01_05_425508	64	28	in	in	IN
10_1101-2021_01_05_425508	64	29	a	a	DT
10_1101-2021_01_05_425508	64	30	group	group	NN
10_1101-2021_01_05_425508	64	31	of	of	IN
10_1101-2021_01_05_425508	64	32	148	148	CD
10_1101-2021_01_05_425508	64	33	mono-	mono-	NN
10_1101-2021_01_05_425508	64	34	and	and	CC
10_1101-2021_01_05_425508	64	35	dinucleotide	dinucleotide	JJ
10_1101-2021_01_05_425508	64	36	compositions	composition	NNS
10_1101-2021_01_05_425508	64	37	,	,	,
10_1101-2021_01_05_425508	64	38	but	but	CC
10_1101-2021_01_05_425508	64	39	these	these	DT
10_1101-2021_01_05_425508	64	40	directional	directional	JJ
10_1101-2021_01_05_425508	64	41	increases	increase	NNS
10_1101-2021_01_05_425508	64	42	/	/	SYM
10_1101-2021_01_05_425508	64	43	decreases	decrease	NNS
10_1101-2021_01_05_425508	64	44	tended	tend	VBD
10_1101-2021_01_05_425508	64	45	149	149	CD
10_1101-2021_01_05_425508	64	46	to	to	TO
10_1101-2021_01_05_425508	64	47	slow	slow	VB
10_1101-2021_01_05_425508	64	48	approximately	approximately	RB
10_1101-2021_01_05_425508	64	49	10	10	CD
10_1101-2021_01_05_425508	64	50	months	month	NNS
10_1101-2021_01_05_425508	64	51	after	after	IN
10_1101-2021_01_05_425508	64	52	the	the	DT
10_1101-2021_01_05_425508	64	53	start	start	NN
10_1101-2021_01_05_425508	64	54	of	of	IN
10_1101-2021_01_05_425508	64	55	the	the	DT
10_1101-2021_01_05_425508	64	56	epidemic	epidemic	NN
10_1101-2021_01_05_425508	64	57	.	.	.
10_1101-2021_01_05_425508	65	1	The	the	DT
10_1101-2021_01_05_425508	65	2	increase	increase	NN
10_1101-2021_01_05_425508	65	3	/	/	SYM
10_1101-2021_01_05_425508	65	4	decrease	decrease	VBP
10_1101-2021_01_05_425508	65	5	150	150	CD
10_1101-2021_01_05_425508	65	6	trend	trend	NN
10_1101-2021_01_05_425508	65	7	for	for	IN
10_1101-2021_01_05_425508	65	8	SARS	SARS	NNP
10_1101-2021_01_05_425508	65	9	-	-	HYPH
10_1101-2021_01_05_425508	65	10	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	65	11	is	be	VBZ
10_1101-2021_01_05_425508	65	12	far	far	RB
10_1101-2021_01_05_425508	65	13	from	from	IN
10_1101-2021_01_05_425508	65	14	slowing	slow	VBG
10_1101-2021_01_05_425508	65	15	after	after	IN
10_1101-2021_01_05_425508	65	16	10	10	CD
10_1101-2021_01_05_425508	65	17	months	month	NNS
10_1101-2021_01_05_425508	65	18	,	,	,
10_1101-2021_01_05_425508	65	19	and	and	CC
10_1101-2021_01_05_425508	65	20	the	the	DT
10_1101-2021_01_05_425508	65	21	next	next	JJ
10_1101-2021_01_05_425508	65	22	important	important	JJ
10_1101-2021_01_05_425508	65	23	151	151	CD
10_1101-2021_01_05_425508	65	24	questions	question	NNS
10_1101-2021_01_05_425508	65	25	are	be	VBP
10_1101-2021_01_05_425508	65	26	how	how	WRB
10_1101-2021_01_05_425508	65	27	long	long	RB
10_1101-2021_01_05_425508	65	28	these	these	DT
10_1101-2021_01_05_425508	65	29	directional	directional	JJ
10_1101-2021_01_05_425508	65	30	changes	change	NNS
10_1101-2021_01_05_425508	65	31	in	in	IN
10_1101-2021_01_05_425508	65	32	this	this	DT
10_1101-2021_01_05_425508	65	33	virus	virus	NN
10_1101-2021_01_05_425508	65	34	will	will	MD
10_1101-2021_01_05_425508	65	35	last	last	VB
10_1101-2021_01_05_425508	65	36	and	and	CC
10_1101-2021_01_05_425508	65	37	whether	whether	IN
10_1101-2021_01_05_425508	65	38	there	there	EX
10_1101-2021_01_05_425508	65	39	152	152	CD
10_1101-2021_01_05_425508	65	40	are	be	VBP
10_1101-2021_01_05_425508	65	41	possible	possible	JJ
10_1101-2021_01_05_425508	65	42	goals	goal	NNS
10_1101-2021_01_05_425508	65	43	to	to	IN
10_1101-2021_01_05_425508	65	44	these	these	DT
10_1101-2021_01_05_425508	65	45	changes	change	NNS
10_1101-2021_01_05_425508	65	46	.	.	.
10_1101-2021_01_05_425508	66	1	153	153	CD
10_1101-2021_01_05_425508	66	2	To	to	TO
10_1101-2021_01_05_425508	66	3	conduct	conduct	VB
10_1101-2021_01_05_425508	66	4	this	this	DT
10_1101-2021_01_05_425508	66	5	near	near	JJ
10_1101-2021_01_05_425508	66	6	-	-	HYPH
10_1101-2021_01_05_425508	66	7	future	future	NN
10_1101-2021_01_05_425508	66	8	prediction	prediction	NN
10_1101-2021_01_05_425508	66	9	,	,	,
10_1101-2021_01_05_425508	66	10	the	the	DT
10_1101-2021_01_05_425508	66	11	following	follow	VBG
10_1101-2021_01_05_425508	66	12	information	information	NN
10_1101-2021_01_05_425508	66	13	concerning	concern	VBG
10_1101-2021_01_05_425508	66	14	154	154	CD
10_1101-2021_01_05_425508	66	15	influenza	influenza	NN
10_1101-2021_01_05_425508	66	16	viruses	virus	NNS
10_1101-2021_01_05_425508	66	17	should	should	MD
10_1101-2021_01_05_425508	66	18	be	be	VB
10_1101-2021_01_05_425508	66	19	useful	useful	JJ
10_1101-2021_01_05_425508	66	20	.	.	.
10_1101-2021_01_05_425508	67	1	As	as	IN
10_1101-2021_01_05_425508	67	2	mentioned	mention	VBN
10_1101-2021_01_05_425508	67	3	before	before	RB
10_1101-2021_01_05_425508	67	4	,	,	,
10_1101-2021_01_05_425508	67	5	mono-	mono-	NN
10_1101-2021_01_05_425508	67	6	and	and	CC
10_1101-2021_01_05_425508	67	7	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	67	8	155	155	CD
10_1101-2021_01_05_425508	67	9	compositions	composition	NNS
10_1101-2021_01_05_425508	67	10	in	in	IN
10_1101-2021_01_05_425508	67	11	influenza	influenza	NNP
10_1101-2021_01_05_425508	67	12	H1N1/09	H1N1/09	NNP
10_1101-2021_01_05_425508	67	13	changed	change	VBD
10_1101-2021_01_05_425508	67	14	towards	towards	IN
10_1101-2021_01_05_425508	67	15	those	those	DT
10_1101-2021_01_05_425508	67	16	of	of	IN
10_1101-2021_01_05_425508	67	17	seasonal	seasonal	JJ
10_1101-2021_01_05_425508	67	18	influenza	influenza	NN
10_1101-2021_01_05_425508	67	19	strains	strain	VBZ
10_1101-2021_01_05_425508	67	20	156	156	CD
10_1101-2021_01_05_425508	67	21	such	such	JJ
10_1101-2021_01_05_425508	67	22	as	as	IN
10_1101-2021_01_05_425508	67	23	the	the	DT
10_1101-2021_01_05_425508	67	24	H1N1	H1N1	NNP
10_1101-2021_01_05_425508	67	25	and	and	CC
10_1101-2021_01_05_425508	67	26	H3N2	H3N2	NNP
10_1101-2021_01_05_425508	67	27	subtypes	subtype	NNS
10_1101-2021_01_05_425508	67	28	[	[	-LRB-
10_1101-2021_01_05_425508	67	29	11	11	CD
10_1101-2021_01_05_425508	67	30	]	]	-RRB-
10_1101-2021_01_05_425508	67	31	.	.	.
10_1101-2021_01_05_425508	68	1	Furthermore	furthermore	RB
10_1101-2021_01_05_425508	68	2	,	,	,
10_1101-2021_01_05_425508	68	3	all	all	PDT
10_1101-2021_01_05_425508	68	4	the	the	DT
10_1101-2021_01_05_425508	68	5	human	human	JJ
10_1101-2021_01_05_425508	68	6	subtypes	subtype	NNS
10_1101-2021_01_05_425508	68	7	157	157	CD
10_1101-2021_01_05_425508	68	8	showed	show	VBD
10_1101-2021_01_05_425508	68	9	directional	directional	JJ
10_1101-2021_01_05_425508	68	10	changes	change	NNS
10_1101-2021_01_05_425508	68	11	away	away	RB
10_1101-2021_01_05_425508	68	12	from	from	IN
10_1101-2021_01_05_425508	68	13	the	the	DT
10_1101-2021_01_05_425508	68	14	compositions	composition	NNS
10_1101-2021_01_05_425508	68	15	of	of	IN
10_1101-2021_01_05_425508	68	16	all	all	DT
10_1101-2021_01_05_425508	68	17	avian	avian	JJ
10_1101-2021_01_05_425508	68	18	influenza	influenza	NN
10_1101-2021_01_05_425508	68	19	A	a	DT
10_1101-2021_01_05_425508	68	20	158	158	CD
10_1101-2021_01_05_425508	68	21	subtypes	subtype	NNS
10_1101-2021_01_05_425508	68	22	and	and	CC
10_1101-2021_01_05_425508	68	23	closer	close	JJR
10_1101-2021_01_05_425508	68	24	to	to	IN
10_1101-2021_01_05_425508	68	25	those	those	DT
10_1101-2021_01_05_425508	68	26	of	of	IN
10_1101-2021_01_05_425508	68	27	the	the	DT
10_1101-2021_01_05_425508	68	28	human	human	JJ
10_1101-2021_01_05_425508	68	29	influenza	influenza	NN
10_1101-2021_01_05_425508	68	30	B	b	NN
10_1101-2021_01_05_425508	68	31	type	type	NN
10_1101-2021_01_05_425508	68	32	,	,	,
10_1101-2021_01_05_425508	68	33	which	which	WDT
10_1101-2021_01_05_425508	68	34	has	have	VBZ
10_1101-2021_01_05_425508	68	35	been	be	VBN
10_1101-2021_01_05_425508	68	36	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	68	37	159	159	CD
10_1101-2021_01_05_425508	68	38	only	only	RB
10_1101-2021_01_05_425508	68	39	in	in	IN
10_1101-2021_01_05_425508	68	40	humans	human	NNS
10_1101-2021_01_05_425508	68	41	[	[	-LRB-
10_1101-2021_01_05_425508	68	42	14	14	CD
10_1101-2021_01_05_425508	68	43	]	]	-RRB-
10_1101-2021_01_05_425508	68	44	.	.	.
10_1101-2021_01_05_425508	69	1	If	if	IN
10_1101-2021_01_05_425508	69	2	we	-PRON-	PRP
10_1101-2021_01_05_425508	69	3	assume	assume	VBP
10_1101-2021_01_05_425508	69	4	that	that	IN
10_1101-2021_01_05_425508	69	5	changes	change	VBZ
10_1101-2021_01_05_425508	69	6	similar	similar	JJ
10_1101-2021_01_05_425508	69	7	to	to	IN
10_1101-2021_01_05_425508	69	8	those	those	DT
10_1101-2021_01_05_425508	69	9	in	in	IN
10_1101-2021_01_05_425508	69	10	the	the	DT
10_1101-2021_01_05_425508	69	11	influenza	influenza	NNP
10_1101-2021_01_05_425508	69	12	virus	virus	NN
10_1101-2021_01_05_425508	69	13	160	160	CD
10_1101-2021_01_05_425508	69	14	.CC	.CC	:
10_1101-2021_01_05_425508	69	15	-	-	:
10_1101-2021_01_05_425508	69	16	BY	BY	NNP
10_1101-2021_01_05_425508	69	17	-	-	HYPH
10_1101-2021_01_05_425508	69	18	NC	NC	NNP
10_1101-2021_01_05_425508	69	19	4.0	4.0	CD
10_1101-2021_01_05_425508	69	20	International	international	JJ
10_1101-2021_01_05_425508	69	21	licensemade	licensemade	NN
10_1101-2021_01_05_425508	69	22	available	available	JJ
10_1101-2021_01_05_425508	69	23	under	under	IN
10_1101-2021_01_05_425508	69	24	a	a	DT
10_1101-2021_01_05_425508	69	25	(	(	-LRB-
10_1101-2021_01_05_425508	69	26	which	which	WDT
10_1101-2021_01_05_425508	69	27	was	be	VBD
10_1101-2021_01_05_425508	69	28	not	not	RB
10_1101-2021_01_05_425508	69	29	certified	certify	VBN
10_1101-2021_01_05_425508	69	30	by	by	IN
10_1101-2021_01_05_425508	69	31	peer	peer	NN
10_1101-2021_01_05_425508	69	32	review	review	NN
10_1101-2021_01_05_425508	69	33	)	)	-RRB-
10_1101-2021_01_05_425508	69	34	is	be	VBZ
10_1101-2021_01_05_425508	69	35	the	the	DT
10_1101-2021_01_05_425508	69	36	author	author	NN
10_1101-2021_01_05_425508	69	37	/	/	SYM
10_1101-2021_01_05_425508	69	38	funder	funder	NN
10_1101-2021_01_05_425508	69	39	,	,	,
10_1101-2021_01_05_425508	69	40	who	who	WP
10_1101-2021_01_05_425508	69	41	has	have	VBZ
10_1101-2021_01_05_425508	69	42	granted	grant	VBN
10_1101-2021_01_05_425508	69	43	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	69	44	a	a	DT
10_1101-2021_01_05_425508	69	45	license	license	NN
10_1101-2021_01_05_425508	69	46	to	to	TO
10_1101-2021_01_05_425508	69	47	display	display	VB
10_1101-2021_01_05_425508	69	48	the	the	DT
10_1101-2021_01_05_425508	69	49	preprint	preprint	NN
10_1101-2021_01_05_425508	69	50	in	in	IN
10_1101-2021_01_05_425508	69	51	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	69	52	.	.	.
10_1101-2021_01_05_425508	70	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	70	2	is	be	VBZ
10_1101-2021_01_05_425508	70	3	The	the	DT
10_1101-2021_01_05_425508	70	4	copyright	copyright	NN
10_1101-2021_01_05_425508	70	5	holder	holder	NN
10_1101-2021_01_05_425508	70	6	for	for	IN
10_1101-2021_01_05_425508	70	7	this	this	DT
10_1101-2021_01_05_425508	70	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	70	9	version	version	NN
10_1101-2021_01_05_425508	70	10	posted	post	VBD
10_1101-2021_01_05_425508	70	11	January	January	NNP
10_1101-2021_01_05_425508	70	12	6	6	CD
10_1101-2021_01_05_425508	70	13	,	,	,
10_1101-2021_01_05_425508	70	14	2021	2021	CD
10_1101-2021_01_05_425508	70	15	.	.	.
10_1101-2021_01_05_425508	70	16	;	;	:
10_1101-2021_01_05_425508	70	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	70	18	:	:	:
10_1101-2021_01_05_425508	70	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	70	20	preprint	preprint	NN
10_1101-2021_01_05_425508	70	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	CD
10_1101-2021_01_05_425508	70	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	70	23	7	7	CD
10_1101-2021_01_05_425508	70	24	will	will	MD
10_1101-2021_01_05_425508	70	25	occur	occur	VB
10_1101-2021_01_05_425508	70	26	,	,	,
10_1101-2021_01_05_425508	70	27	the	the	DT
10_1101-2021_01_05_425508	70	28	mono-	mono-	NN
10_1101-2021_01_05_425508	70	29	and	and	CC
10_1101-2021_01_05_425508	70	30	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	70	31	compositions	composition	NNS
10_1101-2021_01_05_425508	70	32	of	of	IN
10_1101-2021_01_05_425508	70	33	interest	interest	NN
10_1101-2021_01_05_425508	70	34	for	for	IN
10_1101-2021_01_05_425508	70	35	SARS	SARS	NNP
10_1101-2021_01_05_425508	70	36	-	-	HYPH
10_1101-2021_01_05_425508	70	37	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	70	38	are	be	VBP
10_1101-2021_01_05_425508	70	39	161	161	CD
10_1101-2021_01_05_425508	70	40	expected	expect	VBN
10_1101-2021_01_05_425508	70	41	to	to	TO
10_1101-2021_01_05_425508	70	42	change	change	VB
10_1101-2021_01_05_425508	70	43	towards	towards	IN
10_1101-2021_01_05_425508	70	44	those	those	DT
10_1101-2021_01_05_425508	70	45	of	of	IN
10_1101-2021_01_05_425508	70	46	other	other	JJ
10_1101-2021_01_05_425508	70	47	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	70	48	that	that	WDT
10_1101-2021_01_05_425508	70	49	have	have	VBP
10_1101-2021_01_05_425508	70	50	been	be	VBN
10_1101-2021_01_05_425508	70	51	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	70	52	in	in	IN
10_1101-2021_01_05_425508	70	53	162	162	CD
10_1101-2021_01_05_425508	70	54	humans	human	NNS
10_1101-2021_01_05_425508	70	55	and	and	CC
10_1101-2021_01_05_425508	70	56	away	away	RB
10_1101-2021_01_05_425508	70	57	from	from	IN
10_1101-2021_01_05_425508	70	58	those	those	DT
10_1101-2021_01_05_425508	70	59	of	of	IN
10_1101-2021_01_05_425508	70	60	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	70	61	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	70	62	in	in	IN
10_1101-2021_01_05_425508	70	63	bats	bat	NNS
10_1101-2021_01_05_425508	70	64	.	.	.
10_1101-2021_01_05_425508	71	1	To	to	TO
10_1101-2021_01_05_425508	71	2	test	test	VB
10_1101-2021_01_05_425508	71	3	this	this	DT
10_1101-2021_01_05_425508	71	4	hypothesis	hypothesis	NN
10_1101-2021_01_05_425508	71	5	,	,	,
10_1101-2021_01_05_425508	71	6	163	163	CD
10_1101-2021_01_05_425508	71	7	we	-PRON-	PRP
10_1101-2021_01_05_425508	71	8	analyzed	analyze	VBD
10_1101-2021_01_05_425508	71	9	the	the	DT
10_1101-2021_01_05_425508	71	10	following	follow	VBG
10_1101-2021_01_05_425508	71	11	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	71	12	:	:	:
10_1101-2021_01_05_425508	71	13	238	238	CD
10_1101-2021_01_05_425508	71	14	human	human	JJ
10_1101-2021_01_05_425508	71	15	-	-	HYPH
10_1101-2021_01_05_425508	71	16	CoV	cov	NN
10_1101-2021_01_05_425508	71	17	strains	strain	NNS
10_1101-2021_01_05_425508	71	18	(	(	-LRB-
10_1101-2021_01_05_425508	71	19	alphacoronaviruses	alphacoronaviruse	NNS
10_1101-2021_01_05_425508	71	20	164	164	CD
10_1101-2021_01_05_425508	71	21	229E	229e	CD
10_1101-2021_01_05_425508	71	22	and	and	CC
10_1101-2021_01_05_425508	71	23	NL63	NL63	NNP
10_1101-2021_01_05_425508	71	24	:	:	:
10_1101-2021_01_05_425508	71	25	betacoronaviruses	betacoronaviruse	NNS
10_1101-2021_01_05_425508	71	26	HKU1	HKU1	NNP
10_1101-2021_01_05_425508	71	27	and	and	CC
10_1101-2021_01_05_425508	71	28	OC43	OC43	NNP
10_1101-2021_01_05_425508	71	29	)	)	-RRB-
10_1101-2021_01_05_425508	71	30	and	and	CC
10_1101-2021_01_05_425508	71	31	166	166	CD
10_1101-2021_01_05_425508	71	32	bat	bat	NN
10_1101-2021_01_05_425508	71	33	-	-	HYPH
10_1101-2021_01_05_425508	71	34	CoV	cov	NN
10_1101-2021_01_05_425508	71	35	strains	strain	VBZ
10_1101-2021_01_05_425508	71	36	165	165	CD
10_1101-2021_01_05_425508	71	37	(	(	-LRB-
10_1101-2021_01_05_425508	71	38	alphacoronaviruses	alphacoronaviruse	NNS
10_1101-2021_01_05_425508	71	39	and	and	CC
10_1101-2021_01_05_425508	71	40	betacoronaviruses	betacoronaviruse	NNS
10_1101-2021_01_05_425508	71	41	,	,	,
10_1101-2021_01_05_425508	71	42	including	include	VBG
10_1101-2021_01_05_425508	71	43	the	the	DT
10_1101-2021_01_05_425508	71	44	SARS	SARS	NNP
10_1101-2021_01_05_425508	71	45	virus	virus	NN
10_1101-2021_01_05_425508	71	46	)	)	-RRB-
10_1101-2021_01_05_425508	71	47	.	.	.
10_1101-2021_01_05_425508	72	1	166	166	CD
10_1101-2021_01_05_425508	72	2	As	as	IN
10_1101-2021_01_05_425508	72	3	shown	show	VBN
10_1101-2021_01_05_425508	72	4	in	in	IN
10_1101-2021_01_05_425508	72	5	Fig	Fig	NNP
10_1101-2021_01_05_425508	72	6	.	.	.
10_1101-2021_01_05_425508	73	1	3A	3A	NNP
10_1101-2021_01_05_425508	73	2	,	,	,
10_1101-2021_01_05_425508	73	3	we	-PRON-	PRP
10_1101-2021_01_05_425508	73	4	compared	compare	VBD
10_1101-2021_01_05_425508	73	5	the	the	DT
10_1101-2021_01_05_425508	73	6	mononucleotide	mononucleotide	NN
10_1101-2021_01_05_425508	73	7	compositions	composition	NNS
10_1101-2021_01_05_425508	73	8	of	of	IN
10_1101-2021_01_05_425508	73	9	167	167	CD
10_1101-2021_01_05_425508	73	10	SARS	SARS	NNP
10_1101-2021_01_05_425508	73	11	-	-	HYPH
10_1101-2021_01_05_425508	73	12	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	73	13	with	with	IN
10_1101-2021_01_05_425508	73	14	those	those	DT
10_1101-2021_01_05_425508	73	15	of	of	IN
10_1101-2021_01_05_425508	73	16	the	the	DT
10_1101-2021_01_05_425508	73	17	human-	human-	NN
10_1101-2021_01_05_425508	73	18	and	and	CC
10_1101-2021_01_05_425508	73	19	bat	bat	NN
10_1101-2021_01_05_425508	73	20	-	-	HYPH
10_1101-2021_01_05_425508	73	21	CoV	cov	NN
10_1101-2021_01_05_425508	73	22	strains	strain	NNS
10_1101-2021_01_05_425508	73	23	;	;	:
10_1101-2021_01_05_425508	73	24	the	the	DT
10_1101-2021_01_05_425508	73	25	data	datum	NNS
10_1101-2021_01_05_425508	73	26	for	for	IN
10_1101-2021_01_05_425508	73	27	bat	bat	NNP
10_1101-2021_01_05_425508	73	28	SARS	SARS	NNP
10_1101-2021_01_05_425508	73	29	168	168	CD
10_1101-2021_01_05_425508	73	30	among	among	IN
10_1101-2021_01_05_425508	73	31	bat	bat	NN
10_1101-2021_01_05_425508	73	32	-	-	HYPH
10_1101-2021_01_05_425508	73	33	CoV	cov	NN
10_1101-2021_01_05_425508	73	34	strains	strain	NNS
10_1101-2021_01_05_425508	73	35	,	,	,
10_1101-2021_01_05_425508	73	36	which	which	WDT
10_1101-2021_01_05_425508	73	37	is	be	VBZ
10_1101-2021_01_05_425508	73	38	thought	think	VBN
10_1101-2021_01_05_425508	73	39	to	to	TO
10_1101-2021_01_05_425508	73	40	be	be	VB
10_1101-2021_01_05_425508	73	41	the	the	DT
10_1101-2021_01_05_425508	73	42	original	original	JJ
10_1101-2021_01_05_425508	73	43	strain	strain	NN
10_1101-2021_01_05_425508	73	44	that	that	WDT
10_1101-2021_01_05_425508	73	45	caused	cause	VBD
10_1101-2021_01_05_425508	73	46	the	the	DT
10_1101-2021_01_05_425508	73	47	current	current	JJ
10_1101-2021_01_05_425508	73	48	169	169	CD
10_1101-2021_01_05_425508	73	49	COVID-19	covid-19	NN
10_1101-2021_01_05_425508	73	50	pandemic	pandemic	NN
10_1101-2021_01_05_425508	73	51	,	,	,
10_1101-2021_01_05_425508	73	52	are	be	VBP
10_1101-2021_01_05_425508	73	53	marked	mark	VBN
10_1101-2021_01_05_425508	73	54	in	in	IN
10_1101-2021_01_05_425508	73	55	pink	pink	NN
10_1101-2021_01_05_425508	73	56	.	.	.
10_1101-2021_01_05_425508	74	1	Interestingly	interestingly	RB
10_1101-2021_01_05_425508	74	2	,	,	,
10_1101-2021_01_05_425508	74	3	concerning	concern	VBG
10_1101-2021_01_05_425508	74	4	the	the	DT
10_1101-2021_01_05_425508	74	5	human-	human-	NN
10_1101-2021_01_05_425508	74	6	and	and	CC
10_1101-2021_01_05_425508	74	7	170	170	CD
10_1101-2021_01_05_425508	74	8	bat	bat	NN
10_1101-2021_01_05_425508	74	9	-	-	HYPH
10_1101-2021_01_05_425508	74	10	CoV	cov	NN
10_1101-2021_01_05_425508	74	11	strains	strain	NNS
10_1101-2021_01_05_425508	74	12	,	,	,
10_1101-2021_01_05_425508	74	13	differences	difference	NNS
10_1101-2021_01_05_425508	74	14	in	in	IN
10_1101-2021_01_05_425508	74	15	mononucleotide	mononucleotide	NN
10_1101-2021_01_05_425508	74	16	composition	composition	NN
10_1101-2021_01_05_425508	74	17	were	be	VBD
10_1101-2021_01_05_425508	74	18	more	more	RBR
10_1101-2021_01_05_425508	74	19	pronounced	pronounce	VBN
10_1101-2021_01_05_425508	74	20	171	171	CD
10_1101-2021_01_05_425508	74	21	between	between	IN
10_1101-2021_01_05_425508	74	22	hosts	host	NNS
10_1101-2021_01_05_425508	74	23	than	than	IN
10_1101-2021_01_05_425508	74	24	between	between	IN
10_1101-2021_01_05_425508	74	25	the	the	DT
10_1101-2021_01_05_425508	74	26	alpha	alpha	NN
10_1101-2021_01_05_425508	74	27	and	and	CC
10_1101-2021_01_05_425508	74	28	beta	beta	NN
10_1101-2021_01_05_425508	74	29	linages	linage	NNS
10_1101-2021_01_05_425508	74	30	,	,	,
10_1101-2021_01_05_425508	74	31	and	and	CC
10_1101-2021_01_05_425508	74	32	the	the	DT
10_1101-2021_01_05_425508	74	33	levels	level	NNS
10_1101-2021_01_05_425508	74	34	for	for	IN
10_1101-2021_01_05_425508	74	35	all	all	DT
10_1101-2021_01_05_425508	74	36	six	six	CD
10_1101-2021_01_05_425508	74	37	clades	clade	NNS
10_1101-2021_01_05_425508	74	38	172	172	CD
10_1101-2021_01_05_425508	74	39	of	of	IN
10_1101-2021_01_05_425508	74	40	SARS	SARS	NNP
10_1101-2021_01_05_425508	74	41	-	-	HYPH
10_1101-2021_01_05_425508	74	42	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	74	43	were	be	VBD
10_1101-2021_01_05_425508	74	44	between	between	IN
10_1101-2021_01_05_425508	74	45	those	those	DT
10_1101-2021_01_05_425508	74	46	for	for	IN
10_1101-2021_01_05_425508	74	47	the	the	DT
10_1101-2021_01_05_425508	74	48	two	two	CD
10_1101-2021_01_05_425508	74	49	hosts	host	NNS
10_1101-2021_01_05_425508	74	50	.	.	.
10_1101-2021_01_05_425508	75	1	Fig	fig	NN
10_1101-2021_01_05_425508	75	2	.	.	.
10_1101-2021_01_05_425508	76	1	3B	3B	NNP
10_1101-2021_01_05_425508	76	2	shows	show	VBZ
10_1101-2021_01_05_425508	76	3	the	the	DT
10_1101-2021_01_05_425508	76	4	results	result	NNS
10_1101-2021_01_05_425508	76	5	of	of	IN
10_1101-2021_01_05_425508	76	6	di-	di-	NNP
10_1101-2021_01_05_425508	76	7	173	173	CD
10_1101-2021_01_05_425508	76	8	and	and	CC
10_1101-2021_01_05_425508	76	9	trinucleotides	trinucleotide	NNS
10_1101-2021_01_05_425508	76	10	,	,	,
10_1101-2021_01_05_425508	76	11	for	for	IN
10_1101-2021_01_05_425508	76	12	which	which	WDT
10_1101-2021_01_05_425508	76	13	the	the	DT
10_1101-2021_01_05_425508	76	14	directional	directional	JJ
10_1101-2021_01_05_425508	76	15	,	,	,
10_1101-2021_01_05_425508	76	16	time	time	NN
10_1101-2021_01_05_425508	76	17	-	-	HYPH
10_1101-2021_01_05_425508	76	18	dependent	dependent	JJ
10_1101-2021_01_05_425508	76	19	changes	change	NNS
10_1101-2021_01_05_425508	76	20	were	be	VBD
10_1101-2021_01_05_425508	76	21	primarily	primarily	RB
10_1101-2021_01_05_425508	76	22	174	174	CD
10_1101-2021_01_05_425508	76	23	common	common	JJ
10_1101-2021_01_05_425508	76	24	among	among	IN
10_1101-2021_01_05_425508	76	25	the	the	DT
10_1101-2021_01_05_425508	76	26	six	six	CD
10_1101-2021_01_05_425508	76	27	clades	clade	NNS
10_1101-2021_01_05_425508	76	28	.	.	.
10_1101-2021_01_05_425508	77	1	The	the	DT
10_1101-2021_01_05_425508	77	2	increases	increase	NNS
10_1101-2021_01_05_425508	77	3	and	and	CC
10_1101-2021_01_05_425508	77	4	decreases	decrease	NNS
10_1101-2021_01_05_425508	77	5	in	in	IN
10_1101-2021_01_05_425508	77	6	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	77	7	composition	composition	NN
10_1101-2021_01_05_425508	77	8	175	175	CD
10_1101-2021_01_05_425508	77	9	observed	observe	VBN
10_1101-2021_01_05_425508	77	10	for	for	IN
10_1101-2021_01_05_425508	77	11	SARS	SARS	NNP
10_1101-2021_01_05_425508	77	12	-	-	HYPH
10_1101-2021_01_05_425508	77	13	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	77	14	in	in	IN
10_1101-2021_01_05_425508	77	15	Figs	Figs	NNP
10_1101-2021_01_05_425508	77	16	.	.	.
10_1101-2021_01_05_425508	78	1	1	1	CD
10_1101-2021_01_05_425508	78	2	and	and	CC
10_1101-2021_01_05_425508	78	3	2	2	CD
10_1101-2021_01_05_425508	78	4	are	be	VBP
10_1101-2021_01_05_425508	78	5	indicated	indicate	VBN
10_1101-2021_01_05_425508	78	6	by	by	IN
10_1101-2021_01_05_425508	78	7	hollow	hollow	JJ
10_1101-2021_01_05_425508	78	8	up	up	RP
10_1101-2021_01_05_425508	78	9	and	and	CC
10_1101-2021_01_05_425508	78	10	down	down	IN
10_1101-2021_01_05_425508	78	11	176	176	CD
10_1101-2021_01_05_425508	78	12	arrows	arrow	NNS
10_1101-2021_01_05_425508	78	13	,	,	,
10_1101-2021_01_05_425508	78	14	respectively	respectively	RB
10_1101-2021_01_05_425508	78	15	.	.	.
10_1101-2021_01_05_425508	79	1	Interestingly	interestingly	RB
10_1101-2021_01_05_425508	79	2	,	,	,
10_1101-2021_01_05_425508	79	3	all	all	DT
10_1101-2021_01_05_425508	79	4	changes	change	NNS
10_1101-2021_01_05_425508	79	5	of	of	IN
10_1101-2021_01_05_425508	79	6	interest	interest	NN
10_1101-2021_01_05_425508	79	7	tended	tend	VBD
10_1101-2021_01_05_425508	79	8	to	to	TO
10_1101-2021_01_05_425508	79	9	move	move	VB
10_1101-2021_01_05_425508	79	10	away	away	RB
10_1101-2021_01_05_425508	79	11	from	from	IN
10_1101-2021_01_05_425508	79	12	the	the	DT
10_1101-2021_01_05_425508	79	13	177	177	CD
10_1101-2021_01_05_425508	79	14	compositions	composition	NNS
10_1101-2021_01_05_425508	79	15	of	of	IN
10_1101-2021_01_05_425508	79	16	bat	bat	NN
10_1101-2021_01_05_425508	79	17	SARS	SARS	NNP
10_1101-2021_01_05_425508	79	18	and	and	CC
10_1101-2021_01_05_425508	79	19	approach	approach	VBP
10_1101-2021_01_05_425508	79	20	those	those	DT
10_1101-2021_01_05_425508	79	21	of	of	IN
10_1101-2021_01_05_425508	79	22	human	human	NN
10_1101-2021_01_05_425508	79	23	-	-	HYPH
10_1101-2021_01_05_425508	79	24	CoV	cov	NN
10_1101-2021_01_05_425508	79	25	,	,	,
10_1101-2021_01_05_425508	79	26	supporting	support	VBG
10_1101-2021_01_05_425508	79	27	the	the	DT
10_1101-2021_01_05_425508	79	28	view	view	NN
10_1101-2021_01_05_425508	79	29	that	that	IN
10_1101-2021_01_05_425508	79	30	178	178	CD
10_1101-2021_01_05_425508	79	31	the	the	DT
10_1101-2021_01_05_425508	79	32	directional	directional	JJ
10_1101-2021_01_05_425508	79	33	changes	change	NNS
10_1101-2021_01_05_425508	79	34	of	of	IN
10_1101-2021_01_05_425508	79	35	interest	interest	NN
10_1101-2021_01_05_425508	79	36	have	have	VBP
10_1101-2021_01_05_425508	79	37	biological	biological	JJ
10_1101-2021_01_05_425508	79	38	significance	significance	NN
10_1101-2021_01_05_425508	79	39	and	and	CC
10_1101-2021_01_05_425508	79	40	are	be	VBP
10_1101-2021_01_05_425508	79	41	possibly	possibly	RB
10_1101-2021_01_05_425508	79	42	179	179	CD
10_1101-2021_01_05_425508	79	43	inevitable	inevitable	JJ
10_1101-2021_01_05_425508	79	44	,	,	,
10_1101-2021_01_05_425508	79	45	as	as	IN
10_1101-2021_01_05_425508	79	46	observed	observe	VBN
10_1101-2021_01_05_425508	79	47	for	for	IN
10_1101-2021_01_05_425508	79	48	influenza	influenza	NN
10_1101-2021_01_05_425508	79	49	viruses	virus	NNS
10_1101-2021_01_05_425508	79	50	.	.	.
10_1101-2021_01_05_425508	80	1	Assuming	assume	VBG
10_1101-2021_01_05_425508	80	2	that	that	IN
10_1101-2021_01_05_425508	80	3	approaching	approach	VBG
10_1101-2021_01_05_425508	80	4	the	the	DT
10_1101-2021_01_05_425508	80	5	levels	level	NNS
10_1101-2021_01_05_425508	80	6	in	in	IN
10_1101-2021_01_05_425508	80	7	180	180	CD
10_1101-2021_01_05_425508	80	8	human	human	JJ
10_1101-2021_01_05_425508	80	9	-	-	HYPH
10_1101-2021_01_05_425508	80	10	CoV	cov	NN
10_1101-2021_01_05_425508	80	11	strains	strain	NNS
10_1101-2021_01_05_425508	80	12	is	be	VBZ
10_1101-2021_01_05_425508	80	13	the	the	DT
10_1101-2021_01_05_425508	80	14	hypothetical	hypothetical	JJ
10_1101-2021_01_05_425508	80	15	goal	goal	NN
10_1101-2021_01_05_425508	80	16	of	of	IN
10_1101-2021_01_05_425508	80	17	the	the	DT
10_1101-2021_01_05_425508	80	18	directional	directional	JJ
10_1101-2021_01_05_425508	80	19	change	change	NN
10_1101-2021_01_05_425508	80	20	of	of	IN
10_1101-2021_01_05_425508	80	21	SARS	SARS	NNP
10_1101-2021_01_05_425508	80	22	-	-	HYPH
10_1101-2021_01_05_425508	80	23	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	80	24	,	,	,
10_1101-2021_01_05_425508	80	25	181	181	CD
10_1101-2021_01_05_425508	80	26	the	the	DT
10_1101-2021_01_05_425508	80	27	current	current	JJ
10_1101-2021_01_05_425508	80	28	compositions	composition	NNS
10_1101-2021_01_05_425508	80	29	are	be	VBP
10_1101-2021_01_05_425508	80	30	far	far	RB
10_1101-2021_01_05_425508	80	31	from	from	IN
10_1101-2021_01_05_425508	80	32	this	this	DT
10_1101-2021_01_05_425508	80	33	hypothetical	hypothetical	JJ
10_1101-2021_01_05_425508	80	34	goal	goal	NN
10_1101-2021_01_05_425508	80	35	(	(	-LRB-
10_1101-2021_01_05_425508	80	36	Fig	fig	NN
10_1101-2021_01_05_425508	80	37	.	.	.
10_1101-2021_01_05_425508	81	1	3	3	LS
10_1101-2021_01_05_425508	81	2	)	)	-RRB-
10_1101-2021_01_05_425508	81	3	;	;	:
10_1101-2021_01_05_425508	81	4	therefore	therefore	RB
10_1101-2021_01_05_425508	81	5	,	,	,
10_1101-2021_01_05_425508	81	6	we	-PRON-	PRP
10_1101-2021_01_05_425508	81	7	182	182	CD
10_1101-2021_01_05_425508	81	8	predict	predict	VBP
10_1101-2021_01_05_425508	81	9	that	that	IN
10_1101-2021_01_05_425508	81	10	directional	directional	JJ
10_1101-2021_01_05_425508	81	11	changes	change	NNS
10_1101-2021_01_05_425508	81	12	of	of	IN
10_1101-2021_01_05_425508	81	13	interest	interest	NN
10_1101-2021_01_05_425508	81	14	will	will	MD
10_1101-2021_01_05_425508	81	15	continue	continue	VB
10_1101-2021_01_05_425508	81	16	in	in	IN
10_1101-2021_01_05_425508	81	17	the	the	DT
10_1101-2021_01_05_425508	81	18	near	near	JJ
10_1101-2021_01_05_425508	81	19	future	future	NN
10_1101-2021_01_05_425508	81	20	.	.	.
10_1101-2021_01_05_425508	82	1	183	183	CD
10_1101-2021_01_05_425508	82	2	Then	then	RB
10_1101-2021_01_05_425508	82	3	,	,	,
10_1101-2021_01_05_425508	82	4	assuming	assume	VBG
10_1101-2021_01_05_425508	82	5	that	that	IN
10_1101-2021_01_05_425508	82	6	the	the	DT
10_1101-2021_01_05_425508	82	7	average	average	JJ
10_1101-2021_01_05_425508	82	8	value	value	NN
10_1101-2021_01_05_425508	82	9	for	for	IN
10_1101-2021_01_05_425508	82	10	all	all	DT
10_1101-2021_01_05_425508	82	11	human	human	JJ
10_1101-2021_01_05_425508	82	12	-	-	HYPH
10_1101-2021_01_05_425508	82	13	CoV	cov	NN
10_1101-2021_01_05_425508	82	14	strains	strain	NNS
10_1101-2021_01_05_425508	82	15	is	be	VBZ
10_1101-2021_01_05_425508	82	16	a	a	DT
10_1101-2021_01_05_425508	82	17	184	184	CD
10_1101-2021_01_05_425508	82	18	hypothetical	hypothetical	JJ
10_1101-2021_01_05_425508	82	19	goal	goal	NN
10_1101-2021_01_05_425508	82	20	,	,	,
10_1101-2021_01_05_425508	82	21	we	-PRON-	PRP
10_1101-2021_01_05_425508	82	22	investigated	investigate	VBD
10_1101-2021_01_05_425508	82	23	how	how	WRB
10_1101-2021_01_05_425508	82	24	SARS	SARS	NNP
10_1101-2021_01_05_425508	82	25	-	-	HYPH
10_1101-2021_01_05_425508	82	26	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	82	27	has	have	VBZ
10_1101-2021_01_05_425508	82	28	approached	approach	VBN
10_1101-2021_01_05_425508	82	29	this	this	DT
10_1101-2021_01_05_425508	82	30	possible	possible	JJ
10_1101-2021_01_05_425508	82	31	goal	goal	NN
10_1101-2021_01_05_425508	82	32	.	.	.
10_1101-2021_01_05_425508	83	1	185	185	CD
10_1101-2021_01_05_425508	83	2	Specifically	specifically	RB
10_1101-2021_01_05_425508	83	3	,	,	,
10_1101-2021_01_05_425508	83	4	we	-PRON-	PRP
10_1101-2021_01_05_425508	83	5	calculated	calculate	VBD
10_1101-2021_01_05_425508	83	6	the	the	DT
10_1101-2021_01_05_425508	83	7	square	square	NN
10_1101-2021_01_05_425508	83	8	of	of	IN
10_1101-2021_01_05_425508	83	9	the	the	DT
10_1101-2021_01_05_425508	83	10	difference	difference	NN
10_1101-2021_01_05_425508	83	11	between	between	IN
10_1101-2021_01_05_425508	83	12	the	the	DT
10_1101-2021_01_05_425508	83	13	composition	composition	NN
10_1101-2021_01_05_425508	83	14	of	of	IN
10_1101-2021_01_05_425508	83	15	each	each	DT
10_1101-2021_01_05_425508	83	16	186	186	CD
10_1101-2021_01_05_425508	83	17	nucleotide	nucleotide	RB
10_1101-2021_01_05_425508	83	18	in	in	IN
10_1101-2021_01_05_425508	83	19	SARS	SARS	NNP
10_1101-2021_01_05_425508	83	20	-	-	HYPH
10_1101-2021_01_05_425508	83	21	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	83	22	and	and	CC
10_1101-2021_01_05_425508	83	23	the	the	DT
10_1101-2021_01_05_425508	83	24	average	average	JJ
10_1101-2021_01_05_425508	83	25	value	value	NN
10_1101-2021_01_05_425508	83	26	for	for	IN
10_1101-2021_01_05_425508	83	27	human	human	NN
10_1101-2021_01_05_425508	83	28	-	-	HYPH
10_1101-2021_01_05_425508	83	29	CoV	cov	NN
10_1101-2021_01_05_425508	83	30	strains	strain	NNS
10_1101-2021_01_05_425508	83	31	and	and	CC
10_1101-2021_01_05_425508	83	32	plotted	plot	VBD
10_1101-2021_01_05_425508	83	33	187	187	CD
10_1101-2021_01_05_425508	83	34	.CC	.CC	,
10_1101-2021_01_05_425508	83	35	-	-	HYPH
10_1101-2021_01_05_425508	83	36	BY	BY	NNP
10_1101-2021_01_05_425508	83	37	-	-	HYPH
10_1101-2021_01_05_425508	83	38	NC	NC	NNP
10_1101-2021_01_05_425508	83	39	4.0	4.0	CD
10_1101-2021_01_05_425508	83	40	International	international	JJ
10_1101-2021_01_05_425508	83	41	licensemade	licensemade	NN
10_1101-2021_01_05_425508	83	42	available	available	JJ
10_1101-2021_01_05_425508	83	43	under	under	IN
10_1101-2021_01_05_425508	83	44	a	a	DT
10_1101-2021_01_05_425508	83	45	(	(	-LRB-
10_1101-2021_01_05_425508	83	46	which	which	WDT
10_1101-2021_01_05_425508	83	47	was	be	VBD
10_1101-2021_01_05_425508	83	48	not	not	RB
10_1101-2021_01_05_425508	83	49	certified	certify	VBN
10_1101-2021_01_05_425508	83	50	by	by	IN
10_1101-2021_01_05_425508	83	51	peer	peer	NN
10_1101-2021_01_05_425508	83	52	review	review	NN
10_1101-2021_01_05_425508	83	53	)	)	-RRB-
10_1101-2021_01_05_425508	83	54	is	be	VBZ
10_1101-2021_01_05_425508	83	55	the	the	DT
10_1101-2021_01_05_425508	83	56	author	author	NN
10_1101-2021_01_05_425508	83	57	/	/	SYM
10_1101-2021_01_05_425508	83	58	funder	funder	NN
10_1101-2021_01_05_425508	83	59	,	,	,
10_1101-2021_01_05_425508	83	60	who	who	WP
10_1101-2021_01_05_425508	83	61	has	have	VBZ
10_1101-2021_01_05_425508	83	62	granted	grant	VBN
10_1101-2021_01_05_425508	83	63	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	83	64	a	a	DT
10_1101-2021_01_05_425508	83	65	license	license	NN
10_1101-2021_01_05_425508	83	66	to	to	TO
10_1101-2021_01_05_425508	83	67	display	display	VB
10_1101-2021_01_05_425508	83	68	the	the	DT
10_1101-2021_01_05_425508	83	69	preprint	preprint	NN
10_1101-2021_01_05_425508	83	70	in	in	IN
10_1101-2021_01_05_425508	83	71	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	83	72	.	.	.
10_1101-2021_01_05_425508	84	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	84	2	is	be	VBZ
10_1101-2021_01_05_425508	84	3	The	the	DT
10_1101-2021_01_05_425508	84	4	copyright	copyright	NN
10_1101-2021_01_05_425508	84	5	holder	holder	NN
10_1101-2021_01_05_425508	84	6	for	for	IN
10_1101-2021_01_05_425508	84	7	this	this	DT
10_1101-2021_01_05_425508	84	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	84	9	version	version	NN
10_1101-2021_01_05_425508	84	10	posted	post	VBD
10_1101-2021_01_05_425508	84	11	January	January	NNP
10_1101-2021_01_05_425508	84	12	6	6	CD
10_1101-2021_01_05_425508	84	13	,	,	,
10_1101-2021_01_05_425508	84	14	2021	2021	CD
10_1101-2021_01_05_425508	84	15	.	.	.
10_1101-2021_01_05_425508	84	16	;	;	:
10_1101-2021_01_05_425508	84	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	84	18	:	:	:
10_1101-2021_01_05_425508	84	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	84	20	preprint	preprint	NN
10_1101-2021_01_05_425508	84	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	84	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	84	23	8	8	CD
10_1101-2021_01_05_425508	84	24	the	the	DT
10_1101-2021_01_05_425508	84	25	values	value	NNS
10_1101-2021_01_05_425508	84	26	of	of	IN
10_1101-2021_01_05_425508	84	27	the	the	DT
10_1101-2021_01_05_425508	84	28	difference	difference	NN
10_1101-2021_01_05_425508	84	29	according	accord	VBG
10_1101-2021_01_05_425508	84	30	to	to	IN
10_1101-2021_01_05_425508	84	31	the	the	DT
10_1101-2021_01_05_425508	84	32	elapsed	elapse	VBN
10_1101-2021_01_05_425508	84	33	month	month	NN
10_1101-2021_01_05_425508	84	34	for	for	IN
10_1101-2021_01_05_425508	84	35	each	each	DT
10_1101-2021_01_05_425508	84	36	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	84	37	.	.	.
10_1101-2021_01_05_425508	85	1	188	188	CD
10_1101-2021_01_05_425508	85	2	Changes	change	NNS
10_1101-2021_01_05_425508	85	3	in	in	IN
10_1101-2021_01_05_425508	85	4	the	the	DT
10_1101-2021_01_05_425508	85	5	compositions	composition	NNS
10_1101-2021_01_05_425508	85	6	of	of	IN
10_1101-2021_01_05_425508	85	7	both	both	DT
10_1101-2021_01_05_425508	85	8	C	C	NNP
10_1101-2021_01_05_425508	85	9	and	and	CC
10_1101-2021_01_05_425508	85	10	U	U	NNP
10_1101-2021_01_05_425508	85	11	clearly	clearly	RB
10_1101-2021_01_05_425508	85	12	reduced	reduce	VBD
10_1101-2021_01_05_425508	85	13	this	this	DT
10_1101-2021_01_05_425508	85	14	difference	difference	NN
10_1101-2021_01_05_425508	85	15	,	,	,
10_1101-2021_01_05_425508	85	16	as	as	IN
10_1101-2021_01_05_425508	85	17	the	the	DT
10_1101-2021_01_05_425508	85	18	189	189	CD
10_1101-2021_01_05_425508	85	19	compositions	composition	NNS
10_1101-2021_01_05_425508	85	20	of	of	IN
10_1101-2021_01_05_425508	85	21	these	these	DT
10_1101-2021_01_05_425508	85	22	nucleotides	nucleotide	NNS
10_1101-2021_01_05_425508	85	23	approached	approach	VBD
10_1101-2021_01_05_425508	85	24	the	the	DT
10_1101-2021_01_05_425508	85	25	hypothetical	hypothetical	JJ
10_1101-2021_01_05_425508	85	26	goal	goal	NN
10_1101-2021_01_05_425508	85	27	(	(	-LRB-
10_1101-2021_01_05_425508	85	28	Fig	fig	NN
10_1101-2021_01_05_425508	85	29	.	.	.
10_1101-2021_01_05_425508	86	1	4A	4A	NNP
10_1101-2021_01_05_425508	86	2	)	)	-RRB-
10_1101-2021_01_05_425508	86	3	;	;	:
10_1101-2021_01_05_425508	86	4	their	-PRON-	PRP$
10_1101-2021_01_05_425508	86	5	190	190	CD
10_1101-2021_01_05_425508	86	6	linear	linear	JJ
10_1101-2021_01_05_425508	86	7	reduction	reduction	NN
10_1101-2021_01_05_425508	86	8	supports	support	VBZ
10_1101-2021_01_05_425508	86	9	the	the	DT
10_1101-2021_01_05_425508	86	10	prediction	prediction	NN
10_1101-2021_01_05_425508	86	11	that	that	IN
10_1101-2021_01_05_425508	86	12	directional	directional	JJ
10_1101-2021_01_05_425508	86	13	changes	change	NNS
10_1101-2021_01_05_425508	86	14	in	in	IN
10_1101-2021_01_05_425508	86	15	the	the	DT
10_1101-2021_01_05_425508	86	16	composition	composition	NN
10_1101-2021_01_05_425508	86	17	of	of	IN
10_1101-2021_01_05_425508	86	18	C	C	NNP
10_1101-2021_01_05_425508	86	19	191	191	CD
10_1101-2021_01_05_425508	86	20	and	and	CC
10_1101-2021_01_05_425508	86	21	U	u	NN
10_1101-2021_01_05_425508	86	22	will	will	MD
10_1101-2021_01_05_425508	86	23	continue	continue	VB
10_1101-2021_01_05_425508	86	24	for	for	IN
10_1101-2021_01_05_425508	86	25	the	the	DT
10_1101-2021_01_05_425508	86	26	foreseeable	foreseeable	JJ
10_1101-2021_01_05_425508	86	27	future	future	NN
10_1101-2021_01_05_425508	86	28	.	.	.
10_1101-2021_01_05_425508	87	1	In	in	IN
10_1101-2021_01_05_425508	87	2	contrast	contrast	NN
10_1101-2021_01_05_425508	87	3	,	,	,
10_1101-2021_01_05_425508	87	4	A	a	NN
10_1101-2021_01_05_425508	87	5	and	and	CC
10_1101-2021_01_05_425508	87	6	G	G	NNP
10_1101-2021_01_05_425508	87	7	did	do	VBD
10_1101-2021_01_05_425508	87	8	not	not	RB
10_1101-2021_01_05_425508	87	9	show	show	VB
10_1101-2021_01_05_425508	87	10	192	192	CD
10_1101-2021_01_05_425508	87	11	directional	directional	JJ
10_1101-2021_01_05_425508	87	12	changes	change	NNS
10_1101-2021_01_05_425508	87	13	in	in	IN
10_1101-2021_01_05_425508	87	14	composition	composition	NN
10_1101-2021_01_05_425508	87	15	,	,	,
10_1101-2021_01_05_425508	87	16	which	which	WDT
10_1101-2021_01_05_425508	87	17	is	be	VBZ
10_1101-2021_01_05_425508	87	18	most	most	RBS
10_1101-2021_01_05_425508	87	19	likely	likely	JJ
10_1101-2021_01_05_425508	87	20	due	due	IN
10_1101-2021_01_05_425508	87	21	to	to	IN
10_1101-2021_01_05_425508	87	22	the	the	DT
10_1101-2021_01_05_425508	87	23	absence	absence	NN
10_1101-2021_01_05_425508	87	24	of	of	IN
10_1101-2021_01_05_425508	87	25	clear	clear	JJ
10_1101-2021_01_05_425508	87	26	193	193	CD
10_1101-2021_01_05_425508	87	27	differences	difference	NNS
10_1101-2021_01_05_425508	87	28	in	in	IN
10_1101-2021_01_05_425508	87	29	the	the	DT
10_1101-2021_01_05_425508	87	30	A	a	NN
10_1101-2021_01_05_425508	87	31	and	and	CC
10_1101-2021_01_05_425508	87	32	G	g	NN
10_1101-2021_01_05_425508	87	33	compositions	composition	NNS
10_1101-2021_01_05_425508	87	34	of	of	IN
10_1101-2021_01_05_425508	87	35	human-	human-	NN
10_1101-2021_01_05_425508	87	36	and	and	CC
10_1101-2021_01_05_425508	87	37	bat	bat	NN
10_1101-2021_01_05_425508	87	38	-	-	HYPH
10_1101-2021_01_05_425508	87	39	CoV	cov	NN
10_1101-2021_01_05_425508	87	40	,	,	,
10_1101-2021_01_05_425508	87	41	i.e.	i.e.	FW
10_1101-2021_01_05_425508	87	42	,	,	,
10_1101-2021_01_05_425508	87	43	there	there	EX
10_1101-2021_01_05_425508	87	44	is	be	VBZ
10_1101-2021_01_05_425508	87	45	no	no	DT
10_1101-2021_01_05_425508	87	46	194	194	CD
10_1101-2021_01_05_425508	87	47	possible	possible	JJ
10_1101-2021_01_05_425508	87	48	target	target	NN
10_1101-2021_01_05_425508	87	49	(	(	-LRB-
10_1101-2021_01_05_425508	87	50	Fig	fig	NN
10_1101-2021_01_05_425508	87	51	.	.	.
10_1101-2021_01_05_425508	88	1	3A	3A	NNP
10_1101-2021_01_05_425508	88	2	)	)	-RRB-
10_1101-2021_01_05_425508	88	3	.	.	.
10_1101-2021_01_05_425508	89	1	Fig	fig	NN
10_1101-2021_01_05_425508	89	2	.	.	.
10_1101-2021_01_05_425508	90	1	4B	4B	NNP
10_1101-2021_01_05_425508	90	2	shows	show	VBZ
10_1101-2021_01_05_425508	90	3	examples	example	NNS
10_1101-2021_01_05_425508	90	4	of	of	IN
10_1101-2021_01_05_425508	90	5	di-	di-	XX
10_1101-2021_01_05_425508	90	6	and	and	CC
10_1101-2021_01_05_425508	90	7	trinucleotides	trinucleotide	NNS
10_1101-2021_01_05_425508	90	8	whose	whose	WP$
10_1101-2021_01_05_425508	90	9	195	195	CD
10_1101-2021_01_05_425508	90	10	compositions	composition	NNS
10_1101-2021_01_05_425508	90	11	have	have	VBP
10_1101-2021_01_05_425508	90	12	moved	move	VBN
10_1101-2021_01_05_425508	90	13	towards	towards	IN
10_1101-2021_01_05_425508	90	14	the	the	DT
10_1101-2021_01_05_425508	90	15	hypothetical	hypothetical	JJ
10_1101-2021_01_05_425508	90	16	goal	goal	NN
10_1101-2021_01_05_425508	90	17	,	,	,
10_1101-2021_01_05_425508	90	18	but	but	CC
10_1101-2021_01_05_425508	90	19	Fig	Fig	NNP
10_1101-2021_01_05_425508	90	20	.	.	.
10_1101-2021_01_05_425508	91	1	4C	4C	NNP
10_1101-2021_01_05_425508	91	2	shows	show	VBZ
10_1101-2021_01_05_425508	91	3	a	a	DT
10_1101-2021_01_05_425508	91	4	few	few	JJ
10_1101-2021_01_05_425508	91	5	196	196	CD
10_1101-2021_01_05_425508	91	6	exceptional	exceptional	JJ
10_1101-2021_01_05_425508	91	7	nucleotides	nucleotide	NNS
10_1101-2021_01_05_425508	91	8	whose	whose	WP$
10_1101-2021_01_05_425508	91	9	compositions	composition	NNS
10_1101-2021_01_05_425508	91	10	have	have	VBP
10_1101-2021_01_05_425508	91	11	not	not	RB
10_1101-2021_01_05_425508	91	12	changed	change	VBN
10_1101-2021_01_05_425508	91	13	towards	towards	IN
10_1101-2021_01_05_425508	91	14	the	the	DT
10_1101-2021_01_05_425508	91	15	hypothetical	hypothetical	JJ
10_1101-2021_01_05_425508	91	16	197	197	CD
10_1101-2021_01_05_425508	91	17	goal	goal	NN
10_1101-2021_01_05_425508	91	18	but	but	CC
10_1101-2021_01_05_425508	91	19	have	have	VBP
10_1101-2021_01_05_425508	91	20	changed	change	VBN
10_1101-2021_01_05_425508	91	21	with	with	IN
10_1101-2021_01_05_425508	91	22	a	a	DT
10_1101-2021_01_05_425508	91	23	common	common	JJ
10_1101-2021_01_05_425508	91	24	directionality	directionality	NN
10_1101-2021_01_05_425508	91	25	among	among	IN
10_1101-2021_01_05_425508	91	26	the	the	DT
10_1101-2021_01_05_425508	91	27	six	six	CD
10_1101-2021_01_05_425508	91	28	clades	clade	NNS
10_1101-2021_01_05_425508	91	29	.	.	.
10_1101-2021_01_05_425508	92	1	In	in	IN
10_1101-2021_01_05_425508	92	2	Fig	Fig	NNP
10_1101-2021_01_05_425508	92	3	.	.	.
10_1101-2021_01_05_425508	93	1	4D	4d	CD
10_1101-2021_01_05_425508	93	2	,	,	,
10_1101-2021_01_05_425508	93	3	198	198	CD
10_1101-2021_01_05_425508	93	4	correlation	correlation	NN
10_1101-2021_01_05_425508	93	5	coefficients	coefficient	NNS
10_1101-2021_01_05_425508	93	6	between	between	IN
10_1101-2021_01_05_425508	93	7	the	the	DT
10_1101-2021_01_05_425508	93	8	above	above	JJ
10_1101-2021_01_05_425508	93	9	difference	difference	NN
10_1101-2021_01_05_425508	93	10	and	and	CC
10_1101-2021_01_05_425508	93	11	the	the	DT
10_1101-2021_01_05_425508	93	12	elapsed	elapse	VBN
10_1101-2021_01_05_425508	93	13	month	month	NN
10_1101-2021_01_05_425508	93	14	are	be	VBP
10_1101-2021_01_05_425508	93	15	199	199	CD
10_1101-2021_01_05_425508	93	16	presented	present	VBN
10_1101-2021_01_05_425508	93	17	.	.	.
10_1101-2021_01_05_425508	94	1	Most	Most	JJS
10_1101-2021_01_05_425508	94	2	nucleotides	nucleotide	NNS
10_1101-2021_01_05_425508	94	3	of	of	IN
10_1101-2021_01_05_425508	94	4	interest	interest	NN
10_1101-2021_01_05_425508	94	5	showed	show	VBD
10_1101-2021_01_05_425508	94	6	a	a	DT
10_1101-2021_01_05_425508	94	7	negative	negative	JJ
10_1101-2021_01_05_425508	94	8	coefficient	coefficient	NN
10_1101-2021_01_05_425508	94	9	(	(	-LRB-
10_1101-2021_01_05_425508	94	10	i.e.	i.e.	FW
10_1101-2021_01_05_425508	94	11	,	,	,
10_1101-2021_01_05_425508	94	12	a	a	DT
10_1101-2021_01_05_425508	94	13	directional	directional	JJ
10_1101-2021_01_05_425508	94	14	200	200	CD
10_1101-2021_01_05_425508	94	15	change	change	NN
10_1101-2021_01_05_425508	94	16	towards	towards	IN
10_1101-2021_01_05_425508	94	17	human	human	NN
10_1101-2021_01_05_425508	94	18	-	-	HYPH
10_1101-2021_01_05_425508	94	19	CoV	cov	NN
10_1101-2021_01_05_425508	94	20	)	)	-RRB-
10_1101-2021_01_05_425508	94	21	,	,	,
10_1101-2021_01_05_425508	94	22	but	but	CC
10_1101-2021_01_05_425508	94	23	three	three	CD
10_1101-2021_01_05_425508	94	24	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	94	25	,	,	,
10_1101-2021_01_05_425508	94	26	GG	GG	NNP
10_1101-2021_01_05_425508	94	27	,	,	,
10_1101-2021_01_05_425508	94	28	AGC	AGC	NNP
10_1101-2021_01_05_425508	94	29	and	and	CC
10_1101-2021_01_05_425508	94	30	CAU	CAU	NNP
10_1101-2021_01_05_425508	94	31	,	,	,
10_1101-2021_01_05_425508	94	32	showed	show	VBD
10_1101-2021_01_05_425508	94	33	201	201	CD
10_1101-2021_01_05_425508	94	34	positive	positive	JJ
10_1101-2021_01_05_425508	94	35	coefficients	coefficient	NNS
10_1101-2021_01_05_425508	94	36	indicating	indicate	VBG
10_1101-2021_01_05_425508	94	37	an	an	DT
10_1101-2021_01_05_425508	94	38	increase	increase	NN
10_1101-2021_01_05_425508	94	39	in	in	IN
10_1101-2021_01_05_425508	94	40	the	the	DT
10_1101-2021_01_05_425508	94	41	difference	difference	NN
10_1101-2021_01_05_425508	94	42	(	(	-LRB-
10_1101-2021_01_05_425508	94	43	i.e.	i.e.	FW
10_1101-2021_01_05_425508	94	44	,	,	,
10_1101-2021_01_05_425508	94	45	moving	move	VBG
10_1101-2021_01_05_425508	94	46	away	away	RB
10_1101-2021_01_05_425508	94	47	from	from	IN
10_1101-2021_01_05_425508	94	48	the	the	DT
10_1101-2021_01_05_425508	94	49	202	202	CD
10_1101-2021_01_05_425508	94	50	human	human	JJ
10_1101-2021_01_05_425508	94	51	-	-	HYPH
10_1101-2021_01_05_425508	94	52	CoV	cov	NN
10_1101-2021_01_05_425508	94	53	level	level	NN
10_1101-2021_01_05_425508	94	54	)	)	-RRB-
10_1101-2021_01_05_425508	94	55	.	.	.
10_1101-2021_01_05_425508	95	1	For	for	IN
10_1101-2021_01_05_425508	95	2	these	these	DT
10_1101-2021_01_05_425508	95	3	opposing	oppose	VBG
10_1101-2021_01_05_425508	95	4	directional	directional	JJ
10_1101-2021_01_05_425508	95	5	changes	change	NNS
10_1101-2021_01_05_425508	95	6	,	,	,
10_1101-2021_01_05_425508	95	7	certain	certain	JJ
10_1101-2021_01_05_425508	95	8	causes	cause	NNS
10_1101-2021_01_05_425508	95	9	specific	specific	JJ
10_1101-2021_01_05_425508	95	10	to	to	IN
10_1101-2021_01_05_425508	95	11	203	203	CD
10_1101-2021_01_05_425508	95	12	SARS	SARS	NNP
10_1101-2021_01_05_425508	95	13	-	-	HYPH
10_1101-2021_01_05_425508	95	14	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	95	15	may	may	MD
10_1101-2021_01_05_425508	95	16	be	be	VB
10_1101-2021_01_05_425508	95	17	assumed	assume	VBN
10_1101-2021_01_05_425508	95	18	.	.	.
10_1101-2021_01_05_425508	96	1	204	204	CD
10_1101-2021_01_05_425508	96	2	205	205	CD
10_1101-2021_01_05_425508	96	3	Motifs	motif	NNS
10_1101-2021_01_05_425508	96	4	for	for	IN
10_1101-2021_01_05_425508	96	5	RNA	RNA	NNP
10_1101-2021_01_05_425508	96	6	-	-	HYPH
10_1101-2021_01_05_425508	96	7	binding	bind	VBG
10_1101-2021_01_05_425508	96	8	proteins	protein	NNS
10_1101-2021_01_05_425508	96	9	206	206	CD
10_1101-2021_01_05_425508	96	10	Next	next	RB
10_1101-2021_01_05_425508	96	11	,	,	,
10_1101-2021_01_05_425508	96	12	we	-PRON-	PRP
10_1101-2021_01_05_425508	96	13	considered	consider	VBD
10_1101-2021_01_05_425508	96	14	the	the	DT
10_1101-2021_01_05_425508	96	15	mechanisms	mechanism	NNS
10_1101-2021_01_05_425508	96	16	that	that	WDT
10_1101-2021_01_05_425508	96	17	move	move	VBP
10_1101-2021_01_05_425508	96	18	oligonucleotide	oligonucleotide	RB
10_1101-2021_01_05_425508	96	19	compositions	composition	NNS
10_1101-2021_01_05_425508	96	20	away	away	RB
10_1101-2021_01_05_425508	96	21	207	207	CD
10_1101-2021_01_05_425508	96	22	from	from	IN
10_1101-2021_01_05_425508	96	23	those	those	DT
10_1101-2021_01_05_425508	96	24	of	of	IN
10_1101-2021_01_05_425508	96	25	bat	bat	NN
10_1101-2021_01_05_425508	96	26	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	96	27	and	and	CC
10_1101-2021_01_05_425508	96	28	closer	close	JJR
10_1101-2021_01_05_425508	96	29	to	to	IN
10_1101-2021_01_05_425508	96	30	those	those	DT
10_1101-2021_01_05_425508	96	31	of	of	IN
10_1101-2021_01_05_425508	96	32	human	human	JJ
10_1101-2021_01_05_425508	96	33	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	96	34	.	.	.
10_1101-2021_01_05_425508	97	1	Certain	certain	JJ
10_1101-2021_01_05_425508	97	2	208	208	CD
10_1101-2021_01_05_425508	97	3	human	human	JJ
10_1101-2021_01_05_425508	97	4	cellular	cellular	JJ
10_1101-2021_01_05_425508	97	5	factors	factor	NNS
10_1101-2021_01_05_425508	97	6	involved	involve	VBN
10_1101-2021_01_05_425508	97	7	in	in	IN
10_1101-2021_01_05_425508	97	8	viral	viral	JJ
10_1101-2021_01_05_425508	97	9	growth	growth	NN
10_1101-2021_01_05_425508	97	10	may	may	MD
10_1101-2021_01_05_425508	97	11	be	be	VB
10_1101-2021_01_05_425508	97	12	candidates	candidate	NNS
10_1101-2021_01_05_425508	97	13	in	in	IN
10_1101-2021_01_05_425508	97	14	such	such	JJ
10_1101-2021_01_05_425508	97	15	mechanisms	mechanism	NNS
10_1101-2021_01_05_425508	97	16	.	.	.
10_1101-2021_01_05_425508	98	1	209	209	CD
10_1101-2021_01_05_425508	98	2	When	when	WRB
10_1101-2021_01_05_425508	98	3	considering	consider	VBG
10_1101-2021_01_05_425508	98	4	possible	possible	JJ
10_1101-2021_01_05_425508	98	5	protein	protein	NN
10_1101-2021_01_05_425508	98	6	factors	factor	NNS
10_1101-2021_01_05_425508	98	7	,	,	,
10_1101-2021_01_05_425508	98	8	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	98	9	longer	long	JJR
10_1101-2021_01_05_425508	98	10	than	than	IN
10_1101-2021_01_05_425508	98	11	trinucleotides	trinucleotide	NNS
10_1101-2021_01_05_425508	98	12	210	210	CD
10_1101-2021_01_05_425508	98	13	should	should	MD
10_1101-2021_01_05_425508	98	14	be	be	VB
10_1101-2021_01_05_425508	98	15	a	a	DT
10_1101-2021_01_05_425508	98	16	focus	focus	NN
10_1101-2021_01_05_425508	98	17	.	.	.
10_1101-2021_01_05_425508	99	1	As	as	IN
10_1101-2021_01_05_425508	99	2	an	an	DT
10_1101-2021_01_05_425508	99	3	attempt	attempt	NN
10_1101-2021_01_05_425508	99	4	,	,	,
10_1101-2021_01_05_425508	99	5	we	-PRON-	PRP
10_1101-2021_01_05_425508	99	6	here	here	RB
10_1101-2021_01_05_425508	99	7	focused	focus	VBD
10_1101-2021_01_05_425508	99	8	on	on	IN
10_1101-2021_01_05_425508	99	9	host	host	NN
10_1101-2021_01_05_425508	99	10	RNA	RNA	NNP
10_1101-2021_01_05_425508	99	11	-	-	HYPH
10_1101-2021_01_05_425508	99	12	binding	bind	VBG
10_1101-2021_01_05_425508	99	13	proteins	protein	NNS
10_1101-2021_01_05_425508	99	14	211	211	CD
10_1101-2021_01_05_425508	99	15	because	because	IN
10_1101-2021_01_05_425508	99	16	their	-PRON-	PRP$
10_1101-2021_01_05_425508	99	17	binding	binding	NN
10_1101-2021_01_05_425508	99	18	to	to	IN
10_1101-2021_01_05_425508	99	19	hepatitis	hepatitis	NNP
10_1101-2021_01_05_425508	99	20	C	C	NNP
10_1101-2021_01_05_425508	99	21	virus	virus	NN
10_1101-2021_01_05_425508	99	22	is	be	VBZ
10_1101-2021_01_05_425508	99	23	known	know	VBN
10_1101-2021_01_05_425508	99	24	to	to	TO
10_1101-2021_01_05_425508	99	25	be	be	VB
10_1101-2021_01_05_425508	99	26	involved	involve	VBN
10_1101-2021_01_05_425508	99	27	in	in	IN
10_1101-2021_01_05_425508	99	28	the	the	DT
10_1101-2021_01_05_425508	99	29	growth	growth	NN
10_1101-2021_01_05_425508	99	30	of	of	IN
10_1101-2021_01_05_425508	99	31	this	this	DT
10_1101-2021_01_05_425508	99	32	212	212	CD
10_1101-2021_01_05_425508	99	33	RNA	RNA	NNP
10_1101-2021_01_05_425508	99	34	virus	virus	NN
10_1101-2021_01_05_425508	99	35	[	[	-LRB-
10_1101-2021_01_05_425508	99	36	20	20	CD
10_1101-2021_01_05_425508	99	37	]	]	-RRB-
10_1101-2021_01_05_425508	99	38	.	.	.
10_1101-2021_01_05_425508	100	1	We	-PRON-	PRP
10_1101-2021_01_05_425508	100	2	thus	thus	RB
10_1101-2021_01_05_425508	100	3	searched	search	VBD
10_1101-2021_01_05_425508	100	4	for	for	IN
10_1101-2021_01_05_425508	100	5	motifs	motif	NNS
10_1101-2021_01_05_425508	100	6	for	for	IN
10_1101-2021_01_05_425508	100	7	human	human	JJ
10_1101-2021_01_05_425508	100	8	RNA	RNA	NNP
10_1101-2021_01_05_425508	100	9	-	-	HYPH
10_1101-2021_01_05_425508	100	10	binding	bind	VBG
10_1101-2021_01_05_425508	100	11	proteins	protein	NNS
10_1101-2021_01_05_425508	100	12	in	in	IN
10_1101-2021_01_05_425508	100	13	213	213	CD
10_1101-2021_01_05_425508	100	14	coronavirus	coronavirus	NN
10_1101-2021_01_05_425508	100	15	genomes	genome	NNS
10_1101-2021_01_05_425508	100	16	(	(	-LRB-
10_1101-2021_01_05_425508	100	17	see	see	VB
10_1101-2021_01_05_425508	100	18	Methods	Methods	NNP
10_1101-2021_01_05_425508	100	19	section	section	NN
10_1101-2021_01_05_425508	100	20	)	)	-RRB-
10_1101-2021_01_05_425508	100	21	and	and	CC
10_1101-2021_01_05_425508	100	22	found	find	VBD
10_1101-2021_01_05_425508	100	23	multiple	multiple	JJ
10_1101-2021_01_05_425508	100	24	loci	loci	NN
10_1101-2021_01_05_425508	100	25	with	with	IN
10_1101-2021_01_05_425508	100	26	binding	bind	VBG
10_1101-2021_01_05_425508	100	27	motifs	motif	NNS
10_1101-2021_01_05_425508	100	28	214	214	CD
10_1101-2021_01_05_425508	100	29	.CC	.CC	,
10_1101-2021_01_05_425508	100	30	-	-	:
10_1101-2021_01_05_425508	100	31	BY	BY	NNP
10_1101-2021_01_05_425508	100	32	-	-	HYPH
10_1101-2021_01_05_425508	100	33	NC	NC	NNP
10_1101-2021_01_05_425508	100	34	4.0	4.0	CD
10_1101-2021_01_05_425508	100	35	International	international	JJ
10_1101-2021_01_05_425508	100	36	licensemade	licensemade	NN
10_1101-2021_01_05_425508	100	37	available	available	JJ
10_1101-2021_01_05_425508	100	38	under	under	IN
10_1101-2021_01_05_425508	100	39	a	a	DT
10_1101-2021_01_05_425508	100	40	(	(	-LRB-
10_1101-2021_01_05_425508	100	41	which	which	WDT
10_1101-2021_01_05_425508	100	42	was	be	VBD
10_1101-2021_01_05_425508	100	43	not	not	RB
10_1101-2021_01_05_425508	100	44	certified	certify	VBN
10_1101-2021_01_05_425508	100	45	by	by	IN
10_1101-2021_01_05_425508	100	46	peer	peer	NN
10_1101-2021_01_05_425508	100	47	review	review	NN
10_1101-2021_01_05_425508	100	48	)	)	-RRB-
10_1101-2021_01_05_425508	100	49	is	be	VBZ
10_1101-2021_01_05_425508	100	50	the	the	DT
10_1101-2021_01_05_425508	100	51	author	author	NN
10_1101-2021_01_05_425508	100	52	/	/	SYM
10_1101-2021_01_05_425508	100	53	funder	funder	NN
10_1101-2021_01_05_425508	100	54	,	,	,
10_1101-2021_01_05_425508	100	55	who	who	WP
10_1101-2021_01_05_425508	100	56	has	have	VBZ
10_1101-2021_01_05_425508	100	57	granted	grant	VBN
10_1101-2021_01_05_425508	100	58	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	100	59	a	a	DT
10_1101-2021_01_05_425508	100	60	license	license	NN
10_1101-2021_01_05_425508	100	61	to	to	TO
10_1101-2021_01_05_425508	100	62	display	display	VB
10_1101-2021_01_05_425508	100	63	the	the	DT
10_1101-2021_01_05_425508	100	64	preprint	preprint	NN
10_1101-2021_01_05_425508	100	65	in	in	IN
10_1101-2021_01_05_425508	100	66	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	100	67	.	.	.
10_1101-2021_01_05_425508	101	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	101	2	is	be	VBZ
10_1101-2021_01_05_425508	101	3	The	the	DT
10_1101-2021_01_05_425508	101	4	copyright	copyright	NN
10_1101-2021_01_05_425508	101	5	holder	holder	NN
10_1101-2021_01_05_425508	101	6	for	for	IN
10_1101-2021_01_05_425508	101	7	this	this	DT
10_1101-2021_01_05_425508	101	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	101	9	version	version	NN
10_1101-2021_01_05_425508	101	10	posted	post	VBD
10_1101-2021_01_05_425508	101	11	January	January	NNP
10_1101-2021_01_05_425508	101	12	6	6	CD
10_1101-2021_01_05_425508	101	13	,	,	,
10_1101-2021_01_05_425508	101	14	2021	2021	CD
10_1101-2021_01_05_425508	101	15	.	.	.
10_1101-2021_01_05_425508	101	16	;	;	:
10_1101-2021_01_05_425508	101	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	101	18	:	:	:
10_1101-2021_01_05_425508	101	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	101	20	preprint	preprint	NN
10_1101-2021_01_05_425508	101	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	CD
10_1101-2021_01_05_425508	101	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NN
10_1101-2021_01_05_425508	101	23	9	9	CD
10_1101-2021_01_05_425508	101	24	for	for	IN
10_1101-2021_01_05_425508	101	25	each	each	DT
10_1101-2021_01_05_425508	101	26	protein	protein	NN
10_1101-2021_01_05_425508	101	27	.	.	.
10_1101-2021_01_05_425508	102	1	Table	table	NN
10_1101-2021_01_05_425508	102	2	3	3	CD
10_1101-2021_01_05_425508	102	3	(	(	-LRB-
10_1101-2021_01_05_425508	102	4	and	and	CC
10_1101-2021_01_05_425508	102	5	Table	Table	NNP
10_1101-2021_01_05_425508	102	6	S10	S10	NNP
10_1101-2021_01_05_425508	102	7	)	)	-RRB-
10_1101-2021_01_05_425508	102	8	lists	list	VBZ
10_1101-2021_01_05_425508	102	9	the	the	DT
10_1101-2021_01_05_425508	102	10	motifs	motif	NNS
10_1101-2021_01_05_425508	102	11	for	for	IN
10_1101-2021_01_05_425508	102	12	which	which	WDT
10_1101-2021_01_05_425508	102	13	a	a	DT
10_1101-2021_01_05_425508	102	14	directional	directional	JJ
10_1101-2021_01_05_425508	102	15	time-215	time-215	JJ
10_1101-2021_01_05_425508	102	16	dependent	dependent	JJ
10_1101-2021_01_05_425508	102	17	change	change	NN
10_1101-2021_01_05_425508	102	18	was	be	VBD
10_1101-2021_01_05_425508	102	19	primarily	primarily	RB
10_1101-2021_01_05_425508	102	20	common	common	JJ
10_1101-2021_01_05_425508	102	21	among	among	IN
10_1101-2021_01_05_425508	102	22	six	six	CD
10_1101-2021_01_05_425508	102	23	clades	clade	NNS
10_1101-2021_01_05_425508	102	24	.	.	.
10_1101-2021_01_05_425508	103	1	Table	table	NN
10_1101-2021_01_05_425508	103	2	3	3	CD
10_1101-2021_01_05_425508	103	3	and	and	CC
10_1101-2021_01_05_425508	103	4	Fig	Fig	NNP
10_1101-2021_01_05_425508	103	5	.	.	.
10_1101-2021_01_05_425508	104	1	5A	5a	RB
10_1101-2021_01_05_425508	104	2	show	show	VB
10_1101-2021_01_05_425508	104	3	216	216	CD
10_1101-2021_01_05_425508	104	4	that	that	WDT
10_1101-2021_01_05_425508	104	5	only	only	RB
10_1101-2021_01_05_425508	104	6	ELAVL1	elavl1	NN
10_1101-2021_01_05_425508	104	7	showed	show	VBD
10_1101-2021_01_05_425508	104	8	a	a	DT
10_1101-2021_01_05_425508	104	9	positive	positive	JJ
10_1101-2021_01_05_425508	104	10	correlation	correlation	NN
10_1101-2021_01_05_425508	104	11	,	,	,
10_1101-2021_01_05_425508	104	12	but	but	CC
10_1101-2021_01_05_425508	104	13	the	the	DT
10_1101-2021_01_05_425508	104	14	other	other	JJ
10_1101-2021_01_05_425508	104	15	nine	nine	CD
10_1101-2021_01_05_425508	104	16	proteins	protein	NNS
10_1101-2021_01_05_425508	104	17	in	in	IN
10_1101-2021_01_05_425508	104	18	Table	table	NN
10_1101-2021_01_05_425508	104	19	3	3	CD
10_1101-2021_01_05_425508	104	20	217	217	CD
10_1101-2021_01_05_425508	104	21	showed	show	VBD
10_1101-2021_01_05_425508	104	22	a	a	DT
10_1101-2021_01_05_425508	104	23	negative	negative	JJ
10_1101-2021_01_05_425508	104	24	correlation	correlation	NN
10_1101-2021_01_05_425508	104	25	for	for	IN
10_1101-2021_01_05_425508	104	26	almost	almost	RB
10_1101-2021_01_05_425508	104	27	all	all	DT
10_1101-2021_01_05_425508	104	28	clades	clade	NNS
10_1101-2021_01_05_425508	104	29	;	;	:
10_1101-2021_01_05_425508	104	30	the	the	DT
10_1101-2021_01_05_425508	104	31	results	result	NNS
10_1101-2021_01_05_425508	104	32	for	for	IN
10_1101-2021_01_05_425508	104	33	other	other	JJ
10_1101-2021_01_05_425508	104	34	motifs	motif	NNS
10_1101-2021_01_05_425508	104	35	are	be	VBP
10_1101-2021_01_05_425508	104	36	218	218	CD
10_1101-2021_01_05_425508	104	37	presented	present	VBN
10_1101-2021_01_05_425508	104	38	in	in	IN
10_1101-2021_01_05_425508	104	39	Table	Table	NNP
10_1101-2021_01_05_425508	104	40	S12	S12	NNP
10_1101-2021_01_05_425508	104	41	.	.	.
10_1101-2021_01_05_425508	105	1	219	219	CD
10_1101-2021_01_05_425508	105	2	We	-PRON-	PRP
10_1101-2021_01_05_425508	105	3	next	next	RB
10_1101-2021_01_05_425508	105	4	compared	compare	VBD
10_1101-2021_01_05_425508	105	5	the	the	DT
10_1101-2021_01_05_425508	105	6	numbers	number	NNS
10_1101-2021_01_05_425508	105	7	of	of	IN
10_1101-2021_01_05_425508	105	8	these	these	DT
10_1101-2021_01_05_425508	105	9	motifs	motif	NNS
10_1101-2021_01_05_425508	105	10	in	in	IN
10_1101-2021_01_05_425508	105	11	SARS	SARS	NNP
10_1101-2021_01_05_425508	105	12	-	-	HYPH
10_1101-2021_01_05_425508	105	13	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	105	14	with	with	IN
10_1101-2021_01_05_425508	105	15	the	the	DT
10_1101-2021_01_05_425508	105	16	220	220	CD
10_1101-2021_01_05_425508	105	17	numbers	number	NNS
10_1101-2021_01_05_425508	105	18	of	of	IN
10_1101-2021_01_05_425508	105	19	human-	human-	NN
10_1101-2021_01_05_425508	105	20	and	and	CC
10_1101-2021_01_05_425508	105	21	bat	bat	NN
10_1101-2021_01_05_425508	105	22	-	-	HYPH
10_1101-2021_01_05_425508	105	23	CoV	cov	NN
10_1101-2021_01_05_425508	105	24	motifs	motif	NNS
10_1101-2021_01_05_425508	105	25	(	(	-LRB-
10_1101-2021_01_05_425508	105	26	Fig	fig	NN
10_1101-2021_01_05_425508	105	27	.	.	.
10_1101-2021_01_05_425508	106	1	5B	5b	JJ
10_1101-2021_01_05_425508	106	2	)	)	-RRB-
10_1101-2021_01_05_425508	106	3	.	.	.
10_1101-2021_01_05_425508	107	1	Of	of	IN
10_1101-2021_01_05_425508	107	2	the	the	DT
10_1101-2021_01_05_425508	107	3	ten	ten	CD
10_1101-2021_01_05_425508	107	4	proteins	protein	NNS
10_1101-2021_01_05_425508	107	5	shown	show	VBN
10_1101-2021_01_05_425508	107	6	in	in	IN
10_1101-2021_01_05_425508	107	7	Table	Table	NNP
10_1101-2021_01_05_425508	107	8	3	3	CD
10_1101-2021_01_05_425508	107	9	,	,	,
10_1101-2021_01_05_425508	107	10	221	221	CD
10_1101-2021_01_05_425508	107	11	the	the	DT
10_1101-2021_01_05_425508	107	12	only	only	JJ
10_1101-2021_01_05_425508	107	13	elevated	elevated	JJ
10_1101-2021_01_05_425508	107	14	motif	motif	NN
10_1101-2021_01_05_425508	107	15	,	,	,
10_1101-2021_01_05_425508	107	16	that	that	IN
10_1101-2021_01_05_425508	107	17	for	for	IN
10_1101-2021_01_05_425508	107	18	ELAVL1	elavl1	NN
10_1101-2021_01_05_425508	107	19	binding	binding	NN
10_1101-2021_01_05_425508	107	20	,	,	,
10_1101-2021_01_05_425508	107	21	was	be	VBD
10_1101-2021_01_05_425508	107	22	found	find	VBN
10_1101-2021_01_05_425508	107	23	in	in	IN
10_1101-2021_01_05_425508	107	24	a	a	DT
10_1101-2021_01_05_425508	107	25	significantly	significantly	RB
10_1101-2021_01_05_425508	107	26	higher	high	JJR
10_1101-2021_01_05_425508	107	27	222	222	CD
10_1101-2021_01_05_425508	107	28	number	number	NN
10_1101-2021_01_05_425508	107	29	of	of	IN
10_1101-2021_01_05_425508	107	30	loci	loci	NN
10_1101-2021_01_05_425508	107	31	in	in	IN
10_1101-2021_01_05_425508	107	32	human	human	NN
10_1101-2021_01_05_425508	107	33	-	-	HYPH
10_1101-2021_01_05_425508	107	34	CoV	cov	NN
10_1101-2021_01_05_425508	107	35	than	than	IN
10_1101-2021_01_05_425508	107	36	in	in	IN
10_1101-2021_01_05_425508	107	37	bat	bat	NN
10_1101-2021_01_05_425508	107	38	-	-	HYPH
10_1101-2021_01_05_425508	107	39	CoV	cov	NN
10_1101-2021_01_05_425508	107	40	,	,	,
10_1101-2021_01_05_425508	107	41	but	but	CC
10_1101-2021_01_05_425508	107	42	motifs	motif	NNS
10_1101-2021_01_05_425508	107	43	for	for	IN
10_1101-2021_01_05_425508	107	44	PCBP2	pcbp2	NN
10_1101-2021_01_05_425508	107	45	and	and	CC
10_1101-2021_01_05_425508	107	46	SRSF1	SRSF1	NNP
10_1101-2021_01_05_425508	107	47	223	223	CD
10_1101-2021_01_05_425508	107	48	binding	bind	VBG
10_1101-2021_01_05_425508	107	49	,	,	,
10_1101-2021_01_05_425508	107	50	which	which	WDT
10_1101-2021_01_05_425508	107	51	tended	tend	VBD
10_1101-2021_01_05_425508	107	52	to	to	TO
10_1101-2021_01_05_425508	107	53	decrease	decrease	VB
10_1101-2021_01_05_425508	107	54	(	(	-LRB-
10_1101-2021_01_05_425508	107	55	Table	table	NN
10_1101-2021_01_05_425508	107	56	3	3	CD
10_1101-2021_01_05_425508	107	57	)	)	-RRB-
10_1101-2021_01_05_425508	107	58	,	,	,
10_1101-2021_01_05_425508	107	59	were	be	VBD
10_1101-2021_01_05_425508	107	60	found	find	VBN
10_1101-2021_01_05_425508	107	61	in	in	IN
10_1101-2021_01_05_425508	107	62	significantly	significantly	RB
10_1101-2021_01_05_425508	107	63	fewer	few	JJR
10_1101-2021_01_05_425508	107	64	loci	loci	NN
10_1101-2021_01_05_425508	107	65	in	in	IN
10_1101-2021_01_05_425508	107	66	224	224	CD
10_1101-2021_01_05_425508	107	67	human	human	JJ
10_1101-2021_01_05_425508	107	68	-	-	HYPH
10_1101-2021_01_05_425508	107	69	CoV.	cov.	NN
10_1101-2021_01_05_425508	108	1	These	these	DT
10_1101-2021_01_05_425508	108	2	observations	observation	NNS
10_1101-2021_01_05_425508	108	3	appear	appear	VBP
10_1101-2021_01_05_425508	108	4	to	to	TO
10_1101-2021_01_05_425508	108	5	be	be	VB
10_1101-2021_01_05_425508	108	6	consistent	consistent	JJ
10_1101-2021_01_05_425508	108	7	with	with	IN
10_1101-2021_01_05_425508	108	8	the	the	DT
10_1101-2021_01_05_425508	108	9	features	feature	NNS
10_1101-2021_01_05_425508	108	10	found	find	VBN
10_1101-2021_01_05_425508	108	11	in	in	IN
10_1101-2021_01_05_425508	108	12	the	the	DT
10_1101-2021_01_05_425508	108	13	225	225	CD
10_1101-2021_01_05_425508	108	14	mono-	mono-	NN
10_1101-2021_01_05_425508	108	15	,	,	,
10_1101-2021_01_05_425508	108	16	di-	di-	XX
10_1101-2021_01_05_425508	108	17	and	and	CC
10_1101-2021_01_05_425508	108	18	trinucleotide	trinucleotide	VB
10_1101-2021_01_05_425508	108	19	compositions	composition	NNS
10_1101-2021_01_05_425508	108	20	of	of	IN
10_1101-2021_01_05_425508	108	21	interest	interest	NN
10_1101-2021_01_05_425508	108	22	.	.	.
10_1101-2021_01_05_425508	109	1	However	however	RB
10_1101-2021_01_05_425508	109	2	,	,	,
10_1101-2021_01_05_425508	109	3	unlike	unlike	IN
10_1101-2021_01_05_425508	109	4	these	these	DT
10_1101-2021_01_05_425508	109	5	changes	change	NNS
10_1101-2021_01_05_425508	109	6	,	,	,
10_1101-2021_01_05_425508	109	7	226	226	CD
10_1101-2021_01_05_425508	109	8	there	there	EX
10_1101-2021_01_05_425508	109	9	was	be	VBD
10_1101-2021_01_05_425508	109	10	significant	significant	JJ
10_1101-2021_01_05_425508	109	11	diversity	diversity	NN
10_1101-2021_01_05_425508	109	12	within	within	IN
10_1101-2021_01_05_425508	109	13	even	even	RB
10_1101-2021_01_05_425508	109	14	a	a	DT
10_1101-2021_01_05_425508	109	15	single	single	JJ
10_1101-2021_01_05_425508	109	16	clade	clade	NN
10_1101-2021_01_05_425508	109	17	,	,	,
10_1101-2021_01_05_425508	109	18	which	which	WDT
10_1101-2021_01_05_425508	109	19	appears	appear	VBZ
10_1101-2021_01_05_425508	109	20	to	to	TO
10_1101-2021_01_05_425508	109	21	be	be	VB
10_1101-2021_01_05_425508	109	22	greater	great	JJR
10_1101-2021_01_05_425508	109	23	227	227	CD
10_1101-2021_01_05_425508	109	24	than	than	IN
10_1101-2021_01_05_425508	109	25	the	the	DT
10_1101-2021_01_05_425508	109	26	differences	difference	NNS
10_1101-2021_01_05_425508	109	27	between	between	IN
10_1101-2021_01_05_425508	109	28	hosts	host	NNS
10_1101-2021_01_05_425508	109	29	,	,	,
10_1101-2021_01_05_425508	109	30	with	with	IN
10_1101-2021_01_05_425508	109	31	the	the	DT
10_1101-2021_01_05_425508	109	32	possible	possible	JJ
10_1101-2021_01_05_425508	109	33	exception	exception	NN
10_1101-2021_01_05_425508	109	34	of	of	IN
10_1101-2021_01_05_425508	109	35	ELAVL1	elavl1	NN
10_1101-2021_01_05_425508	109	36	.	.	.
10_1101-2021_01_05_425508	110	1	In	in	IN
10_1101-2021_01_05_425508	110	2	regard	regard	NN
10_1101-2021_01_05_425508	110	3	228	228	CD
10_1101-2021_01_05_425508	110	4	to	to	IN
10_1101-2021_01_05_425508	110	5	long	long	JJ
10_1101-2021_01_05_425508	110	6	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	110	7	,	,	,
10_1101-2021_01_05_425508	110	8	they	-PRON-	PRP
10_1101-2021_01_05_425508	110	9	should	should	MD
10_1101-2021_01_05_425508	110	10	carry	carry	VB
10_1101-2021_01_05_425508	110	11	out	out	RP
10_1101-2021_01_05_425508	110	12	a	a	DT
10_1101-2021_01_05_425508	110	13	variety	variety	NN
10_1101-2021_01_05_425508	110	14	of	of	IN
10_1101-2021_01_05_425508	110	15	functions	function	NNS
10_1101-2021_01_05_425508	110	16	,	,	,
10_1101-2021_01_05_425508	110	17	and	and	CC
10_1101-2021_01_05_425508	110	18	mutations	mutation	NNS
10_1101-2021_01_05_425508	110	19	that	that	IN
10_1101-2021_01_05_425508	110	20	229	229	CD
10_1101-2021_01_05_425508	110	21	accumulate	accumulate	NN
10_1101-2021_01_05_425508	110	22	in	in	IN
10_1101-2021_01_05_425508	110	23	their	-PRON-	PRP$
10_1101-2021_01_05_425508	110	24	functional	functional	JJ
10_1101-2021_01_05_425508	110	25	motifs	motif	NNS
10_1101-2021_01_05_425508	110	26	may	may	MD
10_1101-2021_01_05_425508	110	27	have	have	VB
10_1101-2021_01_05_425508	110	28	complex	complex	JJ
10_1101-2021_01_05_425508	110	29	effects	effect	NNS
10_1101-2021_01_05_425508	110	30	on	on	IN
10_1101-2021_01_05_425508	110	31	the	the	DT
10_1101-2021_01_05_425508	110	32	presence	presence	NN
10_1101-2021_01_05_425508	110	33	of	of	IN
10_1101-2021_01_05_425508	110	34	230	230	CD
10_1101-2021_01_05_425508	110	35	functional	functional	JJ
10_1101-2021_01_05_425508	110	36	motif	motif	NN
10_1101-2021_01_05_425508	110	37	sequences	sequence	NNS
10_1101-2021_01_05_425508	110	38	,	,	,
10_1101-2021_01_05_425508	110	39	so	so	CC
10_1101-2021_01_05_425508	110	40	an	an	DT
10_1101-2021_01_05_425508	110	41	analysis	analysis	NN
10_1101-2021_01_05_425508	110	42	from	from	IN
10_1101-2021_01_05_425508	110	43	a	a	DT
10_1101-2021_01_05_425508	110	44	new	new	JJ
10_1101-2021_01_05_425508	110	45	perspective	perspective	NN
10_1101-2021_01_05_425508	110	46	appears	appear	VBZ
10_1101-2021_01_05_425508	110	47	to	to	TO
10_1101-2021_01_05_425508	110	48	become	become	VB
10_1101-2021_01_05_425508	110	49	231	231	CD
10_1101-2021_01_05_425508	110	50	important	important	JJ
10_1101-2021_01_05_425508	110	51	.	.	.
10_1101-2021_01_05_425508	111	1	232	232	CD
10_1101-2021_01_05_425508	111	2	233	233	CD
10_1101-2021_01_05_425508	111	3	Discussion	Discussion	NNP
10_1101-2021_01_05_425508	111	4	234	234	CD
10_1101-2021_01_05_425508	111	5	We	-PRON-	PRP
10_1101-2021_01_05_425508	111	6	first	first	RB
10_1101-2021_01_05_425508	111	7	discuss	discuss	VBP
10_1101-2021_01_05_425508	111	8	possible	possible	JJ
10_1101-2021_01_05_425508	111	9	molecular	molecular	JJ
10_1101-2021_01_05_425508	111	10	mechanisms	mechanism	NNS
10_1101-2021_01_05_425508	111	11	related	relate	VBN
10_1101-2021_01_05_425508	111	12	to	to	IN
10_1101-2021_01_05_425508	111	13	time	time	NN
10_1101-2021_01_05_425508	111	14	-	-	HYPH
10_1101-2021_01_05_425508	111	15	dependent	dependent	JJ
10_1101-2021_01_05_425508	111	16	directional	directional	JJ
10_1101-2021_01_05_425508	111	17	235	235	CD
10_1101-2021_01_05_425508	111	18	changes	change	NNS
10_1101-2021_01_05_425508	111	19	in	in	IN
10_1101-2021_01_05_425508	111	20	mononucleotide	mononucleotide	NNP
10_1101-2021_01_05_425508	111	21	composition	composition	NN
10_1101-2021_01_05_425508	111	22	.	.	.
10_1101-2021_01_05_425508	112	1	Fig	fig	NN
10_1101-2021_01_05_425508	112	2	.	.	.
10_1101-2021_01_05_425508	113	1	1A	1A	NNP
10_1101-2021_01_05_425508	113	2	shows	show	VBZ
10_1101-2021_01_05_425508	113	3	that	that	IN
10_1101-2021_01_05_425508	113	4	the	the	DT
10_1101-2021_01_05_425508	113	5	frequency	frequency	NN
10_1101-2021_01_05_425508	113	6	of	of	IN
10_1101-2021_01_05_425508	113	7	C	C	NNP
10_1101-2021_01_05_425508	113	8	tended	tend	VBD
10_1101-2021_01_05_425508	113	9	236	236	CD
10_1101-2021_01_05_425508	113	10	to	to	TO
10_1101-2021_01_05_425508	113	11	decrease	decrease	VB
10_1101-2021_01_05_425508	113	12	in	in	IN
10_1101-2021_01_05_425508	113	13	SARS	SARS	NNP
10_1101-2021_01_05_425508	113	14	-	-	HYPH
10_1101-2021_01_05_425508	113	15	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	113	16	,	,	,
10_1101-2021_01_05_425508	113	17	while	while	IN
10_1101-2021_01_05_425508	113	18	that	that	DT
10_1101-2021_01_05_425508	113	19	of	of	IN
10_1101-2021_01_05_425508	113	20	U	u	PRP
10_1101-2021_01_05_425508	113	21	tended	tend	VBD
10_1101-2021_01_05_425508	113	22	to	to	TO
10_1101-2021_01_05_425508	113	23	increase	increase	VB
10_1101-2021_01_05_425508	113	24	.	.	.
10_1101-2021_01_05_425508	114	1	Since	since	IN
10_1101-2021_01_05_425508	114	2	a	a	DT
10_1101-2021_01_05_425508	114	3	similar	similar	JJ
10_1101-2021_01_05_425508	114	4	change	change	NN
10_1101-2021_01_05_425508	114	5	237	237	CD
10_1101-2021_01_05_425508	114	6	was	be	VBD
10_1101-2021_01_05_425508	114	7	previously	previously	RB
10_1101-2021_01_05_425508	114	8	found	find	VBN
10_1101-2021_01_05_425508	114	9	for	for	IN
10_1101-2021_01_05_425508	114	10	MERS	MERS	NNP
10_1101-2021_01_05_425508	114	11	and	and	CC
10_1101-2021_01_05_425508	114	12	all	all	DT
10_1101-2021_01_05_425508	114	13	A	a	NN
10_1101-2021_01_05_425508	114	14	-	-	HYPH
10_1101-2021_01_05_425508	114	15	type	type	NN
10_1101-2021_01_05_425508	114	16	influenza	influenza	NN
10_1101-2021_01_05_425508	114	17	subtypes	subtype	NNS
10_1101-2021_01_05_425508	114	18	[	[	-LRB-
10_1101-2021_01_05_425508	114	19	12,14	12,14	CD
10_1101-2021_01_05_425508	114	20	]	]	-RRB-
10_1101-2021_01_05_425508	114	21	,	,	,
10_1101-2021_01_05_425508	114	22	these	these	DT
10_1101-2021_01_05_425508	114	23	238	238	CD
10_1101-2021_01_05_425508	114	24	changes	change	NNS
10_1101-2021_01_05_425508	114	25	may	may	MD
10_1101-2021_01_05_425508	114	26	have	have	VB
10_1101-2021_01_05_425508	114	27	biological	biological	JJ
10_1101-2021_01_05_425508	114	28	significance	significance	NN
10_1101-2021_01_05_425508	114	29	for	for	IN
10_1101-2021_01_05_425508	114	30	a	a	DT
10_1101-2021_01_05_425508	114	31	wide	wide	JJ
10_1101-2021_01_05_425508	114	32	range	range	NN
10_1101-2021_01_05_425508	114	33	of	of	IN
10_1101-2021_01_05_425508	114	34	RNA	RNA	NNP
10_1101-2021_01_05_425508	114	35	viruses	virus	NNS
10_1101-2021_01_05_425508	114	36	that	that	WDT
10_1101-2021_01_05_425508	114	37	invade	invade	VBP
10_1101-2021_01_05_425508	114	38	239	239	CD
10_1101-2021_01_05_425508	114	39	from	from	IN
10_1101-2021_01_05_425508	114	40	nonhuman	nonhuman	NNP
10_1101-2021_01_05_425508	114	41	hosts	host	NNS
10_1101-2021_01_05_425508	114	42	.	.	.
10_1101-2021_01_05_425508	115	1	One	one	CD
10_1101-2021_01_05_425508	115	2	possible	possible	JJ
10_1101-2021_01_05_425508	115	3	mechanism	mechanism	NN
10_1101-2021_01_05_425508	115	4	is	be	VBZ
10_1101-2021_01_05_425508	115	5	the	the	DT
10_1101-2021_01_05_425508	115	6	host	host	NN
10_1101-2021_01_05_425508	115	7	RNA	rna	NN
10_1101-2021_01_05_425508	115	8	-	-	HYPH
10_1101-2021_01_05_425508	115	9	editing	edit	VBG
10_1101-2021_01_05_425508	115	10	function	function	NN
10_1101-2021_01_05_425508	115	11	;	;	:
10_1101-2021_01_05_425508	115	12	240	240	CD
10_1101-2021_01_05_425508	115	13	Simmonds	Simmonds	NNPS
10_1101-2021_01_05_425508	115	14	(	(	-LRB-
10_1101-2021_01_05_425508	115	15	2020	2020	CD
10_1101-2021_01_05_425508	115	16	)	)	-RRB-
10_1101-2021_01_05_425508	115	17	proposed	propose	VBD
10_1101-2021_01_05_425508	115	18	that	that	IN
10_1101-2021_01_05_425508	115	19	the	the	DT
10_1101-2021_01_05_425508	115	20	C→U	C→U	NNP
10_1101-2021_01_05_425508	115	21	hypermutation	hypermutation	NN
10_1101-2021_01_05_425508	115	22	in	in	IN
10_1101-2021_01_05_425508	115	23	SARS	SARS	NNP
10_1101-2021_01_05_425508	115	24	-	-	HYPH
10_1101-2021_01_05_425508	115	25	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	115	26	may	may	MD
10_1101-2021_01_05_425508	115	27	be	be	VB
10_1101-2021_01_05_425508	115	28	due	due	JJ
10_1101-2021_01_05_425508	115	29	241	241	CD
10_1101-2021_01_05_425508	115	30	.CC	.CC	:
10_1101-2021_01_05_425508	115	31	-	-	:
10_1101-2021_01_05_425508	115	32	BY	BY	NNP
10_1101-2021_01_05_425508	115	33	-	-	HYPH
10_1101-2021_01_05_425508	115	34	NC	NC	NNP
10_1101-2021_01_05_425508	115	35	4.0	4.0	CD
10_1101-2021_01_05_425508	115	36	International	international	JJ
10_1101-2021_01_05_425508	115	37	licensemade	licensemade	NN
10_1101-2021_01_05_425508	115	38	available	available	JJ
10_1101-2021_01_05_425508	115	39	under	under	IN
10_1101-2021_01_05_425508	115	40	a	a	DT
10_1101-2021_01_05_425508	115	41	(	(	-LRB-
10_1101-2021_01_05_425508	115	42	which	which	WDT
10_1101-2021_01_05_425508	115	43	was	be	VBD
10_1101-2021_01_05_425508	115	44	not	not	RB
10_1101-2021_01_05_425508	115	45	certified	certify	VBN
10_1101-2021_01_05_425508	115	46	by	by	IN
10_1101-2021_01_05_425508	115	47	peer	peer	NN
10_1101-2021_01_05_425508	115	48	review	review	NN
10_1101-2021_01_05_425508	115	49	)	)	-RRB-
10_1101-2021_01_05_425508	115	50	is	be	VBZ
10_1101-2021_01_05_425508	115	51	the	the	DT
10_1101-2021_01_05_425508	115	52	author	author	NN
10_1101-2021_01_05_425508	115	53	/	/	SYM
10_1101-2021_01_05_425508	115	54	funder	funder	NN
10_1101-2021_01_05_425508	115	55	,	,	,
10_1101-2021_01_05_425508	115	56	who	who	WP
10_1101-2021_01_05_425508	115	57	has	have	VBZ
10_1101-2021_01_05_425508	115	58	granted	grant	VBN
10_1101-2021_01_05_425508	115	59	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	115	60	a	a	DT
10_1101-2021_01_05_425508	115	61	license	license	NN
10_1101-2021_01_05_425508	115	62	to	to	TO
10_1101-2021_01_05_425508	115	63	display	display	VB
10_1101-2021_01_05_425508	115	64	the	the	DT
10_1101-2021_01_05_425508	115	65	preprint	preprint	NN
10_1101-2021_01_05_425508	115	66	in	in	IN
10_1101-2021_01_05_425508	115	67	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	115	68	.	.	.
10_1101-2021_01_05_425508	116	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	116	2	is	be	VBZ
10_1101-2021_01_05_425508	116	3	The	the	DT
10_1101-2021_01_05_425508	116	4	copyright	copyright	NN
10_1101-2021_01_05_425508	116	5	holder	holder	NN
10_1101-2021_01_05_425508	116	6	for	for	IN
10_1101-2021_01_05_425508	116	7	this	this	DT
10_1101-2021_01_05_425508	116	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	116	9	version	version	NN
10_1101-2021_01_05_425508	116	10	posted	post	VBD
10_1101-2021_01_05_425508	116	11	January	January	NNP
10_1101-2021_01_05_425508	116	12	6	6	CD
10_1101-2021_01_05_425508	116	13	,	,	,
10_1101-2021_01_05_425508	116	14	2021	2021	CD
10_1101-2021_01_05_425508	116	15	.	.	.
10_1101-2021_01_05_425508	116	16	;	;	:
10_1101-2021_01_05_425508	116	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	116	18	:	:	:
10_1101-2021_01_05_425508	116	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	116	20	preprint	preprint	NN
10_1101-2021_01_05_425508	116	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	116	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	116	23	10	10	CD
10_1101-2021_01_05_425508	116	24	to	to	IN
10_1101-2021_01_05_425508	116	25	the	the	DT
10_1101-2021_01_05_425508	116	26	influence	influence	NN
10_1101-2021_01_05_425508	116	27	of	of	IN
10_1101-2021_01_05_425508	116	28	APOBEC	APOBEC	NNP
10_1101-2021_01_05_425508	116	29	family	family	NN
10_1101-2021_01_05_425508	116	30	proteins	protein	NNS
10_1101-2021_01_05_425508	116	31	in	in	IN
10_1101-2021_01_05_425508	116	32	humans	human	NNS
10_1101-2021_01_05_425508	116	33	[	[	-LRB-
10_1101-2021_01_05_425508	116	34	19	19	CD
10_1101-2021_01_05_425508	116	35	]	]	-RRB-
10_1101-2021_01_05_425508	116	36	.	.	.
10_1101-2021_01_05_425508	117	1	APOBEC	APOBEC	NNP
10_1101-2021_01_05_425508	117	2	is	be	VBZ
10_1101-2021_01_05_425508	117	3	an	an	DT
10_1101-2021_01_05_425508	117	4	antiviral	antiviral	JJ
10_1101-2021_01_05_425508	117	5	242	242	CD
10_1101-2021_01_05_425508	117	6	protein	protein	NN
10_1101-2021_01_05_425508	117	7	in	in	IN
10_1101-2021_01_05_425508	117	8	various	various	JJ
10_1101-2021_01_05_425508	117	9	animal	animal	NN
10_1101-2021_01_05_425508	117	10	species	specie	NNS
10_1101-2021_01_05_425508	117	11	,	,	,
10_1101-2021_01_05_425508	117	12	including	include	VBG
10_1101-2021_01_05_425508	117	13	humans	human	NNS
10_1101-2021_01_05_425508	117	14	,	,	,
10_1101-2021_01_05_425508	117	15	that	that	WDT
10_1101-2021_01_05_425508	117	16	can	can	MD
10_1101-2021_01_05_425508	117	17	convert	convert	VB
10_1101-2021_01_05_425508	117	18	C	C	NNP
10_1101-2021_01_05_425508	117	19	to	to	IN
10_1101-2021_01_05_425508	117	20	U	u	NN
10_1101-2021_01_05_425508	117	21	by	by	IN
10_1101-2021_01_05_425508	117	22	the	the	DT
10_1101-2021_01_05_425508	117	23	243	243	CD
10_1101-2021_01_05_425508	117	24	deacetylation	deacetylation	NN
10_1101-2021_01_05_425508	117	25	of	of	IN
10_1101-2021_01_05_425508	117	26	C	C	NNP
10_1101-2021_01_05_425508	117	27	[	[	-LRB-
10_1101-2021_01_05_425508	117	28	21	21	CD
10_1101-2021_01_05_425508	117	29	-	-	SYM
10_1101-2021_01_05_425508	117	30	23	23	CD
10_1101-2021_01_05_425508	117	31	]	]	-RRB-
10_1101-2021_01_05_425508	117	32	.	.	.
10_1101-2021_01_05_425508	118	1	Such	such	JJ
10_1101-2021_01_05_425508	118	2	RNA	RNA	NNP
10_1101-2021_01_05_425508	118	3	editing	editing	NN
10_1101-2021_01_05_425508	118	4	is	be	VBZ
10_1101-2021_01_05_425508	118	5	also	also	RB
10_1101-2021_01_05_425508	118	6	known	know	VBN
10_1101-2021_01_05_425508	118	7	to	to	TO
10_1101-2021_01_05_425508	118	8	act	act	VB
10_1101-2021_01_05_425508	118	9	as	as	IN
10_1101-2021_01_05_425508	118	10	a	a	DT
10_1101-2021_01_05_425508	118	11	defense	defense	NN
10_1101-2021_01_05_425508	118	12	244	244	CD
10_1101-2021_01_05_425508	118	13	mechanism	mechanism	NN
10_1101-2021_01_05_425508	118	14	against	against	IN
10_1101-2021_01_05_425508	118	15	various	various	JJ
10_1101-2021_01_05_425508	118	16	viruses	virus	NNS
10_1101-2021_01_05_425508	118	17	,	,	,
10_1101-2021_01_05_425508	118	18	including	include	VBG
10_1101-2021_01_05_425508	118	19	retroviruses	retrovirus	NNS
10_1101-2021_01_05_425508	118	20	[	[	-LRB-
10_1101-2021_01_05_425508	118	21	24	24	CD
10_1101-2021_01_05_425508	118	22	]	]	-RRB-
10_1101-2021_01_05_425508	118	23	.	.	.
10_1101-2021_01_05_425508	119	1	The	the	DT
10_1101-2021_01_05_425508	119	2	APOBEC	APOBEC	NNP
10_1101-2021_01_05_425508	119	3	gene	gene	NN
10_1101-2021_01_05_425508	119	4	245	245	CD
10_1101-2021_01_05_425508	119	5	family	family	NN
10_1101-2021_01_05_425508	119	6	has	have	VBZ
10_1101-2021_01_05_425508	119	7	generated	generate	VBN
10_1101-2021_01_05_425508	119	8	various	various	JJ
10_1101-2021_01_05_425508	119	9	paralogs	paralog	NNS
10_1101-2021_01_05_425508	119	10	during	during	IN
10_1101-2021_01_05_425508	119	11	mammalian	mammalian	JJ
10_1101-2021_01_05_425508	119	12	evolution	evolution	NN
10_1101-2021_01_05_425508	119	13	,	,	,
10_1101-2021_01_05_425508	119	14	with	with	IN
10_1101-2021_01_05_425508	119	15	seven	seven	CD
10_1101-2021_01_05_425508	119	16	known	know	VBN
10_1101-2021_01_05_425508	119	17	246	246	CD
10_1101-2021_01_05_425508	119	18	APOBEC	APOBEC	NNP
10_1101-2021_01_05_425508	119	19	genes	gene	NNS
10_1101-2021_01_05_425508	119	20	in	in	IN
10_1101-2021_01_05_425508	119	21	humans	human	NNS
10_1101-2021_01_05_425508	119	22	and	and	CC
10_1101-2021_01_05_425508	119	23	ten	ten	CD
10_1101-2021_01_05_425508	119	24	in	in	IN
10_1101-2021_01_05_425508	119	25	bat	bat	NN
10_1101-2021_01_05_425508	119	26	families	family	NNS
10_1101-2021_01_05_425508	119	27	[	[	-LRB-
10_1101-2021_01_05_425508	119	28	25	25	CD
10_1101-2021_01_05_425508	119	29	-	-	SYM
10_1101-2021_01_05_425508	119	30	27	27	CD
10_1101-2021_01_05_425508	119	31	]	]	-RRB-
10_1101-2021_01_05_425508	119	32	.	.	.
10_1101-2021_01_05_425508	120	1	The	the	DT
10_1101-2021_01_05_425508	120	2	prevalence	prevalence	NN
10_1101-2021_01_05_425508	120	3	C→U	C→U	NNP
10_1101-2021_01_05_425508	120	4	247	247	CD
10_1101-2021_01_05_425508	120	5	change	change	NN
10_1101-2021_01_05_425508	120	6	in	in	IN
10_1101-2021_01_05_425508	120	7	SARS	SARS	NNP
10_1101-2021_01_05_425508	120	8	-	-	HYPH
10_1101-2021_01_05_425508	120	9	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	120	10	upon	upon	IN
10_1101-2021_01_05_425508	120	11	transfer	transfer	NN
10_1101-2021_01_05_425508	120	12	of	of	IN
10_1101-2021_01_05_425508	120	13	its	-PRON-	PRP$
10_1101-2021_01_05_425508	120	14	host	host	NN
10_1101-2021_01_05_425508	120	15	environment	environment	NN
10_1101-2021_01_05_425508	120	16	from	from	IN
10_1101-2021_01_05_425508	120	17	bats	bat	NNS
10_1101-2021_01_05_425508	120	18	to	to	IN
10_1101-2021_01_05_425508	120	19	humans	human	NNS
10_1101-2021_01_05_425508	120	20	248	248	CD
10_1101-2021_01_05_425508	120	21	suggests	suggest	VBZ
10_1101-2021_01_05_425508	120	22	that	that	IN
10_1101-2021_01_05_425508	120	23	these	these	DT
10_1101-2021_01_05_425508	120	24	changes	change	NNS
10_1101-2021_01_05_425508	120	25	may	may	MD
10_1101-2021_01_05_425508	120	26	be	be	VB
10_1101-2021_01_05_425508	120	27	due	due	IN
10_1101-2021_01_05_425508	120	28	to	to	IN
10_1101-2021_01_05_425508	120	29	human	human	NN
10_1101-2021_01_05_425508	120	30	-	-	HYPH
10_1101-2021_01_05_425508	120	31	specific	specific	JJ
10_1101-2021_01_05_425508	120	32	APOBEC	APOBEC	NNP
10_1101-2021_01_05_425508	120	33	genes	gene	NNS
10_1101-2021_01_05_425508	120	34	.	.	.
10_1101-2021_01_05_425508	121	1	249	249	CD
10_1101-2021_01_05_425508	121	2	We	-PRON-	PRP
10_1101-2021_01_05_425508	121	3	next	next	JJ
10_1101-2021_01_05_425508	121	4	discuss	discuss	VBP
10_1101-2021_01_05_425508	121	5	changes	change	NNS
10_1101-2021_01_05_425508	121	6	in	in	IN
10_1101-2021_01_05_425508	121	7	short	short	JJ
10_1101-2021_01_05_425508	121	8	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	121	9	.	.	.
10_1101-2021_01_05_425508	122	1	Directional	directional	JJ
10_1101-2021_01_05_425508	122	2	changes	change	NNS
10_1101-2021_01_05_425508	122	3	in	in	IN
10_1101-2021_01_05_425508	122	4	250	250	CD
10_1101-2021_01_05_425508	122	5	some	some	DT
10_1101-2021_01_05_425508	122	6	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	122	7	,	,	,
10_1101-2021_01_05_425508	122	8	such	such	JJ
10_1101-2021_01_05_425508	122	9	as	as	IN
10_1101-2021_01_05_425508	122	10	GAG	GAG	NNP
10_1101-2021_01_05_425508	122	11	and	and	CC
10_1101-2021_01_05_425508	122	12	GGA	GGA	NNP
10_1101-2021_01_05_425508	122	13	,	,	,
10_1101-2021_01_05_425508	122	14	can	can	MD
10_1101-2021_01_05_425508	122	15	not	not	RB
10_1101-2021_01_05_425508	122	16	be	be	VB
10_1101-2021_01_05_425508	122	17	explained	explain	VBN
10_1101-2021_01_05_425508	122	18	by	by	IN
10_1101-2021_01_05_425508	122	19	APOBEC-251	APOBEC-251	NNP
10_1101-2021_01_05_425508	122	20	induced	induce	VBD
10_1101-2021_01_05_425508	122	21	C→U	C→U	NNP
10_1101-2021_01_05_425508	122	22	mutations	mutation	NNS
10_1101-2021_01_05_425508	122	23	alone	alone	RB
10_1101-2021_01_05_425508	122	24	.	.	.
10_1101-2021_01_05_425508	123	1	Although	although	IN
10_1101-2021_01_05_425508	123	2	the	the	DT
10_1101-2021_01_05_425508	123	3	evidence	evidence	NN
10_1101-2021_01_05_425508	123	4	is	be	VBZ
10_1101-2021_01_05_425508	123	5	weak	weak	JJ
10_1101-2021_01_05_425508	123	6	,	,	,
10_1101-2021_01_05_425508	123	7	these	these	DT
10_1101-2021_01_05_425508	123	8	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	123	9	252	252	CD
10_1101-2021_01_05_425508	123	10	are	be	VBP
10_1101-2021_01_05_425508	123	11	part	part	NN
10_1101-2021_01_05_425508	123	12	of	of	IN
10_1101-2021_01_05_425508	123	13	the	the	DT
10_1101-2021_01_05_425508	123	14	binding	bind	VBG
10_1101-2021_01_05_425508	123	15	motifs	motif	NNS
10_1101-2021_01_05_425508	123	16	of	of	IN
10_1101-2021_01_05_425508	123	17	several	several	JJ
10_1101-2021_01_05_425508	123	18	RNA	RNA	NNP
10_1101-2021_01_05_425508	123	19	-	-	HYPH
10_1101-2021_01_05_425508	123	20	binding	bind	VBG
10_1101-2021_01_05_425508	123	21	proteins	protein	NNS
10_1101-2021_01_05_425508	123	22	,	,	,
10_1101-2021_01_05_425508	123	23	such	such	JJ
10_1101-2021_01_05_425508	123	24	as	as	IN
10_1101-2021_01_05_425508	123	25	SRSF1	SRSF1	NNP
10_1101-2021_01_05_425508	123	26	and	and	CC
10_1101-2021_01_05_425508	123	27	253	253	CD
10_1101-2021_01_05_425508	123	28	PCBP2	pcbp2	CD
10_1101-2021_01_05_425508	123	29	(	(	-LRB-
10_1101-2021_01_05_425508	123	30	Table	table	NN
10_1101-2021_01_05_425508	123	31	S9	s9	NN
10_1101-2021_01_05_425508	123	32	)	)	-RRB-
10_1101-2021_01_05_425508	123	33	;	;	:
10_1101-2021_01_05_425508	123	34	the	the	DT
10_1101-2021_01_05_425508	123	35	number	number	NN
10_1101-2021_01_05_425508	123	36	of	of	IN
10_1101-2021_01_05_425508	123	37	loci	loci	NN
10_1101-2021_01_05_425508	123	38	for	for	IN
10_1101-2021_01_05_425508	123	39	these	these	DT
10_1101-2021_01_05_425508	123	40	motifs	motif	NNS
10_1101-2021_01_05_425508	123	41	has	have	VBZ
10_1101-2021_01_05_425508	123	42	decreased	decrease	VBN
10_1101-2021_01_05_425508	123	43	independently	independently	RB
10_1101-2021_01_05_425508	123	44	of	of	IN
10_1101-2021_01_05_425508	123	45	254	254	CD
10_1101-2021_01_05_425508	123	46	clade	clade	NN
10_1101-2021_01_05_425508	123	47	.	.	.
10_1101-2021_01_05_425508	124	1	In	in	IN
10_1101-2021_01_05_425508	124	2	contrast	contrast	NN
10_1101-2021_01_05_425508	124	3	,	,	,
10_1101-2021_01_05_425508	124	4	the	the	DT
10_1101-2021_01_05_425508	124	5	number	number	NN
10_1101-2021_01_05_425508	124	6	of	of	IN
10_1101-2021_01_05_425508	124	7	motif	motif	NN
10_1101-2021_01_05_425508	124	8	loci	loci	NN
10_1101-2021_01_05_425508	124	9	for	for	IN
10_1101-2021_01_05_425508	124	10	only	only	JJ
10_1101-2021_01_05_425508	124	11	ELAVL1	elavl1	NN
10_1101-2021_01_05_425508	124	12	among	among	IN
10_1101-2021_01_05_425508	124	13	the	the	DT
10_1101-2021_01_05_425508	124	14	ten	ten	CD
10_1101-2021_01_05_425508	124	15	proteins	protein	NNS
10_1101-2021_01_05_425508	124	16	255	255	CD
10_1101-2021_01_05_425508	124	17	listed	list	VBN
10_1101-2021_01_05_425508	124	18	in	in	IN
10_1101-2021_01_05_425508	124	19	Table	table	NN
10_1101-2021_01_05_425508	124	20	3	3	CD
10_1101-2021_01_05_425508	124	21	has	have	VBZ
10_1101-2021_01_05_425508	124	22	increased	increase	VBN
10_1101-2021_01_05_425508	124	23	independently	independently	RB
10_1101-2021_01_05_425508	124	24	of	of	IN
10_1101-2021_01_05_425508	124	25	clade	clade	NN
10_1101-2021_01_05_425508	124	26	.	.	.
10_1101-2021_01_05_425508	125	1	As	as	IN
10_1101-2021_01_05_425508	125	2	an	an	DT
10_1101-2021_01_05_425508	125	3	RNA	RNA	NNP
10_1101-2021_01_05_425508	125	4	-	-	HYPH
10_1101-2021_01_05_425508	125	5	binding	bind	VBG
10_1101-2021_01_05_425508	125	6	protein	protein	NN
10_1101-2021_01_05_425508	125	7	that	that	IN
10_1101-2021_01_05_425508	125	8	256	256	CD
10_1101-2021_01_05_425508	125	9	binds	bind	NNS
10_1101-2021_01_05_425508	125	10	A-	a-	XX
10_1101-2021_01_05_425508	125	11	or	or	CC
10_1101-2021_01_05_425508	125	12	U	u	JJ
10_1101-2021_01_05_425508	125	13	-	-	HYPH
10_1101-2021_01_05_425508	125	14	rich	rich	JJ
10_1101-2021_01_05_425508	125	15	elements	element	NNS
10_1101-2021_01_05_425508	125	16	,	,	,
10_1101-2021_01_05_425508	125	17	ELAVL1	ELAVL1	''
10_1101-2021_01_05_425508	125	18	binding	bind	VBG
10_1101-2021_01_05_425508	125	19	to	to	IN
10_1101-2021_01_05_425508	125	20	mRNA	mRNA	NNP
10_1101-2021_01_05_425508	125	21	is	be	VBZ
10_1101-2021_01_05_425508	125	22	known	know	VBN
10_1101-2021_01_05_425508	125	23	to	to	TO
10_1101-2021_01_05_425508	125	24	contribute	contribute	VB
10_1101-2021_01_05_425508	125	25	to	to	IN
10_1101-2021_01_05_425508	125	26	257	257	CD
10_1101-2021_01_05_425508	125	27	RNA	RNA	NNP
10_1101-2021_01_05_425508	125	28	stability	stability	NN
10_1101-2021_01_05_425508	125	29	[	[	-LRB-
10_1101-2021_01_05_425508	125	30	28	28	CD
10_1101-2021_01_05_425508	125	31	,	,	,
10_1101-2021_01_05_425508	125	32	29	29	CD
10_1101-2021_01_05_425508	125	33	]	]	-RRB-
10_1101-2021_01_05_425508	125	34	;	;	:
10_1101-2021_01_05_425508	125	35	SARS	SARS	NNP
10_1101-2021_01_05_425508	125	36	-	-	HYPH
10_1101-2021_01_05_425508	125	37	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	125	38	and	and	CC
10_1101-2021_01_05_425508	125	39	human	human	NN
10_1101-2021_01_05_425508	125	40	-	-	HYPH
10_1101-2021_01_05_425508	125	41	CoV	cov	NN
10_1101-2021_01_05_425508	125	42	,	,	,
10_1101-2021_01_05_425508	125	43	which	which	WDT
10_1101-2021_01_05_425508	125	44	are	be	VBP
10_1101-2021_01_05_425508	125	45	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	125	46	in	in	IN
10_1101-2021_01_05_425508	125	47	humans	human	NNS
10_1101-2021_01_05_425508	125	48	,	,	,
10_1101-2021_01_05_425508	125	49	258	258	CD
10_1101-2021_01_05_425508	125	50	may	may	MD
10_1101-2021_01_05_425508	125	51	contain	contain	VB
10_1101-2021_01_05_425508	125	52	increased	increase	VBN
10_1101-2021_01_05_425508	125	53	binding	bind	VBG
10_1101-2021_01_05_425508	125	54	motifs	motif	NNS
10_1101-2021_01_05_425508	125	55	for	for	IN
10_1101-2021_01_05_425508	125	56	ELAVL1	elavl1	NN
10_1101-2021_01_05_425508	125	57	for	for	IN
10_1101-2021_01_05_425508	125	58	efficient	efficient	JJ
10_1101-2021_01_05_425508	125	59	growth	growth	NN
10_1101-2021_01_05_425508	125	60	in	in	IN
10_1101-2021_01_05_425508	125	61	the	the	DT
10_1101-2021_01_05_425508	125	62	human	human	JJ
10_1101-2021_01_05_425508	125	63	259	259	CD
10_1101-2021_01_05_425508	125	64	cellular	cellular	JJ
10_1101-2021_01_05_425508	125	65	environment	environment	NN
10_1101-2021_01_05_425508	125	66	.	.	.
10_1101-2021_01_05_425508	126	1	However	however	RB
10_1101-2021_01_05_425508	126	2	,	,	,
10_1101-2021_01_05_425508	126	3	for	for	IN
10_1101-2021_01_05_425508	126	4	further	further	JJ
10_1101-2021_01_05_425508	126	5	analysis	analysis	NN
10_1101-2021_01_05_425508	126	6	,	,	,
10_1101-2021_01_05_425508	126	7	information	information	NN
10_1101-2021_01_05_425508	126	8	on	on	IN
10_1101-2021_01_05_425508	126	9	RNA	RNA	NNP
10_1101-2021_01_05_425508	126	10	-	-	HYPH
10_1101-2021_01_05_425508	126	11	binding	bind	VBG
10_1101-2021_01_05_425508	126	12	260	260	CD
10_1101-2021_01_05_425508	126	13	proteins	protein	NNS
10_1101-2021_01_05_425508	126	14	in	in	IN
10_1101-2021_01_05_425508	126	15	bat	bat	NN
10_1101-2021_01_05_425508	126	16	cells	cell	NNS
10_1101-2021_01_05_425508	126	17	is	be	VBZ
10_1101-2021_01_05_425508	126	18	needed	need	VBN
10_1101-2021_01_05_425508	126	19	.	.	.
10_1101-2021_01_05_425508	127	1	261	261	CD
10_1101-2021_01_05_425508	127	2	262	262	CD
10_1101-2021_01_05_425508	127	3	Conclusions	conclusion	NNS
10_1101-2021_01_05_425508	127	4	263	263	CD
10_1101-2021_01_05_425508	127	5	In	in	IN
10_1101-2021_01_05_425508	127	6	the	the	DT
10_1101-2021_01_05_425508	127	7	present	present	JJ
10_1101-2021_01_05_425508	127	8	study	study	NN
10_1101-2021_01_05_425508	127	9	,	,	,
10_1101-2021_01_05_425508	127	10	we	-PRON-	PRP
10_1101-2021_01_05_425508	127	11	found	find	VBD
10_1101-2021_01_05_425508	127	12	that	that	IN
10_1101-2021_01_05_425508	127	13	the	the	DT
10_1101-2021_01_05_425508	127	14	compositions	composition	NNS
10_1101-2021_01_05_425508	127	15	of	of	IN
10_1101-2021_01_05_425508	127	16	a	a	DT
10_1101-2021_01_05_425508	127	17	group	group	NN
10_1101-2021_01_05_425508	127	18	of	of	IN
10_1101-2021_01_05_425508	127	19	mono-	mono-	NN
10_1101-2021_01_05_425508	127	20	and	and	CC
10_1101-2021_01_05_425508	127	21	264	264	CD
10_1101-2021_01_05_425508	127	22	oligonucleotide	oligonucleotide	RB
10_1101-2021_01_05_425508	127	23	in	in	IN
10_1101-2021_01_05_425508	127	24	SARS	SARS	NNP
10_1101-2021_01_05_425508	127	25	-	-	HYPH
10_1101-2021_01_05_425508	127	26	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	127	27	genomes	genome	NNS
10_1101-2021_01_05_425508	127	28	have	have	VBP
10_1101-2021_01_05_425508	127	29	changed	change	VBN
10_1101-2021_01_05_425508	127	30	in	in	IN
10_1101-2021_01_05_425508	127	31	a	a	DT
10_1101-2021_01_05_425508	127	32	host	host	NN
10_1101-2021_01_05_425508	127	33	cell	cell	NN
10_1101-2021_01_05_425508	127	34	-	-	HYPH
10_1101-2021_01_05_425508	127	35	dependent	dependent	JJ
10_1101-2021_01_05_425508	127	36	265	265	CD
10_1101-2021_01_05_425508	127	37	manner	manner	NN
10_1101-2021_01_05_425508	127	38	.	.	.
10_1101-2021_01_05_425508	128	1	This	this	DT
10_1101-2021_01_05_425508	128	2	is	be	VBZ
10_1101-2021_01_05_425508	128	3	totally	totally	RB
10_1101-2021_01_05_425508	128	4	consistent	consistent	JJ
10_1101-2021_01_05_425508	128	5	to	to	IN
10_1101-2021_01_05_425508	128	6	our	-PRON-	PRP$
10_1101-2021_01_05_425508	128	7	previous	previous	JJ
10_1101-2021_01_05_425508	128	8	finding	finding	NN
10_1101-2021_01_05_425508	128	9	for	for	IN
10_1101-2021_01_05_425508	128	10	influenza	influenza	NNP
10_1101-2021_01_05_425508	128	11	A	A	NNP
10_1101-2021_01_05_425508	128	12	and	and	CC
10_1101-2021_01_05_425508	128	13	B	b	NN
10_1101-2021_01_05_425508	128	14	viruses	virus	NNS
10_1101-2021_01_05_425508	128	15	266	266	CD
10_1101-2021_01_05_425508	128	16	[	[	-LRB-
10_1101-2021_01_05_425508	128	17	11,12,14	11,12,14	CD
10_1101-2021_01_05_425508	128	18	]	]	-RRB-
10_1101-2021_01_05_425508	128	19	,	,	,
10_1101-2021_01_05_425508	128	20	supporting	support	VBG
10_1101-2021_01_05_425508	128	21	the	the	DT
10_1101-2021_01_05_425508	128	22	previous	previous	JJ
10_1101-2021_01_05_425508	128	23	prediction	prediction	NN
10_1101-2021_01_05_425508	128	24	that	that	WDT
10_1101-2021_01_05_425508	128	25	the	the	DT
10_1101-2021_01_05_425508	128	26	host	host	NN
10_1101-2021_01_05_425508	128	27	-	-	HYPH
10_1101-2021_01_05_425508	128	28	dependent	dependent	JJ
10_1101-2021_01_05_425508	128	29	directional	directional	JJ
10_1101-2021_01_05_425508	128	30	267	267	CD
10_1101-2021_01_05_425508	128	31	changes	change	NNS
10_1101-2021_01_05_425508	128	32	of	of	IN
10_1101-2021_01_05_425508	128	33	various	various	JJ
10_1101-2021_01_05_425508	128	34	mono-	mono-	NN
10_1101-2021_01_05_425508	128	35	and	and	CC
10_1101-2021_01_05_425508	128	36	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	128	37	should	should	MD
10_1101-2021_01_05_425508	128	38	inevitably	inevitably	RB
10_1101-2021_01_05_425508	128	39	occur	occur	VB
10_1101-2021_01_05_425508	128	40	in	in	IN
10_1101-2021_01_05_425508	128	41	zoonotic	zoonotic	JJ
10_1101-2021_01_05_425508	128	42	268	268	CD
10_1101-2021_01_05_425508	128	43	.CC	.CC	NFP
10_1101-2021_01_05_425508	128	44	-	-	HYPH
10_1101-2021_01_05_425508	128	45	BY	BY	NNP
10_1101-2021_01_05_425508	128	46	-	-	HYPH
10_1101-2021_01_05_425508	128	47	NC	NC	NNP
10_1101-2021_01_05_425508	128	48	4.0	4.0	CD
10_1101-2021_01_05_425508	128	49	International	international	JJ
10_1101-2021_01_05_425508	128	50	licensemade	licensemade	NN
10_1101-2021_01_05_425508	128	51	available	available	JJ
10_1101-2021_01_05_425508	128	52	under	under	IN
10_1101-2021_01_05_425508	128	53	a	a	DT
10_1101-2021_01_05_425508	128	54	(	(	-LRB-
10_1101-2021_01_05_425508	128	55	which	which	WDT
10_1101-2021_01_05_425508	128	56	was	be	VBD
10_1101-2021_01_05_425508	128	57	not	not	RB
10_1101-2021_01_05_425508	128	58	certified	certify	VBN
10_1101-2021_01_05_425508	128	59	by	by	IN
10_1101-2021_01_05_425508	128	60	peer	peer	NN
10_1101-2021_01_05_425508	128	61	review	review	NN
10_1101-2021_01_05_425508	128	62	)	)	-RRB-
10_1101-2021_01_05_425508	128	63	is	be	VBZ
10_1101-2021_01_05_425508	128	64	the	the	DT
10_1101-2021_01_05_425508	128	65	author	author	NN
10_1101-2021_01_05_425508	128	66	/	/	SYM
10_1101-2021_01_05_425508	128	67	funder	funder	NN
10_1101-2021_01_05_425508	128	68	,	,	,
10_1101-2021_01_05_425508	128	69	who	who	WP
10_1101-2021_01_05_425508	128	70	has	have	VBZ
10_1101-2021_01_05_425508	128	71	granted	grant	VBN
10_1101-2021_01_05_425508	128	72	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	128	73	a	a	DT
10_1101-2021_01_05_425508	128	74	license	license	NN
10_1101-2021_01_05_425508	128	75	to	to	TO
10_1101-2021_01_05_425508	128	76	display	display	VB
10_1101-2021_01_05_425508	128	77	the	the	DT
10_1101-2021_01_05_425508	128	78	preprint	preprint	NN
10_1101-2021_01_05_425508	128	79	in	in	IN
10_1101-2021_01_05_425508	128	80	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	128	81	.	.	.
10_1101-2021_01_05_425508	129	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	129	2	is	be	VBZ
10_1101-2021_01_05_425508	129	3	The	the	DT
10_1101-2021_01_05_425508	129	4	copyright	copyright	NN
10_1101-2021_01_05_425508	129	5	holder	holder	NN
10_1101-2021_01_05_425508	129	6	for	for	IN
10_1101-2021_01_05_425508	129	7	this	this	DT
10_1101-2021_01_05_425508	129	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	129	9	version	version	NN
10_1101-2021_01_05_425508	129	10	posted	post	VBD
10_1101-2021_01_05_425508	129	11	January	January	NNP
10_1101-2021_01_05_425508	129	12	6	6	CD
10_1101-2021_01_05_425508	129	13	,	,	,
10_1101-2021_01_05_425508	129	14	2021	2021	CD
10_1101-2021_01_05_425508	129	15	.	.	.
10_1101-2021_01_05_425508	129	16	;	;	:
10_1101-2021_01_05_425508	129	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	129	18	:	:	:
10_1101-2021_01_05_425508	129	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	129	20	preprint	preprint	NN
10_1101-2021_01_05_425508	129	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	POS
10_1101-2021_01_05_425508	129	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	129	23	11	11	CD
10_1101-2021_01_05_425508	129	24	RNA	RNA	NNP
10_1101-2021_01_05_425508	129	25	viruses	virus	NNS
10_1101-2021_01_05_425508	129	26	that	that	WDT
10_1101-2021_01_05_425508	129	27	have	have	VBP
10_1101-2021_01_05_425508	129	28	invaded	invade	VBN
10_1101-2021_01_05_425508	129	29	from	from	IN
10_1101-2021_01_05_425508	129	30	nonhuman	nonhuman	NNP
10_1101-2021_01_05_425508	129	31	hosts	host	NNS
10_1101-2021_01_05_425508	129	32	.	.	.
10_1101-2021_01_05_425508	130	1	Phylogenetic	phylogenetic	JJ
10_1101-2021_01_05_425508	130	2	methods	method	NNS
10_1101-2021_01_05_425508	130	3	based	base	VBN
10_1101-2021_01_05_425508	130	4	on	on	IN
10_1101-2021_01_05_425508	130	5	269	269	CD
10_1101-2021_01_05_425508	130	6	sequence	sequence	NN
10_1101-2021_01_05_425508	130	7	alignment	alignment	NN
10_1101-2021_01_05_425508	130	8	[	[	-LRB-
10_1101-2021_01_05_425508	130	9	7,8	7,8	CD
10_1101-2021_01_05_425508	130	10	]	]	-RRB-
10_1101-2021_01_05_425508	130	11	are	be	VBP
10_1101-2021_01_05_425508	130	12	well	well	RB
10_1101-2021_01_05_425508	130	13	refined	refined	JJ
10_1101-2021_01_05_425508	130	14	and	and	CC
10_1101-2021_01_05_425508	130	15	undoubtedly	undoubtedly	RB
10_1101-2021_01_05_425508	130	16	essential	essential	JJ
10_1101-2021_01_05_425508	130	17	for	for	IN
10_1101-2021_01_05_425508	130	18	studying	study	VBG
10_1101-2021_01_05_425508	130	19	the	the	DT
10_1101-2021_01_05_425508	130	20	270	270	CD
10_1101-2021_01_05_425508	130	21	phylogenetic	phylogenetic	JJ
10_1101-2021_01_05_425508	130	22	relationships	relationship	NNS
10_1101-2021_01_05_425508	130	23	between	between	IN
10_1101-2021_01_05_425508	130	24	viruses	virus	NNS
10_1101-2021_01_05_425508	130	25	.	.	.
10_1101-2021_01_05_425508	131	1	The	the	DT
10_1101-2021_01_05_425508	131	2	present	present	JJ
10_1101-2021_01_05_425508	131	3	alignment	alignment	NN
10_1101-2021_01_05_425508	131	4	-	-	HYPH
10_1101-2021_01_05_425508	131	5	free	free	JJ
10_1101-2021_01_05_425508	131	6	method	method	NN
10_1101-2021_01_05_425508	131	7	to	to	IN
10_1101-2021_01_05_425508	131	8	271	271	CD
10_1101-2021_01_05_425508	131	9	analyze	analyze	VB
10_1101-2021_01_05_425508	131	10	mono-	mono-	NN
10_1101-2021_01_05_425508	131	11	and	and	CC
10_1101-2021_01_05_425508	131	12	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	131	13	compositions	composition	NNS
10_1101-2021_01_05_425508	131	14	can	can	MD
10_1101-2021_01_05_425508	131	15	also	also	RB
10_1101-2021_01_05_425508	131	16	serve	serve	VB
10_1101-2021_01_05_425508	131	17	as	as	IN
10_1101-2021_01_05_425508	131	18	a	a	DT
10_1101-2021_01_05_425508	131	19	powerful	powerful	JJ
10_1101-2021_01_05_425508	131	20	tool	tool	NN
10_1101-2021_01_05_425508	131	21	for	for	IN
10_1101-2021_01_05_425508	131	22	272	272	CD
10_1101-2021_01_05_425508	131	23	molecular	molecular	JJ
10_1101-2021_01_05_425508	131	24	evolutionary	evolutionary	JJ
10_1101-2021_01_05_425508	131	25	studies	study	NNS
10_1101-2021_01_05_425508	131	26	of	of	IN
10_1101-2021_01_05_425508	131	27	viruses	virus	NNS
10_1101-2021_01_05_425508	131	28	,	,	,
10_1101-2021_01_05_425508	131	29	revealing	reveal	VBG
10_1101-2021_01_05_425508	131	30	directional	directional	JJ
10_1101-2021_01_05_425508	131	31	changes	change	NNS
10_1101-2021_01_05_425508	131	32	in	in	IN
10_1101-2021_01_05_425508	131	33	viruses	virus	NNS
10_1101-2021_01_05_425508	131	34	and	and	CC
10_1101-2021_01_05_425508	131	35	273	273	CD
10_1101-2021_01_05_425508	131	36	predicting	predict	VBG
10_1101-2021_01_05_425508	131	37	the	the	DT
10_1101-2021_01_05_425508	131	38	possible	possible	JJ
10_1101-2021_01_05_425508	131	39	goals	goal	NNS
10_1101-2021_01_05_425508	131	40	of	of	IN
10_1101-2021_01_05_425508	131	41	these	these	DT
10_1101-2021_01_05_425508	131	42	changes	change	NNS
10_1101-2021_01_05_425508	131	43	.	.	.
10_1101-2021_01_05_425508	132	1	274	274	CD
10_1101-2021_01_05_425508	132	2	275	275	CD
10_1101-2021_01_05_425508	132	3	276	276	CD
10_1101-2021_01_05_425508	132	4	Methods	Methods	NNPS
10_1101-2021_01_05_425508	132	5	277	277	CD
10_1101-2021_01_05_425508	132	6	SARS	SARS	NNP
10_1101-2021_01_05_425508	132	7	-	-	HYPH
10_1101-2021_01_05_425508	132	8	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	132	9	genome	genome	JJ
10_1101-2021_01_05_425508	132	10	sequences	sequence	NNS
10_1101-2021_01_05_425508	132	11	278	278	CD
10_1101-2021_01_05_425508	132	12	Human	Human	NNP
10_1101-2021_01_05_425508	132	13	SARS	SARS	NNP
10_1101-2021_01_05_425508	132	14	-	-	HYPH
10_1101-2021_01_05_425508	132	15	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	132	16	genome	genome	NNP
10_1101-2021_01_05_425508	132	17	sequences	sequence	NNS
10_1101-2021_01_05_425508	132	18	were	be	VBD
10_1101-2021_01_05_425508	132	19	downloaded	download	VBN
10_1101-2021_01_05_425508	132	20	from	from	IN
10_1101-2021_01_05_425508	132	21	the	the	DT
10_1101-2021_01_05_425508	132	22	GISAID	GISAID	NNP
10_1101-2021_01_05_425508	132	23	database	database	NN
10_1101-2021_01_05_425508	132	24	279	279	CD
10_1101-2021_01_05_425508	132	25	(	(	-LRB-
10_1101-2021_01_05_425508	132	26	https://www.gisaid.org/	https://www.gisaid.org/	NN
10_1101-2021_01_05_425508	132	27	)	)	-RRB-
10_1101-2021_01_05_425508	132	28	;	;	:
10_1101-2021_01_05_425508	132	29	sequences	sequence	NNS
10_1101-2021_01_05_425508	132	30	that	that	WDT
10_1101-2021_01_05_425508	132	31	were	be	VBD
10_1101-2021_01_05_425508	132	32	complete	complete	JJ
10_1101-2021_01_05_425508	132	33	,	,	,
10_1101-2021_01_05_425508	132	34	showed	show	VBD
10_1101-2021_01_05_425508	132	35	high	high	JJ
10_1101-2021_01_05_425508	132	36	coverage	coverage	NN
10_1101-2021_01_05_425508	132	37	and	and	CC
10_1101-2021_01_05_425508	132	38	had	have	VBD
10_1101-2021_01_05_425508	132	39	280	280	CD
10_1101-2021_01_05_425508	132	40	been	be	VBN
10_1101-2021_01_05_425508	132	41	isolated	isolate	VBN
10_1101-2021_01_05_425508	132	42	from	from	IN
10_1101-2021_01_05_425508	132	43	humans	human	NNS
10_1101-2021_01_05_425508	132	44	were	be	VBD
10_1101-2021_01_05_425508	132	45	downloaded	download	VBN
10_1101-2021_01_05_425508	132	46	on	on	IN
10_1101-2021_01_05_425508	132	47	Sep	Sep	NNP
10_1101-2021_01_05_425508	132	48	17	17	CD
10_1101-2021_01_05_425508	132	49	,	,	,
10_1101-2021_01_05_425508	132	50	2020	2020	CD
10_1101-2021_01_05_425508	132	51	.	.	.
10_1101-2021_01_05_425508	133	1	Among	among	IN
10_1101-2021_01_05_425508	133	2	the	the	DT
10_1101-2021_01_05_425508	133	3	acquired	acquire	VBN
10_1101-2021_01_05_425508	133	4	281	281	CD
10_1101-2021_01_05_425508	133	5	sequences	sequence	NNS
10_1101-2021_01_05_425508	133	6	,	,	,
10_1101-2021_01_05_425508	133	7	strains	strain	VBZ
10_1101-2021_01_05_425508	133	8	with	with	IN
10_1101-2021_01_05_425508	133	9	an	an	DT
10_1101-2021_01_05_425508	133	10	unknown	unknown	JJ
10_1101-2021_01_05_425508	133	11	isolation	isolation	NN
10_1101-2021_01_05_425508	133	12	month	month	NN
10_1101-2021_01_05_425508	133	13	were	be	VBD
10_1101-2021_01_05_425508	133	14	excluded	exclude	VBN
10_1101-2021_01_05_425508	133	15	from	from	IN
10_1101-2021_01_05_425508	133	16	the	the	DT
10_1101-2021_01_05_425508	133	17	analysis	analysis	NN
10_1101-2021_01_05_425508	133	18	,	,	,
10_1101-2021_01_05_425508	133	19	282	282	CD
10_1101-2021_01_05_425508	133	20	and	and	CC
10_1101-2021_01_05_425508	133	21	the	the	DT
10_1101-2021_01_05_425508	133	22	polyA	polyA	NNP
10_1101-2021_01_05_425508	133	23	tail	tail	NN
10_1101-2021_01_05_425508	133	24	was	be	VBD
10_1101-2021_01_05_425508	133	25	removed	remove	VBN
10_1101-2021_01_05_425508	133	26	.	.	.
10_1101-2021_01_05_425508	134	1	A	a	DT
10_1101-2021_01_05_425508	134	2	list	list	NN
10_1101-2021_01_05_425508	134	3	of	of	IN
10_1101-2021_01_05_425508	134	4	all	all	DT
10_1101-2021_01_05_425508	134	5	72,314	72,314	CD
10_1101-2021_01_05_425508	134	6	strains	strain	NNS
10_1101-2021_01_05_425508	134	7	used	use	VBN
10_1101-2021_01_05_425508	134	8	is	be	VBZ
10_1101-2021_01_05_425508	134	9	provided	provide	VBN
10_1101-2021_01_05_425508	134	10	in	in	IN
10_1101-2021_01_05_425508	134	11	Table	table	NN
10_1101-2021_01_05_425508	134	12	283	283	CD
10_1101-2021_01_05_425508	134	13	S1	S1	NNS
10_1101-2021_01_05_425508	134	14	.	.	.
10_1101-2021_01_05_425508	135	1	284	284	CD
10_1101-2021_01_05_425508	135	2	285	285	CD
10_1101-2021_01_05_425508	135	3	Genome	genome	JJ
10_1101-2021_01_05_425508	135	4	sequences	sequence	NNS
10_1101-2021_01_05_425508	135	5	of	of	IN
10_1101-2021_01_05_425508	135	6	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	135	7	prevalent	prevalent	JJ
10_1101-2021_01_05_425508	135	8	in	in	IN
10_1101-2021_01_05_425508	135	9	humans	human	NNS
10_1101-2021_01_05_425508	135	10	or	or	CC
10_1101-2021_01_05_425508	135	11	bats	bat	NNS
10_1101-2021_01_05_425508	135	12	286	286	CD
10_1101-2021_01_05_425508	135	13	The	the	DT
10_1101-2021_01_05_425508	135	14	complete	complete	JJ
10_1101-2021_01_05_425508	135	15	sequences	sequence	NNS
10_1101-2021_01_05_425508	135	16	of	of	IN
10_1101-2021_01_05_425508	135	17	two	two	CD
10_1101-2021_01_05_425508	135	18	types	type	NNS
10_1101-2021_01_05_425508	135	19	of	of	IN
10_1101-2021_01_05_425508	135	20	human	human	JJ
10_1101-2021_01_05_425508	135	21	coronavirus	coronavirus	NN
10_1101-2021_01_05_425508	135	22	(	(	-LRB-
10_1101-2021_01_05_425508	135	23	human	human	NNP
10_1101-2021_01_05_425508	135	24	-	-	HYPH
10_1101-2021_01_05_425508	135	25	CoV	cov	NN
10_1101-2021_01_05_425508	135	26	)	)	-RRB-
10_1101-2021_01_05_425508	135	27	strains	strain	VBZ
10_1101-2021_01_05_425508	135	28	,	,	,
10_1101-2021_01_05_425508	135	29	287	287	CD
10_1101-2021_01_05_425508	135	30	alphacoronaviruses	alphacoronaviruse	NNS
10_1101-2021_01_05_425508	135	31	(	(	-LRB-
10_1101-2021_01_05_425508	135	32	27	27	CD
10_1101-2021_01_05_425508	135	33	229E	229e	CD
10_1101-2021_01_05_425508	135	34	and	and	CC
10_1101-2021_01_05_425508	135	35	55	55	CD
10_1101-2021_01_05_425508	135	36	NL63	NL63	NNP
10_1101-2021_01_05_425508	135	37	strains	strain	NNS
10_1101-2021_01_05_425508	135	38	)	)	-RRB-
10_1101-2021_01_05_425508	135	39	and	and	CC
10_1101-2021_01_05_425508	135	40	betacoronaviruses	betacoronaviruse	NNS
10_1101-2021_01_05_425508	135	41	(	(	-LRB-
10_1101-2021_01_05_425508	135	42	18	18	CD
10_1101-2021_01_05_425508	135	43	HKU1	HKU1	NNP
10_1101-2021_01_05_425508	135	44	288	288	CD
10_1101-2021_01_05_425508	135	45	and	and	CC
10_1101-2021_01_05_425508	135	46	138	138	CD
10_1101-2021_01_05_425508	135	47	OC43	OC43	NNP
10_1101-2021_01_05_425508	135	48	strains	strain	VBZ
10_1101-2021_01_05_425508	135	49	)	)	-RRB-
10_1101-2021_01_05_425508	135	50	,	,	,
10_1101-2021_01_05_425508	135	51	were	be	VBD
10_1101-2021_01_05_425508	135	52	obtained	obtain	VBN
10_1101-2021_01_05_425508	135	53	from	from	IN
10_1101-2021_01_05_425508	135	54	the	the	DT
10_1101-2021_01_05_425508	135	55	NCBI	NCBI	NNP
10_1101-2021_01_05_425508	135	56	virus	virus	NN
10_1101-2021_01_05_425508	135	57	database	database	NN
10_1101-2021_01_05_425508	135	58	289	289	CD
10_1101-2021_01_05_425508	135	59	(	(	-LRB-
10_1101-2021_01_05_425508	135	60	https://www.ncbi.nlm.nih.gov/labs/virus/	https://www.ncbi.nlm.nih.gov/labs/virus/	NNP
10_1101-2021_01_05_425508	135	61	)	)	-RRB-
10_1101-2021_01_05_425508	135	62	.	.	.
10_1101-2021_01_05_425508	136	1	The	the	DT
10_1101-2021_01_05_425508	136	2	complete	complete	JJ
10_1101-2021_01_05_425508	136	3	genome	genome	JJ
10_1101-2021_01_05_425508	136	4	sequences	sequence	NNS
10_1101-2021_01_05_425508	136	5	of	of	IN
10_1101-2021_01_05_425508	136	6	two	two	CD
10_1101-2021_01_05_425508	136	7	290	290	CD
10_1101-2021_01_05_425508	136	8	types	type	NNS
10_1101-2021_01_05_425508	136	9	of	of	IN
10_1101-2021_01_05_425508	136	10	bat	bat	NN
10_1101-2021_01_05_425508	136	11	coronavirus	coronaviru	NNS
10_1101-2021_01_05_425508	136	12	(	(	-LRB-
10_1101-2021_01_05_425508	136	13	bat	bat	NN
10_1101-2021_01_05_425508	136	14	-	-	HYPH
10_1101-2021_01_05_425508	136	15	CoV	cov	NN
10_1101-2021_01_05_425508	136	16	)	)	-RRB-
10_1101-2021_01_05_425508	136	17	strains	strain	VBZ
10_1101-2021_01_05_425508	136	18	,	,	,
10_1101-2021_01_05_425508	136	19	alphacoronaviruses	alphacoronaviruse	NNS
10_1101-2021_01_05_425508	136	20	(	(	-LRB-
10_1101-2021_01_05_425508	136	21	87	87	CD
10_1101-2021_01_05_425508	136	22	strains	strain	NNS
10_1101-2021_01_05_425508	136	23	)	)	-RRB-
10_1101-2021_01_05_425508	136	24	and	and	CC
10_1101-2021_01_05_425508	136	25	291	291	CD
10_1101-2021_01_05_425508	136	26	betacoronaviruses	betacoronaviruse	NNS
10_1101-2021_01_05_425508	136	27	(	(	-LRB-
10_1101-2021_01_05_425508	136	28	79	79	CD
10_1101-2021_01_05_425508	136	29	strains	strain	NNS
10_1101-2021_01_05_425508	136	30	,	,	,
10_1101-2021_01_05_425508	136	31	including	include	VBG
10_1101-2021_01_05_425508	136	32	34	34	CD
10_1101-2021_01_05_425508	136	33	SARS	SARS	NNP
10_1101-2021_01_05_425508	136	34	-	-	HYPH
10_1101-2021_01_05_425508	136	35	CoV	CoV	NNP
10_1101-2021_01_05_425508	136	36	)	)	-RRB-
10_1101-2021_01_05_425508	136	37	,	,	,
10_1101-2021_01_05_425508	136	38	isolated	isolate	VBN
10_1101-2021_01_05_425508	136	39	from	from	IN
10_1101-2021_01_05_425508	136	40	three	three	CD
10_1101-2021_01_05_425508	136	41	types	type	NNS
10_1101-2021_01_05_425508	136	42	of	of	IN
10_1101-2021_01_05_425508	136	43	292	292	CD
10_1101-2021_01_05_425508	136	44	bats	bat	NNS
10_1101-2021_01_05_425508	136	45	(	(	-LRB-
10_1101-2021_01_05_425508	136	46	Chiroptera	Chiroptera	NNP
10_1101-2021_01_05_425508	136	47	,	,	,
10_1101-2021_01_05_425508	136	48	Vespertilionidae	Vespertilionidae	NNP
10_1101-2021_01_05_425508	136	49	and	and	CC
10_1101-2021_01_05_425508	136	50	Rhinolophidae	Rhinolophidae	NNP
10_1101-2021_01_05_425508	136	51	)	)	-RRB-
10_1101-2021_01_05_425508	136	52	were	be	VBD
10_1101-2021_01_05_425508	136	53	obtained	obtain	VBN
10_1101-2021_01_05_425508	136	54	from	from	IN
10_1101-2021_01_05_425508	136	55	the	the	DT
10_1101-2021_01_05_425508	136	56	NCBI	NCBI	NNP
10_1101-2021_01_05_425508	136	57	293	293	CD
10_1101-2021_01_05_425508	136	58	virus	virus	NN
10_1101-2021_01_05_425508	136	59	database	database	NN
10_1101-2021_01_05_425508	136	60	(	(	-LRB-
10_1101-2021_01_05_425508	136	61	https://www.ncbi.nlm.nih.gov/labs/virus/	https://www.ncbi.nlm.nih.gov/labs/virus/	NNP
10_1101-2021_01_05_425508	136	62	)	)	-RRB-
10_1101-2021_01_05_425508	136	63	,	,	,
10_1101-2021_01_05_425508	136	64	and	and	CC
10_1101-2021_01_05_425508	136	65	the	the	DT
10_1101-2021_01_05_425508	136	66	polyA	polyA	NNP
10_1101-2021_01_05_425508	136	67	tail	tail	NN
10_1101-2021_01_05_425508	136	68	of	of	IN
10_1101-2021_01_05_425508	136	69	each	each	DT
10_1101-2021_01_05_425508	136	70	294	294	CD
10_1101-2021_01_05_425508	136	71	sequence	sequence	NN
10_1101-2021_01_05_425508	136	72	was	be	VBD
10_1101-2021_01_05_425508	136	73	removed	remove	VBN
10_1101-2021_01_05_425508	136	74	.	.	.
10_1101-2021_01_05_425508	137	1	The	the	DT
10_1101-2021_01_05_425508	137	2	strains	strain	NNS
10_1101-2021_01_05_425508	137	3	are	be	VBP
10_1101-2021_01_05_425508	137	4	listed	list	VBN
10_1101-2021_01_05_425508	137	5	in	in	IN
10_1101-2021_01_05_425508	137	6	Table	Table	NNP
10_1101-2021_01_05_425508	137	7	S2	S2	NNP
10_1101-2021_01_05_425508	137	8	.	.	.
10_1101-2021_01_05_425508	138	1	295	295	CD
10_1101-2021_01_05_425508	138	2	.CC	.CC	:
10_1101-2021_01_05_425508	138	3	-	-	HYPH
10_1101-2021_01_05_425508	138	4	BY	BY	NNP
10_1101-2021_01_05_425508	138	5	-	-	HYPH
10_1101-2021_01_05_425508	138	6	NC	NC	NNP
10_1101-2021_01_05_425508	138	7	4.0	4.0	CD
10_1101-2021_01_05_425508	138	8	International	international	JJ
10_1101-2021_01_05_425508	138	9	licensemade	licensemade	NN
10_1101-2021_01_05_425508	138	10	available	available	JJ
10_1101-2021_01_05_425508	138	11	under	under	IN
10_1101-2021_01_05_425508	138	12	a	a	DT
10_1101-2021_01_05_425508	138	13	(	(	-LRB-
10_1101-2021_01_05_425508	138	14	which	which	WDT
10_1101-2021_01_05_425508	138	15	was	be	VBD
10_1101-2021_01_05_425508	138	16	not	not	RB
10_1101-2021_01_05_425508	138	17	certified	certify	VBN
10_1101-2021_01_05_425508	138	18	by	by	IN
10_1101-2021_01_05_425508	138	19	peer	peer	NN
10_1101-2021_01_05_425508	138	20	review	review	NN
10_1101-2021_01_05_425508	138	21	)	)	-RRB-
10_1101-2021_01_05_425508	138	22	is	be	VBZ
10_1101-2021_01_05_425508	138	23	the	the	DT
10_1101-2021_01_05_425508	138	24	author	author	NN
10_1101-2021_01_05_425508	138	25	/	/	SYM
10_1101-2021_01_05_425508	138	26	funder	funder	NN
10_1101-2021_01_05_425508	138	27	,	,	,
10_1101-2021_01_05_425508	138	28	who	who	WP
10_1101-2021_01_05_425508	138	29	has	have	VBZ
10_1101-2021_01_05_425508	138	30	granted	grant	VBN
10_1101-2021_01_05_425508	138	31	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	138	32	a	a	DT
10_1101-2021_01_05_425508	138	33	license	license	NN
10_1101-2021_01_05_425508	138	34	to	to	TO
10_1101-2021_01_05_425508	138	35	display	display	VB
10_1101-2021_01_05_425508	138	36	the	the	DT
10_1101-2021_01_05_425508	138	37	preprint	preprint	NN
10_1101-2021_01_05_425508	138	38	in	in	IN
10_1101-2021_01_05_425508	138	39	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	138	40	.	.	.
10_1101-2021_01_05_425508	139	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	139	2	is	be	VBZ
10_1101-2021_01_05_425508	139	3	The	the	DT
10_1101-2021_01_05_425508	139	4	copyright	copyright	NN
10_1101-2021_01_05_425508	139	5	holder	holder	NN
10_1101-2021_01_05_425508	139	6	for	for	IN
10_1101-2021_01_05_425508	139	7	this	this	DT
10_1101-2021_01_05_425508	139	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	139	9	version	version	NN
10_1101-2021_01_05_425508	139	10	posted	post	VBD
10_1101-2021_01_05_425508	139	11	January	January	NNP
10_1101-2021_01_05_425508	139	12	6	6	CD
10_1101-2021_01_05_425508	139	13	,	,	,
10_1101-2021_01_05_425508	139	14	2021	2021	CD
10_1101-2021_01_05_425508	139	15	.	.	.
10_1101-2021_01_05_425508	139	16	;	;	:
10_1101-2021_01_05_425508	139	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	139	18	:	:	:
10_1101-2021_01_05_425508	139	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	139	20	preprint	preprint	NN
10_1101-2021_01_05_425508	139	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	POS
10_1101-2021_01_05_425508	139	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	139	23	12	12	CD
10_1101-2021_01_05_425508	139	24	296	296	CD
10_1101-2021_01_05_425508	139	25	Time	Time	NNP
10_1101-2021_01_05_425508	139	26	-	-	HYPH
10_1101-2021_01_05_425508	139	27	series	series	NN
10_1101-2021_01_05_425508	139	28	analysis	analysis	NN
10_1101-2021_01_05_425508	139	29	of	of	IN
10_1101-2021_01_05_425508	139	30	changes	change	NNS
10_1101-2021_01_05_425508	139	31	in	in	IN
10_1101-2021_01_05_425508	139	32	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	139	33	compositions	composition	NNS
10_1101-2021_01_05_425508	139	34	297	297	CD
10_1101-2021_01_05_425508	139	35	In	in	IN
10_1101-2021_01_05_425508	139	36	the	the	DT
10_1101-2021_01_05_425508	139	37	time	time	NN
10_1101-2021_01_05_425508	139	38	-	-	HYPH
10_1101-2021_01_05_425508	139	39	series	series	NN
10_1101-2021_01_05_425508	139	40	analysis	analysis	NN
10_1101-2021_01_05_425508	139	41	,	,	,
10_1101-2021_01_05_425508	139	42	the	the	DT
10_1101-2021_01_05_425508	139	43	average	average	JJ
10_1101-2021_01_05_425508	139	44	mono-	mono-	NN
10_1101-2021_01_05_425508	139	45	and	and	CC
10_1101-2021_01_05_425508	139	46	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	139	47	compositions	composition	NNS
10_1101-2021_01_05_425508	139	48	(	(	-LRB-
10_1101-2021_01_05_425508	139	49	%	%	NN
10_1101-2021_01_05_425508	139	50	)	)	-RRB-
10_1101-2021_01_05_425508	139	51	of	of	IN
10_1101-2021_01_05_425508	139	52	298	298	CD
10_1101-2021_01_05_425508	139	53	viruses	virus	NNS
10_1101-2021_01_05_425508	139	54	collected	collect	VBN
10_1101-2021_01_05_425508	139	55	in	in	IN
10_1101-2021_01_05_425508	139	56	each	each	DT
10_1101-2021_01_05_425508	139	57	month	month	NN
10_1101-2021_01_05_425508	139	58	were	be	VBD
10_1101-2021_01_05_425508	139	59	calculated	calculate	VBN
10_1101-2021_01_05_425508	139	60	for	for	IN
10_1101-2021_01_05_425508	139	61	each	each	DT
10_1101-2021_01_05_425508	139	62	clade	clade	NN
10_1101-2021_01_05_425508	139	63	.	.	.
10_1101-2021_01_05_425508	140	1	To	to	TO
10_1101-2021_01_05_425508	140	2	avoid	avoid	VB
10_1101-2021_01_05_425508	140	3	statistical	statistical	JJ
10_1101-2021_01_05_425508	140	4	299	299	CD
10_1101-2021_01_05_425508	140	5	fluctuations	fluctuation	NNS
10_1101-2021_01_05_425508	140	6	due	due	JJ
10_1101-2021_01_05_425508	140	7	to	to	IN
10_1101-2021_01_05_425508	140	8	the	the	DT
10_1101-2021_01_05_425508	140	9	small	small	JJ
10_1101-2021_01_05_425508	140	10	sample	sample	NN
10_1101-2021_01_05_425508	140	11	size	size	NN
10_1101-2021_01_05_425508	140	12	,	,	,
10_1101-2021_01_05_425508	140	13	months	month	NNS
10_1101-2021_01_05_425508	140	14	in	in	IN
10_1101-2021_01_05_425508	140	15	which	which	WDT
10_1101-2021_01_05_425508	140	16	fewer	few	JJR
10_1101-2021_01_05_425508	140	17	than	than	IN
10_1101-2021_01_05_425508	140	18	10	10	CD
10_1101-2021_01_05_425508	140	19	strains	strain	NNS
10_1101-2021_01_05_425508	140	20	had	have	VBD
10_1101-2021_01_05_425508	140	21	300	300	CD
10_1101-2021_01_05_425508	140	22	been	be	VBN
10_1101-2021_01_05_425508	140	23	collected	collect	VBN
10_1101-2021_01_05_425508	140	24	were	be	VBD
10_1101-2021_01_05_425508	140	25	excluded	exclude	VBN
10_1101-2021_01_05_425508	140	26	from	from	IN
10_1101-2021_01_05_425508	140	27	the	the	DT
10_1101-2021_01_05_425508	140	28	monthly	monthly	JJ
10_1101-2021_01_05_425508	140	29	analysis	analysis	NN
10_1101-2021_01_05_425508	140	30	.	.	.
10_1101-2021_01_05_425508	141	1	301	301	CD
10_1101-2021_01_05_425508	141	2	302	302	CD
10_1101-2021_01_05_425508	141	3	RNA	rna	NN
10_1101-2021_01_05_425508	141	4	-	-	HYPH
10_1101-2021_01_05_425508	141	5	binding	bind	VBG
10_1101-2021_01_05_425508	141	6	motif	motif	NN
10_1101-2021_01_05_425508	141	7	analysis	analysis	NN
10_1101-2021_01_05_425508	141	8	303	303	CD
10_1101-2021_01_05_425508	141	9	RNA	rna	NN
10_1101-2021_01_05_425508	141	10	-	-	HYPH
10_1101-2021_01_05_425508	141	11	binding	bind	VBG
10_1101-2021_01_05_425508	141	12	motifs	motif	NNS
10_1101-2021_01_05_425508	141	13	were	be	VBD
10_1101-2021_01_05_425508	141	14	obtained	obtain	VBN
10_1101-2021_01_05_425508	141	15	from	from	IN
10_1101-2021_01_05_425508	141	16	the	the	DT
10_1101-2021_01_05_425508	141	17	ATtRACT	ATtRACT	NNP
10_1101-2021_01_05_425508	141	18	database	database	NN
10_1101-2021_01_05_425508	141	19	[	[	-LRB-
10_1101-2021_01_05_425508	141	20	30	30	CD
10_1101-2021_01_05_425508	141	21	]	]	-RRB-
10_1101-2021_01_05_425508	141	22	.	.	.
10_1101-2021_01_05_425508	142	1	In	in	IN
10_1101-2021_01_05_425508	142	2	this	this	DT
10_1101-2021_01_05_425508	142	3	database	database	NN
10_1101-2021_01_05_425508	142	4	,	,	,
10_1101-2021_01_05_425508	142	5	304	304	CD
10_1101-2021_01_05_425508	142	6	multiple	multiple	JJ
10_1101-2021_01_05_425508	142	7	binding	bind	VBG
10_1101-2021_01_05_425508	142	8	motifs	motif	NNS
10_1101-2021_01_05_425508	142	9	are	be	VBP
10_1101-2021_01_05_425508	142	10	registered	register	VBN
10_1101-2021_01_05_425508	142	11	as	as	IN
10_1101-2021_01_05_425508	142	12	corresponding	correspond	VBG
10_1101-2021_01_05_425508	142	13	to	to	IN
10_1101-2021_01_05_425508	142	14	one	one	CD
10_1101-2021_01_05_425508	142	15	RNA	RNA	NNP
10_1101-2021_01_05_425508	142	16	-	-	HYPH
10_1101-2021_01_05_425508	142	17	binding	bind	VBG
10_1101-2021_01_05_425508	142	18	protein	protein	NN
10_1101-2021_01_05_425508	142	19	;	;	:
10_1101-2021_01_05_425508	142	20	305	305	CD
10_1101-2021_01_05_425508	142	21	we	-PRON-	PRP
10_1101-2021_01_05_425508	142	22	calculated	calculate	VBD
10_1101-2021_01_05_425508	142	23	the	the	DT
10_1101-2021_01_05_425508	142	24	total	total	JJ
10_1101-2021_01_05_425508	142	25	number	number	NN
10_1101-2021_01_05_425508	142	26	of	of	IN
10_1101-2021_01_05_425508	142	27	loci	loci	NN
10_1101-2021_01_05_425508	142	28	containing	contain	VBG
10_1101-2021_01_05_425508	142	29	the	the	DT
10_1101-2021_01_05_425508	142	30	binding	bind	VBG
10_1101-2021_01_05_425508	142	31	motifs	motif	NNS
10_1101-2021_01_05_425508	142	32	for	for	IN
10_1101-2021_01_05_425508	142	33	each	each	DT
10_1101-2021_01_05_425508	142	34	protein	protein	NN
10_1101-2021_01_05_425508	142	35	in	in	IN
10_1101-2021_01_05_425508	142	36	306	306	CD
10_1101-2021_01_05_425508	142	37	the	the	DT
10_1101-2021_01_05_425508	142	38	viral	viral	JJ
10_1101-2021_01_05_425508	142	39	genomes	genome	NNS
10_1101-2021_01_05_425508	142	40	.	.	.
10_1101-2021_01_05_425508	143	1	307	307	CD
10_1101-2021_01_05_425508	143	2	308	308	CD
10_1101-2021_01_05_425508	143	3	309	309	CD
10_1101-2021_01_05_425508	143	4	310	310	CD
10_1101-2021_01_05_425508	143	5	311	311	CD
10_1101-2021_01_05_425508	143	6	List	List	NNP
10_1101-2021_01_05_425508	143	7	of	of	IN
10_1101-2021_01_05_425508	143	8	abbreviations	abbreviation	NNS
10_1101-2021_01_05_425508	143	9	312	312	CD
10_1101-2021_01_05_425508	143	10	SARS	SARS	NNP
10_1101-2021_01_05_425508	143	11	-	-	HYPH
10_1101-2021_01_05_425508	143	12	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	143	13	:	:	:
10_1101-2021_01_05_425508	143	14	Severe	severe	JJ
10_1101-2021_01_05_425508	143	15	acute	acute	JJ
10_1101-2021_01_05_425508	143	16	respiratory	respiratory	JJ
10_1101-2021_01_05_425508	143	17	syndrome	syndrome	NN
10_1101-2021_01_05_425508	143	18	coronavirus-2	coronavirus-2	NNP
10_1101-2021_01_05_425508	143	19	313	313	CD
10_1101-2021_01_05_425508	143	20	human	human	NN
10_1101-2021_01_05_425508	143	21	-	-	HYPH
10_1101-2021_01_05_425508	143	22	CoV	cov	NN
10_1101-2021_01_05_425508	143	23	:	:	:
10_1101-2021_01_05_425508	143	24	human	human	JJ
10_1101-2021_01_05_425508	143	25	coronavirus	coronavirus	NNP
10_1101-2021_01_05_425508	143	26	314	314	CD
10_1101-2021_01_05_425508	143	27	bat	bat	NN
10_1101-2021_01_05_425508	143	28	-	-	HYPH
10_1101-2021_01_05_425508	143	29	CoV	cov	NN
10_1101-2021_01_05_425508	143	30	:	:	:
10_1101-2021_01_05_425508	143	31	bat	bat	NN
10_1101-2021_01_05_425508	143	32	coronavirus	coronavirus	NNP
10_1101-2021_01_05_425508	143	33	315	315	CD
10_1101-2021_01_05_425508	143	34	316	316	CD
10_1101-2021_01_05_425508	143	35	Ethics	Ethics	NNP
10_1101-2021_01_05_425508	143	36	approval	approval	NN
10_1101-2021_01_05_425508	143	37	and	and	CC
10_1101-2021_01_05_425508	143	38	consent	consent	NN
10_1101-2021_01_05_425508	143	39	to	to	TO
10_1101-2021_01_05_425508	143	40	participate	participate	VB
10_1101-2021_01_05_425508	143	41	317	317	CD
10_1101-2021_01_05_425508	143	42	Not	not	RB
10_1101-2021_01_05_425508	143	43	applicable	applicable	JJ
10_1101-2021_01_05_425508	143	44	318	318	CD
10_1101-2021_01_05_425508	143	45	319	319	CD
10_1101-2021_01_05_425508	143	46	Consent	Consent	NNP
10_1101-2021_01_05_425508	143	47	for	for	IN
10_1101-2021_01_05_425508	143	48	publication	publication	NN
10_1101-2021_01_05_425508	143	49	320	320	CD
10_1101-2021_01_05_425508	143	50	Not	not	RB
10_1101-2021_01_05_425508	143	51	applicable	applicable	JJ
10_1101-2021_01_05_425508	143	52	321	321	CD
10_1101-2021_01_05_425508	143	53	322	322	CD
10_1101-2021_01_05_425508	143	54	.CC	.CC	:
10_1101-2021_01_05_425508	143	55	-	-	:
10_1101-2021_01_05_425508	143	56	BY	BY	NNP
10_1101-2021_01_05_425508	143	57	-	-	HYPH
10_1101-2021_01_05_425508	143	58	NC	NC	NNP
10_1101-2021_01_05_425508	143	59	4.0	4.0	CD
10_1101-2021_01_05_425508	143	60	International	international	JJ
10_1101-2021_01_05_425508	143	61	licensemade	licensemade	NN
10_1101-2021_01_05_425508	143	62	available	available	JJ
10_1101-2021_01_05_425508	143	63	under	under	IN
10_1101-2021_01_05_425508	143	64	a	a	DT
10_1101-2021_01_05_425508	143	65	(	(	-LRB-
10_1101-2021_01_05_425508	143	66	which	which	WDT
10_1101-2021_01_05_425508	143	67	was	be	VBD
10_1101-2021_01_05_425508	143	68	not	not	RB
10_1101-2021_01_05_425508	143	69	certified	certify	VBN
10_1101-2021_01_05_425508	143	70	by	by	IN
10_1101-2021_01_05_425508	143	71	peer	peer	NN
10_1101-2021_01_05_425508	143	72	review	review	NN
10_1101-2021_01_05_425508	143	73	)	)	-RRB-
10_1101-2021_01_05_425508	143	74	is	be	VBZ
10_1101-2021_01_05_425508	143	75	the	the	DT
10_1101-2021_01_05_425508	143	76	author	author	NN
10_1101-2021_01_05_425508	143	77	/	/	SYM
10_1101-2021_01_05_425508	143	78	funder	funder	NN
10_1101-2021_01_05_425508	143	79	,	,	,
10_1101-2021_01_05_425508	143	80	who	who	WP
10_1101-2021_01_05_425508	143	81	has	have	VBZ
10_1101-2021_01_05_425508	143	82	granted	grant	VBN
10_1101-2021_01_05_425508	143	83	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	143	84	a	a	DT
10_1101-2021_01_05_425508	143	85	license	license	NN
10_1101-2021_01_05_425508	143	86	to	to	TO
10_1101-2021_01_05_425508	143	87	display	display	VB
10_1101-2021_01_05_425508	143	88	the	the	DT
10_1101-2021_01_05_425508	143	89	preprint	preprint	NN
10_1101-2021_01_05_425508	143	90	in	in	IN
10_1101-2021_01_05_425508	143	91	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	143	92	.	.	.
10_1101-2021_01_05_425508	144	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	144	2	is	be	VBZ
10_1101-2021_01_05_425508	144	3	The	the	DT
10_1101-2021_01_05_425508	144	4	copyright	copyright	NN
10_1101-2021_01_05_425508	144	5	holder	holder	NN
10_1101-2021_01_05_425508	144	6	for	for	IN
10_1101-2021_01_05_425508	144	7	this	this	DT
10_1101-2021_01_05_425508	144	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	144	9	version	version	NN
10_1101-2021_01_05_425508	144	10	posted	post	VBD
10_1101-2021_01_05_425508	144	11	January	January	NNP
10_1101-2021_01_05_425508	144	12	6	6	CD
10_1101-2021_01_05_425508	144	13	,	,	,
10_1101-2021_01_05_425508	144	14	2021	2021	CD
10_1101-2021_01_05_425508	144	15	.	.	.
10_1101-2021_01_05_425508	144	16	;	;	:
10_1101-2021_01_05_425508	144	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	144	18	:	:	:
10_1101-2021_01_05_425508	144	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	144	20	preprint	preprint	NN
10_1101-2021_01_05_425508	144	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	144	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	144	23	13	13	CD
10_1101-2021_01_05_425508	144	24	Availability	Availability	NNP
10_1101-2021_01_05_425508	144	25	of	of	IN
10_1101-2021_01_05_425508	144	26	data	datum	NNS
10_1101-2021_01_05_425508	144	27	and	and	CC
10_1101-2021_01_05_425508	144	28	materials	material	NNS
10_1101-2021_01_05_425508	144	29	323	323	CD
10_1101-2021_01_05_425508	144	30	The	the	DT
10_1101-2021_01_05_425508	144	31	sequence	sequence	NN
10_1101-2021_01_05_425508	144	32	dataset	dataset	NN
10_1101-2021_01_05_425508	144	33	analyzed	analyze	VBN
10_1101-2021_01_05_425508	144	34	in	in	IN
10_1101-2021_01_05_425508	144	35	this	this	DT
10_1101-2021_01_05_425508	144	36	study	study	NN
10_1101-2021_01_05_425508	144	37	are	be	VBP
10_1101-2021_01_05_425508	144	38	stored	store	VBN
10_1101-2021_01_05_425508	144	39	in	in	IN
10_1101-2021_01_05_425508	144	40	GISAID	GISAID	NNP
10_1101-2021_01_05_425508	144	41	.	.	.
10_1101-2021_01_05_425508	145	1	Other	other	JJ
10_1101-2021_01_05_425508	145	2	data	datum	NNS
10_1101-2021_01_05_425508	145	3	are	be	VBP
10_1101-2021_01_05_425508	145	4	324	324	CD
10_1101-2021_01_05_425508	145	5	available	available	JJ
10_1101-2021_01_05_425508	145	6	from	from	IN
10_1101-2021_01_05_425508	145	7	YI	YI	NNP
10_1101-2021_01_05_425508	145	8	.	.	.
10_1101-2021_01_05_425508	146	1	325	325	CD
10_1101-2021_01_05_425508	146	2	326	326	CD
10_1101-2021_01_05_425508	146	3	Competing	compete	VBG
10_1101-2021_01_05_425508	146	4	interests	interest	NNS
10_1101-2021_01_05_425508	146	5	327	327	CD
10_1101-2021_01_05_425508	146	6	The	the	DT
10_1101-2021_01_05_425508	146	7	authors	author	NNS
10_1101-2021_01_05_425508	146	8	declared	declare	VBD
10_1101-2021_01_05_425508	146	9	that	that	IN
10_1101-2021_01_05_425508	146	10	there	there	EX
10_1101-2021_01_05_425508	146	11	are	be	VBP
10_1101-2021_01_05_425508	146	12	no	no	DT
10_1101-2021_01_05_425508	146	13	conflicts	conflict	NNS
10_1101-2021_01_05_425508	146	14	of	of	IN
10_1101-2021_01_05_425508	146	15	interests	interest	NNS
10_1101-2021_01_05_425508	146	16	.	.	.
10_1101-2021_01_05_425508	147	1	328	328	CD
10_1101-2021_01_05_425508	147	2	329	329	CD
10_1101-2021_01_05_425508	147	3	Funding	funding	NN
10_1101-2021_01_05_425508	147	4	330	330	CD
10_1101-2021_01_05_425508	147	5	This	this	DT
10_1101-2021_01_05_425508	147	6	work	work	NN
10_1101-2021_01_05_425508	147	7	was	be	VBD
10_1101-2021_01_05_425508	147	8	supported	support	VBN
10_1101-2021_01_05_425508	147	9	by	by	IN
10_1101-2021_01_05_425508	147	10	JSPS	JSPS	NNP
10_1101-2021_01_05_425508	147	11	KAKENHI	KAKENHI	NNP
10_1101-2021_01_05_425508	147	12	Grant	Grant	NNP
10_1101-2021_01_05_425508	147	13	Number	Number	NNP
10_1101-2021_01_05_425508	147	14	18K07151	18k07151	NN
10_1101-2021_01_05_425508	147	15	,	,	,
10_1101-2021_01_05_425508	147	16	by	by	IN
10_1101-2021_01_05_425508	147	17	AMED	amed	NN
10_1101-2021_01_05_425508	147	18	331	331	CD
10_1101-2021_01_05_425508	147	19	under	under	IN
10_1101-2021_01_05_425508	147	20	Grant	Grant	NNP
10_1101-2021_01_05_425508	147	21	Number	Number	NNP
10_1101-2021_01_05_425508	147	22	JP20he0622033	JP20he0622033	NNP
10_1101-2021_01_05_425508	147	23	and	and	CC
10_1101-2021_01_05_425508	147	24	by	by	IN
10_1101-2021_01_05_425508	147	25	COVID-19	COVID-19	NNP
10_1101-2021_01_05_425508	147	26	Counterplan	Counterplan	NNP
10_1101-2021_01_05_425508	147	27	Research	Research	NNP
10_1101-2021_01_05_425508	147	28	Project	Project	NNP
10_1101-2021_01_05_425508	147	29	332	332	CD
10_1101-2021_01_05_425508	147	30	(	(	-LRB-
10_1101-2021_01_05_425508	147	31	supervised	supervise	VBN
10_1101-2021_01_05_425508	147	32	by	by	IN
10_1101-2021_01_05_425508	147	33	Prof.	Prof.	NNP
10_1101-2021_01_05_425508	147	34	Tatsumi	Tatsumi	NNP
10_1101-2021_01_05_425508	147	35	Hirata	Hirata	NNP
10_1101-2021_01_05_425508	147	36	,	,	,
10_1101-2021_01_05_425508	147	37	NIG	NIG	NNP
10_1101-2021_01_05_425508	147	38	)	)	-RRB-
10_1101-2021_01_05_425508	147	39	from	from	IN
10_1101-2021_01_05_425508	147	40	the	the	DT
10_1101-2021_01_05_425508	147	41	Research	Research	NNP
10_1101-2021_01_05_425508	147	42	Organization	Organization	NNP
10_1101-2021_01_05_425508	147	43	of	of	IN
10_1101-2021_01_05_425508	147	44	333	333	CD
10_1101-2021_01_05_425508	147	45	Information	Information	NNP
10_1101-2021_01_05_425508	147	46	and	and	CC
10_1101-2021_01_05_425508	147	47	Systems	Systems	NNP
10_1101-2021_01_05_425508	147	48	(	(	-LRB-
10_1101-2021_01_05_425508	147	49	ROIS	ROIS	NNP
10_1101-2021_01_05_425508	147	50	)	)	-RRB-
10_1101-2021_01_05_425508	147	51	.	.	.
10_1101-2021_01_05_425508	148	1	334	334	CD
10_1101-2021_01_05_425508	148	2	335	335	CD
10_1101-2021_01_05_425508	148	3	Authors	Authors	NNPS
10_1101-2021_01_05_425508	148	4	'	'	POS
10_1101-2021_01_05_425508	148	5	contributions	contribution	NNS
10_1101-2021_01_05_425508	148	6	336	336	CD
10_1101-2021_01_05_425508	148	7	YI	YI	NNP
10_1101-2021_01_05_425508	148	8	conceived	conceive	VBD
10_1101-2021_01_05_425508	148	9	the	the	DT
10_1101-2021_01_05_425508	148	10	approach	approach	NN
10_1101-2021_01_05_425508	148	11	and	and	CC
10_1101-2021_01_05_425508	148	12	conducted	conduct	VBD
10_1101-2021_01_05_425508	148	13	this	this	DT
10_1101-2021_01_05_425508	148	14	analysis	analysis	NN
10_1101-2021_01_05_425508	148	15	.	.	.
10_1101-2021_01_05_425508	149	1	TA	TA	NNP
10_1101-2021_01_05_425508	149	2	developed	develop	VBD
10_1101-2021_01_05_425508	149	3	the	the	DT
10_1101-2021_01_05_425508	149	4	algorithm	algorithm	NN
10_1101-2021_01_05_425508	149	5	.	.	.
10_1101-2021_01_05_425508	150	1	TI	TI	NNP
10_1101-2021_01_05_425508	150	2	337	337	CD
10_1101-2021_01_05_425508	150	3	supervised	supervise	VBD
10_1101-2021_01_05_425508	150	4	this	this	DT
10_1101-2021_01_05_425508	150	5	study	study	NN
10_1101-2021_01_05_425508	150	6	.	.	.
10_1101-2021_01_05_425508	151	1	338	338	CD
10_1101-2021_01_05_425508	151	2	339	339	CD
10_1101-2021_01_05_425508	151	3	Acknowledgements	acknowledgement	NNS
10_1101-2021_01_05_425508	151	4	340	340	CD
10_1101-2021_01_05_425508	151	5	We	-PRON-	PRP
10_1101-2021_01_05_425508	151	6	gratefully	gratefully	RB
10_1101-2021_01_05_425508	151	7	acknowledge	acknowledge	VBP
10_1101-2021_01_05_425508	151	8	the	the	DT
10_1101-2021_01_05_425508	151	9	authors	author	NNS
10_1101-2021_01_05_425508	151	10	submitting	submit	VBG
10_1101-2021_01_05_425508	151	11	their	-PRON-	PRP$
10_1101-2021_01_05_425508	151	12	sequences	sequence	NNS
10_1101-2021_01_05_425508	151	13	from	from	IN
10_1101-2021_01_05_425508	151	14	GISAID	GISAID	NNP
10_1101-2021_01_05_425508	151	15	’s	’s	POS
10_1101-2021_01_05_425508	151	16	341	341	CD
10_1101-2021_01_05_425508	151	17	Database	Database	NNP
10_1101-2021_01_05_425508	151	18	and	and	CC
10_1101-2021_01_05_425508	151	19	also	also	RB
10_1101-2021_01_05_425508	151	20	the	the	DT
10_1101-2021_01_05_425508	151	21	valuable	valuable	JJ
10_1101-2021_01_05_425508	151	22	comments	comment	NNS
10_1101-2021_01_05_425508	151	23	of	of	IN
10_1101-2021_01_05_425508	151	24	Dr.	Dr.	NNP
10_1101-2021_01_05_425508	151	25	Yashushi	Yashushi	NNP
10_1101-2021_01_05_425508	151	26	Hiromi	Hiromi	NNP
10_1101-2021_01_05_425508	151	27	of	of	IN
10_1101-2021_01_05_425508	151	28	National	National	NNP
10_1101-2021_01_05_425508	151	29	Institute	Institute	NNP
10_1101-2021_01_05_425508	151	30	342	342	CD
10_1101-2021_01_05_425508	151	31	of	of	IN
10_1101-2021_01_05_425508	151	32	Genetics	Genetics	NNP
10_1101-2021_01_05_425508	151	33	(	(	-LRB-
10_1101-2021_01_05_425508	151	34	Mishima	Mishima	NNP
10_1101-2021_01_05_425508	151	35	)	)	-RRB-
10_1101-2021_01_05_425508	151	36	.	.	.
10_1101-2021_01_05_425508	152	1	We	-PRON-	PRP
10_1101-2021_01_05_425508	152	2	thank	thank	VBP
10_1101-2021_01_05_425508	152	3	Springer	Springer	NNP
10_1101-2021_01_05_425508	152	4	Nature	Nature	NNP
10_1101-2021_01_05_425508	152	5	Author	Author	NNP
10_1101-2021_01_05_425508	152	6	Services	Services	NNPS
10_1101-2021_01_05_425508	152	7	for	for	IN
10_1101-2021_01_05_425508	152	8	editing	edit	VBG
10_1101-2021_01_05_425508	152	9	this	this	DT
10_1101-2021_01_05_425508	152	10	343	343	CD
10_1101-2021_01_05_425508	152	11	manuscript	manuscript	NN
10_1101-2021_01_05_425508	152	12	for	for	IN
10_1101-2021_01_05_425508	152	13	English	english	JJ
10_1101-2021_01_05_425508	152	14	language	language	NN
10_1101-2021_01_05_425508	152	15	.	.	.
10_1101-2021_01_05_425508	153	1	344	344	CD
10_1101-2021_01_05_425508	153	2	345	345	CD
10_1101-2021_01_05_425508	153	3	Figure	figure	NN
10_1101-2021_01_05_425508	153	4	legends	legend	VBZ
10_1101-2021_01_05_425508	153	5	346	346	CD
10_1101-2021_01_05_425508	153	6	Fig	fig	NN
10_1101-2021_01_05_425508	153	7	.	.	.
10_1101-2021_01_05_425508	154	1	1	1	LS
10_1101-2021_01_05_425508	154	2	.	.	.
10_1101-2021_01_05_425508	155	1	Time	time	NN
10_1101-2021_01_05_425508	155	2	-	-	HYPH
10_1101-2021_01_05_425508	155	3	dependent	dependent	JJ
10_1101-2021_01_05_425508	155	4	directional	directional	JJ
10_1101-2021_01_05_425508	155	5	changes	change	NNS
10_1101-2021_01_05_425508	155	6	in	in	IN
10_1101-2021_01_05_425508	155	7	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	155	8	compositions	composition	NNS
10_1101-2021_01_05_425508	155	9	.	.	.
10_1101-2021_01_05_425508	156	1	(	(	-LRB-
10_1101-2021_01_05_425508	156	2	A	a	DT
10_1101-2021_01_05_425508	156	3	)	)	-RRB-
10_1101-2021_01_05_425508	156	4	347	347	CD
10_1101-2021_01_05_425508	156	5	Average	average	JJ
10_1101-2021_01_05_425508	156	6	mononucleotide	mononucleotide	NN
10_1101-2021_01_05_425508	156	7	compositions	composition	NNS
10_1101-2021_01_05_425508	156	8	(	(	-LRB-
10_1101-2021_01_05_425508	156	9	%	%	NN
10_1101-2021_01_05_425508	156	10	)	)	-RRB-
10_1101-2021_01_05_425508	156	11	in	in	IN
10_1101-2021_01_05_425508	156	12	the	the	DT
10_1101-2021_01_05_425508	156	13	SARS	SARS	NNP
10_1101-2021_01_05_425508	156	14	-	-	HYPH
10_1101-2021_01_05_425508	156	15	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	156	16	genomes	genome	NNS
10_1101-2021_01_05_425508	156	17	of	of	IN
10_1101-2021_01_05_425508	156	18	each	each	DT
10_1101-2021_01_05_425508	156	19	clade	clade	NN
10_1101-2021_01_05_425508	156	20	348	348	CD
10_1101-2021_01_05_425508	156	21	isolated	isolate	VBN
10_1101-2021_01_05_425508	156	22	in	in	IN
10_1101-2021_01_05_425508	156	23	each	each	DT
10_1101-2021_01_05_425508	156	24	month	month	NN
10_1101-2021_01_05_425508	156	25	are	be	VBP
10_1101-2021_01_05_425508	156	26	plotted	plot	VBN
10_1101-2021_01_05_425508	156	27	against	against	IN
10_1101-2021_01_05_425508	156	28	the	the	DT
10_1101-2021_01_05_425508	156	29	elapsed	elapse	VBN
10_1101-2021_01_05_425508	156	30	month	month	NN
10_1101-2021_01_05_425508	156	31	.	.	.
10_1101-2021_01_05_425508	157	1	To	to	TO
10_1101-2021_01_05_425508	157	2	compare	compare	VB
10_1101-2021_01_05_425508	157	3	the	the	DT
10_1101-2021_01_05_425508	157	4	four	four	CD
10_1101-2021_01_05_425508	157	5	349	349	CD
10_1101-2021_01_05_425508	157	6	.CC	.CC	,
10_1101-2021_01_05_425508	157	7	-	-	HYPH
10_1101-2021_01_05_425508	157	8	BY	BY	NNP
10_1101-2021_01_05_425508	157	9	-	-	HYPH
10_1101-2021_01_05_425508	157	10	NC	NC	NNP
10_1101-2021_01_05_425508	157	11	4.0	4.0	CD
10_1101-2021_01_05_425508	157	12	International	international	JJ
10_1101-2021_01_05_425508	157	13	licensemade	licensemade	NN
10_1101-2021_01_05_425508	157	14	available	available	JJ
10_1101-2021_01_05_425508	157	15	under	under	IN
10_1101-2021_01_05_425508	157	16	a	a	DT
10_1101-2021_01_05_425508	157	17	(	(	-LRB-
10_1101-2021_01_05_425508	157	18	which	which	WDT
10_1101-2021_01_05_425508	157	19	was	be	VBD
10_1101-2021_01_05_425508	157	20	not	not	RB
10_1101-2021_01_05_425508	157	21	certified	certify	VBN
10_1101-2021_01_05_425508	157	22	by	by	IN
10_1101-2021_01_05_425508	157	23	peer	peer	NN
10_1101-2021_01_05_425508	157	24	review	review	NN
10_1101-2021_01_05_425508	157	25	)	)	-RRB-
10_1101-2021_01_05_425508	157	26	is	be	VBZ
10_1101-2021_01_05_425508	157	27	the	the	DT
10_1101-2021_01_05_425508	157	28	author	author	NN
10_1101-2021_01_05_425508	157	29	/	/	SYM
10_1101-2021_01_05_425508	157	30	funder	funder	NN
10_1101-2021_01_05_425508	157	31	,	,	,
10_1101-2021_01_05_425508	157	32	who	who	WP
10_1101-2021_01_05_425508	157	33	has	have	VBZ
10_1101-2021_01_05_425508	157	34	granted	grant	VBN
10_1101-2021_01_05_425508	157	35	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	157	36	a	a	DT
10_1101-2021_01_05_425508	157	37	license	license	NN
10_1101-2021_01_05_425508	157	38	to	to	TO
10_1101-2021_01_05_425508	157	39	display	display	VB
10_1101-2021_01_05_425508	157	40	the	the	DT
10_1101-2021_01_05_425508	157	41	preprint	preprint	NN
10_1101-2021_01_05_425508	157	42	in	in	IN
10_1101-2021_01_05_425508	157	43	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	157	44	.	.	.
10_1101-2021_01_05_425508	158	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	158	2	is	be	VBZ
10_1101-2021_01_05_425508	158	3	The	the	DT
10_1101-2021_01_05_425508	158	4	copyright	copyright	NN
10_1101-2021_01_05_425508	158	5	holder	holder	NN
10_1101-2021_01_05_425508	158	6	for	for	IN
10_1101-2021_01_05_425508	158	7	this	this	DT
10_1101-2021_01_05_425508	158	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	158	9	version	version	NN
10_1101-2021_01_05_425508	158	10	posted	post	VBD
10_1101-2021_01_05_425508	158	11	January	January	NNP
10_1101-2021_01_05_425508	158	12	6	6	CD
10_1101-2021_01_05_425508	158	13	,	,	,
10_1101-2021_01_05_425508	158	14	2021	2021	CD
10_1101-2021_01_05_425508	158	15	.	.	.
10_1101-2021_01_05_425508	158	16	;	;	:
10_1101-2021_01_05_425508	158	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	158	18	:	:	:
10_1101-2021_01_05_425508	158	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	158	20	preprint	preprint	NN
10_1101-2021_01_05_425508	158	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	158	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	158	23	14	14	CD
10_1101-2021_01_05_425508	158	24	mononucleotides	mononucleotide	NNS
10_1101-2021_01_05_425508	158	25	,	,	,
10_1101-2021_01_05_425508	158	26	the	the	DT
10_1101-2021_01_05_425508	158	27	scale	scale	NN
10_1101-2021_01_05_425508	158	28	widths	width	NNS
10_1101-2021_01_05_425508	158	29	on	on	IN
10_1101-2021_01_05_425508	158	30	the	the	DT
10_1101-2021_01_05_425508	158	31	vertical	vertical	JJ
10_1101-2021_01_05_425508	158	32	axis	axi	NNS
10_1101-2021_01_05_425508	158	33	are	be	VBP
10_1101-2021_01_05_425508	158	34	set	set	VBN
10_1101-2021_01_05_425508	158	35	to	to	IN
10_1101-2021_01_05_425508	158	36	the	the	DT
10_1101-2021_01_05_425508	158	37	same	same	JJ
10_1101-2021_01_05_425508	158	38	values	value	NNS
10_1101-2021_01_05_425508	158	39	.	.	.
10_1101-2021_01_05_425508	159	1	The	the	DT
10_1101-2021_01_05_425508	159	2	350	350	CD
10_1101-2021_01_05_425508	159	3	colored	colored	JJ
10_1101-2021_01_05_425508	159	4	lines	line	NNS
10_1101-2021_01_05_425508	159	5	distinguishing	distinguish	VBG
10_1101-2021_01_05_425508	159	6	the	the	DT
10_1101-2021_01_05_425508	159	7	clade	clade	NN
10_1101-2021_01_05_425508	159	8	(	(	-LRB-
10_1101-2021_01_05_425508	159	9	G	G	NNP
10_1101-2021_01_05_425508	159	10	,	,	,
10_1101-2021_01_05_425508	159	11	GH	GH	NNP
10_1101-2021_01_05_425508	159	12	,	,	,
10_1101-2021_01_05_425508	159	13	GR	GR	NNP
10_1101-2021_01_05_425508	159	14	,	,	,
10_1101-2021_01_05_425508	159	15	L	L	NNP
10_1101-2021_01_05_425508	159	16	,	,	,
10_1101-2021_01_05_425508	159	17	V	V	NNP
10_1101-2021_01_05_425508	159	18	and	and	CC
10_1101-2021_01_05_425508	159	19	S	S	NNP
10_1101-2021_01_05_425508	159	20	)	)	-RRB-
10_1101-2021_01_05_425508	159	21	are	be	VBP
10_1101-2021_01_05_425508	159	22	shown	show	VBN
10_1101-2021_01_05_425508	159	23	at	at	IN
10_1101-2021_01_05_425508	159	24	the	the	DT
10_1101-2021_01_05_425508	159	25	bottom	bottom	JJ
10_1101-2021_01_05_425508	159	26	351	351	CD
10_1101-2021_01_05_425508	159	27	of	of	IN
10_1101-2021_01_05_425508	159	28	the	the	DT
10_1101-2021_01_05_425508	159	29	figure	figure	NN
10_1101-2021_01_05_425508	159	30	.	.	.
10_1101-2021_01_05_425508	160	1	The	the	DT
10_1101-2021_01_05_425508	160	2	dashed	dashed	JJ
10_1101-2021_01_05_425508	160	3	line	line	NN
10_1101-2021_01_05_425508	160	4	shows	show	VBZ
10_1101-2021_01_05_425508	160	5	the	the	DT
10_1101-2021_01_05_425508	160	6	averaged	averaged	JJ
10_1101-2021_01_05_425508	160	7	compositions	composition	NNS
10_1101-2021_01_05_425508	160	8	for	for	IN
10_1101-2021_01_05_425508	160	9	all	all	DT
10_1101-2021_01_05_425508	160	10	strains	strain	NNS
10_1101-2021_01_05_425508	160	11	isolated	isolate	VBN
10_1101-2021_01_05_425508	160	12	in	in	IN
10_1101-2021_01_05_425508	160	13	352	352	CD
10_1101-2021_01_05_425508	160	14	each	each	DT
10_1101-2021_01_05_425508	160	15	month	month	NN
10_1101-2021_01_05_425508	160	16	.	.	.
10_1101-2021_01_05_425508	161	1	(	(	-LRB-
10_1101-2021_01_05_425508	161	2	B	b	NN
10_1101-2021_01_05_425508	161	3	)	)	-RRB-
10_1101-2021_01_05_425508	161	4	The	the	DT
10_1101-2021_01_05_425508	161	5	average	average	JJ
10_1101-2021_01_05_425508	161	6	di-	di-	NN
10_1101-2021_01_05_425508	161	7	and	and	CC
10_1101-2021_01_05_425508	161	8	trinucleotide	trinucleotide	VB
10_1101-2021_01_05_425508	161	9	compositions	composition	NNS
10_1101-2021_01_05_425508	161	10	that	that	WDT
10_1101-2021_01_05_425508	161	11	primarily	primarily	RB
10_1101-2021_01_05_425508	161	12	undergo	undergo	VBP
10_1101-2021_01_05_425508	161	13	353	353	CD
10_1101-2021_01_05_425508	161	14	common	common	JJ
10_1101-2021_01_05_425508	161	15	directional	directional	JJ
10_1101-2021_01_05_425508	161	16	changes	change	NNS
10_1101-2021_01_05_425508	161	17	among	among	IN
10_1101-2021_01_05_425508	161	18	the	the	DT
10_1101-2021_01_05_425508	161	19	six	six	CD
10_1101-2021_01_05_425508	161	20	clades	clade	NNS
10_1101-2021_01_05_425508	161	21	are	be	VBP
10_1101-2021_01_05_425508	161	22	plotted	plot	VBN
10_1101-2021_01_05_425508	161	23	against	against	IN
10_1101-2021_01_05_425508	161	24	the	the	DT
10_1101-2021_01_05_425508	161	25	elapsed	elapse	VBN
10_1101-2021_01_05_425508	161	26	354	354	CD
10_1101-2021_01_05_425508	161	27	month	month	NN
10_1101-2021_01_05_425508	161	28	.	.	.
10_1101-2021_01_05_425508	162	1	355	355	CD
10_1101-2021_01_05_425508	162	2	356	356	CD
10_1101-2021_01_05_425508	162	3	Fig	Fig	NNP
10_1101-2021_01_05_425508	162	4	.	.	.
10_1101-2021_01_05_425508	163	1	2	2	LS
10_1101-2021_01_05_425508	163	2	.	.	.
10_1101-2021_01_05_425508	164	1	Fold	fold	VB
10_1101-2021_01_05_425508	164	2	changes	change	NNS
10_1101-2021_01_05_425508	164	3	in	in	IN
10_1101-2021_01_05_425508	164	4	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	164	5	composition	composition	NN
10_1101-2021_01_05_425508	164	6	between	between	IN
10_1101-2021_01_05_425508	164	7	the	the	DT
10_1101-2021_01_05_425508	164	8	epidemic	epidemic	NN
10_1101-2021_01_05_425508	164	9	start	start	NN
10_1101-2021_01_05_425508	164	10	and	and	CC
10_1101-2021_01_05_425508	164	11	the	the	DT
10_1101-2021_01_05_425508	164	12	357	357	CD
10_1101-2021_01_05_425508	164	13	last	last	JJ
10_1101-2021_01_05_425508	164	14	month	month	NN
10_1101-2021_01_05_425508	164	15	of	of	IN
10_1101-2021_01_05_425508	164	16	analysis	analysis	NN
10_1101-2021_01_05_425508	164	17	.	.	.
10_1101-2021_01_05_425508	165	1	A	a	DT
10_1101-2021_01_05_425508	165	2	bar	bar	NN
10_1101-2021_01_05_425508	165	3	plot	plot	NN
10_1101-2021_01_05_425508	165	4	shows	show	VBZ
10_1101-2021_01_05_425508	165	5	the	the	DT
10_1101-2021_01_05_425508	165	6	fold	fold	JJ
10_1101-2021_01_05_425508	165	7	change	change	NN
10_1101-2021_01_05_425508	165	8	in	in	IN
10_1101-2021_01_05_425508	165	9	composition	composition	NN
10_1101-2021_01_05_425508	165	10	of	of	IN
10_1101-2021_01_05_425508	165	11	each	each	DT
10_1101-2021_01_05_425508	165	12	mono-	mono-	NN
10_1101-2021_01_05_425508	165	13	358	358	CD
10_1101-2021_01_05_425508	165	14	or	or	CC
10_1101-2021_01_05_425508	165	15	oligonucleotide	oligonucleotide	RB
10_1101-2021_01_05_425508	165	16	;	;	:
10_1101-2021_01_05_425508	165	17	this	this	DT
10_1101-2021_01_05_425508	165	18	value	value	NN
10_1101-2021_01_05_425508	165	19	was	be	VBD
10_1101-2021_01_05_425508	165	20	calculated	calculate	VBN
10_1101-2021_01_05_425508	165	21	by	by	IN
10_1101-2021_01_05_425508	165	22	dividing	divide	VBG
10_1101-2021_01_05_425508	165	23	the	the	DT
10_1101-2021_01_05_425508	165	24	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	165	25	composition	composition	NN
10_1101-2021_01_05_425508	165	26	in	in	IN
10_1101-2021_01_05_425508	165	27	359	359	CD
10_1101-2021_01_05_425508	165	28	the	the	DT
10_1101-2021_01_05_425508	165	29	last	last	JJ
10_1101-2021_01_05_425508	165	30	month	month	NN
10_1101-2021_01_05_425508	165	31	of	of	IN
10_1101-2021_01_05_425508	165	32	analysis	analysis	NN
10_1101-2021_01_05_425508	165	33	by	by	IN
10_1101-2021_01_05_425508	165	34	that	that	DT
10_1101-2021_01_05_425508	165	35	at	at	IN
10_1101-2021_01_05_425508	165	36	the	the	DT
10_1101-2021_01_05_425508	165	37	start	start	NN
10_1101-2021_01_05_425508	165	38	of	of	IN
10_1101-2021_01_05_425508	165	39	the	the	DT
10_1101-2021_01_05_425508	165	40	epidemic	epidemic	NN
10_1101-2021_01_05_425508	165	41	.	.	.
10_1101-2021_01_05_425508	166	1	Each	each	DT
10_1101-2021_01_05_425508	166	2	bar	bar	NN
10_1101-2021_01_05_425508	166	3	is	be	VBZ
10_1101-2021_01_05_425508	166	4	colored	color	VBN
10_1101-2021_01_05_425508	166	5	to	to	IN
10_1101-2021_01_05_425508	166	6	360	360	CD
10_1101-2021_01_05_425508	166	7	indicate	indicate	VBP
10_1101-2021_01_05_425508	166	8	the	the	DT
10_1101-2021_01_05_425508	166	9	clade	clade	NN
10_1101-2021_01_05_425508	166	10	,	,	,
10_1101-2021_01_05_425508	166	11	as	as	IN
10_1101-2021_01_05_425508	166	12	described	describe	VBN
10_1101-2021_01_05_425508	166	13	in	in	IN
10_1101-2021_01_05_425508	166	14	Fig	Fig	NNP
10_1101-2021_01_05_425508	166	15	.	.	.
10_1101-2021_01_05_425508	167	1	1	1	LS
10_1101-2021_01_05_425508	167	2	.	.	.
10_1101-2021_01_05_425508	168	1	Since	since	IN
10_1101-2021_01_05_425508	168	2	we	-PRON-	PRP
10_1101-2021_01_05_425508	168	3	analyzed	analyze	VBD
10_1101-2021_01_05_425508	168	4	strains	strain	NNS
10_1101-2021_01_05_425508	168	5	belonging	belong	VBG
10_1101-2021_01_05_425508	168	6	to	to	IN
10_1101-2021_01_05_425508	168	7	361	361	CD
10_1101-2021_01_05_425508	168	8	different	different	JJ
10_1101-2021_01_05_425508	168	9	clades	clade	NNS
10_1101-2021_01_05_425508	168	10	separately	separately	RB
10_1101-2021_01_05_425508	168	11	,	,	,
10_1101-2021_01_05_425508	168	12	data	datum	NNS
10_1101-2021_01_05_425508	168	13	from	from	IN
10_1101-2021_01_05_425508	168	14	the	the	DT
10_1101-2021_01_05_425508	168	15	first	first	JJ
10_1101-2021_01_05_425508	168	16	or	or	CC
10_1101-2021_01_05_425508	168	17	last	last	JJ
10_1101-2021_01_05_425508	168	18	month	month	NN
10_1101-2021_01_05_425508	168	19	differed	differ	VBN
10_1101-2021_01_05_425508	168	20	among	among	IN
10_1101-2021_01_05_425508	168	21	clades	clade	NNS
10_1101-2021_01_05_425508	168	22	;	;	:
10_1101-2021_01_05_425508	168	23	see	see	VB
10_1101-2021_01_05_425508	168	24	362	362	CD
10_1101-2021_01_05_425508	168	25	also	also	RB
10_1101-2021_01_05_425508	168	26	the	the	DT
10_1101-2021_01_05_425508	168	27	Methods	Methods	NNP
10_1101-2021_01_05_425508	168	28	section	section	NN
10_1101-2021_01_05_425508	168	29	.	.	.
10_1101-2021_01_05_425508	169	1	363	363	CD
10_1101-2021_01_05_425508	169	2	364	364	CD
10_1101-2021_01_05_425508	169	3	Fig	fig	NN
10_1101-2021_01_05_425508	169	4	.	.	.
10_1101-2021_01_05_425508	170	1	3	3	LS
10_1101-2021_01_05_425508	170	2	.	.	.
10_1101-2021_01_05_425508	171	1	Nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	171	2	compositions	composition	NNS
10_1101-2021_01_05_425508	171	3	of	of	IN
10_1101-2021_01_05_425508	171	4	human	human	NN
10_1101-2021_01_05_425508	171	5	and	and	CC
10_1101-2021_01_05_425508	171	6	bat	bat	NN
10_1101-2021_01_05_425508	171	7	coronavirus	coronavirus	NNP
10_1101-2021_01_05_425508	171	8	sequences	sequence	NNS
10_1101-2021_01_05_425508	171	9	.	.	.
10_1101-2021_01_05_425508	172	1	A	a	DT
10_1101-2021_01_05_425508	172	2	365	365	CD
10_1101-2021_01_05_425508	172	3	boxplot	boxplot	NN
10_1101-2021_01_05_425508	172	4	shows	show	VBZ
10_1101-2021_01_05_425508	172	5	the	the	DT
10_1101-2021_01_05_425508	172	6	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	172	7	compositions	composition	NNS
10_1101-2021_01_05_425508	172	8	in	in	IN
10_1101-2021_01_05_425508	172	9	human	human	NN
10_1101-2021_01_05_425508	172	10	-	-	HYPH
10_1101-2021_01_05_425508	172	11	CoV	cov	NN
10_1101-2021_01_05_425508	172	12	(	(	-LRB-
10_1101-2021_01_05_425508	172	13	alpha	alpha	NN
10_1101-2021_01_05_425508	172	14	229E	229e	CD
10_1101-2021_01_05_425508	172	15	,	,	,
10_1101-2021_01_05_425508	172	16	alpha	alpha	NN
10_1101-2021_01_05_425508	172	17	NL63	NL63	NNP
10_1101-2021_01_05_425508	172	18	,	,	,
10_1101-2021_01_05_425508	172	19	366	366	CD
10_1101-2021_01_05_425508	172	20	beta	beta	JJ
10_1101-2021_01_05_425508	172	21	HKU1	HKU1	NNS
10_1101-2021_01_05_425508	172	22	and	and	CC
10_1101-2021_01_05_425508	172	23	beta	beta	NN
10_1101-2021_01_05_425508	172	24	OC43	OC43	NNP
10_1101-2021_01_05_425508	172	25	)	)	-RRB-
10_1101-2021_01_05_425508	172	26	,	,	,
10_1101-2021_01_05_425508	172	27	bat	bat	NN
10_1101-2021_01_05_425508	172	28	-	-	HYPH
10_1101-2021_01_05_425508	172	29	CoV	cov	NN
10_1101-2021_01_05_425508	172	30	(	(	-LRB-
10_1101-2021_01_05_425508	172	31	bat	bat	NNP
10_1101-2021_01_05_425508	172	32	SARS	SARS	NNP
10_1101-2021_01_05_425508	172	33	,	,	,
10_1101-2021_01_05_425508	172	34	alphacoronavirus	alphacoronavirus	NN
10_1101-2021_01_05_425508	172	35	and	and	CC
10_1101-2021_01_05_425508	172	36	367	367	CD
10_1101-2021_01_05_425508	172	37	betacoronavirus	betacoronavirus	NN
10_1101-2021_01_05_425508	172	38	)	)	-RRB-
10_1101-2021_01_05_425508	172	39	and	and	CC
10_1101-2021_01_05_425508	172	40	SARS	SARS	NNP
10_1101-2021_01_05_425508	172	41	-	-	HYPH
10_1101-2021_01_05_425508	172	42	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	172	43	strains	strain	NNS
10_1101-2021_01_05_425508	172	44	.	.	.
10_1101-2021_01_05_425508	173	1	Bat	Bat	NNP
10_1101-2021_01_05_425508	173	2	SARS	SARS	NNP
10_1101-2021_01_05_425508	173	3	are	be	VBP
10_1101-2021_01_05_425508	173	4	marked	mark	VBN
10_1101-2021_01_05_425508	173	5	pink	pink	JJ
10_1101-2021_01_05_425508	173	6	.	.	.
10_1101-2021_01_05_425508	174	1	A	a	DT
10_1101-2021_01_05_425508	174	2	hollow	hollow	JJ
10_1101-2021_01_05_425508	174	3	arrow	arrow	NN
10_1101-2021_01_05_425508	174	4	368	368	CD
10_1101-2021_01_05_425508	174	5	indicates	indicate	VBZ
10_1101-2021_01_05_425508	174	6	the	the	DT
10_1101-2021_01_05_425508	174	7	direction	direction	NN
10_1101-2021_01_05_425508	174	8	of	of	IN
10_1101-2021_01_05_425508	174	9	change	change	NN
10_1101-2021_01_05_425508	174	10	in	in	IN
10_1101-2021_01_05_425508	174	11	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	174	12	composition	composition	NN
10_1101-2021_01_05_425508	174	13	observed	observe	VBN
10_1101-2021_01_05_425508	174	14	for	for	IN
10_1101-2021_01_05_425508	174	15	SARS-369	SARS-369	NNP
10_1101-2021_01_05_425508	174	16	CoV-2	cov-2	DT
10_1101-2021_01_05_425508	174	17	in	in	IN
10_1101-2021_01_05_425508	174	18	Figs	Figs	NNP
10_1101-2021_01_05_425508	174	19	.	.	.
10_1101-2021_01_05_425508	175	1	1	1	CD
10_1101-2021_01_05_425508	175	2	and	and	CC
10_1101-2021_01_05_425508	175	3	2	2	CD
10_1101-2021_01_05_425508	175	4	.	.	.
10_1101-2021_01_05_425508	176	1	(	(	-LRB-
10_1101-2021_01_05_425508	176	2	A	a	NN
10_1101-2021_01_05_425508	176	3	)	)	-RRB-
10_1101-2021_01_05_425508	176	4	Mononucleotides	mononucleotide	NNS
10_1101-2021_01_05_425508	176	5	.	.	.
10_1101-2021_01_05_425508	177	1	To	to	TO
10_1101-2021_01_05_425508	177	2	compare	compare	VB
10_1101-2021_01_05_425508	177	3	the	the	DT
10_1101-2021_01_05_425508	177	4	four	four	CD
10_1101-2021_01_05_425508	177	5	mononucleotides	mononucleotide	NNS
10_1101-2021_01_05_425508	177	6	,	,	,
10_1101-2021_01_05_425508	177	7	370	370	CD
10_1101-2021_01_05_425508	177	8	the	the	DT
10_1101-2021_01_05_425508	177	9	scale	scale	NN
10_1101-2021_01_05_425508	177	10	widths	width	NNS
10_1101-2021_01_05_425508	177	11	on	on	IN
10_1101-2021_01_05_425508	177	12	the	the	DT
10_1101-2021_01_05_425508	177	13	vertical	vertical	JJ
10_1101-2021_01_05_425508	177	14	axis	axi	NNS
10_1101-2021_01_05_425508	177	15	scale	scale	NN
10_1101-2021_01_05_425508	177	16	are	be	VBP
10_1101-2021_01_05_425508	177	17	set	set	VBN
10_1101-2021_01_05_425508	177	18	to	to	IN
10_1101-2021_01_05_425508	177	19	the	the	DT
10_1101-2021_01_05_425508	177	20	same	same	JJ
10_1101-2021_01_05_425508	177	21	values	value	NNS
10_1101-2021_01_05_425508	177	22	.	.	.
10_1101-2021_01_05_425508	178	1	(	(	-LRB-
10_1101-2021_01_05_425508	178	2	B	b	NN
10_1101-2021_01_05_425508	178	3	)	)	-RRB-
10_1101-2021_01_05_425508	178	4	Di-	Di-	NNP
10_1101-2021_01_05_425508	178	5	and	and	CC
10_1101-2021_01_05_425508	178	6	371	371	CD
10_1101-2021_01_05_425508	178	7	trinucleotides	trinucleotide	NNS
10_1101-2021_01_05_425508	178	8	.	.	.
10_1101-2021_01_05_425508	179	1	372	372	CD
10_1101-2021_01_05_425508	179	2	373	373	CD
10_1101-2021_01_05_425508	179	3	Fig	fig	NN
10_1101-2021_01_05_425508	179	4	.	.	.
10_1101-2021_01_05_425508	180	1	4	4	LS
10_1101-2021_01_05_425508	180	2	.	.	.
10_1101-2021_01_05_425508	181	1	Differences	difference	NNS
10_1101-2021_01_05_425508	181	2	in	in	IN
10_1101-2021_01_05_425508	181	3	nucleotide	nucleotide	JJ
10_1101-2021_01_05_425508	181	4	composition	composition	NN
10_1101-2021_01_05_425508	181	5	between	between	IN
10_1101-2021_01_05_425508	181	6	SARS	SARS	NNP
10_1101-2021_01_05_425508	181	7	-	-	HYPH
10_1101-2021_01_05_425508	181	8	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	181	9	and	and	CC
10_1101-2021_01_05_425508	181	10	human-374	human-374	NNP
10_1101-2021_01_05_425508	181	11	CoV.	CoV.	NNP
10_1101-2021_01_05_425508	182	1	(	(	-LRB-
10_1101-2021_01_05_425508	182	2	A	a	DT
10_1101-2021_01_05_425508	182	3	)	)	-RRB-
10_1101-2021_01_05_425508	182	4	Values	value	NNS
10_1101-2021_01_05_425508	182	5	for	for	IN
10_1101-2021_01_05_425508	182	6	the	the	DT
10_1101-2021_01_05_425508	182	7	square	square	NN
10_1101-2021_01_05_425508	182	8	of	of	IN
10_1101-2021_01_05_425508	182	9	the	the	DT
10_1101-2021_01_05_425508	182	10	difference	difference	NN
10_1101-2021_01_05_425508	182	11	in	in	IN
10_1101-2021_01_05_425508	182	12	mononucleotide	mononucleotide	NNP
10_1101-2021_01_05_425508	182	13	composition	composition	NN
10_1101-2021_01_05_425508	182	14	375	375	CD
10_1101-2021_01_05_425508	182	15	between	between	IN
10_1101-2021_01_05_425508	182	16	SARS	SARS	NNP
10_1101-2021_01_05_425508	182	17	-	-	HYPH
10_1101-2021_01_05_425508	182	18	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	182	19	isolated	isolate	VBD
10_1101-2021_01_05_425508	182	20	in	in	IN
10_1101-2021_01_05_425508	182	21	each	each	DT
10_1101-2021_01_05_425508	182	22	month	month	NN
10_1101-2021_01_05_425508	182	23	and	and	CC
10_1101-2021_01_05_425508	182	24	human	human	NN
10_1101-2021_01_05_425508	182	25	-	-	HYPH
10_1101-2021_01_05_425508	182	26	CoV	cov	NN
10_1101-2021_01_05_425508	182	27	are	be	VBP
10_1101-2021_01_05_425508	182	28	plotted	plot	VBN
10_1101-2021_01_05_425508	182	29	against	against	IN
10_1101-2021_01_05_425508	182	30	the	the	DT
10_1101-2021_01_05_425508	182	31	376	376	CD
10_1101-2021_01_05_425508	182	32	.CC	.CC	:
10_1101-2021_01_05_425508	182	33	-	-	HYPH
10_1101-2021_01_05_425508	182	34	BY	BY	NNP
10_1101-2021_01_05_425508	182	35	-	-	HYPH
10_1101-2021_01_05_425508	182	36	NC	NC	NNP
10_1101-2021_01_05_425508	182	37	4.0	4.0	CD
10_1101-2021_01_05_425508	182	38	International	international	JJ
10_1101-2021_01_05_425508	182	39	licensemade	licensemade	NN
10_1101-2021_01_05_425508	182	40	available	available	JJ
10_1101-2021_01_05_425508	182	41	under	under	IN
10_1101-2021_01_05_425508	182	42	a	a	DT
10_1101-2021_01_05_425508	182	43	(	(	-LRB-
10_1101-2021_01_05_425508	182	44	which	which	WDT
10_1101-2021_01_05_425508	182	45	was	be	VBD
10_1101-2021_01_05_425508	182	46	not	not	RB
10_1101-2021_01_05_425508	182	47	certified	certify	VBN
10_1101-2021_01_05_425508	182	48	by	by	IN
10_1101-2021_01_05_425508	182	49	peer	peer	NN
10_1101-2021_01_05_425508	182	50	review	review	NN
10_1101-2021_01_05_425508	182	51	)	)	-RRB-
10_1101-2021_01_05_425508	182	52	is	be	VBZ
10_1101-2021_01_05_425508	182	53	the	the	DT
10_1101-2021_01_05_425508	182	54	author	author	NN
10_1101-2021_01_05_425508	182	55	/	/	SYM
10_1101-2021_01_05_425508	182	56	funder	funder	NN
10_1101-2021_01_05_425508	182	57	,	,	,
10_1101-2021_01_05_425508	182	58	who	who	WP
10_1101-2021_01_05_425508	182	59	has	have	VBZ
10_1101-2021_01_05_425508	182	60	granted	grant	VBN
10_1101-2021_01_05_425508	182	61	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	182	62	a	a	DT
10_1101-2021_01_05_425508	182	63	license	license	NN
10_1101-2021_01_05_425508	182	64	to	to	TO
10_1101-2021_01_05_425508	182	65	display	display	VB
10_1101-2021_01_05_425508	182	66	the	the	DT
10_1101-2021_01_05_425508	182	67	preprint	preprint	NN
10_1101-2021_01_05_425508	182	68	in	in	IN
10_1101-2021_01_05_425508	182	69	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	182	70	.	.	.
10_1101-2021_01_05_425508	183	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	183	2	is	be	VBZ
10_1101-2021_01_05_425508	183	3	The	the	DT
10_1101-2021_01_05_425508	183	4	copyright	copyright	NN
10_1101-2021_01_05_425508	183	5	holder	holder	NN
10_1101-2021_01_05_425508	183	6	for	for	IN
10_1101-2021_01_05_425508	183	7	this	this	DT
10_1101-2021_01_05_425508	183	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	183	9	version	version	NN
10_1101-2021_01_05_425508	183	10	posted	post	VBD
10_1101-2021_01_05_425508	183	11	January	January	NNP
10_1101-2021_01_05_425508	183	12	6	6	CD
10_1101-2021_01_05_425508	183	13	,	,	,
10_1101-2021_01_05_425508	183	14	2021	2021	CD
10_1101-2021_01_05_425508	183	15	.	.	.
10_1101-2021_01_05_425508	183	16	;	;	:
10_1101-2021_01_05_425508	183	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	183	18	:	:	:
10_1101-2021_01_05_425508	183	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	183	20	preprint	preprint	NN
10_1101-2021_01_05_425508	183	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	183	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	183	23	15	15	CD
10_1101-2021_01_05_425508	183	24	elapsed	elapse	VBN
10_1101-2021_01_05_425508	183	25	month	month	NN
10_1101-2021_01_05_425508	183	26	.	.	.
10_1101-2021_01_05_425508	184	1	The	the	DT
10_1101-2021_01_05_425508	184	2	data	datum	NNS
10_1101-2021_01_05_425508	184	3	are	be	VBP
10_1101-2021_01_05_425508	184	4	presented	present	VBN
10_1101-2021_01_05_425508	184	5	as	as	IN
10_1101-2021_01_05_425508	184	6	colored	colored	JJ
10_1101-2021_01_05_425508	184	7	or	or	CC
10_1101-2021_01_05_425508	184	8	dashed	dash	VBN
10_1101-2021_01_05_425508	184	9	lines	line	NNS
10_1101-2021_01_05_425508	184	10	,	,	,
10_1101-2021_01_05_425508	184	11	as	as	IN
10_1101-2021_01_05_425508	184	12	described	describe	VBN
10_1101-2021_01_05_425508	184	13	in	in	IN
10_1101-2021_01_05_425508	184	14	Fig	Fig	NNP
10_1101-2021_01_05_425508	184	15	.	.	.
10_1101-2021_01_05_425508	185	1	1	1	LS
10_1101-2021_01_05_425508	185	2	.	.	.
10_1101-2021_01_05_425508	186	1	377	377	CD
10_1101-2021_01_05_425508	186	2	(	(	-LRB-
10_1101-2021_01_05_425508	186	3	B	b	NN
10_1101-2021_01_05_425508	186	4	and	and	CC
10_1101-2021_01_05_425508	186	5	C	C	NNP
10_1101-2021_01_05_425508	186	6	)	)	-RRB-
10_1101-2021_01_05_425508	186	7	Oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	186	8	compositions	composition	NNS
10_1101-2021_01_05_425508	186	9	that	that	DT
10_1101-2021_01_05_425508	186	10	approach	approach	VBP
10_1101-2021_01_05_425508	186	11	and	and	CC
10_1101-2021_01_05_425508	186	12	move	move	VBP
10_1101-2021_01_05_425508	186	13	from	from	IN
10_1101-2021_01_05_425508	186	14	those	those	DT
10_1101-2021_01_05_425508	186	15	of	of	IN
10_1101-2021_01_05_425508	186	16	human-378	human-378	NNP
10_1101-2021_01_05_425508	186	17	CoV	CoV	NNP
10_1101-2021_01_05_425508	186	18	are	be	VBP
10_1101-2021_01_05_425508	186	19	presented	present	VBN
10_1101-2021_01_05_425508	186	20	,	,	,
10_1101-2021_01_05_425508	186	21	respectively	respectively	RB
10_1101-2021_01_05_425508	186	22	.	.	.
10_1101-2021_01_05_425508	187	1	(	(	-LRB-
10_1101-2021_01_05_425508	187	2	D	d	NN
10_1101-2021_01_05_425508	187	3	)	)	-RRB-
10_1101-2021_01_05_425508	187	4	The	the	DT
10_1101-2021_01_05_425508	187	5	correlation	correlation	NN
10_1101-2021_01_05_425508	187	6	coefficients	coefficient	NNS
10_1101-2021_01_05_425508	187	7	between	between	IN
10_1101-2021_01_05_425508	187	8	the	the	DT
10_1101-2021_01_05_425508	187	9	elapsed	elapse	VBN
10_1101-2021_01_05_425508	187	10	379	379	CD
10_1101-2021_01_05_425508	187	11	month	month	NN
10_1101-2021_01_05_425508	187	12	from	from	IN
10_1101-2021_01_05_425508	187	13	the	the	DT
10_1101-2021_01_05_425508	187	14	start	start	NN
10_1101-2021_01_05_425508	187	15	of	of	IN
10_1101-2021_01_05_425508	187	16	the	the	DT
10_1101-2021_01_05_425508	187	17	epidemic	epidemic	NN
10_1101-2021_01_05_425508	187	18	and	and	CC
10_1101-2021_01_05_425508	187	19	the	the	DT
10_1101-2021_01_05_425508	187	20	above	above	JJ
10_1101-2021_01_05_425508	187	21	differences	difference	NNS
10_1101-2021_01_05_425508	187	22	in	in	IN
10_1101-2021_01_05_425508	187	23	mono-	mono-	NN
10_1101-2021_01_05_425508	187	24	and	and	CC
10_1101-2021_01_05_425508	187	25	380	380	CD
10_1101-2021_01_05_425508	187	26	oligonucleotides	oligonucleotide	NNS
10_1101-2021_01_05_425508	187	27	whose	whose	WP$
10_1101-2021_01_05_425508	187	28	directionality	directionality	NN
10_1101-2021_01_05_425508	187	29	of	of	IN
10_1101-2021_01_05_425508	187	30	change	change	NN
10_1101-2021_01_05_425508	187	31	is	be	VBZ
10_1101-2021_01_05_425508	187	32	common	common	JJ
10_1101-2021_01_05_425508	187	33	among	among	IN
10_1101-2021_01_05_425508	187	34	six	six	CD
10_1101-2021_01_05_425508	187	35	clades	clade	NNS
10_1101-2021_01_05_425508	187	36	are	be	VBP
10_1101-2021_01_05_425508	187	37	381	381	CD
10_1101-2021_01_05_425508	187	38	presented	present	VBN
10_1101-2021_01_05_425508	187	39	.	.	.
10_1101-2021_01_05_425508	188	1	The	the	DT
10_1101-2021_01_05_425508	188	2	results	result	NNS
10_1101-2021_01_05_425508	188	3	for	for	IN
10_1101-2021_01_05_425508	188	4	A	a	NN
10_1101-2021_01_05_425508	188	5	and	and	CC
10_1101-2021_01_05_425508	188	6	G	g	NN
10_1101-2021_01_05_425508	188	7	mononucleotides	mononucleotide	NNS
10_1101-2021_01_05_425508	188	8	,	,	,
10_1101-2021_01_05_425508	188	9	which	which	WDT
10_1101-2021_01_05_425508	188	10	show	show	VBP
10_1101-2021_01_05_425508	188	11	nondirectional	nondirectional	JJ
10_1101-2021_01_05_425508	188	12	382	382	CD
10_1101-2021_01_05_425508	188	13	change	change	NN
10_1101-2021_01_05_425508	188	14	,	,	,
10_1101-2021_01_05_425508	188	15	are	be	VBP
10_1101-2021_01_05_425508	188	16	also	also	RB
10_1101-2021_01_05_425508	188	17	presented	present	VBN
10_1101-2021_01_05_425508	188	18	.	.	.
10_1101-2021_01_05_425508	189	1	383	383	CD
10_1101-2021_01_05_425508	189	2	384	384	CD
10_1101-2021_01_05_425508	189	3	Fig	fig	NN
10_1101-2021_01_05_425508	189	4	.	.	.
10_1101-2021_01_05_425508	190	1	5	5	CD
10_1101-2021_01_05_425508	190	2	.	.	.
10_1101-2021_01_05_425508	191	1	Time	time	NN
10_1101-2021_01_05_425508	191	2	-	-	HYPH
10_1101-2021_01_05_425508	191	3	dependent	dependent	JJ
10_1101-2021_01_05_425508	191	4	changes	change	NNS
10_1101-2021_01_05_425508	191	5	in	in	IN
10_1101-2021_01_05_425508	191	6	the	the	DT
10_1101-2021_01_05_425508	191	7	numbers	number	NNS
10_1101-2021_01_05_425508	191	8	of	of	IN
10_1101-2021_01_05_425508	191	9	RNA	RNA	NNP
10_1101-2021_01_05_425508	191	10	-	-	HYPH
10_1101-2021_01_05_425508	191	11	binding	bind	VBG
10_1101-2021_01_05_425508	191	12	motif	motif	NN
10_1101-2021_01_05_425508	191	13	loci	loci	NN
10_1101-2021_01_05_425508	191	14	.	.	.
10_1101-2021_01_05_425508	192	1	(	(	-LRB-
10_1101-2021_01_05_425508	192	2	A	a	NN
10_1101-2021_01_05_425508	192	3	)	)	-RRB-
10_1101-2021_01_05_425508	192	4	The	the	DT
10_1101-2021_01_05_425508	192	5	385	385	CD
10_1101-2021_01_05_425508	192	6	numbers	number	NNS
10_1101-2021_01_05_425508	192	7	of	of	IN
10_1101-2021_01_05_425508	192	8	loci	loci	NN
10_1101-2021_01_05_425508	192	9	containing	contain	VBG
10_1101-2021_01_05_425508	192	10	RNA	RNA	NNP
10_1101-2021_01_05_425508	192	11	-	-	HYPH
10_1101-2021_01_05_425508	192	12	binding	bind	VBG
10_1101-2021_01_05_425508	192	13	motifs	motif	NNS
10_1101-2021_01_05_425508	192	14	per	per	IN
10_1101-2021_01_05_425508	192	15	genome	genome	JJ
10_1101-2021_01_05_425508	192	16	are	be	VBP
10_1101-2021_01_05_425508	192	17	plotted	plot	VBN
10_1101-2021_01_05_425508	192	18	against	against	IN
10_1101-2021_01_05_425508	192	19	the	the	DT
10_1101-2021_01_05_425508	192	20	386	386	CD
10_1101-2021_01_05_425508	192	21	elapsed	elapse	VBN
10_1101-2021_01_05_425508	192	22	month	month	NN
10_1101-2021_01_05_425508	192	23	.	.	.
10_1101-2021_01_05_425508	193	1	Here	here	RB
10_1101-2021_01_05_425508	193	2	,	,	,
10_1101-2021_01_05_425508	193	3	we	-PRON-	PRP
10_1101-2021_01_05_425508	193	4	selected	select	VBD
10_1101-2021_01_05_425508	193	5	RNA	RNA	NNP
10_1101-2021_01_05_425508	193	6	-	-	HYPH
10_1101-2021_01_05_425508	193	7	binding	bind	VBG
10_1101-2021_01_05_425508	193	8	proteins	protein	NNS
10_1101-2021_01_05_425508	193	9	for	for	IN
10_1101-2021_01_05_425508	193	10	which	which	WDT
10_1101-2021_01_05_425508	193	11	the	the	DT
10_1101-2021_01_05_425508	193	12	number	number	NN
10_1101-2021_01_05_425508	193	13	of	of	IN
10_1101-2021_01_05_425508	193	14	motif	motif	NN
10_1101-2021_01_05_425508	193	15	387	387	CD
10_1101-2021_01_05_425508	193	16	loci	loci	NN
10_1101-2021_01_05_425508	193	17	increased	increase	VBD
10_1101-2021_01_05_425508	193	18	or	or	CC
10_1101-2021_01_05_425508	193	19	decreased	decrease	VBN
10_1101-2021_01_05_425508	193	20	by	by	IN
10_1101-2021_01_05_425508	193	21	at	at	RB
10_1101-2021_01_05_425508	193	22	least	least	RBS
10_1101-2021_01_05_425508	193	23	one	one	CD
10_1101-2021_01_05_425508	193	24	for	for	IN
10_1101-2021_01_05_425508	193	25	all	all	DT
10_1101-2021_01_05_425508	193	26	six	six	CD
10_1101-2021_01_05_425508	193	27	clades	clade	NNS
10_1101-2021_01_05_425508	193	28	from	from	IN
10_1101-2021_01_05_425508	193	29	the	the	DT
10_1101-2021_01_05_425508	193	30	epidemic	epidemic	NN
10_1101-2021_01_05_425508	193	31	start	start	NN
10_1101-2021_01_05_425508	193	32	.	.	.
10_1101-2021_01_05_425508	194	1	The	the	DT
10_1101-2021_01_05_425508	194	2	388	388	CD
10_1101-2021_01_05_425508	194	3	data	datum	NNS
10_1101-2021_01_05_425508	194	4	are	be	VBP
10_1101-2021_01_05_425508	194	5	presented	present	VBN
10_1101-2021_01_05_425508	194	6	as	as	IN
10_1101-2021_01_05_425508	194	7	colored	colored	JJ
10_1101-2021_01_05_425508	194	8	or	or	CC
10_1101-2021_01_05_425508	194	9	dashed	dash	VBN
10_1101-2021_01_05_425508	194	10	lines	line	NNS
10_1101-2021_01_05_425508	194	11	,	,	,
10_1101-2021_01_05_425508	194	12	as	as	IN
10_1101-2021_01_05_425508	194	13	described	describe	VBN
10_1101-2021_01_05_425508	194	14	in	in	IN
10_1101-2021_01_05_425508	194	15	Fig	Fig	NNP
10_1101-2021_01_05_425508	194	16	.	.	.
10_1101-2021_01_05_425508	195	1	1A.	1a.	CD
10_1101-2021_01_05_425508	196	1	(	(	-LRB-
10_1101-2021_01_05_425508	196	2	B	b	NN
10_1101-2021_01_05_425508	196	3	)	)	-RRB-
10_1101-2021_01_05_425508	196	4	A	a	DT
10_1101-2021_01_05_425508	196	5	boxplot	boxplot	NN
10_1101-2021_01_05_425508	196	6	389	389	CD
10_1101-2021_01_05_425508	196	7	shows	show	VBZ
10_1101-2021_01_05_425508	196	8	the	the	DT
10_1101-2021_01_05_425508	196	9	number	number	NN
10_1101-2021_01_05_425508	196	10	of	of	IN
10_1101-2021_01_05_425508	196	11	loci	loci	NN
10_1101-2021_01_05_425508	196	12	containing	contain	VBG
10_1101-2021_01_05_425508	196	13	RNA	RNA	NNP
10_1101-2021_01_05_425508	196	14	-	-	HYPH
10_1101-2021_01_05_425508	196	15	binding	bind	VBG
10_1101-2021_01_05_425508	196	16	motifs	motif	NNS
10_1101-2021_01_05_425508	196	17	in	in	IN
10_1101-2021_01_05_425508	196	18	human	human	NN
10_1101-2021_01_05_425508	196	19	-	-	HYPH
10_1101-2021_01_05_425508	196	20	CoV	cov	NN
10_1101-2021_01_05_425508	196	21	(	(	-LRB-
10_1101-2021_01_05_425508	196	22	alpha	alpha	NN
10_1101-2021_01_05_425508	196	23	229E	229e	CD
10_1101-2021_01_05_425508	196	24	390	390	CD
10_1101-2021_01_05_425508	196	25	and	and	CC
10_1101-2021_01_05_425508	196	26	NL63	NL63	NNP
10_1101-2021_01_05_425508	196	27	:	:	:
10_1101-2021_01_05_425508	196	28	beta	beta	NN
10_1101-2021_01_05_425508	196	29	HKU1	HKU1	NNP
10_1101-2021_01_05_425508	196	30	and	and	CC
10_1101-2021_01_05_425508	196	31	OC43	OC43	NNP
10_1101-2021_01_05_425508	196	32	)	)	-RRB-
10_1101-2021_01_05_425508	196	33	,	,	,
10_1101-2021_01_05_425508	196	34	bat	bat	NN
10_1101-2021_01_05_425508	196	35	-	-	HYPH
10_1101-2021_01_05_425508	196	36	CoV	cov	NN
10_1101-2021_01_05_425508	196	37	(	(	-LRB-
10_1101-2021_01_05_425508	196	38	bat	bat	NNP
10_1101-2021_01_05_425508	196	39	SARS	SARS	NNP
10_1101-2021_01_05_425508	196	40	,	,	,
10_1101-2021_01_05_425508	196	41	alphacoronavirus	alphacoronavirus	NN
10_1101-2021_01_05_425508	196	42	and	and	CC
10_1101-2021_01_05_425508	196	43	391	391	CD
10_1101-2021_01_05_425508	196	44	betacoronavirus	betacoronavirus	NN
10_1101-2021_01_05_425508	196	45	)	)	-RRB-
10_1101-2021_01_05_425508	196	46	and	and	CC
10_1101-2021_01_05_425508	196	47	SARS	SARS	NNP
10_1101-2021_01_05_425508	196	48	-	-	HYPH
10_1101-2021_01_05_425508	196	49	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	196	50	strains	strain	NNS
10_1101-2021_01_05_425508	196	51	.	.	.
10_1101-2021_01_05_425508	197	1	Bat	Bat	NNP
10_1101-2021_01_05_425508	197	2	SARS	SARS	NNP
10_1101-2021_01_05_425508	197	3	are	be	VBP
10_1101-2021_01_05_425508	197	4	marked	mark	VBN
10_1101-2021_01_05_425508	197	5	pink	pink	JJ
10_1101-2021_01_05_425508	197	6	.	.	.
10_1101-2021_01_05_425508	198	1	A	a	DT
10_1101-2021_01_05_425508	198	2	hallow	hallow	JJ
10_1101-2021_01_05_425508	198	3	arrow	arrow	NN
10_1101-2021_01_05_425508	198	4	392	392	CD
10_1101-2021_01_05_425508	198	5	indicates	indicate	VBZ
10_1101-2021_01_05_425508	198	6	the	the	DT
10_1101-2021_01_05_425508	198	7	direction	direction	NN
10_1101-2021_01_05_425508	198	8	shown	show	VBN
10_1101-2021_01_05_425508	198	9	in	in	IN
10_1101-2021_01_05_425508	198	10	Fig	Fig	NNP
10_1101-2021_01_05_425508	198	11	.	.	.
10_1101-2021_01_05_425508	199	1	5A	5a	CC
10_1101-2021_01_05_425508	199	2	with	with	IN
10_1101-2021_01_05_425508	199	3	which	which	WDT
10_1101-2021_01_05_425508	199	4	the	the	DT
10_1101-2021_01_05_425508	199	5	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	199	6	compositions	composition	NNS
10_1101-2021_01_05_425508	199	7	of	of	IN
10_1101-2021_01_05_425508	199	8	393	393	CD
10_1101-2021_01_05_425508	199	9	SARS	SARS	NNP
10_1101-2021_01_05_425508	199	10	-	-	HYPH
10_1101-2021_01_05_425508	199	11	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	199	12	changed	change	VBD
10_1101-2021_01_05_425508	199	13	.	.	.
10_1101-2021_01_05_425508	200	1	394	394	CD
10_1101-2021_01_05_425508	200	2	395	395	CD
10_1101-2021_01_05_425508	200	3	396	396	CD
10_1101-2021_01_05_425508	200	4	Table	table	NN
10_1101-2021_01_05_425508	200	5	1	1	CD
10_1101-2021_01_05_425508	200	6	.	.	.
10_1101-2021_01_05_425508	201	1	Correlation	correlation	NN
10_1101-2021_01_05_425508	201	2	coefficients	coefficient	NNS
10_1101-2021_01_05_425508	201	3	for	for	IN
10_1101-2021_01_05_425508	201	4	time	time	NN
10_1101-2021_01_05_425508	201	5	-	-	HYPH
10_1101-2021_01_05_425508	201	6	dependent	dependent	JJ
10_1101-2021_01_05_425508	201	7	changes	change	NNS
10_1101-2021_01_05_425508	201	8	in	in	IN
10_1101-2021_01_05_425508	201	9	mono-	mono-	NN
10_1101-2021_01_05_425508	201	10	and	and	CC
10_1101-2021_01_05_425508	201	11	397	397	CD
10_1101-2021_01_05_425508	201	12	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	201	13	compositions	composition	NNS
10_1101-2021_01_05_425508	201	14	in	in	IN
10_1101-2021_01_05_425508	201	15	SARS	SARS	NNP
10_1101-2021_01_05_425508	201	16	-	-	HYPH
10_1101-2021_01_05_425508	201	17	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	201	18	that	that	WDT
10_1101-2021_01_05_425508	201	19	have	have	VBP
10_1101-2021_01_05_425508	201	20	increased	increase	VBN
10_1101-2021_01_05_425508	201	21	.	.	.
10_1101-2021_01_05_425508	202	1	398	398	CD
10_1101-2021_01_05_425508	202	2	399	399	CD
10_1101-2021_01_05_425508	202	3	Table	table	NN
10_1101-2021_01_05_425508	202	4	2	2	CD
10_1101-2021_01_05_425508	202	5	.	.	.
10_1101-2021_01_05_425508	203	1	Correlation	correlation	NN
10_1101-2021_01_05_425508	203	2	coefficients	coefficient	NNS
10_1101-2021_01_05_425508	203	3	for	for	IN
10_1101-2021_01_05_425508	203	4	time	time	NN
10_1101-2021_01_05_425508	203	5	-	-	HYPH
10_1101-2021_01_05_425508	203	6	dependent	dependent	JJ
10_1101-2021_01_05_425508	203	7	changes	change	NNS
10_1101-2021_01_05_425508	203	8	in	in	IN
10_1101-2021_01_05_425508	203	9	mono-	mono-	NN
10_1101-2021_01_05_425508	203	10	and	and	CC
10_1101-2021_01_05_425508	203	11	400	400	CD
10_1101-2021_01_05_425508	203	12	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	203	13	compositions	composition	NNS
10_1101-2021_01_05_425508	203	14	in	in	IN
10_1101-2021_01_05_425508	203	15	SARS	SARS	NNP
10_1101-2021_01_05_425508	203	16	-	-	HYPH
10_1101-2021_01_05_425508	203	17	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	203	18	that	that	WDT
10_1101-2021_01_05_425508	203	19	have	have	VBP
10_1101-2021_01_05_425508	203	20	decreased	decrease	VBN
10_1101-2021_01_05_425508	203	21	.	.	.
10_1101-2021_01_05_425508	204	1	401	401	CD
10_1101-2021_01_05_425508	204	2	402	402	CD
10_1101-2021_01_05_425508	204	3	.CC	.CC	:
10_1101-2021_01_05_425508	204	4	-	-	HYPH
10_1101-2021_01_05_425508	204	5	BY	BY	NNP
10_1101-2021_01_05_425508	204	6	-	-	HYPH
10_1101-2021_01_05_425508	204	7	NC	NC	NNP
10_1101-2021_01_05_425508	204	8	4.0	4.0	CD
10_1101-2021_01_05_425508	204	9	International	international	JJ
10_1101-2021_01_05_425508	204	10	licensemade	licensemade	NN
10_1101-2021_01_05_425508	204	11	available	available	JJ
10_1101-2021_01_05_425508	204	12	under	under	IN
10_1101-2021_01_05_425508	204	13	a	a	DT
10_1101-2021_01_05_425508	204	14	(	(	-LRB-
10_1101-2021_01_05_425508	204	15	which	which	WDT
10_1101-2021_01_05_425508	204	16	was	be	VBD
10_1101-2021_01_05_425508	204	17	not	not	RB
10_1101-2021_01_05_425508	204	18	certified	certify	VBN
10_1101-2021_01_05_425508	204	19	by	by	IN
10_1101-2021_01_05_425508	204	20	peer	peer	NN
10_1101-2021_01_05_425508	204	21	review	review	NN
10_1101-2021_01_05_425508	204	22	)	)	-RRB-
10_1101-2021_01_05_425508	204	23	is	be	VBZ
10_1101-2021_01_05_425508	204	24	the	the	DT
10_1101-2021_01_05_425508	204	25	author	author	NN
10_1101-2021_01_05_425508	204	26	/	/	SYM
10_1101-2021_01_05_425508	204	27	funder	funder	NN
10_1101-2021_01_05_425508	204	28	,	,	,
10_1101-2021_01_05_425508	204	29	who	who	WP
10_1101-2021_01_05_425508	204	30	has	have	VBZ
10_1101-2021_01_05_425508	204	31	granted	grant	VBN
10_1101-2021_01_05_425508	204	32	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	204	33	a	a	DT
10_1101-2021_01_05_425508	204	34	license	license	NN
10_1101-2021_01_05_425508	204	35	to	to	TO
10_1101-2021_01_05_425508	204	36	display	display	VB
10_1101-2021_01_05_425508	204	37	the	the	DT
10_1101-2021_01_05_425508	204	38	preprint	preprint	NN
10_1101-2021_01_05_425508	204	39	in	in	IN
10_1101-2021_01_05_425508	204	40	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	204	41	.	.	.
10_1101-2021_01_05_425508	205	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	205	2	is	be	VBZ
10_1101-2021_01_05_425508	205	3	The	the	DT
10_1101-2021_01_05_425508	205	4	copyright	copyright	NN
10_1101-2021_01_05_425508	205	5	holder	holder	NN
10_1101-2021_01_05_425508	205	6	for	for	IN
10_1101-2021_01_05_425508	205	7	this	this	DT
10_1101-2021_01_05_425508	205	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	205	9	version	version	NN
10_1101-2021_01_05_425508	205	10	posted	post	VBD
10_1101-2021_01_05_425508	205	11	January	January	NNP
10_1101-2021_01_05_425508	205	12	6	6	CD
10_1101-2021_01_05_425508	205	13	,	,	,
10_1101-2021_01_05_425508	205	14	2021	2021	CD
10_1101-2021_01_05_425508	205	15	.	.	.
10_1101-2021_01_05_425508	205	16	;	;	:
10_1101-2021_01_05_425508	205	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	205	18	:	:	:
10_1101-2021_01_05_425508	205	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	205	20	preprint	preprint	NN
10_1101-2021_01_05_425508	205	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NN
10_1101-2021_01_05_425508	205	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	205	23	16	16	CD
10_1101-2021_01_05_425508	205	24	Table	table	NN
10_1101-2021_01_05_425508	205	25	3	3	CD
10_1101-2021_01_05_425508	205	26	.	.	.
10_1101-2021_01_05_425508	206	1	The	the	DT
10_1101-2021_01_05_425508	206	2	number	number	NN
10_1101-2021_01_05_425508	206	3	motif	motif	NN
10_1101-2021_01_05_425508	206	4	-	-	HYPH
10_1101-2021_01_05_425508	206	5	containing	contain	VBG
10_1101-2021_01_05_425508	206	6	loci	loci	NN
10_1101-2021_01_05_425508	206	7	for	for	IN
10_1101-2021_01_05_425508	206	8	RNA	RNA	NNP
10_1101-2021_01_05_425508	206	9	-	-	HYPH
10_1101-2021_01_05_425508	206	10	binding	bind	VBG
10_1101-2021_01_05_425508	206	11	proteins	protein	NNS
10_1101-2021_01_05_425508	206	12	whose	whose	WP$
10_1101-2021_01_05_425508	206	13	403	403	CD
10_1101-2021_01_05_425508	206	14	occurrences	occurrence	NNS
10_1101-2021_01_05_425508	206	15	have	have	VBP
10_1101-2021_01_05_425508	206	16	increased	increase	VBN
10_1101-2021_01_05_425508	206	17	or	or	CC
10_1101-2021_01_05_425508	206	18	decreased	decrease	VBN
10_1101-2021_01_05_425508	206	19	between	between	IN
10_1101-2021_01_05_425508	206	20	strains	strain	NNS
10_1101-2021_01_05_425508	206	21	of	of	IN
10_1101-2021_01_05_425508	206	22	the	the	DT
10_1101-2021_01_05_425508	206	23	first	first	JJ
10_1101-2021_01_05_425508	206	24	and	and	CC
10_1101-2021_01_05_425508	206	25	last	last	JJ
10_1101-2021_01_05_425508	206	26	month	month	NN
10_1101-2021_01_05_425508	206	27	of	of	IN
10_1101-2021_01_05_425508	206	28	404	404	CD
10_1101-2021_01_05_425508	206	29	the	the	DT
10_1101-2021_01_05_425508	206	30	analysis	analysis	NN
10_1101-2021_01_05_425508	206	31	.	.	.
10_1101-2021_01_05_425508	207	1	405	405	CD
10_1101-2021_01_05_425508	207	2	406	406	CD
10_1101-2021_01_05_425508	207	3	407	407	CD
10_1101-2021_01_05_425508	207	4	Additional	additional	JJ
10_1101-2021_01_05_425508	207	5	file	file	NN
10_1101-2021_01_05_425508	207	6	1	1	CD
10_1101-2021_01_05_425508	207	7	408	408	CD
10_1101-2021_01_05_425508	207	8	Fig	fig	NN
10_1101-2021_01_05_425508	207	9	.	.	.
10_1101-2021_01_05_425508	208	1	S1	S1	NNS
10_1101-2021_01_05_425508	208	2	:	:	:
10_1101-2021_01_05_425508	208	3	Average	average	JJ
10_1101-2021_01_05_425508	208	4	di-	di-	NNS
10_1101-2021_01_05_425508	208	5	and	and	CC
10_1101-2021_01_05_425508	208	6	trinucleotide	trinucleotide	NN
10_1101-2021_01_05_425508	208	7	compositions	composition	NNS
10_1101-2021_01_05_425508	208	8	(	(	-LRB-
10_1101-2021_01_05_425508	208	9	A	a	NN
10_1101-2021_01_05_425508	208	10	and	and	CC
10_1101-2021_01_05_425508	208	11	B	b	NN
10_1101-2021_01_05_425508	208	12	)	)	-RRB-
10_1101-2021_01_05_425508	208	13	of	of	IN
10_1101-2021_01_05_425508	208	14	for	for	IN
10_1101-2021_01_05_425508	208	15	SARS	SARS	NNP
10_1101-2021_01_05_425508	208	16	-	-	HYPH
10_1101-2021_01_05_425508	208	17	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	208	18	409	409	CD
10_1101-2021_01_05_425508	208	19	strains	strain	NNS
10_1101-2021_01_05_425508	208	20	collected	collect	VBN
10_1101-2021_01_05_425508	208	21	in	in	IN
10_1101-2021_01_05_425508	208	22	each	each	DT
10_1101-2021_01_05_425508	208	23	elapsed	elapse	VBN
10_1101-2021_01_05_425508	208	24	month	month	NN
10_1101-2021_01_05_425508	208	25	.	.	.
10_1101-2021_01_05_425508	209	1	410	410	CD
10_1101-2021_01_05_425508	209	2	Fig	Fig	NNP
10_1101-2021_01_05_425508	209	3	.	.	.
10_1101-2021_01_05_425508	210	1	S2	s2	NN
10_1101-2021_01_05_425508	210	2	:	:	:
10_1101-2021_01_05_425508	210	3	Oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	210	4	compositions	composition	NNS
10_1101-2021_01_05_425508	210	5	of	of	IN
10_1101-2021_01_05_425508	210	6	human	human	NN
10_1101-2021_01_05_425508	210	7	and	and	CC
10_1101-2021_01_05_425508	210	8	bat	bat	NN
10_1101-2021_01_05_425508	210	9	coronavirus	coronavirus	NNP
10_1101-2021_01_05_425508	210	10	sequences	sequence	NNS
10_1101-2021_01_05_425508	210	11	.	.	.
10_1101-2021_01_05_425508	211	1	411	411	CD
10_1101-2021_01_05_425508	211	2	Fig	Fig	NNP
10_1101-2021_01_05_425508	211	3	.	.	.
10_1101-2021_01_05_425508	212	1	S3	s3	NN
10_1101-2021_01_05_425508	212	2	:	:	:
10_1101-2021_01_05_425508	212	3	Differences	difference	NNS
10_1101-2021_01_05_425508	212	4	in	in	IN
10_1101-2021_01_05_425508	212	5	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	212	6	composition	composition	NN
10_1101-2021_01_05_425508	212	7	between	between	IN
10_1101-2021_01_05_425508	212	8	SARS	SARS	NNP
10_1101-2021_01_05_425508	212	9	-	-	HYPH
10_1101-2021_01_05_425508	212	10	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	212	11	and	and	CC
10_1101-2021_01_05_425508	212	12	human-412	human-412	NNP
10_1101-2021_01_05_425508	212	13	CoV.	CoV.	NNP
10_1101-2021_01_05_425508	213	1	413	413	CD
10_1101-2021_01_05_425508	213	2	414	414	CD
10_1101-2021_01_05_425508	213	3	415	415	CD
10_1101-2021_01_05_425508	213	4	Additional	additional	JJ
10_1101-2021_01_05_425508	213	5	file	file	NN
10_1101-2021_01_05_425508	213	6	2	2	CD
10_1101-2021_01_05_425508	213	7	416	416	CD
10_1101-2021_01_05_425508	213	8	Table	table	NN
10_1101-2021_01_05_425508	213	9	S1	S1	NNS
10_1101-2021_01_05_425508	213	10	:	:	:
10_1101-2021_01_05_425508	213	11	List	List	NNP
10_1101-2021_01_05_425508	213	12	of	of	IN
10_1101-2021_01_05_425508	213	13	SARS	SARS	NNP
10_1101-2021_01_05_425508	213	14	-	-	HYPH
10_1101-2021_01_05_425508	213	15	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	213	16	strains	strain	NNS
10_1101-2021_01_05_425508	213	17	used	use	VBN
10_1101-2021_01_05_425508	213	18	in	in	IN
10_1101-2021_01_05_425508	213	19	the	the	DT
10_1101-2021_01_05_425508	213	20	analysis	analysis	NN
10_1101-2021_01_05_425508	213	21	.	.	.
10_1101-2021_01_05_425508	214	1	417	417	CD
10_1101-2021_01_05_425508	214	2	418	418	CD
10_1101-2021_01_05_425508	214	3	Table	table	NN
10_1101-2021_01_05_425508	214	4	S2	s2	NN
10_1101-2021_01_05_425508	214	5	:	:	:
10_1101-2021_01_05_425508	214	6	List	list	NN
10_1101-2021_01_05_425508	214	7	of	of	IN
10_1101-2021_01_05_425508	214	8	human	human	NN
10_1101-2021_01_05_425508	214	9	-	-	HYPH
10_1101-2021_01_05_425508	214	10	and	and	CC
10_1101-2021_01_05_425508	214	11	bat	bat	NN
10_1101-2021_01_05_425508	214	12	-	-	HYPH
10_1101-2021_01_05_425508	214	13	CoV	cov	NN
10_1101-2021_01_05_425508	214	14	strains	strain	NNS
10_1101-2021_01_05_425508	214	15	used	use	VBN
10_1101-2021_01_05_425508	214	16	in	in	IN
10_1101-2021_01_05_425508	214	17	the	the	DT
10_1101-2021_01_05_425508	214	18	analysis	analysis	NN
10_1101-2021_01_05_425508	214	19	.	.	.
10_1101-2021_01_05_425508	215	1	419	419	CD
10_1101-2021_01_05_425508	215	2	420	420	CD
10_1101-2021_01_05_425508	215	3	Table	table	NN
10_1101-2021_01_05_425508	215	4	S3	s3	NN
10_1101-2021_01_05_425508	215	5	:	:	:
10_1101-2021_01_05_425508	215	6	Number	Number	NNP
10_1101-2021_01_05_425508	215	7	of	of	IN
10_1101-2021_01_05_425508	215	8	SARS	SARS	NNP
10_1101-2021_01_05_425508	215	9	-	-	HYPH
10_1101-2021_01_05_425508	215	10	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	215	11	strains	strain	VBZ
10_1101-2021_01_05_425508	215	12	in	in	IN
10_1101-2021_01_05_425508	215	13	each	each	DT
10_1101-2021_01_05_425508	215	14	clade	clade	NN
10_1101-2021_01_05_425508	215	15	isolated	isolate	VBN
10_1101-2021_01_05_425508	215	16	in	in	IN
10_1101-2021_01_05_425508	215	17	each	each	DT
10_1101-2021_01_05_425508	215	18	elapsed	elapse	VBN
10_1101-2021_01_05_425508	215	19	month	month	NN
10_1101-2021_01_05_425508	215	20	.	.	.
10_1101-2021_01_05_425508	216	1	421	421	CD
10_1101-2021_01_05_425508	216	2	422	422	CD
10_1101-2021_01_05_425508	216	3	Table	table	NN
10_1101-2021_01_05_425508	216	4	S4	s4	NN
10_1101-2021_01_05_425508	216	5	:	:	:
10_1101-2021_01_05_425508	216	6	Average	average	JJ
10_1101-2021_01_05_425508	216	7	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	216	8	compositions	composition	NNS
10_1101-2021_01_05_425508	216	9	for	for	IN
10_1101-2021_01_05_425508	216	10	SARS	SARS	NNP
10_1101-2021_01_05_425508	216	11	-	-	HYPH
10_1101-2021_01_05_425508	216	12	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	216	13	strains	strain	VBZ
10_1101-2021_01_05_425508	216	14	in	in	IN
10_1101-2021_01_05_425508	216	15	each	each	DT
10_1101-2021_01_05_425508	216	16	clade	clade	NN
10_1101-2021_01_05_425508	216	17	423	423	CD
10_1101-2021_01_05_425508	216	18	isolated	isolate	VBN
10_1101-2021_01_05_425508	216	19	in	in	IN
10_1101-2021_01_05_425508	216	20	each	each	DT
10_1101-2021_01_05_425508	216	21	elapsed	elapse	VBN
10_1101-2021_01_05_425508	216	22	month	month	NN
10_1101-2021_01_05_425508	216	23	.	.	.
10_1101-2021_01_05_425508	217	1	424	424	CD
10_1101-2021_01_05_425508	217	2	425	425	CD
10_1101-2021_01_05_425508	217	3	Table	table	NN
10_1101-2021_01_05_425508	217	4	S5	s5	NN
10_1101-2021_01_05_425508	217	5	:	:	:
10_1101-2021_01_05_425508	217	6	Correlation	correlation	NN
10_1101-2021_01_05_425508	217	7	coefficients	coefficient	NNS
10_1101-2021_01_05_425508	217	8	for	for	IN
10_1101-2021_01_05_425508	217	9	time	time	NN
10_1101-2021_01_05_425508	217	10	-	-	HYPH
10_1101-2021_01_05_425508	217	11	dependent	dependent	JJ
10_1101-2021_01_05_425508	217	12	changes	change	NNS
10_1101-2021_01_05_425508	217	13	in	in	IN
10_1101-2021_01_05_425508	217	14	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	217	15	426	426	CD
10_1101-2021_01_05_425508	217	16	compositions	composition	NNS
10_1101-2021_01_05_425508	217	17	of	of	IN
10_1101-2021_01_05_425508	217	18	SARS	SARS	NNP
10_1101-2021_01_05_425508	217	19	-	-	HYPH
10_1101-2021_01_05_425508	217	20	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	217	21	.	.	.
10_1101-2021_01_05_425508	218	1	427	427	CD
10_1101-2021_01_05_425508	218	2	428	428	CD
10_1101-2021_01_05_425508	218	3	.CC	.cc	CD
10_1101-2021_01_05_425508	218	4	-	-	HYPH
10_1101-2021_01_05_425508	218	5	BY	BY	NNP
10_1101-2021_01_05_425508	218	6	-	-	HYPH
10_1101-2021_01_05_425508	218	7	NC	NC	NNP
10_1101-2021_01_05_425508	218	8	4.0	4.0	CD
10_1101-2021_01_05_425508	218	9	International	international	JJ
10_1101-2021_01_05_425508	218	10	licensemade	licensemade	NN
10_1101-2021_01_05_425508	218	11	available	available	JJ
10_1101-2021_01_05_425508	218	12	under	under	IN
10_1101-2021_01_05_425508	218	13	a	a	DT
10_1101-2021_01_05_425508	218	14	(	(	-LRB-
10_1101-2021_01_05_425508	218	15	which	which	WDT
10_1101-2021_01_05_425508	218	16	was	be	VBD
10_1101-2021_01_05_425508	218	17	not	not	RB
10_1101-2021_01_05_425508	218	18	certified	certify	VBN
10_1101-2021_01_05_425508	218	19	by	by	IN
10_1101-2021_01_05_425508	218	20	peer	peer	NN
10_1101-2021_01_05_425508	218	21	review	review	NN
10_1101-2021_01_05_425508	218	22	)	)	-RRB-
10_1101-2021_01_05_425508	218	23	is	be	VBZ
10_1101-2021_01_05_425508	218	24	the	the	DT
10_1101-2021_01_05_425508	218	25	author	author	NN
10_1101-2021_01_05_425508	218	26	/	/	SYM
10_1101-2021_01_05_425508	218	27	funder	funder	NN
10_1101-2021_01_05_425508	218	28	,	,	,
10_1101-2021_01_05_425508	218	29	who	who	WP
10_1101-2021_01_05_425508	218	30	has	have	VBZ
10_1101-2021_01_05_425508	218	31	granted	grant	VBN
10_1101-2021_01_05_425508	218	32	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	218	33	a	a	DT
10_1101-2021_01_05_425508	218	34	license	license	NN
10_1101-2021_01_05_425508	218	35	to	to	TO
10_1101-2021_01_05_425508	218	36	display	display	VB
10_1101-2021_01_05_425508	218	37	the	the	DT
10_1101-2021_01_05_425508	218	38	preprint	preprint	NN
10_1101-2021_01_05_425508	218	39	in	in	IN
10_1101-2021_01_05_425508	218	40	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	218	41	.	.	.
10_1101-2021_01_05_425508	219	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	219	2	is	be	VBZ
10_1101-2021_01_05_425508	219	3	The	the	DT
10_1101-2021_01_05_425508	219	4	copyright	copyright	NN
10_1101-2021_01_05_425508	219	5	holder	holder	NN
10_1101-2021_01_05_425508	219	6	for	for	IN
10_1101-2021_01_05_425508	219	7	this	this	DT
10_1101-2021_01_05_425508	219	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	219	9	version	version	NN
10_1101-2021_01_05_425508	219	10	posted	post	VBD
10_1101-2021_01_05_425508	219	11	January	January	NNP
10_1101-2021_01_05_425508	219	12	6	6	CD
10_1101-2021_01_05_425508	219	13	,	,	,
10_1101-2021_01_05_425508	219	14	2021	2021	CD
10_1101-2021_01_05_425508	219	15	.	.	.
10_1101-2021_01_05_425508	219	16	;	;	:
10_1101-2021_01_05_425508	219	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	219	18	:	:	:
10_1101-2021_01_05_425508	219	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	219	20	preprint	preprint	NN
10_1101-2021_01_05_425508	219	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	POS
10_1101-2021_01_05_425508	219	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NN
10_1101-2021_01_05_425508	219	23	17	17	CD
10_1101-2021_01_05_425508	219	24	Table	table	NN
10_1101-2021_01_05_425508	219	25	S6	s6	NN
10_1101-2021_01_05_425508	219	26	:	:	:
10_1101-2021_01_05_425508	219	27	Fold	fold	VB
10_1101-2021_01_05_425508	219	28	change	change	NN
10_1101-2021_01_05_425508	219	29	in	in	IN
10_1101-2021_01_05_425508	219	30	compositions	composition	NNS
10_1101-2021_01_05_425508	219	31	between	between	IN
10_1101-2021_01_05_425508	219	32	strains	strain	NNS
10_1101-2021_01_05_425508	219	33	of	of	IN
10_1101-2021_01_05_425508	219	34	the	the	DT
10_1101-2021_01_05_425508	219	35	first	first	JJ
10_1101-2021_01_05_425508	219	36	and	and	CC
10_1101-2021_01_05_425508	219	37	last	last	JJ
10_1101-2021_01_05_425508	219	38	month	month	NN
10_1101-2021_01_05_425508	219	39	of	of	IN
10_1101-2021_01_05_425508	219	40	the	the	DT
10_1101-2021_01_05_425508	219	41	429	429	CD
10_1101-2021_01_05_425508	219	42	analysis	analysis	NN
10_1101-2021_01_05_425508	219	43	.	.	.
10_1101-2021_01_05_425508	220	1	430	430	CD
10_1101-2021_01_05_425508	220	2	Table	table	NN
10_1101-2021_01_05_425508	220	3	S7	s7	NN
10_1101-2021_01_05_425508	220	4	:	:	:
10_1101-2021_01_05_425508	220	5	Distance	distance	NN
10_1101-2021_01_05_425508	220	6	between	between	IN
10_1101-2021_01_05_425508	220	7	the	the	DT
10_1101-2021_01_05_425508	220	8	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	220	9	composition	composition	NN
10_1101-2021_01_05_425508	220	10	of	of	IN
10_1101-2021_01_05_425508	220	11	SARS	SARS	NNP
10_1101-2021_01_05_425508	220	12	-	-	HYPH
10_1101-2021_01_05_425508	220	13	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	220	14	isolated	isolate	VBD
10_1101-2021_01_05_425508	220	15	431	431	CD
10_1101-2021_01_05_425508	220	16	in	in	IN
10_1101-2021_01_05_425508	220	17	each	each	DT
10_1101-2021_01_05_425508	220	18	elapsed	elapse	VBN
10_1101-2021_01_05_425508	220	19	month	month	NN
10_1101-2021_01_05_425508	220	20	and	and	CC
10_1101-2021_01_05_425508	220	21	that	that	DT
10_1101-2021_01_05_425508	220	22	of	of	IN
10_1101-2021_01_05_425508	220	23	human	human	NN
10_1101-2021_01_05_425508	220	24	-	-	HYPH
10_1101-2021_01_05_425508	220	25	CoV.	CoV.	NNP
10_1101-2021_01_05_425508	221	1	432	432	CD
10_1101-2021_01_05_425508	221	2	433	433	CD
10_1101-2021_01_05_425508	221	3	Table	table	NN
10_1101-2021_01_05_425508	221	4	S8	S8	VBN
10_1101-2021_01_05_425508	221	5	:	:	:
10_1101-2021_01_05_425508	221	6	Correlation	correlation	NN
10_1101-2021_01_05_425508	221	7	coefficients	coefficient	NNS
10_1101-2021_01_05_425508	221	8	for	for	IN
10_1101-2021_01_05_425508	221	9	time	time	NN
10_1101-2021_01_05_425508	221	10	-	-	HYPH
10_1101-2021_01_05_425508	221	11	series	series	NN
10_1101-2021_01_05_425508	221	12	changes	change	NNS
10_1101-2021_01_05_425508	221	13	in	in	IN
10_1101-2021_01_05_425508	221	14	the	the	DT
10_1101-2021_01_05_425508	221	15	distance	distance	NN
10_1101-2021_01_05_425508	221	16	between	between	IN
10_1101-2021_01_05_425508	221	17	434	434	CD
10_1101-2021_01_05_425508	221	18	oligonucleotide	oligonucleotide	JJ
10_1101-2021_01_05_425508	221	19	compositions	composition	NNS
10_1101-2021_01_05_425508	221	20	of	of	IN
10_1101-2021_01_05_425508	221	21	SARS	SARS	NNP
10_1101-2021_01_05_425508	221	22	-	-	HYPH
10_1101-2021_01_05_425508	221	23	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	221	24	and	and	CC
10_1101-2021_01_05_425508	221	25	human	human	JJ
10_1101-2021_01_05_425508	221	26	-	-	HYPH
10_1101-2021_01_05_425508	221	27	CoV.	CoV.	NNP
10_1101-2021_01_05_425508	222	1	435	435	CD
10_1101-2021_01_05_425508	222	2	436	436	CD
10_1101-2021_01_05_425508	222	3	Table	table	NN
10_1101-2021_01_05_425508	222	4	S9	s9	NN
10_1101-2021_01_05_425508	222	5	:	:	:
10_1101-2021_01_05_425508	222	6	List	List	NNP
10_1101-2021_01_05_425508	222	7	of	of	IN
10_1101-2021_01_05_425508	222	8	RNA	RNA	NNP
10_1101-2021_01_05_425508	222	9	-	-	HYPH
10_1101-2021_01_05_425508	222	10	binding	bind	VBG
10_1101-2021_01_05_425508	222	11	motifs	motif	NNS
10_1101-2021_01_05_425508	222	12	.	.	.
10_1101-2021_01_05_425508	223	1	437	437	CD
10_1101-2021_01_05_425508	223	2	438	438	CD
10_1101-2021_01_05_425508	223	3	Table	table	NN
10_1101-2021_01_05_425508	223	4	S10	S10	NNP
10_1101-2021_01_05_425508	223	5	:	:	:
10_1101-2021_01_05_425508	223	6	Numbers	number	NNS
10_1101-2021_01_05_425508	223	7	of	of	IN
10_1101-2021_01_05_425508	223	8	motif	motif	NN
10_1101-2021_01_05_425508	223	9	-	-	HYPH
10_1101-2021_01_05_425508	223	10	containing	contain	VBG
10_1101-2021_01_05_425508	223	11	loci	loci	NN
10_1101-2021_01_05_425508	223	12	for	for	IN
10_1101-2021_01_05_425508	223	13	RNA	RNA	NNP
10_1101-2021_01_05_425508	223	14	-	-	HYPH
10_1101-2021_01_05_425508	223	15	binding	bind	VBG
10_1101-2021_01_05_425508	223	16	proteins	protein	NNS
10_1101-2021_01_05_425508	223	17	whose	whose	WP$
10_1101-2021_01_05_425508	223	18	439	439	CD
10_1101-2021_01_05_425508	223	19	abundance	abundance	NN
10_1101-2021_01_05_425508	223	20	increases	increase	NNS
10_1101-2021_01_05_425508	223	21	or	or	CC
10_1101-2021_01_05_425508	223	22	decreases	decrease	NNS
10_1101-2021_01_05_425508	223	23	between	between	IN
10_1101-2021_01_05_425508	223	24	strains	strain	NNS
10_1101-2021_01_05_425508	223	25	of	of	IN
10_1101-2021_01_05_425508	223	26	the	the	DT
10_1101-2021_01_05_425508	223	27	first	first	JJ
10_1101-2021_01_05_425508	223	28	and	and	CC
10_1101-2021_01_05_425508	223	29	last	last	JJ
10_1101-2021_01_05_425508	223	30	month	month	NN
10_1101-2021_01_05_425508	223	31	of	of	IN
10_1101-2021_01_05_425508	223	32	the	the	DT
10_1101-2021_01_05_425508	223	33	440	440	CD
10_1101-2021_01_05_425508	223	34	analysis	analysis	NN
10_1101-2021_01_05_425508	223	35	.	.	.
10_1101-2021_01_05_425508	224	1	441	441	CD
10_1101-2021_01_05_425508	224	2	442	442	CD
10_1101-2021_01_05_425508	224	3	Table	table	NN
10_1101-2021_01_05_425508	224	4	S11	S11	NNP
10_1101-2021_01_05_425508	224	5	:	:	:
10_1101-2021_01_05_425508	224	6	P	p	NN
10_1101-2021_01_05_425508	224	7	-	-	HYPH
10_1101-2021_01_05_425508	224	8	value	value	NN
10_1101-2021_01_05_425508	224	9	from	from	IN
10_1101-2021_01_05_425508	224	10	t	t	NN
10_1101-2021_01_05_425508	224	11	-	-	HYPH
10_1101-2021_01_05_425508	224	12	test	test	NN
10_1101-2021_01_05_425508	224	13	to	to	TO
10_1101-2021_01_05_425508	224	14	analyze	analyze	VB
10_1101-2021_01_05_425508	224	15	the	the	DT
10_1101-2021_01_05_425508	224	16	number	number	NN
10_1101-2021_01_05_425508	224	17	of	of	IN
10_1101-2021_01_05_425508	224	18	RNA	RNA	NNP
10_1101-2021_01_05_425508	224	19	-	-	HYPH
10_1101-2021_01_05_425508	224	20	binding	bind	VBG
10_1101-2021_01_05_425508	224	21	motif	motif	NN
10_1101-2021_01_05_425508	224	22	loci	loci	NN
10_1101-2021_01_05_425508	224	23	whose	whose	WP$
10_1101-2021_01_05_425508	224	24	443	443	CD
10_1101-2021_01_05_425508	224	25	abundance	abundance	NN
10_1101-2021_01_05_425508	224	26	increases	increase	NNS
10_1101-2021_01_05_425508	224	27	or	or	CC
10_1101-2021_01_05_425508	224	28	decreases	decrease	NNS
10_1101-2021_01_05_425508	224	29	between	between	IN
10_1101-2021_01_05_425508	224	30	strains	strain	NNS
10_1101-2021_01_05_425508	224	31	of	of	IN
10_1101-2021_01_05_425508	224	32	the	the	DT
10_1101-2021_01_05_425508	224	33	first	first	JJ
10_1101-2021_01_05_425508	224	34	and	and	CC
10_1101-2021_01_05_425508	224	35	last	last	JJ
10_1101-2021_01_05_425508	224	36	month	month	NN
10_1101-2021_01_05_425508	224	37	of	of	IN
10_1101-2021_01_05_425508	224	38	the	the	DT
10_1101-2021_01_05_425508	224	39	444	444	CD
10_1101-2021_01_05_425508	224	40	analysis	analysis	NN
10_1101-2021_01_05_425508	224	41	.	.	.
10_1101-2021_01_05_425508	225	1	445	445	CD
10_1101-2021_01_05_425508	225	2	446	446	CD
10_1101-2021_01_05_425508	225	3	Table	Table	NNP
10_1101-2021_01_05_425508	225	4	S12	S12	NNP
10_1101-2021_01_05_425508	225	5	:	:	:
10_1101-2021_01_05_425508	225	6	Correlation	correlation	NN
10_1101-2021_01_05_425508	225	7	coefficients	coefficient	NNS
10_1101-2021_01_05_425508	225	8	for	for	IN
10_1101-2021_01_05_425508	225	9	time	time	NN
10_1101-2021_01_05_425508	225	10	-	-	HYPH
10_1101-2021_01_05_425508	225	11	dependent	dependent	JJ
10_1101-2021_01_05_425508	225	12	changes	change	NNS
10_1101-2021_01_05_425508	225	13	in	in	IN
10_1101-2021_01_05_425508	225	14	the	the	DT
10_1101-2021_01_05_425508	225	15	number	number	NN
10_1101-2021_01_05_425508	225	16	of	of	IN
10_1101-2021_01_05_425508	225	17	loci	loci	NN
10_1101-2021_01_05_425508	225	18	447	447	CD
10_1101-2021_01_05_425508	225	19	containing	contain	VBG
10_1101-2021_01_05_425508	225	20	RNA	RNA	NNP
10_1101-2021_01_05_425508	225	21	-	-	HYPH
10_1101-2021_01_05_425508	225	22	binding	bind	VBG
10_1101-2021_01_05_425508	225	23	motifs	motif	NNS
10_1101-2021_01_05_425508	225	24	.	.	.
10_1101-2021_01_05_425508	226	1	448	448	CD
10_1101-2021_01_05_425508	226	2	449	449	CD
10_1101-2021_01_05_425508	226	3	450	450	CD
10_1101-2021_01_05_425508	226	4	Reference	reference	NN
10_1101-2021_01_05_425508	226	5	451	451	CD
10_1101-2021_01_05_425508	226	6	1	1	CD
10_1101-2021_01_05_425508	226	7	.	.	.
10_1101-2021_01_05_425508	227	1	Singhal	Singhal	NNP
10_1101-2021_01_05_425508	227	2	T	T	NNP
10_1101-2021_01_05_425508	227	3	:	:	:
10_1101-2021_01_05_425508	227	4	A	a	DT
10_1101-2021_01_05_425508	227	5	review	review	NN
10_1101-2021_01_05_425508	227	6	of	of	IN
10_1101-2021_01_05_425508	227	7	coronavirus	coronavirus	NNP
10_1101-2021_01_05_425508	227	8	disease-2019	disease-2019	NNP
10_1101-2021_01_05_425508	227	9	(	(	-LRB-
10_1101-2021_01_05_425508	227	10	COVID-19	COVID-19	NNP
10_1101-2021_01_05_425508	227	11	)	)	-RRB-
10_1101-2021_01_05_425508	227	12	.	.	.
10_1101-2021_01_05_425508	228	1	Indian	Indian	NNP
10_1101-2021_01_05_425508	228	2	J	J	NNP
10_1101-2021_01_05_425508	228	3	Pediatr	Pediatr	NNP
10_1101-2021_01_05_425508	228	4	.	.	.
10_1101-2021_01_05_425508	229	1	452	452	CD
10_1101-2021_01_05_425508	229	2	2020	2020	CD
10_1101-2021_01_05_425508	229	3	;	;	:
10_1101-2021_01_05_425508	229	4	87:281	87:281	CD
10_1101-2021_01_05_425508	229	5	-	-	CD
10_1101-2021_01_05_425508	229	6	86	86	CD
10_1101-2021_01_05_425508	229	7	.	.	.
10_1101-2021_01_05_425508	230	1	453	453	CD
10_1101-2021_01_05_425508	230	2	2	2	CD
10_1101-2021_01_05_425508	230	3	.	.	.
10_1101-2021_01_05_425508	231	1	García	García	NNP
10_1101-2021_01_05_425508	231	2	-	-	HYPH
10_1101-2021_01_05_425508	231	3	Sastre	Sastre	NNP
10_1101-2021_01_05_425508	231	4	A	A	NNP
10_1101-2021_01_05_425508	231	5	:	:	:
10_1101-2021_01_05_425508	231	6	Inhibition	inhibition	NN
10_1101-2021_01_05_425508	231	7	of	of	IN
10_1101-2021_01_05_425508	231	8	interferon	interferon	NNP
10_1101-2021_01_05_425508	231	9	-	-	HYPH
10_1101-2021_01_05_425508	231	10	mediated	mediate	VBN
10_1101-2021_01_05_425508	231	11	antiviral	antiviral	JJ
10_1101-2021_01_05_425508	231	12	responses	response	NNS
10_1101-2021_01_05_425508	231	13	by	by	IN
10_1101-2021_01_05_425508	231	14	influenza	influenza	NNP
10_1101-2021_01_05_425508	231	15	454	454	CD
10_1101-2021_01_05_425508	231	16	A	a	DT
10_1101-2021_01_05_425508	231	17	viruses	virus	NNS
10_1101-2021_01_05_425508	231	18	and	and	CC
10_1101-2021_01_05_425508	231	19	other	other	JJ
10_1101-2021_01_05_425508	231	20	negative	negative	JJ
10_1101-2021_01_05_425508	231	21	-	-	HYPH
10_1101-2021_01_05_425508	231	22	strand	strand	NNP
10_1101-2021_01_05_425508	231	23	RNA	RNA	NNP
10_1101-2021_01_05_425508	231	24	viruses	virus	NNS
10_1101-2021_01_05_425508	231	25	.	.	.
10_1101-2021_01_05_425508	232	1	Virology	virology	NN
10_1101-2021_01_05_425508	232	2	.	.	.
10_1101-2021_01_05_425508	233	1	2001;279	2001;279	CD
10_1101-2021_01_05_425508	233	2	:	:	:
10_1101-2021_01_05_425508	233	3	375–84	375–84	CD
10_1101-2021_01_05_425508	233	4	.	.	.
10_1101-2021_01_05_425508	234	1	455	455	CD
10_1101-2021_01_05_425508	234	2	.CC	.CC	:
10_1101-2021_01_05_425508	234	3	-	-	HYPH
10_1101-2021_01_05_425508	234	4	BY	BY	NNP
10_1101-2021_01_05_425508	234	5	-	-	HYPH
10_1101-2021_01_05_425508	234	6	NC	NC	NNP
10_1101-2021_01_05_425508	234	7	4.0	4.0	CD
10_1101-2021_01_05_425508	234	8	International	international	JJ
10_1101-2021_01_05_425508	234	9	licensemade	licensemade	NN
10_1101-2021_01_05_425508	234	10	available	available	JJ
10_1101-2021_01_05_425508	234	11	under	under	IN
10_1101-2021_01_05_425508	234	12	a	a	DT
10_1101-2021_01_05_425508	234	13	(	(	-LRB-
10_1101-2021_01_05_425508	234	14	which	which	WDT
10_1101-2021_01_05_425508	234	15	was	be	VBD
10_1101-2021_01_05_425508	234	16	not	not	RB
10_1101-2021_01_05_425508	234	17	certified	certify	VBN
10_1101-2021_01_05_425508	234	18	by	by	IN
10_1101-2021_01_05_425508	234	19	peer	peer	NN
10_1101-2021_01_05_425508	234	20	review	review	NN
10_1101-2021_01_05_425508	234	21	)	)	-RRB-
10_1101-2021_01_05_425508	234	22	is	be	VBZ
10_1101-2021_01_05_425508	234	23	the	the	DT
10_1101-2021_01_05_425508	234	24	author	author	NN
10_1101-2021_01_05_425508	234	25	/	/	SYM
10_1101-2021_01_05_425508	234	26	funder	funder	NN
10_1101-2021_01_05_425508	234	27	,	,	,
10_1101-2021_01_05_425508	234	28	who	who	WP
10_1101-2021_01_05_425508	234	29	has	have	VBZ
10_1101-2021_01_05_425508	234	30	granted	grant	VBN
10_1101-2021_01_05_425508	234	31	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	234	32	a	a	DT
10_1101-2021_01_05_425508	234	33	license	license	NN
10_1101-2021_01_05_425508	234	34	to	to	TO
10_1101-2021_01_05_425508	234	35	display	display	VB
10_1101-2021_01_05_425508	234	36	the	the	DT
10_1101-2021_01_05_425508	234	37	preprint	preprint	NN
10_1101-2021_01_05_425508	234	38	in	in	IN
10_1101-2021_01_05_425508	234	39	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	234	40	.	.	.
10_1101-2021_01_05_425508	235	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	235	2	is	be	VBZ
10_1101-2021_01_05_425508	235	3	The	the	DT
10_1101-2021_01_05_425508	235	4	copyright	copyright	NN
10_1101-2021_01_05_425508	235	5	holder	holder	NN
10_1101-2021_01_05_425508	235	6	for	for	IN
10_1101-2021_01_05_425508	235	7	this	this	DT
10_1101-2021_01_05_425508	235	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	235	9	version	version	NN
10_1101-2021_01_05_425508	235	10	posted	post	VBD
10_1101-2021_01_05_425508	235	11	January	January	NNP
10_1101-2021_01_05_425508	235	12	6	6	CD
10_1101-2021_01_05_425508	235	13	,	,	,
10_1101-2021_01_05_425508	235	14	2021	2021	CD
10_1101-2021_01_05_425508	235	15	.	.	.
10_1101-2021_01_05_425508	235	16	;	;	:
10_1101-2021_01_05_425508	235	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	235	18	:	:	:
10_1101-2021_01_05_425508	235	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	235	20	preprint	preprint	NN
10_1101-2021_01_05_425508	235	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	235	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	235	23	18	18	CD
10_1101-2021_01_05_425508	235	24	3	3	CD
10_1101-2021_01_05_425508	235	25	.	.	.
10_1101-2021_01_05_425508	236	1	Voinnet	Voinnet	NNP
10_1101-2021_01_05_425508	236	2	O	o	NN
10_1101-2021_01_05_425508	236	3	:	:	:
10_1101-2021_01_05_425508	236	4	Induction	induction	NN
10_1101-2021_01_05_425508	236	5	and	and	CC
10_1101-2021_01_05_425508	236	6	suppression	suppression	NN
10_1101-2021_01_05_425508	236	7	of	of	IN
10_1101-2021_01_05_425508	236	8	RNA	RNA	NNP
10_1101-2021_01_05_425508	236	9	silencing	silence	VBG
10_1101-2021_01_05_425508	236	10	:	:	:
10_1101-2021_01_05_425508	236	11	insights	insight	NNS
10_1101-2021_01_05_425508	236	12	from	from	IN
10_1101-2021_01_05_425508	236	13	viral	viral	JJ
10_1101-2021_01_05_425508	236	14	456	456	CD
10_1101-2021_01_05_425508	236	15	infections	infection	NNS
10_1101-2021_01_05_425508	236	16	.	.	.
10_1101-2021_01_05_425508	237	1	Nat	Nat	NNP
10_1101-2021_01_05_425508	237	2	.	.	.
10_1101-2021_01_05_425508	238	1	Rev.	Rev.	NNP
10_1101-2021_01_05_425508	239	1	Genet	Genet	NNP
10_1101-2021_01_05_425508	239	2	.	.	.
10_1101-2021_01_05_425508	240	1	2005;6:206–20	2005;6:206–20	CD
10_1101-2021_01_05_425508	240	2	.	.	.
10_1101-2021_01_05_425508	241	1	457	457	CD
10_1101-2021_01_05_425508	241	2	4	4	CD
10_1101-2021_01_05_425508	241	3	.	.	.
10_1101-2021_01_05_425508	242	1	Randall	Randall	NNP
10_1101-2021_01_05_425508	242	2	RE	RE	NNP
10_1101-2021_01_05_425508	242	3	,	,	,
10_1101-2021_01_05_425508	242	4	Goodbourn	Goodbourn	NNP
10_1101-2021_01_05_425508	242	5	S	S	NNP
10_1101-2021_01_05_425508	242	6	:	:	:
10_1101-2021_01_05_425508	242	7	Interferons	interferon	NNS
10_1101-2021_01_05_425508	242	8	and	and	CC
10_1101-2021_01_05_425508	242	9	viruses	virus	NNS
10_1101-2021_01_05_425508	242	10	:	:	:
10_1101-2021_01_05_425508	242	11	an	an	DT
10_1101-2021_01_05_425508	242	12	interplay	interplay	NN
10_1101-2021_01_05_425508	242	13	between	between	IN
10_1101-2021_01_05_425508	242	14	induction	induction	NN
10_1101-2021_01_05_425508	242	15	,	,	,
10_1101-2021_01_05_425508	242	16	458	458	CD
10_1101-2021_01_05_425508	242	17	signalling	signal	VBG
10_1101-2021_01_05_425508	242	18	,	,	,
10_1101-2021_01_05_425508	242	19	antiviral	antiviral	JJ
10_1101-2021_01_05_425508	242	20	responses	response	NNS
10_1101-2021_01_05_425508	242	21	and	and	CC
10_1101-2021_01_05_425508	242	22	virus	virus	NN
10_1101-2021_01_05_425508	242	23	countermeasures	countermeasure	NNS
10_1101-2021_01_05_425508	242	24	.	.	.
10_1101-2021_01_05_425508	243	1	J.	J.	NNP
10_1101-2021_01_05_425508	243	2	Gen.	Gen.	NNP
10_1101-2021_01_05_425508	243	3	Virol	Virol	NNP
10_1101-2021_01_05_425508	243	4	.	.	.
10_1101-2021_01_05_425508	244	1	2008;89:1–459	2008;89:1–459	CD
10_1101-2021_01_05_425508	244	2	47	47	CD
10_1101-2021_01_05_425508	244	3	.	.	.
10_1101-2021_01_05_425508	245	1	460	460	CD
10_1101-2021_01_05_425508	245	2	5	5	CD
10_1101-2021_01_05_425508	245	3	.	.	.
10_1101-2021_01_05_425508	246	1	Konno	Konno	NNP
10_1101-2021_01_05_425508	246	2	Y	Y	NNP
10_1101-2021_01_05_425508	246	3	,	,	,
10_1101-2021_01_05_425508	246	4	Kimura	Kimura	NNP
10_1101-2021_01_05_425508	246	5	I	I	NNP
10_1101-2021_01_05_425508	246	6	,	,	,
10_1101-2021_01_05_425508	246	7	Uriu	Uriu	NNP
10_1101-2021_01_05_425508	246	8	K	K	NNP
10_1101-2021_01_05_425508	246	9	,	,	,
10_1101-2021_01_05_425508	246	10	et	et	NNP
10_1101-2021_01_05_425508	246	11	al	al	NNP
10_1101-2021_01_05_425508	246	12	:	:	:
10_1101-2021_01_05_425508	246	13	SARS	SARS	NNP
10_1101-2021_01_05_425508	246	14	-	-	HYPH
10_1101-2021_01_05_425508	246	15	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	246	16	ORF3b	ORF3b	NNP
10_1101-2021_01_05_425508	246	17	is	be	VBZ
10_1101-2021_01_05_425508	246	18	a	a	DT
10_1101-2021_01_05_425508	246	19	potent	potent	JJ
10_1101-2021_01_05_425508	246	20	interferon	interferon	NN
10_1101-2021_01_05_425508	246	21	461	461	CD
10_1101-2021_01_05_425508	246	22	antagonist	antagonist	NN
10_1101-2021_01_05_425508	246	23	whose	whose	WP$
10_1101-2021_01_05_425508	246	24	activity	activity	NN
10_1101-2021_01_05_425508	246	25	is	be	VBZ
10_1101-2021_01_05_425508	246	26	increased	increase	VBN
10_1101-2021_01_05_425508	246	27	by	by	IN
10_1101-2021_01_05_425508	246	28	a	a	DT
10_1101-2021_01_05_425508	246	29	naturally	naturally	RB
10_1101-2021_01_05_425508	246	30	occurring	occur	VBG
10_1101-2021_01_05_425508	246	31	elongation	elongation	NN
10_1101-2021_01_05_425508	246	32	variant	variant	NN
10_1101-2021_01_05_425508	246	33	.	.	.
10_1101-2021_01_05_425508	247	1	462	462	CD
10_1101-2021_01_05_425508	247	2	Cell	Cell	NNP
10_1101-2021_01_05_425508	247	3	Rep.	Rep.	NNP
10_1101-2021_01_05_425508	247	4	2020;32:108185	2020;32:108185	CD
10_1101-2021_01_05_425508	247	5	.	.	.
10_1101-2021_01_05_425508	248	1	463	463	CD
10_1101-2021_01_05_425508	248	2	6	6	CD
10_1101-2021_01_05_425508	248	3	.	.	.
10_1101-2021_01_05_425508	249	1	Zhou	Zhou	NNP
10_1101-2021_01_05_425508	249	2	et	et	NNP
10_1101-2021_01_05_425508	249	3	al	al	NNP
10_1101-2021_01_05_425508	249	4	:	:	:
10_1101-2021_01_05_425508	249	5	A	a	DT
10_1101-2021_01_05_425508	249	6	novel	novel	JJ
10_1101-2021_01_05_425508	249	7	bat	bat	NN
10_1101-2021_01_05_425508	249	8	coronavirus	coronavirus	NN
10_1101-2021_01_05_425508	249	9	closely	closely	RB
10_1101-2021_01_05_425508	249	10	related	relate	VBN
10_1101-2021_01_05_425508	249	11	to	to	IN
10_1101-2021_01_05_425508	249	12	SARS	SARS	NNP
10_1101-2021_01_05_425508	249	13	-	-	HYPH
10_1101-2021_01_05_425508	249	14	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	249	15	contains	contain	VBZ
10_1101-2021_01_05_425508	249	16	natural	natural	JJ
10_1101-2021_01_05_425508	249	17	464	464	CD
10_1101-2021_01_05_425508	249	18	insertions	insertion	NNS
10_1101-2021_01_05_425508	249	19	at	at	IN
10_1101-2021_01_05_425508	249	20	the	the	DT
10_1101-2021_01_05_425508	249	21	S1	S1	NNP
10_1101-2021_01_05_425508	249	22	/	/	SYM
10_1101-2021_01_05_425508	249	23	S2	s2	NN
10_1101-2021_01_05_425508	249	24	cleavage	cleavage	NN
10_1101-2021_01_05_425508	249	25	site	site	NN
10_1101-2021_01_05_425508	249	26	of	of	IN
10_1101-2021_01_05_425508	249	27	the	the	DT
10_1101-2021_01_05_425508	249	28	spike	spike	JJ
10_1101-2021_01_05_425508	249	29	protein	protein	NN
10_1101-2021_01_05_425508	249	30	.	.	.
10_1101-2021_01_05_425508	250	1	Curr	Curr	NNP
10_1101-2021_01_05_425508	250	2	Biol	Biol	NNP
10_1101-2021_01_05_425508	250	3	.	.	.
10_1101-2021_01_05_425508	251	1	2020;30:2196	2020;30:2196	LS
10_1101-2021_01_05_425508	251	2	-	-	SYM
10_1101-2021_01_05_425508	251	3	465	465	CD
10_1101-2021_01_05_425508	251	4	203	203	CD
10_1101-2021_01_05_425508	251	5	.	.	.
10_1101-2021_01_05_425508	252	1	466	466	CD
10_1101-2021_01_05_425508	252	2	7	7	CD
10_1101-2021_01_05_425508	252	3	.	.	.
10_1101-2021_01_05_425508	253	1	Nei	Nei	NNP
10_1101-2021_01_05_425508	253	2	M	M	NNP
10_1101-2021_01_05_425508	253	3	:	:	:
10_1101-2021_01_05_425508	253	4	Molecular	molecular	JJ
10_1101-2021_01_05_425508	253	5	evolutionary	evolutionary	JJ
10_1101-2021_01_05_425508	253	6	genetics	genetic	NNS
10_1101-2021_01_05_425508	253	7	.	.	.
10_1101-2021_01_05_425508	254	1	Columbia	Columbia	NNP
10_1101-2021_01_05_425508	254	2	University	University	NNP
10_1101-2021_01_05_425508	254	3	Press	Press	NNP
10_1101-2021_01_05_425508	254	4	:	:	:
10_1101-2021_01_05_425508	254	5	New	New	NNP
10_1101-2021_01_05_425508	254	6	York	York	NNP
10_1101-2021_01_05_425508	254	7	.	.	.
10_1101-2021_01_05_425508	255	1	467	467	CD
10_1101-2021_01_05_425508	255	2	1987	1987	CD
10_1101-2021_01_05_425508	255	3	.	.	.
10_1101-2021_01_05_425508	256	1	468	468	CD
10_1101-2021_01_05_425508	256	2	8	8	CD
10_1101-2021_01_05_425508	256	3	.	.	.
10_1101-2021_01_05_425508	257	1	Kumar	Kumar	NNP
10_1101-2021_01_05_425508	257	2	S	S	NNP
10_1101-2021_01_05_425508	257	3	,	,	,
10_1101-2021_01_05_425508	257	4	Nei	Nei	NNP
10_1101-2021_01_05_425508	257	5	M	M	NNP
10_1101-2021_01_05_425508	257	6	,	,	,
10_1101-2021_01_05_425508	257	7	Dudley	Dudley	NNP
10_1101-2021_01_05_425508	257	8	J	J	NNP
10_1101-2021_01_05_425508	257	9	,	,	,
10_1101-2021_01_05_425508	257	10	Tamura	Tamura	NNP
10_1101-2021_01_05_425508	257	11	K	K	NNP
10_1101-2021_01_05_425508	257	12	:	:	:
10_1101-2021_01_05_425508	257	13	MEGA	mega	NN
10_1101-2021_01_05_425508	257	14	:	:	:
10_1101-2021_01_05_425508	257	15	a	a	DT
10_1101-2021_01_05_425508	257	16	biologist	biologist	JJ
10_1101-2021_01_05_425508	257	17	-	-	HYPH
10_1101-2021_01_05_425508	257	18	centric	centric	NN
10_1101-2021_01_05_425508	257	19	software	software	NN
10_1101-2021_01_05_425508	257	20	for	for	IN
10_1101-2021_01_05_425508	257	21	469	469	CD
10_1101-2021_01_05_425508	257	22	evolutionary	evolutionary	JJ
10_1101-2021_01_05_425508	257	23	analysis	analysis	NN
10_1101-2021_01_05_425508	257	24	of	of	IN
10_1101-2021_01_05_425508	257	25	DNA	dna	NN
10_1101-2021_01_05_425508	257	26	and	and	CC
10_1101-2021_01_05_425508	257	27	protein	protein	NN
10_1101-2021_01_05_425508	257	28	sequences	sequence	NNS
10_1101-2021_01_05_425508	257	29	,	,	,
10_1101-2021_01_05_425508	257	30	Brief	Brief	NNP
10_1101-2021_01_05_425508	257	31	Bioinform	Bioinform	NNP
10_1101-2021_01_05_425508	257	32	.	.	.
10_1101-2021_01_05_425508	258	1	2008;9:299–470	2008;9:299–470	CD
10_1101-2021_01_05_425508	258	2	306	306	CD
10_1101-2021_01_05_425508	258	3	.	.	.
10_1101-2021_01_05_425508	259	1	471	471	CD
10_1101-2021_01_05_425508	259	2	9	9	CD
10_1101-2021_01_05_425508	259	3	.	.	.
10_1101-2021_01_05_425508	260	1	Abe	Abe	NNP
10_1101-2021_01_05_425508	260	2	T	T	NNP
10_1101-2021_01_05_425508	260	3	,	,	,
10_1101-2021_01_05_425508	260	4	Kanaya	Kanaya	NNP
10_1101-2021_01_05_425508	260	5	S	S	NNP
10_1101-2021_01_05_425508	260	6	,	,	,
10_1101-2021_01_05_425508	260	7	Kinouchi	Kinouchi	NNP
10_1101-2021_01_05_425508	260	8	M	M	NNP
10_1101-2021_01_05_425508	260	9	,	,	,
10_1101-2021_01_05_425508	260	10	et	et	NNP
10_1101-2021_01_05_425508	260	11	al	al	NNP
10_1101-2021_01_05_425508	260	12	:	:	:
10_1101-2021_01_05_425508	260	13	Informatics	Informatics	NNP
10_1101-2021_01_05_425508	260	14	for	for	IN
10_1101-2021_01_05_425508	260	15	unveiling	unveil	VBG
10_1101-2021_01_05_425508	260	16	hidden	hide	VBN
10_1101-2021_01_05_425508	260	17	genome	genome	NN
10_1101-2021_01_05_425508	260	18	472	472	CD
10_1101-2021_01_05_425508	260	19	signatures	signature	NNS
10_1101-2021_01_05_425508	260	20	,	,	,
10_1101-2021_01_05_425508	260	21	Genome	Genome	NNP
10_1101-2021_01_05_425508	260	22	Res	Res	NNP
10_1101-2021_01_05_425508	260	23	.	.	.
10_1101-2021_01_05_425508	261	1	2003;13:693–702	2003;13:693–702	LS
10_1101-2021_01_05_425508	261	2	.	.	.
10_1101-2021_01_05_425508	262	1	473	473	CD
10_1101-2021_01_05_425508	262	2	10	10	CD
10_1101-2021_01_05_425508	262	3	.	.	.
10_1101-2021_01_05_425508	263	1	Abe	Abe	NNP
10_1101-2021_01_05_425508	263	2	T	T	NNP
10_1101-2021_01_05_425508	263	3	,	,	,
10_1101-2021_01_05_425508	263	4	Sugawara	Sugawara	NNP
10_1101-2021_01_05_425508	263	5	H	H	NNP
10_1101-2021_01_05_425508	263	6	,	,	,
10_1101-2021_01_05_425508	263	7	Kinouchi	Kinouchi	NNP
10_1101-2021_01_05_425508	263	8	M	M	NNP
10_1101-2021_01_05_425508	263	9	,	,	,
10_1101-2021_01_05_425508	263	10	Kanaya	Kanaya	NNP
10_1101-2021_01_05_425508	263	11	S	S	NNP
10_1101-2021_01_05_425508	263	12	,	,	,
10_1101-2021_01_05_425508	263	13	Ikemura	Ikemura	NNP
10_1101-2021_01_05_425508	263	14	T	T	NNP
10_1101-2021_01_05_425508	263	15	:	:	:
10_1101-2021_01_05_425508	263	16	Novel	novel	JJ
10_1101-2021_01_05_425508	263	17	phylogenetic	phylogenetic	JJ
10_1101-2021_01_05_425508	263	18	474	474	CD
10_1101-2021_01_05_425508	263	19	studies	study	NNS
10_1101-2021_01_05_425508	263	20	of	of	IN
10_1101-2021_01_05_425508	263	21	genomic	genomic	JJ
10_1101-2021_01_05_425508	263	22	sequence	sequence	NN
10_1101-2021_01_05_425508	263	23	fragments	fragment	NNS
10_1101-2021_01_05_425508	263	24	derived	derive	VBN
10_1101-2021_01_05_425508	263	25	from	from	IN
10_1101-2021_01_05_425508	263	26	uncultured	uncultured	JJ
10_1101-2021_01_05_425508	263	27	microbe	microbe	NN
10_1101-2021_01_05_425508	263	28	mixtures	mixture	NNS
10_1101-2021_01_05_425508	263	29	475	475	CD
10_1101-2021_01_05_425508	263	30	in	in	IN
10_1101-2021_01_05_425508	263	31	environmental	environmental	JJ
10_1101-2021_01_05_425508	263	32	and	and	CC
10_1101-2021_01_05_425508	263	33	clinical	clinical	JJ
10_1101-2021_01_05_425508	263	34	samples	sample	NNS
10_1101-2021_01_05_425508	263	35	,	,	,
10_1101-2021_01_05_425508	263	36	DNA	dna	NN
10_1101-2021_01_05_425508	263	37	Res	Res	NNP
10_1101-2021_01_05_425508	263	38	.	.	.
10_1101-2021_01_05_425508	264	1	2005;12:281–90	2005;12:281–90	CD
10_1101-2021_01_05_425508	264	2	.	.	.
10_1101-2021_01_05_425508	265	1	476	476	CD
10_1101-2021_01_05_425508	265	2	11	11	CD
10_1101-2021_01_05_425508	265	3	.	.	.
10_1101-2021_01_05_425508	266	1	Iwasaki	Iwasaki	NNP
10_1101-2021_01_05_425508	266	2	Y	Y	NNP
10_1101-2021_01_05_425508	266	3	,	,	,
10_1101-2021_01_05_425508	266	4	Abe	Abe	NNP
10_1101-2021_01_05_425508	266	5	T	T	NNP
10_1101-2021_01_05_425508	266	6	,	,	,
10_1101-2021_01_05_425508	266	7	Wada	Wada	NNP
10_1101-2021_01_05_425508	266	8	K	K	NNP
10_1101-2021_01_05_425508	266	9	,	,	,
10_1101-2021_01_05_425508	266	10	Itoh	Itoh	NNP
10_1101-2021_01_05_425508	266	11	M	M	NNP
10_1101-2021_01_05_425508	266	12	,	,	,
10_1101-2021_01_05_425508	266	13	Ikemura	Ikemura	NNP
10_1101-2021_01_05_425508	266	14	T	T	NNP
10_1101-2021_01_05_425508	266	15	,	,	,
10_1101-2021_01_05_425508	266	16	:	:	:
10_1101-2021_01_05_425508	266	17	Prediction	prediction	NN
10_1101-2021_01_05_425508	266	18	of	of	IN
10_1101-2021_01_05_425508	266	19	directional	directional	JJ
10_1101-2021_01_05_425508	266	20	changes	change	NNS
10_1101-2021_01_05_425508	266	21	of	of	IN
10_1101-2021_01_05_425508	266	22	477	477	CD
10_1101-2021_01_05_425508	266	23	influenza	influenza	NN
10_1101-2021_01_05_425508	266	24	A	a	DT
10_1101-2021_01_05_425508	266	25	virus	virus	NN
10_1101-2021_01_05_425508	266	26	genome	genome	JJ
10_1101-2021_01_05_425508	266	27	sequences	sequence	NNS
10_1101-2021_01_05_425508	266	28	with	with	IN
10_1101-2021_01_05_425508	266	29	emphasis	emphasis	NN
10_1101-2021_01_05_425508	266	30	on	on	IN
10_1101-2021_01_05_425508	266	31	pandemic	pandemic	JJ
10_1101-2021_01_05_425508	266	32	H1N1/09	H1N1/09	NNP
10_1101-2021_01_05_425508	266	33	as	as	IN
10_1101-2021_01_05_425508	266	34	a	a	DT
10_1101-2021_01_05_425508	266	35	478	478	CD
10_1101-2021_01_05_425508	266	36	model	model	NN
10_1101-2021_01_05_425508	266	37	case	case	NN
10_1101-2021_01_05_425508	266	38	.	.	.
10_1101-2021_01_05_425508	267	1	DNA	dna	NN
10_1101-2021_01_05_425508	267	2	res	re	VBZ
10_1101-2021_01_05_425508	267	3	2011;18:125	2011;18:125	CD
10_1101-2021_01_05_425508	267	4	-	-	HYPH
10_1101-2021_01_05_425508	267	5	36	36	CD
10_1101-2021_01_05_425508	267	6	479	479	CD
10_1101-2021_01_05_425508	267	7	12	12	CD
10_1101-2021_01_05_425508	267	8	.	.	.
10_1101-2021_01_05_425508	268	1	Iwasaki	Iwasaki	NNP
10_1101-2021_01_05_425508	268	2	Y	Y	NNP
10_1101-2021_01_05_425508	268	3	,	,	,
10_1101-2021_01_05_425508	268	4	Abe	Abe	NNP
10_1101-2021_01_05_425508	268	5	T	T	NNP
10_1101-2021_01_05_425508	268	6	,	,	,
10_1101-2021_01_05_425508	268	7	Wada	Wada	NNP
10_1101-2021_01_05_425508	268	8	Y	Y	NNP
10_1101-2021_01_05_425508	268	9	,	,	,
10_1101-2021_01_05_425508	268	10	Wada	Wada	NNP
10_1101-2021_01_05_425508	268	11	K	K	NNP
10_1101-2021_01_05_425508	268	12	,	,	,
10_1101-2021_01_05_425508	268	13	Ikemura	Ikemura	NNP
10_1101-2021_01_05_425508	268	14	T	T	NNP
10_1101-2021_01_05_425508	268	15	:	:	:
10_1101-2021_01_05_425508	268	16	Novel	novel	NN
10_1101-2021_01_05_425508	268	17	bioinformatics	bioinformatic	NNS
10_1101-2021_01_05_425508	268	18	strategies	strategy	NNS
10_1101-2021_01_05_425508	268	19	for	for	IN
10_1101-2021_01_05_425508	268	20	480	480	CD
10_1101-2021_01_05_425508	268	21	prediction	prediction	NN
10_1101-2021_01_05_425508	268	22	of	of	IN
10_1101-2021_01_05_425508	268	23	directional	directional	JJ
10_1101-2021_01_05_425508	268	24	sequence	sequence	NN
10_1101-2021_01_05_425508	268	25	changes	change	NNS
10_1101-2021_01_05_425508	268	26	in	in	IN
10_1101-2021_01_05_425508	268	27	influenza	influenza	NN
10_1101-2021_01_05_425508	268	28	virus	virus	NN
10_1101-2021_01_05_425508	268	29	genomes	genome	NNS
10_1101-2021_01_05_425508	268	30	and	and	CC
10_1101-2021_01_05_425508	268	31	for	for	IN
10_1101-2021_01_05_425508	268	32	481	481	CD
10_1101-2021_01_05_425508	268	33	surveillance	surveillance	NN
10_1101-2021_01_05_425508	268	34	of	of	IN
10_1101-2021_01_05_425508	268	35	potentially	potentially	RB
10_1101-2021_01_05_425508	268	36	hazardous	hazardous	JJ
10_1101-2021_01_05_425508	268	37	strains	strain	NNS
10_1101-2021_01_05_425508	268	38	.	.	.
10_1101-2021_01_05_425508	269	1	BMC	BMC	NNP
10_1101-2021_01_05_425508	269	2	Infect	Infect	NNP
10_1101-2021_01_05_425508	269	3	Dis	Dis	NNP
10_1101-2021_01_05_425508	269	4	.	.	.
10_1101-2021_01_05_425508	270	1	2013;13:386-	2013;13:386-	NNP
10_1101-2021_01_05_425508	270	2	482	482	CD
10_1101-2021_01_05_425508	270	3	.CC	.CC	NFP
10_1101-2021_01_05_425508	270	4	-	-	HYPH
10_1101-2021_01_05_425508	270	5	BY	BY	NNP
10_1101-2021_01_05_425508	270	6	-	-	HYPH
10_1101-2021_01_05_425508	270	7	NC	NC	NNP
10_1101-2021_01_05_425508	270	8	4.0	4.0	CD
10_1101-2021_01_05_425508	270	9	International	international	JJ
10_1101-2021_01_05_425508	270	10	licensemade	licensemade	NN
10_1101-2021_01_05_425508	270	11	available	available	JJ
10_1101-2021_01_05_425508	270	12	under	under	IN
10_1101-2021_01_05_425508	270	13	a	a	DT
10_1101-2021_01_05_425508	270	14	(	(	-LRB-
10_1101-2021_01_05_425508	270	15	which	which	WDT
10_1101-2021_01_05_425508	270	16	was	be	VBD
10_1101-2021_01_05_425508	270	17	not	not	RB
10_1101-2021_01_05_425508	270	18	certified	certify	VBN
10_1101-2021_01_05_425508	270	19	by	by	IN
10_1101-2021_01_05_425508	270	20	peer	peer	NN
10_1101-2021_01_05_425508	270	21	review	review	NN
10_1101-2021_01_05_425508	270	22	)	)	-RRB-
10_1101-2021_01_05_425508	270	23	is	be	VBZ
10_1101-2021_01_05_425508	270	24	the	the	DT
10_1101-2021_01_05_425508	270	25	author	author	NN
10_1101-2021_01_05_425508	270	26	/	/	SYM
10_1101-2021_01_05_425508	270	27	funder	funder	NN
10_1101-2021_01_05_425508	270	28	,	,	,
10_1101-2021_01_05_425508	270	29	who	who	WP
10_1101-2021_01_05_425508	270	30	has	have	VBZ
10_1101-2021_01_05_425508	270	31	granted	grant	VBN
10_1101-2021_01_05_425508	270	32	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	270	33	a	a	DT
10_1101-2021_01_05_425508	270	34	license	license	NN
10_1101-2021_01_05_425508	270	35	to	to	TO
10_1101-2021_01_05_425508	270	36	display	display	VB
10_1101-2021_01_05_425508	270	37	the	the	DT
10_1101-2021_01_05_425508	270	38	preprint	preprint	NN
10_1101-2021_01_05_425508	270	39	in	in	IN
10_1101-2021_01_05_425508	270	40	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	270	41	.	.	.
10_1101-2021_01_05_425508	271	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	271	2	is	be	VBZ
10_1101-2021_01_05_425508	271	3	The	the	DT
10_1101-2021_01_05_425508	271	4	copyright	copyright	NN
10_1101-2021_01_05_425508	271	5	holder	holder	NN
10_1101-2021_01_05_425508	271	6	for	for	IN
10_1101-2021_01_05_425508	271	7	this	this	DT
10_1101-2021_01_05_425508	271	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	271	9	version	version	NN
10_1101-2021_01_05_425508	271	10	posted	post	VBD
10_1101-2021_01_05_425508	271	11	January	January	NNP
10_1101-2021_01_05_425508	271	12	6	6	CD
10_1101-2021_01_05_425508	271	13	,	,	,
10_1101-2021_01_05_425508	271	14	2021	2021	CD
10_1101-2021_01_05_425508	271	15	.	.	.
10_1101-2021_01_05_425508	271	16	;	;	:
10_1101-2021_01_05_425508	271	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	271	18	:	:	:
10_1101-2021_01_05_425508	271	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	271	20	preprint	preprint	NN
10_1101-2021_01_05_425508	271	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	271	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	271	23	19	19	CD
10_1101-2021_01_05_425508	271	24	13	13	CD
10_1101-2021_01_05_425508	271	25	.	.	.
10_1101-2021_01_05_425508	272	1	Karlin	Karlin	NNP
10_1101-2021_01_05_425508	272	2	S	S	NNP
10_1101-2021_01_05_425508	272	3	,	,	,
10_1101-2021_01_05_425508	272	4	Campbell	Campbell	NNP
10_1101-2021_01_05_425508	272	5	AM	AM	NNP
10_1101-2021_01_05_425508	272	6	,	,	,
10_1101-2021_01_05_425508	272	7	Mrazek	Mrazek	NNP
10_1101-2021_01_05_425508	272	8	J	J	NNP
10_1101-2021_01_05_425508	272	9	:	:	:
10_1101-2021_01_05_425508	272	10	Comparative	comparative	JJ
10_1101-2021_01_05_425508	272	11	DNA	dna	NN
10_1101-2021_01_05_425508	272	12	analysis	analysis	NN
10_1101-2021_01_05_425508	272	13	across	across	IN
10_1101-2021_01_05_425508	272	14	diverse	diverse	JJ
10_1101-2021_01_05_425508	272	15	483	483	CD
10_1101-2021_01_05_425508	272	16	genomes	genome	NNS
10_1101-2021_01_05_425508	272	17	.	.	.
10_1101-2021_01_05_425508	273	1	Annu	Annu	NNP
10_1101-2021_01_05_425508	273	2	.	.	.
10_1101-2021_01_05_425508	274	1	Rev.	Rev.	NNP
10_1101-2021_01_05_425508	275	1	Genet	Genet	NNP
10_1101-2021_01_05_425508	275	2	.	.	.
10_1101-2021_01_05_425508	276	1	1998;32:185–225	1998;32:185–225	CD
10_1101-2021_01_05_425508	276	2	.	.	.
10_1101-2021_01_05_425508	277	1	484	484	CD
10_1101-2021_01_05_425508	277	2	14	14	CD
10_1101-2021_01_05_425508	277	3	.	.	.
10_1101-2021_01_05_425508	278	1	Wada	Wada	NNP
10_1101-2021_01_05_425508	278	2	Y	Y	NNP
10_1101-2021_01_05_425508	278	3	,	,	,
10_1101-2021_01_05_425508	278	4	Wada	Wada	NNP
10_1101-2021_01_05_425508	278	5	K	K	NNP
10_1101-2021_01_05_425508	278	6	,	,	,
10_1101-2021_01_05_425508	278	7	Iwasaki	Iwasaki	NNP
10_1101-2021_01_05_425508	278	8	Y	Y	NNP
10_1101-2021_01_05_425508	278	9	,	,	,
10_1101-2021_01_05_425508	278	10	Kanaya	Kanaya	NNP
10_1101-2021_01_05_425508	278	11	S	S	NNP
10_1101-2021_01_05_425508	278	12	,	,	,
10_1101-2021_01_05_425508	278	13	Ikemura	Ikemura	NNP
10_1101-2021_01_05_425508	278	14	T	T	NNP
10_1101-2021_01_05_425508	278	15	:	:	:
10_1101-2021_01_05_425508	278	16	Directional	directional	JJ
10_1101-2021_01_05_425508	278	17	and	and	CC
10_1101-2021_01_05_425508	278	18	reoccurring	reoccurre	VBG
10_1101-2021_01_05_425508	278	19	485	485	CD
10_1101-2021_01_05_425508	278	20	sequence	sequence	NN
10_1101-2021_01_05_425508	278	21	change	change	NN
10_1101-2021_01_05_425508	278	22	in	in	IN
10_1101-2021_01_05_425508	278	23	zoonotic	zoonotic	JJ
10_1101-2021_01_05_425508	278	24	RNA	RNA	NNP
10_1101-2021_01_05_425508	278	25	virus	virus	NN
10_1101-2021_01_05_425508	278	26	genomes	genome	NNS
10_1101-2021_01_05_425508	278	27	visualized	visualize	VBN
10_1101-2021_01_05_425508	278	28	by	by	IN
10_1101-2021_01_05_425508	278	29	time	time	NN
10_1101-2021_01_05_425508	278	30	-	-	HYPH
10_1101-2021_01_05_425508	278	31	series	series	NN
10_1101-2021_01_05_425508	278	32	word	word	NN
10_1101-2021_01_05_425508	278	33	486	486	CD
10_1101-2021_01_05_425508	278	34	count	count	NN
10_1101-2021_01_05_425508	278	35	.	.	.
10_1101-2021_01_05_425508	279	1	Sci	Sci	NNP
10_1101-2021_01_05_425508	279	2	Rep.	Rep.	NNP
10_1101-2021_01_05_425508	279	3	2016;6:36197	2016;6:36197	CD
10_1101-2021_01_05_425508	279	4	.	.	.
10_1101-2021_01_05_425508	280	1	487	487	CD
10_1101-2021_01_05_425508	280	2	15	15	CD
10_1101-2021_01_05_425508	280	3	.	.	.
10_1101-2021_01_05_425508	281	1	Wada	Wada	NNP
10_1101-2021_01_05_425508	281	2	K	K	NNP
10_1101-2021_01_05_425508	281	3	,	,	,
10_1101-2021_01_05_425508	281	4	Wada	Wada	NNP
10_1101-2021_01_05_425508	281	5	Y	Y	NNP
10_1101-2021_01_05_425508	281	6	,	,	,
10_1101-2021_01_05_425508	281	7	Iwasaki	Iwasaki	NNP
10_1101-2021_01_05_425508	281	8	Y	Y	NNP
10_1101-2021_01_05_425508	281	9	,	,	,
10_1101-2021_01_05_425508	281	10	Ikemura	Ikemura	NNP
10_1101-2021_01_05_425508	281	11	T	T	NNP
10_1101-2021_01_05_425508	281	12	:	:	:
10_1101-2021_01_05_425508	281	13	Time	time	NN
10_1101-2021_01_05_425508	281	14	-	-	HYPH
10_1101-2021_01_05_425508	281	15	series	series	NN
10_1101-2021_01_05_425508	281	16	oligonucleotide	oligonucleotide	NN
10_1101-2021_01_05_425508	281	17	count	count	NN
10_1101-2021_01_05_425508	281	18	to	to	IN
10_1101-2021_01_05_425508	281	19	488	488	CD
10_1101-2021_01_05_425508	281	20	assign	assign	NN
10_1101-2021_01_05_425508	281	21	antiviral	antiviral	JJ
10_1101-2021_01_05_425508	281	22	siRNAs	siRNAs	NNP
10_1101-2021_01_05_425508	281	23	with	with	IN
10_1101-2021_01_05_425508	281	24	long	long	JJ
10_1101-2021_01_05_425508	281	25	utility	utility	NN
10_1101-2021_01_05_425508	281	26	fit	fit	NN
10_1101-2021_01_05_425508	281	27	in	in	IN
10_1101-2021_01_05_425508	281	28	the	the	DT
10_1101-2021_01_05_425508	281	29	big	big	NNP
10_1101-2021_01_05_425508	281	30	data	datum	NNS
10_1101-2021_01_05_425508	281	31	era	era	NN
10_1101-2021_01_05_425508	281	32	.	.	.
10_1101-2021_01_05_425508	282	1	Gene	Gene	NNP
10_1101-2021_01_05_425508	282	2	Ther	Ther	NNP
10_1101-2021_01_05_425508	282	3	.	.	.
10_1101-2021_01_05_425508	283	1	489	489	CD
10_1101-2021_01_05_425508	283	2	2017;24:668–73	2017;24:668–73	CD
10_1101-2021_01_05_425508	283	3	.	.	.
10_1101-2021_01_05_425508	284	1	490	490	CD
10_1101-2021_01_05_425508	284	2	16	16	CD
10_1101-2021_01_05_425508	284	3	.	.	.
10_1101-2021_01_05_425508	285	1	Wada	Wada	NNP
10_1101-2021_01_05_425508	285	2	K	K	NNP
10_1101-2021_01_05_425508	285	3	,	,	,
10_1101-2021_01_05_425508	285	4	Wada	Wada	NNP
10_1101-2021_01_05_425508	285	5	Y	Y	NNP
10_1101-2021_01_05_425508	285	6	,	,	,
10_1101-2021_01_05_425508	285	7	Ikemura	Ikemura	NNP
10_1101-2021_01_05_425508	285	8	T	T	NNP
10_1101-2021_01_05_425508	285	9	:	:	:
10_1101-2021_01_05_425508	285	10	Time	time	NN
10_1101-2021_01_05_425508	285	11	-	-	HYPH
10_1101-2021_01_05_425508	285	12	series	series	NN
10_1101-2021_01_05_425508	285	13	analyses	analysis	NNS
10_1101-2021_01_05_425508	285	14	of	of	IN
10_1101-2021_01_05_425508	285	15	directional	directional	JJ
10_1101-2021_01_05_425508	285	16	sequence	sequence	NN
10_1101-2021_01_05_425508	285	17	changes	change	VBZ
10_1101-2021_01_05_425508	285	18	491	491	CD
10_1101-2021_01_05_425508	285	19	in	in	IN
10_1101-2021_01_05_425508	285	20	SARS	SARS	NNP
10_1101-2021_01_05_425508	285	21	-	-	HYPH
10_1101-2021_01_05_425508	285	22	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	285	23	genomes	genome	NNS
10_1101-2021_01_05_425508	285	24	and	and	CC
10_1101-2021_01_05_425508	285	25	an	an	DT
10_1101-2021_01_05_425508	285	26	efficient	efficient	JJ
10_1101-2021_01_05_425508	285	27	search	search	NN
10_1101-2021_01_05_425508	285	28	method	method	NN
10_1101-2021_01_05_425508	285	29	for	for	IN
10_1101-2021_01_05_425508	285	30	candidates	candidate	NNS
10_1101-2021_01_05_425508	285	31	for	for	IN
10_1101-2021_01_05_425508	285	32	492	492	CD
10_1101-2021_01_05_425508	285	33	advantageous	advantageous	JJ
10_1101-2021_01_05_425508	285	34	mutations	mutation	NNS
10_1101-2021_01_05_425508	285	35	for	for	IN
10_1101-2021_01_05_425508	285	36	growth	growth	NN
10_1101-2021_01_05_425508	285	37	in	in	IN
10_1101-2021_01_05_425508	285	38	human	human	JJ
10_1101-2021_01_05_425508	285	39	cells	cell	NNS
10_1101-2021_01_05_425508	285	40	.	.	.
10_1101-2021_01_05_425508	286	1	Gene	gene	NN
10_1101-2021_01_05_425508	286	2	.	.	.
10_1101-2021_01_05_425508	287	1	2020;5:100038	2020;5:100038	CD
10_1101-2021_01_05_425508	287	2	.	.	.
10_1101-2021_01_05_425508	288	1	493	493	CD
10_1101-2021_01_05_425508	288	2	17	17	CD
10_1101-2021_01_05_425508	288	3	.	.	.
10_1101-2021_01_05_425508	289	1	Qiu	Qiu	NNP
10_1101-2021_01_05_425508	289	2	Y	Y	NNP
10_1101-2021_01_05_425508	289	3	,	,	,
10_1101-2021_01_05_425508	289	4	Abe	Abe	NNP
10_1101-2021_01_05_425508	289	5	T	T	NNP
10_1101-2021_01_05_425508	289	6	,	,	,
10_1101-2021_01_05_425508	289	7	Nakao	Nakao	NNP
10_1101-2021_01_05_425508	289	8	R	R	NNP
10_1101-2021_01_05_425508	289	9	,	,	,
10_1101-2021_01_05_425508	289	10	Satoh	Satoh	NNP
10_1101-2021_01_05_425508	289	11	K	K	NNP
10_1101-2021_01_05_425508	289	12	,	,	,
10_1101-2021_01_05_425508	289	13	Sugimoto	Sugimoto	NNP
10_1101-2021_01_05_425508	289	14	C	C	NNP
10_1101-2021_01_05_425508	289	15	:	:	:
10_1101-2021_01_05_425508	289	16	Viral	viral	JJ
10_1101-2021_01_05_425508	289	17	population	population	NN
10_1101-2021_01_05_425508	289	18	analysis	analysis	NN
10_1101-2021_01_05_425508	289	19	of	of	IN
10_1101-2021_01_05_425508	289	20	the	the	DT
10_1101-2021_01_05_425508	289	21	494	494	CD
10_1101-2021_01_05_425508	289	22	taiga	taiga	NNS
10_1101-2021_01_05_425508	289	23	tick	tick	VBP
10_1101-2021_01_05_425508	289	24	,	,	,
10_1101-2021_01_05_425508	289	25	Ixodes	ixode	NNS
10_1101-2021_01_05_425508	289	26	persulcatus	persulcatus	VBP
10_1101-2021_01_05_425508	289	27	,	,	,
10_1101-2021_01_05_425508	289	28	by	by	IN
10_1101-2021_01_05_425508	289	29	using	use	VBG
10_1101-2021_01_05_425508	289	30	Batch	Batch	NNP
10_1101-2021_01_05_425508	289	31	Learning	Learning	NNP
10_1101-2021_01_05_425508	289	32	Self	Self	NNP
10_1101-2021_01_05_425508	289	33	-	-	HYPH
10_1101-2021_01_05_425508	289	34	Organizing	Organizing	NNP
10_1101-2021_01_05_425508	289	35	Maps	Maps	NNPS
10_1101-2021_01_05_425508	289	36	and	and	CC
10_1101-2021_01_05_425508	289	37	495	495	CD
10_1101-2021_01_05_425508	289	38	BLAST	blast	NN
10_1101-2021_01_05_425508	289	39	search	search	NN
10_1101-2021_01_05_425508	289	40	.	.	.
10_1101-2021_01_05_425508	290	1	Journal	Journal	NNP
10_1101-2021_01_05_425508	290	2	of	of	IN
10_1101-2021_01_05_425508	290	3	Veterinary	Veterinary	NNP
10_1101-2021_01_05_425508	290	4	Medical	Medical	NNP
10_1101-2021_01_05_425508	290	5	Science	Science	NNP
10_1101-2021_01_05_425508	290	6	,	,	,
10_1101-2021_01_05_425508	290	7	2019;81(3):401	2019;81(3):401	NNP
10_1101-2021_01_05_425508	290	8	-	-	SYM
10_1101-2021_01_05_425508	290	9	10	10	CD
10_1101-2021_01_05_425508	290	10	.	.	.
10_1101-2021_01_05_425508	291	1	496	496	CD
10_1101-2021_01_05_425508	291	2	18	18	CD
10_1101-2021_01_05_425508	291	3	.	.	.
10_1101-2021_01_05_425508	292	1	Mercatelli	Mercatelli	NNP
10_1101-2021_01_05_425508	292	2	D	D	NNP
10_1101-2021_01_05_425508	292	3	,	,	,
10_1101-2021_01_05_425508	292	4	Giorgi	Giorgi	NNP
10_1101-2021_01_05_425508	292	5	FM	FM	NNP
10_1101-2021_01_05_425508	292	6	:	:	:
10_1101-2021_01_05_425508	292	7	Geographic	geographic	JJ
10_1101-2021_01_05_425508	292	8	and	and	CC
10_1101-2021_01_05_425508	292	9	genomic	genomic	JJ
10_1101-2021_01_05_425508	292	10	distribution	distribution	NN
10_1101-2021_01_05_425508	292	11	of	of	IN
10_1101-2021_01_05_425508	292	12	SARS	SARS	NNP
10_1101-2021_01_05_425508	292	13	-	-	HYPH
10_1101-2021_01_05_425508	292	14	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	292	15	497	497	CD
10_1101-2021_01_05_425508	292	16	mutations	mutation	NNS
10_1101-2021_01_05_425508	292	17	.	.	.
10_1101-2021_01_05_425508	293	1	Front	Front	NNP
10_1101-2021_01_05_425508	293	2	Microbiol	Microbiol	NNP
10_1101-2021_01_05_425508	293	3	.	.	.
10_1101-2021_01_05_425508	294	1	2020;22:11:1800	2020;22:11:1800	NNP
10_1101-2021_01_05_425508	294	2	.	.	.
10_1101-2021_01_05_425508	295	1	498	498	CD
10_1101-2021_01_05_425508	295	2	19	19	CD
10_1101-2021_01_05_425508	295	3	.	.	.
10_1101-2021_01_05_425508	296	1	Simmonds	Simmonds	NNP
10_1101-2021_01_05_425508	296	2	P	p	NN
10_1101-2021_01_05_425508	296	3	:	:	:
10_1101-2021_01_05_425508	296	4	Rampant	rampant	JJ
10_1101-2021_01_05_425508	296	5	C→U	C→U	NNP
10_1101-2021_01_05_425508	296	6	hypermutation	hypermutation	NN
10_1101-2021_01_05_425508	296	7	in	in	IN
10_1101-2021_01_05_425508	296	8	the	the	DT
10_1101-2021_01_05_425508	296	9	genomes	genome	NNS
10_1101-2021_01_05_425508	296	10	of	of	IN
10_1101-2021_01_05_425508	296	11	SARS	SARS	NNP
10_1101-2021_01_05_425508	296	12	-	-	HYPH
10_1101-2021_01_05_425508	296	13	CoV-2	CoV-2	NNP
10_1101-2021_01_05_425508	296	14	and	and	CC
10_1101-2021_01_05_425508	296	15	499	499	CD
10_1101-2021_01_05_425508	296	16	other	other	JJ
10_1101-2021_01_05_425508	296	17	coronaviruses	coronaviruse	NNS
10_1101-2021_01_05_425508	296	18	:	:	:
10_1101-2021_01_05_425508	296	19	causes	cause	NNS
10_1101-2021_01_05_425508	296	20	and	and	CC
10_1101-2021_01_05_425508	296	21	consequences	consequence	NNS
10_1101-2021_01_05_425508	296	22	for	for	IN
10_1101-2021_01_05_425508	296	23	their	-PRON-	PRP$
10_1101-2021_01_05_425508	296	24	short-	short-	NNS
10_1101-2021_01_05_425508	296	25	and	and	CC
10_1101-2021_01_05_425508	296	26	long	long	JJ
10_1101-2021_01_05_425508	296	27	-	-	HYPH
10_1101-2021_01_05_425508	296	28	term	term	NN
10_1101-2021_01_05_425508	296	29	500	500	CD
10_1101-2021_01_05_425508	296	30	evolutionary	evolutionary	JJ
10_1101-2021_01_05_425508	296	31	trajectories	trajectory	NNS
10_1101-2021_01_05_425508	296	32	.	.	.
10_1101-2021_01_05_425508	297	1	mSphere	msphere	RB
10_1101-2021_01_05_425508	297	2	.	.	.
10_1101-2021_01_05_425508	298	1	2020;24	2020;24	CD
10_1101-2021_01_05_425508	298	2	:	:	:
10_1101-2021_01_05_425508	298	3	e00408	e00408	NNP
10_1101-2021_01_05_425508	298	4	-	-	HYPH
10_1101-2021_01_05_425508	298	5	20	20	CD
10_1101-2021_01_05_425508	298	6	.	.	.
10_1101-2021_01_05_425508	299	1	501	501	CD
10_1101-2021_01_05_425508	299	2	20	20	CD
10_1101-2021_01_05_425508	299	3	.	.	.
10_1101-2021_01_05_425508	300	1	Paek	Paek	NNP
10_1101-2021_01_05_425508	300	2	KY	KY	NNP
10_1101-2021_01_05_425508	300	3	,	,	,
10_1101-2021_01_05_425508	300	4	Kim	Kim	NNP
10_1101-2021_01_05_425508	300	5	CS	CS	NNP
10_1101-2021_01_05_425508	300	6	,	,	,
10_1101-2021_01_05_425508	300	7	Park	Park	NNP
10_1101-2021_01_05_425508	300	8	SM	SM	NNP
10_1101-2021_01_05_425508	300	9	,	,	,
10_1101-2021_01_05_425508	300	10	Kim	Kim	NNP
10_1101-2021_01_05_425508	300	11	JH	JH	NNP
10_1101-2021_01_05_425508	300	12	,	,	,
10_1101-2021_01_05_425508	300	13	Jang	Jang	NNP
10_1101-2021_01_05_425508	300	14	SK	SK	NNP
10_1101-2021_01_05_425508	300	15	:	:	:
10_1101-2021_01_05_425508	300	16	RNA	RNA	NNP
10_1101-2021_01_05_425508	300	17	-	-	HYPH
10_1101-2021_01_05_425508	300	18	binding	bind	VBG
10_1101-2021_01_05_425508	300	19	protein	protein	NN
10_1101-2021_01_05_425508	300	20	hnRNP	hnRNP	.
10_1101-2021_01_05_425508	300	21	D	D	NNP
10_1101-2021_01_05_425508	300	22	502	502	CD
10_1101-2021_01_05_425508	300	23	modulates	modulate	VBZ
10_1101-2021_01_05_425508	300	24	internal	internal	JJ
10_1101-2021_01_05_425508	300	25	ribosome	ribosome	NN
10_1101-2021_01_05_425508	300	26	entry	entry	NN
10_1101-2021_01_05_425508	300	27	site	site	NN
10_1101-2021_01_05_425508	300	28	-	-	HYPH
10_1101-2021_01_05_425508	300	29	dependent	dependent	JJ
10_1101-2021_01_05_425508	300	30	translation	translation	NN
10_1101-2021_01_05_425508	300	31	of	of	IN
10_1101-2021_01_05_425508	300	32	hepatitis	hepatitis	NNP
10_1101-2021_01_05_425508	300	33	C	C	NNP
10_1101-2021_01_05_425508	300	34	virus	virus	NN
10_1101-2021_01_05_425508	300	35	503	503	CD
10_1101-2021_01_05_425508	300	36	RNA	RNA	NNP
10_1101-2021_01_05_425508	300	37	.	.	.
10_1101-2021_01_05_425508	301	1	J	J	NNP
10_1101-2021_01_05_425508	301	2	Virol	Virol	NNP
10_1101-2021_01_05_425508	301	3	.	.	.
10_1101-2021_01_05_425508	302	1	2008;82:12082	2008;82:12082	CD
10_1101-2021_01_05_425508	302	2	-	-	SYM
10_1101-2021_01_05_425508	302	3	93	93	CD
10_1101-2021_01_05_425508	302	4	.	.	.
10_1101-2021_01_05_425508	303	1	504	504	CD
10_1101-2021_01_05_425508	303	2	21	21	CD
10_1101-2021_01_05_425508	303	3	.	.	.
10_1101-2021_01_05_425508	304	1	Harris	Harris	NNP
10_1101-2021_01_05_425508	304	2	RS	RS	NNP
10_1101-2021_01_05_425508	304	3	,	,	,
10_1101-2021_01_05_425508	304	4	Bishop	Bishop	NNP
10_1101-2021_01_05_425508	304	5	KN	KN	NNP
10_1101-2021_01_05_425508	304	6	,	,	,
10_1101-2021_01_05_425508	304	7	Sheehy	Sheehy	NNP
10_1101-2021_01_05_425508	304	8	AM	am	NN
10_1101-2021_01_05_425508	304	9	,	,	,
10_1101-2021_01_05_425508	304	10	Craig	Craig	NNP
10_1101-2021_01_05_425508	304	11	HM	HM	NNP
10_1101-2021_01_05_425508	304	12	,	,	,
10_1101-2021_01_05_425508	304	13	Petersen	Petersen	NNP
10_1101-2021_01_05_425508	304	14	-	-	HYPH
10_1101-2021_01_05_425508	304	15	Mahrt	Mahrt	NNP
10_1101-2021_01_05_425508	304	16	SK	SK	NNP
10_1101-2021_01_05_425508	304	17	,	,	,
10_1101-2021_01_05_425508	304	18	Watt	Watt	NNP
10_1101-2021_01_05_425508	304	19	IN	IN	NNP
10_1101-2021_01_05_425508	304	20	,	,	,
10_1101-2021_01_05_425508	304	21	505	505	CD
10_1101-2021_01_05_425508	304	22	Neuberger	Neuberger	NNP
10_1101-2021_01_05_425508	304	23	MS	MS	NNP
10_1101-2021_01_05_425508	304	24	,	,	,
10_1101-2021_01_05_425508	304	25	Malim	Malim	NNP
10_1101-2021_01_05_425508	304	26	MH	MH	NNP
10_1101-2021_01_05_425508	304	27	:	:	:
10_1101-2021_01_05_425508	304	28	DNA	dna	NN
10_1101-2021_01_05_425508	304	29	deamination	deamination	NN
10_1101-2021_01_05_425508	304	30	mediates	mediate	NNS
10_1101-2021_01_05_425508	304	31	innate	innate	VBP
10_1101-2021_01_05_425508	304	32	immunity	immunity	NN
10_1101-2021_01_05_425508	304	33	to	to	IN
10_1101-2021_01_05_425508	304	34	506	506	CD
10_1101-2021_01_05_425508	304	35	retroviral	retroviral	JJ
10_1101-2021_01_05_425508	304	36	infection	infection	NN
10_1101-2021_01_05_425508	304	37	.	.	.
10_1101-2021_01_05_425508	305	1	Cell	cell	NN
10_1101-2021_01_05_425508	305	2	.	.	.
10_1101-2021_01_05_425508	306	1	2003;113:803–809	2003;113:803–809	CD
10_1101-2021_01_05_425508	306	2	.	.	.
10_1101-2021_01_05_425508	307	1	507	507	CD
10_1101-2021_01_05_425508	307	2	.CC	.CC	:
10_1101-2021_01_05_425508	307	3	-	-	:
10_1101-2021_01_05_425508	307	4	BY	BY	NNP
10_1101-2021_01_05_425508	307	5	-	-	HYPH
10_1101-2021_01_05_425508	307	6	NC	NC	NNP
10_1101-2021_01_05_425508	307	7	4.0	4.0	CD
10_1101-2021_01_05_425508	307	8	International	international	JJ
10_1101-2021_01_05_425508	307	9	licensemade	licensemade	NN
10_1101-2021_01_05_425508	307	10	available	available	JJ
10_1101-2021_01_05_425508	307	11	under	under	IN
10_1101-2021_01_05_425508	307	12	a	a	DT
10_1101-2021_01_05_425508	307	13	(	(	-LRB-
10_1101-2021_01_05_425508	307	14	which	which	WDT
10_1101-2021_01_05_425508	307	15	was	be	VBD
10_1101-2021_01_05_425508	307	16	not	not	RB
10_1101-2021_01_05_425508	307	17	certified	certify	VBN
10_1101-2021_01_05_425508	307	18	by	by	IN
10_1101-2021_01_05_425508	307	19	peer	peer	NN
10_1101-2021_01_05_425508	307	20	review	review	NN
10_1101-2021_01_05_425508	307	21	)	)	-RRB-
10_1101-2021_01_05_425508	307	22	is	be	VBZ
10_1101-2021_01_05_425508	307	23	the	the	DT
10_1101-2021_01_05_425508	307	24	author	author	NN
10_1101-2021_01_05_425508	307	25	/	/	SYM
10_1101-2021_01_05_425508	307	26	funder	funder	NN
10_1101-2021_01_05_425508	307	27	,	,	,
10_1101-2021_01_05_425508	307	28	who	who	WP
10_1101-2021_01_05_425508	307	29	has	have	VBZ
10_1101-2021_01_05_425508	307	30	granted	grant	VBN
10_1101-2021_01_05_425508	307	31	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	307	32	a	a	DT
10_1101-2021_01_05_425508	307	33	license	license	NN
10_1101-2021_01_05_425508	307	34	to	to	TO
10_1101-2021_01_05_425508	307	35	display	display	VB
10_1101-2021_01_05_425508	307	36	the	the	DT
10_1101-2021_01_05_425508	307	37	preprint	preprint	NN
10_1101-2021_01_05_425508	307	38	in	in	IN
10_1101-2021_01_05_425508	307	39	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	307	40	.	.	.
10_1101-2021_01_05_425508	308	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	308	2	is	be	VBZ
10_1101-2021_01_05_425508	308	3	The	the	DT
10_1101-2021_01_05_425508	308	4	copyright	copyright	NN
10_1101-2021_01_05_425508	308	5	holder	holder	NN
10_1101-2021_01_05_425508	308	6	for	for	IN
10_1101-2021_01_05_425508	308	7	this	this	DT
10_1101-2021_01_05_425508	308	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	308	9	version	version	NN
10_1101-2021_01_05_425508	308	10	posted	post	VBD
10_1101-2021_01_05_425508	308	11	January	January	NNP
10_1101-2021_01_05_425508	308	12	6	6	CD
10_1101-2021_01_05_425508	308	13	,	,	,
10_1101-2021_01_05_425508	308	14	2021	2021	CD
10_1101-2021_01_05_425508	308	15	.	.	.
10_1101-2021_01_05_425508	308	16	;	;	:
10_1101-2021_01_05_425508	308	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	308	18	:	:	:
10_1101-2021_01_05_425508	308	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	308	20	preprint	preprint	NN
10_1101-2021_01_05_425508	308	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	308	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	308	23	20	20	CD
10_1101-2021_01_05_425508	308	24	22	22	CD
10_1101-2021_01_05_425508	308	25	.	.	.
10_1101-2021_01_05_425508	309	1	Mangeat	Mangeat	NNP
10_1101-2021_01_05_425508	309	2	B	B	NNP
10_1101-2021_01_05_425508	309	3	,	,	,
10_1101-2021_01_05_425508	309	4	Turelli	Turelli	NNP
10_1101-2021_01_05_425508	309	5	P	P	NNP
10_1101-2021_01_05_425508	309	6	,	,	,
10_1101-2021_01_05_425508	309	7	Caron	Caron	NNP
10_1101-2021_01_05_425508	309	8	G	G	NNP
10_1101-2021_01_05_425508	309	9	,	,	,
10_1101-2021_01_05_425508	309	10	Friedli	Friedli	NNP
10_1101-2021_01_05_425508	309	11	M	M	NNP
10_1101-2021_01_05_425508	309	12	,	,	,
10_1101-2021_01_05_425508	309	13	Perrin	Perrin	NNP
10_1101-2021_01_05_425508	309	14	L	L	NNP
10_1101-2021_01_05_425508	309	15	,	,	,
10_1101-2021_01_05_425508	309	16	Trono	Trono	NNP
10_1101-2021_01_05_425508	309	17	D	d	NN
10_1101-2021_01_05_425508	309	18	:	:	:
10_1101-2021_01_05_425508	309	19	Broad	Broad	NNP
10_1101-2021_01_05_425508	309	20	antiretroviral	antiretroviral	JJ
10_1101-2021_01_05_425508	309	21	508	508	CD
10_1101-2021_01_05_425508	309	22	defence	defence	NN
10_1101-2021_01_05_425508	309	23	by	by	IN
10_1101-2021_01_05_425508	309	24	human	human	JJ
10_1101-2021_01_05_425508	309	25	APOBEC3	apobec3	NN
10_1101-2021_01_05_425508	309	26	G	g	NN
10_1101-2021_01_05_425508	309	27	through	through	IN
10_1101-2021_01_05_425508	309	28	lethal	lethal	JJ
10_1101-2021_01_05_425508	309	29	editing	editing	NN
10_1101-2021_01_05_425508	309	30	of	of	IN
10_1101-2021_01_05_425508	309	31	nascent	nascent	JJ
10_1101-2021_01_05_425508	309	32	reverse	reverse	JJ
10_1101-2021_01_05_425508	309	33	transcripts	transcript	NNS
10_1101-2021_01_05_425508	309	34	.	.	.
10_1101-2021_01_05_425508	310	1	509	509	CD
10_1101-2021_01_05_425508	310	2	Nature	nature	NN
10_1101-2021_01_05_425508	310	3	.	.	.
10_1101-2021_01_05_425508	311	1	2003;424:99–103	2003;424:99–103	CD
10_1101-2021_01_05_425508	311	2	.	.	.
10_1101-2021_01_05_425508	312	1	510	510	CD
10_1101-2021_01_05_425508	312	2	23	23	CD
10_1101-2021_01_05_425508	312	3	.	.	.
10_1101-2021_01_05_425508	313	1	Zhang	Zhang	NNP
10_1101-2021_01_05_425508	313	2	H	H	NNP
10_1101-2021_01_05_425508	313	3	,	,	,
10_1101-2021_01_05_425508	313	4	Yang	Yang	NNP
10_1101-2021_01_05_425508	313	5	B	B	NNP
10_1101-2021_01_05_425508	313	6	,	,	,
10_1101-2021_01_05_425508	313	7	Pomerantz	Pomerantz	NNP
10_1101-2021_01_05_425508	313	8	RJ	RJ	NNP
10_1101-2021_01_05_425508	313	9	,	,	,
10_1101-2021_01_05_425508	313	10	Zhang	Zhang	NNP
10_1101-2021_01_05_425508	313	11	C	C	NNP
10_1101-2021_01_05_425508	313	12	,	,	,
10_1101-2021_01_05_425508	313	13	Arunachalam	Arunachalam	NNP
10_1101-2021_01_05_425508	313	14	SC	SC	NNP
10_1101-2021_01_05_425508	313	15	,	,	,
10_1101-2021_01_05_425508	313	16	Gao	Gao	NNP
10_1101-2021_01_05_425508	313	17	L	L	NNP
10_1101-2021_01_05_425508	313	18	:	:	:
10_1101-2021_01_05_425508	313	19	The	the	DT
10_1101-2021_01_05_425508	313	20	cytidine	cytidine	NN
10_1101-2021_01_05_425508	313	21	511	511	CD
10_1101-2021_01_05_425508	313	22	deaminase	deaminase	NN
10_1101-2021_01_05_425508	313	23	CEM15	CEM15	NNP
10_1101-2021_01_05_425508	313	24	induces	induce	VBZ
10_1101-2021_01_05_425508	313	25	hypermutation	hypermutation	NN
10_1101-2021_01_05_425508	313	26	in	in	IN
10_1101-2021_01_05_425508	313	27	newly	newly	RB
10_1101-2021_01_05_425508	313	28	synthesized	synthesize	VBN
10_1101-2021_01_05_425508	313	29	HIV-1	HIV-1	NNP
10_1101-2021_01_05_425508	313	30	DNA	DNA	NNP
10_1101-2021_01_05_425508	313	31	.	.	.
10_1101-2021_01_05_425508	314	1	512	512	CD
10_1101-2021_01_05_425508	314	2	Nature	nature	NN
10_1101-2021_01_05_425508	314	3	.	.	.
10_1101-2021_01_05_425508	315	1	2003	2003	CD
10_1101-2021_01_05_425508	315	2	.	.	.
10_1101-2021_01_05_425508	316	1	424:94–98	424:94–98	CD
10_1101-2021_01_05_425508	316	2	.	.	.
10_1101-2021_01_05_425508	317	1	https://doi.org/10	https://doi.org/10	NNP
10_1101-2021_01_05_425508	317	2	.1038	.1038	.
10_1101-2021_01_05_425508	317	3	/	/	SYM
10_1101-2021_01_05_425508	317	4	nature01707	nature01707	NNP
10_1101-2021_01_05_425508	317	5	.	.	.
10_1101-2021_01_05_425508	318	1	513	513	CD
10_1101-2021_01_05_425508	318	2	24	24	CD
10_1101-2021_01_05_425508	318	3	.	.	.
10_1101-2021_01_05_425508	319	1	Harris	Harris	NNP
10_1101-2021_01_05_425508	319	2	RS	RS	NNP
10_1101-2021_01_05_425508	319	3	,	,	,
10_1101-2021_01_05_425508	319	4	Dudley	Dudley	NNP
10_1101-2021_01_05_425508	319	5	JP	JP	NNP
10_1101-2021_01_05_425508	319	6	:	:	:
10_1101-2021_01_05_425508	319	7	APOBECs	apobec	NNS
10_1101-2021_01_05_425508	319	8	and	and	CC
10_1101-2021_01_05_425508	319	9	virus	virus	NN
10_1101-2021_01_05_425508	319	10	restriction	restriction	NN
10_1101-2021_01_05_425508	319	11	.	.	.
10_1101-2021_01_05_425508	320	1	Virology	virology	NN
10_1101-2021_01_05_425508	320	2	.	.	.
10_1101-2021_01_05_425508	321	1	2015;479–514	2015;479–514	CD
10_1101-2021_01_05_425508	321	2	480:131–45	480:131–45	CD
10_1101-2021_01_05_425508	321	3	.	.	.
10_1101-2021_01_05_425508	322	1	515	515	CD
10_1101-2021_01_05_425508	322	2	25	25	CD
10_1101-2021_01_05_425508	322	3	.	.	.
10_1101-2021_01_05_425508	323	1	Sawyer	Sawyer	NNP
10_1101-2021_01_05_425508	323	2	SL	SL	NNP
10_1101-2021_01_05_425508	323	3	,	,	,
10_1101-2021_01_05_425508	323	4	Emerman	Emerman	NNP
10_1101-2021_01_05_425508	323	5	M	M	NNP
10_1101-2021_01_05_425508	323	6	,	,	,
10_1101-2021_01_05_425508	323	7	Malik	Malik	NNP
10_1101-2021_01_05_425508	323	8	HS	HS	NNP
10_1101-2021_01_05_425508	323	9	:	:	:
10_1101-2021_01_05_425508	323	10	Ancient	ancient	JJ
10_1101-2021_01_05_425508	323	11	adaptive	adaptive	JJ
10_1101-2021_01_05_425508	323	12	evolution	evolution	NN
10_1101-2021_01_05_425508	323	13	of	of	IN
10_1101-2021_01_05_425508	323	14	the	the	DT
10_1101-2021_01_05_425508	323	15	primate	primate	JJ
10_1101-2021_01_05_425508	323	16	516	516	CD
10_1101-2021_01_05_425508	323	17	antiviral	antiviral	JJ
10_1101-2021_01_05_425508	323	18	DNA	dna	NN
10_1101-2021_01_05_425508	323	19	-	-	HYPH
10_1101-2021_01_05_425508	323	20	editing	edit	VBG
10_1101-2021_01_05_425508	323	21	enzyme	enzyme	NNS
10_1101-2021_01_05_425508	323	22	APOBEC3G.	apobec3g.	RB
10_1101-2021_01_05_425508	324	1	PLoS	PLoS	NNP
10_1101-2021_01_05_425508	324	2	Biol	Biol	NNP
10_1101-2021_01_05_425508	324	3	.	.	.
10_1101-2021_01_05_425508	325	1	2004;2	2004;2	LS
10_1101-2021_01_05_425508	325	2	:	:	:
10_1101-2021_01_05_425508	325	3	E275	E275	NNP
10_1101-2021_01_05_425508	325	4	.	.	.
10_1101-2021_01_05_425508	326	1	517	517	CD
10_1101-2021_01_05_425508	326	2	26	26	CD
10_1101-2021_01_05_425508	326	3	.	.	.
10_1101-2021_01_05_425508	327	1	Münk	Münk	NNP
10_1101-2021_01_05_425508	327	2	C	C	NNP
10_1101-2021_01_05_425508	327	3	,	,	,
10_1101-2021_01_05_425508	327	4	Willemsen	Willemsen	NNP
10_1101-2021_01_05_425508	327	5	A	A	NNP
10_1101-2021_01_05_425508	327	6	,	,	,
10_1101-2021_01_05_425508	327	7	Bravo	Bravo	NNP
10_1101-2021_01_05_425508	327	8	IG	IG	NNP
10_1101-2021_01_05_425508	327	9	:	:	:
10_1101-2021_01_05_425508	327	10	An	an	DT
10_1101-2021_01_05_425508	327	11	ancient	ancient	JJ
10_1101-2021_01_05_425508	327	12	history	history	NN
10_1101-2021_01_05_425508	327	13	of	of	IN
10_1101-2021_01_05_425508	327	14	gene	gene	NN
10_1101-2021_01_05_425508	327	15	duplications	duplication	NNS
10_1101-2021_01_05_425508	327	16	,	,	,
10_1101-2021_01_05_425508	327	17	fusions	fusion	NNS
10_1101-2021_01_05_425508	327	18	518	518	CD
10_1101-2021_01_05_425508	327	19	and	and	CC
10_1101-2021_01_05_425508	327	20	losses	loss	NNS
10_1101-2021_01_05_425508	327	21	in	in	IN
10_1101-2021_01_05_425508	327	22	the	the	DT
10_1101-2021_01_05_425508	327	23	evolution	evolution	NN
10_1101-2021_01_05_425508	327	24	of	of	IN
10_1101-2021_01_05_425508	327	25	APOBEC3	apobec3	JJ
10_1101-2021_01_05_425508	327	26	mutators	mutator	NNS
10_1101-2021_01_05_425508	327	27	in	in	IN
10_1101-2021_01_05_425508	327	28	mammals	mammal	NNS
10_1101-2021_01_05_425508	327	29	.	.	.
10_1101-2021_01_05_425508	328	1	BMC	BMC	NNP
10_1101-2021_01_05_425508	328	2	Evol	Evol	NNP
10_1101-2021_01_05_425508	328	3	Biol	Biol	NNP
10_1101-2021_01_05_425508	328	4	.	.	.
10_1101-2021_01_05_425508	329	1	519	519	CD
10_1101-2021_01_05_425508	329	2	2012;12:71	2012;12:71	CD
10_1101-2021_01_05_425508	329	3	.	.	.
10_1101-2021_01_05_425508	330	1	520	520	CD
10_1101-2021_01_05_425508	330	2	27	27	CD
10_1101-2021_01_05_425508	330	3	.	.	.
10_1101-2021_01_05_425508	331	1	Henry	Henry	NNP
10_1101-2021_01_05_425508	331	2	M	M	NNP
10_1101-2021_01_05_425508	331	3	,	,	,
10_1101-2021_01_05_425508	331	4	Terzian	Terzian	NNP
10_1101-2021_01_05_425508	331	5	C	C	NNP
10_1101-2021_01_05_425508	331	6	,	,	,
10_1101-2021_01_05_425508	331	7	Peeters	Peeters	NNP
10_1101-2021_01_05_425508	331	8	M	M	NNP
10_1101-2021_01_05_425508	331	9	,	,	,
10_1101-2021_01_05_425508	331	10	Wain	Wain	NNP
10_1101-2021_01_05_425508	331	11	-	-	HYPH
10_1101-2021_01_05_425508	331	12	Hobson	Hobson	NNP
10_1101-2021_01_05_425508	331	13	S	S	NNP
10_1101-2021_01_05_425508	331	14	,	,	,
10_1101-2021_01_05_425508	331	15	Vartanian	Vartanian	NNP
10_1101-2021_01_05_425508	331	16	JP	JP	NNP
10_1101-2021_01_05_425508	331	17	:	:	:
10_1101-2021_01_05_425508	331	18	Evolution	evolution	NN
10_1101-2021_01_05_425508	331	19	of	of	IN
10_1101-2021_01_05_425508	331	20	the	the	DT
10_1101-2021_01_05_425508	331	21	521	521	CD
10_1101-2021_01_05_425508	331	22	primate	primate	JJ
10_1101-2021_01_05_425508	331	23	APOBEC3A	APOBEC3A	NNP
10_1101-2021_01_05_425508	331	24	cytidine	cytidine	VB
10_1101-2021_01_05_425508	331	25	deaminase	deaminase	NN
10_1101-2021_01_05_425508	331	26	gene	gene	NN
10_1101-2021_01_05_425508	331	27	and	and	CC
10_1101-2021_01_05_425508	331	28	identification	identification	NN
10_1101-2021_01_05_425508	331	29	of	of	IN
10_1101-2021_01_05_425508	331	30	related	relate	VBN
10_1101-2021_01_05_425508	331	31	coding	code	VBG
10_1101-2021_01_05_425508	331	32	522	522	CD
10_1101-2021_01_05_425508	331	33	regions	region	NNS
10_1101-2021_01_05_425508	331	34	.	.	.
10_1101-2021_01_05_425508	332	1	PLoS	PLoS	:
10_1101-2021_01_05_425508	332	2	One	one	CD
10_1101-2021_01_05_425508	332	3	.	.	.
10_1101-2021_01_05_425508	333	1	2012;7	2012;7	LS
10_1101-2021_01_05_425508	333	2	:	:	:
10_1101-2021_01_05_425508	333	3	e30036	e30036	JJ
10_1101-2021_01_05_425508	333	4	.	.	.
10_1101-2021_01_05_425508	334	1	523	523	CD
10_1101-2021_01_05_425508	334	2	28	28	CD
10_1101-2021_01_05_425508	334	3	.	.	.
10_1101-2021_01_05_425508	335	1	Wang	Wang	NNP
10_1101-2021_01_05_425508	335	2	W	W	NNP
10_1101-2021_01_05_425508	335	3	,	,	,
10_1101-2021_01_05_425508	335	4	Caldwell	Caldwell	NNP
10_1101-2021_01_05_425508	335	5	MC	MC	NNP
10_1101-2021_01_05_425508	335	6	,	,	,
10_1101-2021_01_05_425508	335	7	Lin	Lin	NNP
10_1101-2021_01_05_425508	335	8	S	S	NNP
10_1101-2021_01_05_425508	335	9	,	,	,
10_1101-2021_01_05_425508	335	10	Furneaux	Furneaux	NNP
10_1101-2021_01_05_425508	335	11	H	H	NNP
10_1101-2021_01_05_425508	335	12	,	,	,
10_1101-2021_01_05_425508	335	13	Gorospe	Gorospe	NNP
10_1101-2021_01_05_425508	335	14	M	M	NNP
10_1101-2021_01_05_425508	335	15	:	:	:
10_1101-2021_01_05_425508	335	16	HuR	HuR	NNP
10_1101-2021_01_05_425508	335	17	regulates	regulate	NNS
10_1101-2021_01_05_425508	335	18	cyclin	cyclin	NNP
10_1101-2021_01_05_425508	335	19	A	a	DT
10_1101-2021_01_05_425508	335	20	524	524	CD
10_1101-2021_01_05_425508	335	21	and	and	CC
10_1101-2021_01_05_425508	335	22	cyclin	cyclin	NN
10_1101-2021_01_05_425508	335	23	B1	b1	NN
10_1101-2021_01_05_425508	335	24	mRNA	mrna	IN
10_1101-2021_01_05_425508	335	25	stability	stability	NN
10_1101-2021_01_05_425508	335	26	during	during	IN
10_1101-2021_01_05_425508	335	27	cell	cell	NN
10_1101-2021_01_05_425508	335	28	proliferation	proliferation	NN
10_1101-2021_01_05_425508	335	29	.	.	.
10_1101-2021_01_05_425508	336	1	EMBO	EMBO	NNP
10_1101-2021_01_05_425508	336	2	J.	J.	NNP
10_1101-2021_01_05_425508	337	1	525	525	CD
10_1101-2021_01_05_425508	337	2	2000;19(10):2340	2000;19(10):2340	CD
10_1101-2021_01_05_425508	337	3	-	-	SYM
10_1101-2021_01_05_425508	337	4	50	50	CD
10_1101-2021_01_05_425508	337	5	.	.	.
10_1101-2021_01_05_425508	338	1	526	526	CD
10_1101-2021_01_05_425508	338	2	29	29	CD
10_1101-2021_01_05_425508	338	3	.	.	.
10_1101-2021_01_05_425508	339	1	Lal	Lal	NNP
10_1101-2021_01_05_425508	339	2	A	A	NNP
10_1101-2021_01_05_425508	339	3	,	,	,
10_1101-2021_01_05_425508	339	4	Mazan	Mazan	NNP
10_1101-2021_01_05_425508	339	5	-	-	HYPH
10_1101-2021_01_05_425508	339	6	Mamczarz	Mamczarz	NNP
10_1101-2021_01_05_425508	339	7	K	K	NNP
10_1101-2021_01_05_425508	339	8	,	,	,
10_1101-2021_01_05_425508	339	9	Kawai	Kawai	NNP
10_1101-2021_01_05_425508	339	10	T	T	NNP
10_1101-2021_01_05_425508	339	11	,	,	,
10_1101-2021_01_05_425508	339	12	Yang	Yang	NNP
10_1101-2021_01_05_425508	339	13	X	X	NNP
10_1101-2021_01_05_425508	339	14	,	,	,
10_1101-2021_01_05_425508	339	15	Martindale	Martindale	NNP
10_1101-2021_01_05_425508	339	16	JL	JL	NNP
10_1101-2021_01_05_425508	339	17	,	,	,
10_1101-2021_01_05_425508	339	18	Gorospe	Gorospe	NNP
10_1101-2021_01_05_425508	339	19	M	M	NNP
10_1101-2021_01_05_425508	339	20	:	:	:
10_1101-2021_01_05_425508	339	21	527	527	CD
10_1101-2021_01_05_425508	339	22	Concurrent	concurrent	JJ
10_1101-2021_01_05_425508	339	23	versus	versus	IN
10_1101-2021_01_05_425508	339	24	individual	individual	JJ
10_1101-2021_01_05_425508	339	25	binding	binding	NN
10_1101-2021_01_05_425508	339	26	of	of	IN
10_1101-2021_01_05_425508	339	27	HuR	HuR	NNP
10_1101-2021_01_05_425508	339	28	and	and	CC
10_1101-2021_01_05_425508	339	29	AUF1	AUF1	NNP
10_1101-2021_01_05_425508	339	30	to	to	IN
10_1101-2021_01_05_425508	339	31	common	common	JJ
10_1101-2021_01_05_425508	339	32	labile	labile	NN
10_1101-2021_01_05_425508	339	33	target	target	NN
10_1101-2021_01_05_425508	339	34	528	528	CD
10_1101-2021_01_05_425508	339	35	mRNAs	mrnas	ADD
10_1101-2021_01_05_425508	339	36	.	.	.
10_1101-2021_01_05_425508	340	1	EMBO	EMBO	NNP
10_1101-2021_01_05_425508	340	2	J.	J.	NNP
10_1101-2021_01_05_425508	341	1	2004;23(15):3092	2004;23(15):3092	CD
10_1101-2021_01_05_425508	341	2	-	-	SYM
10_1101-2021_01_05_425508	341	3	102	102	CD
10_1101-2021_01_05_425508	341	4	.	.	.
10_1101-2021_01_05_425508	342	1	529	529	CD
10_1101-2021_01_05_425508	342	2	30	30	CD
10_1101-2021_01_05_425508	342	3	.	.	.
10_1101-2021_01_05_425508	343	1	Giudice	giudice	NN
10_1101-2021_01_05_425508	343	2	G	g	NN
10_1101-2021_01_05_425508	343	3	,	,	,
10_1101-2021_01_05_425508	343	4	Sánchez	Sánchez	NNP
10_1101-2021_01_05_425508	343	5	-	-	HYPH
10_1101-2021_01_05_425508	343	6	Cabo	Cabo	NNP
10_1101-2021_01_05_425508	343	7	F	F	NNP
10_1101-2021_01_05_425508	343	8	,	,	,
10_1101-2021_01_05_425508	343	9	Torroja	Torroja	NNP
10_1101-2021_01_05_425508	343	10	C	C	NNP
10_1101-2021_01_05_425508	343	11	,	,	,
10_1101-2021_01_05_425508	343	12	Lara	Lara	NNP
10_1101-2021_01_05_425508	343	13	-	-	HYPH
10_1101-2021_01_05_425508	343	14	Pezzi	Pezzi	NNP
10_1101-2021_01_05_425508	343	15	E	e	NN
10_1101-2021_01_05_425508	343	16	:	:	:
10_1101-2021_01_05_425508	343	17	ATtRACT	attract	VB
10_1101-2021_01_05_425508	343	18	-	-	:
10_1101-2021_01_05_425508	343	19	a	a	DT
10_1101-2021_01_05_425508	343	20	database	database	NN
10_1101-2021_01_05_425508	343	21	of	of	IN
10_1101-2021_01_05_425508	343	22	530	530	CD
10_1101-2021_01_05_425508	343	23	RNA	RNA	NNP
10_1101-2021_01_05_425508	343	24	-	-	HYPH
10_1101-2021_01_05_425508	343	25	binding	bind	VBG
10_1101-2021_01_05_425508	343	26	proteins	protein	NNS
10_1101-2021_01_05_425508	343	27	and	and	CC
10_1101-2021_01_05_425508	343	28	associated	associated	JJ
10_1101-2021_01_05_425508	343	29	motifs	motif	NNS
10_1101-2021_01_05_425508	343	30	.	.	.
10_1101-2021_01_05_425508	344	1	Database	Database	NNP
10_1101-2021_01_05_425508	344	2	(	(	-LRB-
10_1101-2021_01_05_425508	344	3	Oxford	Oxford	NNP
10_1101-2021_01_05_425508	344	4	)	)	-RRB-
10_1101-2021_01_05_425508	344	5	.	.	.
10_1101-2021_01_05_425508	345	1	2016;7	2016;7	LS
10_1101-2021_01_05_425508	345	2	:	:	:
10_1101-2021_01_05_425508	345	3	baw035	baw035	NNS
10_1101-2021_01_05_425508	345	4	.	.	.
10_1101-2021_01_05_425508	346	1	531	531	CD
10_1101-2021_01_05_425508	346	2	532	532	CD
10_1101-2021_01_05_425508	346	3	533	533	CD
10_1101-2021_01_05_425508	346	4	534	534	CD
10_1101-2021_01_05_425508	346	5	.CC	.CC	:
10_1101-2021_01_05_425508	346	6	-	-	HYPH
10_1101-2021_01_05_425508	346	7	BY	BY	NNP
10_1101-2021_01_05_425508	346	8	-	-	HYPH
10_1101-2021_01_05_425508	346	9	NC	NC	NNP
10_1101-2021_01_05_425508	346	10	4.0	4.0	CD
10_1101-2021_01_05_425508	346	11	International	international	JJ
10_1101-2021_01_05_425508	346	12	licensemade	licensemade	NN
10_1101-2021_01_05_425508	346	13	available	available	JJ
10_1101-2021_01_05_425508	346	14	under	under	IN
10_1101-2021_01_05_425508	346	15	a	a	DT
10_1101-2021_01_05_425508	346	16	(	(	-LRB-
10_1101-2021_01_05_425508	346	17	which	which	WDT
10_1101-2021_01_05_425508	346	18	was	be	VBD
10_1101-2021_01_05_425508	346	19	not	not	RB
10_1101-2021_01_05_425508	346	20	certified	certify	VBN
10_1101-2021_01_05_425508	346	21	by	by	IN
10_1101-2021_01_05_425508	346	22	peer	peer	NN
10_1101-2021_01_05_425508	346	23	review	review	NN
10_1101-2021_01_05_425508	346	24	)	)	-RRB-
10_1101-2021_01_05_425508	346	25	is	be	VBZ
10_1101-2021_01_05_425508	346	26	the	the	DT
10_1101-2021_01_05_425508	346	27	author	author	NN
10_1101-2021_01_05_425508	346	28	/	/	SYM
10_1101-2021_01_05_425508	346	29	funder	funder	NN
10_1101-2021_01_05_425508	346	30	,	,	,
10_1101-2021_01_05_425508	346	31	who	who	WP
10_1101-2021_01_05_425508	346	32	has	have	VBZ
10_1101-2021_01_05_425508	346	33	granted	grant	VBN
10_1101-2021_01_05_425508	346	34	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	346	35	a	a	DT
10_1101-2021_01_05_425508	346	36	license	license	NN
10_1101-2021_01_05_425508	346	37	to	to	TO
10_1101-2021_01_05_425508	346	38	display	display	VB
10_1101-2021_01_05_425508	346	39	the	the	DT
10_1101-2021_01_05_425508	346	40	preprint	preprint	NN
10_1101-2021_01_05_425508	346	41	in	in	IN
10_1101-2021_01_05_425508	346	42	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	346	43	.	.	.
10_1101-2021_01_05_425508	347	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	347	2	is	be	VBZ
10_1101-2021_01_05_425508	347	3	The	the	DT
10_1101-2021_01_05_425508	347	4	copyright	copyright	NN
10_1101-2021_01_05_425508	347	5	holder	holder	NN
10_1101-2021_01_05_425508	347	6	for	for	IN
10_1101-2021_01_05_425508	347	7	this	this	DT
10_1101-2021_01_05_425508	347	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	347	9	version	version	NN
10_1101-2021_01_05_425508	347	10	posted	post	VBD
10_1101-2021_01_05_425508	347	11	January	January	NNP
10_1101-2021_01_05_425508	347	12	6	6	CD
10_1101-2021_01_05_425508	347	13	,	,	,
10_1101-2021_01_05_425508	347	14	2021	2021	CD
10_1101-2021_01_05_425508	347	15	.	.	.
10_1101-2021_01_05_425508	347	16	;	;	:
10_1101-2021_01_05_425508	347	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	347	18	:	:	:
10_1101-2021_01_05_425508	347	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	347	20	preprint	preprint	NN
10_1101-2021_01_05_425508	347	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	POS
10_1101-2021_01_05_425508	347	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	347	23	21	21	CD
10_1101-2021_01_05_425508	347	24	Table	table	NN
10_1101-2021_01_05_425508	347	25	1	1	CD
10_1101-2021_01_05_425508	347	26	535	535	CD
10_1101-2021_01_05_425508	347	27	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	28	G	G	NNP
10_1101-2021_01_05_425508	347	29	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	30	GH	GH	NNP
10_1101-2021_01_05_425508	347	31	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	32	GR	GR	NNP
10_1101-2021_01_05_425508	347	33	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	34	L	L	NNP
10_1101-2021_01_05_425508	347	35	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	36	V	V	NNP
10_1101-2021_01_05_425508	347	37	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	38	S	s	NN
10_1101-2021_01_05_425508	347	39	U	u	NN
10_1101-2021_01_05_425508	347	40	0.97	0.97	CD
10_1101-2021_01_05_425508	347	41	0.92	0.92	CD
10_1101-2021_01_05_425508	347	42	0.91	0.91	CD
10_1101-2021_01_05_425508	347	43	0.72	0.72	CD
10_1101-2021_01_05_425508	347	44	0.66	0.66	CD
10_1101-2021_01_05_425508	347	45	0.73	0.73	CD
10_1101-2021_01_05_425508	347	46	UA	UA	NNP
10_1101-2021_01_05_425508	347	47	0.89	0.89	CD
10_1101-2021_01_05_425508	347	48	0.80	0.80	CD
10_1101-2021_01_05_425508	347	49	0.92	0.92	CD
10_1101-2021_01_05_425508	347	50	0.62	0.62	CD
10_1101-2021_01_05_425508	347	51	0.30	0.30	CD
10_1101-2021_01_05_425508	347	52	0.50	0.50	CD
10_1101-2021_01_05_425508	347	53	AUU	AUU	NNP
10_1101-2021_01_05_425508	347	54	0.81	0.81	CD
10_1101-2021_01_05_425508	347	55	0.78	0.78	CD
10_1101-2021_01_05_425508	347	56	0.92	0.92	CD
10_1101-2021_01_05_425508	347	57	0.90	0.90	CD
10_1101-2021_01_05_425508	347	58	0.27	0.27	CD
10_1101-2021_01_05_425508	347	59	0.05	0.05	CD
10_1101-2021_01_05_425508	347	60	CAU	CAU	NNP
10_1101-2021_01_05_425508	347	61	0.56	0.56	CD
10_1101-2021_01_05_425508	347	62	0.59	0.59	CD
10_1101-2021_01_05_425508	347	63	0.54	0.54	CD
10_1101-2021_01_05_425508	347	64	0.51	0.51	CD
10_1101-2021_01_05_425508	347	65	0.55	0.55	CD
10_1101-2021_01_05_425508	347	66	0.17	0.17	CD
10_1101-2021_01_05_425508	347	67	UGU	UGU	NNP
10_1101-2021_01_05_425508	347	68	0.68	0.68	CD
10_1101-2021_01_05_425508	347	69	0.82	0.82	CD
10_1101-2021_01_05_425508	347	70	0.52	0.52	CD
10_1101-2021_01_05_425508	347	71	0.59	0.59	CD
10_1101-2021_01_05_425508	347	72	0.88	0.88	CD
10_1101-2021_01_05_425508	347	73	0.50	0.50	CD
10_1101-2021_01_05_425508	347	74	UUA	UUA	NNP
10_1101-2021_01_05_425508	347	75	0.96	0.96	CD
10_1101-2021_01_05_425508	347	76	0.72	0.72	CD
10_1101-2021_01_05_425508	347	77	0.93	0.93	CD
10_1101-2021_01_05_425508	347	78	0.80	0.80	CD
10_1101-2021_01_05_425508	347	79	0.19	0.19	CD
10_1101-2021_01_05_425508	347	80	0.34	0.34	CD
10_1101-2021_01_05_425508	347	81	UUG	UUG	NNP
10_1101-2021_01_05_425508	347	82	0.67	0.67	CD
10_1101-2021_01_05_425508	347	83	0.78	0.78	CD
10_1101-2021_01_05_425508	347	84	0.20	0.20	CD
10_1101-2021_01_05_425508	347	85	0.92	0.92	CD
10_1101-2021_01_05_425508	347	86	0.69	0.69	CD
10_1101-2021_01_05_425508	347	87	0.05	0.05	CD
10_1101-2021_01_05_425508	347	88	UUU	UUU	NNP
10_1101-2021_01_05_425508	347	89	0.94	0.94	CD
10_1101-2021_01_05_425508	347	90	0.82	0.82	CD
10_1101-2021_01_05_425508	347	91	0.89	0.89	CD
10_1101-2021_01_05_425508	347	92	0.80	0.80	CD
10_1101-2021_01_05_425508	347	93	0.41	0.41	CD
10_1101-2021_01_05_425508	347	94	0.93	0.93	CD
10_1101-2021_01_05_425508	347	95	536	536	CD
10_1101-2021_01_05_425508	347	96	Table	table	NN
10_1101-2021_01_05_425508	347	97	2	2	CD
10_1101-2021_01_05_425508	347	98	537	537	CD
10_1101-2021_01_05_425508	347	99	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	100	G	G	NNP
10_1101-2021_01_05_425508	347	101	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	102	GH	GH	NNP
10_1101-2021_01_05_425508	347	103	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	104	GR	GR	NNP
10_1101-2021_01_05_425508	347	105	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	106	L	L	NNP
10_1101-2021_01_05_425508	347	107	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	108	V	V	NNP
10_1101-2021_01_05_425508	347	109	Clade	Clade	NNP
10_1101-2021_01_05_425508	347	110	S	s	NN
10_1101-2021_01_05_425508	347	111	C	C	NNP
10_1101-2021_01_05_425508	347	112	-0.95	-0.95	CD
10_1101-2021_01_05_425508	347	113	-0.83	-0.83	CD
10_1101-2021_01_05_425508	347	114	-0.95	-0.95	CD
10_1101-2021_01_05_425508	347	115	-0.98	-0.98	CD
10_1101-2021_01_05_425508	347	116	-0.97	-0.97	CD
10_1101-2021_01_05_425508	347	117	-0.35	-0.35	CD
10_1101-2021_01_05_425508	347	118	AG	AG	NNP
10_1101-2021_01_05_425508	347	119	-0.77	-0.77	CD
10_1101-2021_01_05_425508	347	120	-0.71	-0.71	CD
10_1101-2021_01_05_425508	347	121	-0.27	-0.27	CD
10_1101-2021_01_05_425508	347	122	-0.57	-0.57	CD
10_1101-2021_01_05_425508	347	123	-0.67	-0.67	CD
10_1101-2021_01_05_425508	347	124	-0.44	-0.44	CD
10_1101-2021_01_05_425508	347	125	CA	ca	NN
10_1101-2021_01_05_425508	347	126	-0.73	-0.73	CD
10_1101-2021_01_05_425508	347	127	-0.93	-0.93	CD
10_1101-2021_01_05_425508	347	128	-0.85	-0.85	CD
10_1101-2021_01_05_425508	347	129	-0.16	-0.16	CD
10_1101-2021_01_05_425508	347	130	-0.45	-0.45	CD
10_1101-2021_01_05_425508	347	131	-0.82	-0.82	CD
10_1101-2021_01_05_425508	347	132	CC	cc	NN
10_1101-2021_01_05_425508	347	133	-0.93	-0.93	CD
10_1101-2021_01_05_425508	347	134	-0.87	-0.87	CD
10_1101-2021_01_05_425508	347	135	-0.75	-0.75	CD
10_1101-2021_01_05_425508	347	136	-0.90	-0.90	CD
10_1101-2021_01_05_425508	347	137	-0.90	-0.90	CD
10_1101-2021_01_05_425508	347	138	-0.09	-0.09	CD
10_1101-2021_01_05_425508	347	139	CU	cu	NN
10_1101-2021_01_05_425508	347	140	-0.81	-0.81	CD
10_1101-2021_01_05_425508	347	141	-0.40	-0.40	CD
10_1101-2021_01_05_425508	347	142	-0.79	-0.79	CD
10_1101-2021_01_05_425508	347	143	-0.52	-0.52	CD
10_1101-2021_01_05_425508	347	144	-0.15	-0.15	CD
10_1101-2021_01_05_425508	347	145	-0.10	-0.10	CD
10_1101-2021_01_05_425508	347	146	GA	GA	NNP
10_1101-2021_01_05_425508	347	147	-0.28	-0.28	CD
10_1101-2021_01_05_425508	347	148	-0.90	-0.90	CD
10_1101-2021_01_05_425508	347	149	-0.80	-0.80	CD
10_1101-2021_01_05_425508	347	150	-0.62	-0.62	CD
10_1101-2021_01_05_425508	347	151	-0.73	-0.73	CD
10_1101-2021_01_05_425508	347	152	-0.29	-0.29	CD
10_1101-2021_01_05_425508	347	153	GG	GG	NNP
10_1101-2021_01_05_425508	347	154	-0.60	-0.60	CD
10_1101-2021_01_05_425508	347	155	-0.79	-0.79	CD
10_1101-2021_01_05_425508	347	156	-0.65	-0.65	CD
10_1101-2021_01_05_425508	347	157	-0.03	-0.03	CD
10_1101-2021_01_05_425508	347	158	-0.10	-0.10	CD
10_1101-2021_01_05_425508	347	159	-0.23	-0.23	NFP
10_1101-2021_01_05_425508	347	160	UC	UC	NNP
10_1101-2021_01_05_425508	347	161	-0.33	-0.33	CD
10_1101-2021_01_05_425508	347	162	-0.23	-0.23	CD
10_1101-2021_01_05_425508	347	163	-0.10	-0.10	CD
10_1101-2021_01_05_425508	347	164	-0.58	-0.58	CD
10_1101-2021_01_05_425508	347	165	-0.93	-0.93	CD
10_1101-2021_01_05_425508	347	166	-0.41	-0.41	CD
10_1101-2021_01_05_425508	347	167	AGC	AGC	NNP
10_1101-2021_01_05_425508	347	168	-0.57	-0.57	CD
10_1101-2021_01_05_425508	347	169	-0.87	-0.87	CD
10_1101-2021_01_05_425508	347	170	-0.41	-0.41	CD
10_1101-2021_01_05_425508	347	171	-0.80	-0.80	CD
10_1101-2021_01_05_425508	347	172	-0.78	-0.78	CD
10_1101-2021_01_05_425508	347	173	-0.12	-0.12	CD
10_1101-2021_01_05_425508	347	174	CCC	CCC	NNP
10_1101-2021_01_05_425508	347	175	-0.69	-0.69	CD
10_1101-2021_01_05_425508	347	176	-0.81	-0.81	CD
10_1101-2021_01_05_425508	347	177	-0.67	-0.67	CD
10_1101-2021_01_05_425508	347	178	-0.94	-0.94	CD
10_1101-2021_01_05_425508	347	179	-0.81	-0.81	CD
10_1101-2021_01_05_425508	347	180	-0.50	-0.50	CD
10_1101-2021_01_05_425508	347	181	GAC	GAC	NNP
10_1101-2021_01_05_425508	347	182	-0.73	-0.73	CD
10_1101-2021_01_05_425508	347	183	-0.91	-0.91	CD
10_1101-2021_01_05_425508	347	184	-0.65	-0.65	CD
10_1101-2021_01_05_425508	347	185	-0.35	-0.35	CD
10_1101-2021_01_05_425508	347	186	-0.18	-0.18	CD
10_1101-2021_01_05_425508	347	187	-0.55	-0.55	CD
10_1101-2021_01_05_425508	347	188	GAG	GAG	NNP
10_1101-2021_01_05_425508	347	189	-0.11	-0.11	CD
10_1101-2021_01_05_425508	347	190	-0.58	-0.58	CD
10_1101-2021_01_05_425508	347	191	-0.64	-0.64	CD
10_1101-2021_01_05_425508	347	192	-0.50	-0.50	CD
10_1101-2021_01_05_425508	347	193	-0.81	-0.81	CD
10_1101-2021_01_05_425508	347	194	-0.02	-0.02	CD
10_1101-2021_01_05_425508	347	195	GGA	GGA	NNP
10_1101-2021_01_05_425508	347	196	-0.73	-0.73	CD
10_1101-2021_01_05_425508	347	197	-0.84	-0.84	CD
10_1101-2021_01_05_425508	347	198	-0.75	-0.75	CD
10_1101-2021_01_05_425508	347	199	-0.65	-0.65	CD
10_1101-2021_01_05_425508	347	200	-0.81	-0.81	CD
10_1101-2021_01_05_425508	347	201	-0.52	-0.52	CD
10_1101-2021_01_05_425508	347	202	538	538	CD
10_1101-2021_01_05_425508	347	203	.CC	.CC	:
10_1101-2021_01_05_425508	347	204	-	-	HYPH
10_1101-2021_01_05_425508	347	205	BY	BY	NNP
10_1101-2021_01_05_425508	347	206	-	-	HYPH
10_1101-2021_01_05_425508	347	207	NC	NC	NNP
10_1101-2021_01_05_425508	347	208	4.0	4.0	CD
10_1101-2021_01_05_425508	347	209	International	international	JJ
10_1101-2021_01_05_425508	347	210	licensemade	licensemade	NN
10_1101-2021_01_05_425508	347	211	available	available	JJ
10_1101-2021_01_05_425508	347	212	under	under	IN
10_1101-2021_01_05_425508	347	213	a	a	DT
10_1101-2021_01_05_425508	347	214	(	(	-LRB-
10_1101-2021_01_05_425508	347	215	which	which	WDT
10_1101-2021_01_05_425508	347	216	was	be	VBD
10_1101-2021_01_05_425508	347	217	not	not	RB
10_1101-2021_01_05_425508	347	218	certified	certify	VBN
10_1101-2021_01_05_425508	347	219	by	by	IN
10_1101-2021_01_05_425508	347	220	peer	peer	NN
10_1101-2021_01_05_425508	347	221	review	review	NN
10_1101-2021_01_05_425508	347	222	)	)	-RRB-
10_1101-2021_01_05_425508	347	223	is	be	VBZ
10_1101-2021_01_05_425508	347	224	the	the	DT
10_1101-2021_01_05_425508	347	225	author	author	NN
10_1101-2021_01_05_425508	347	226	/	/	SYM
10_1101-2021_01_05_425508	347	227	funder	funder	NN
10_1101-2021_01_05_425508	347	228	,	,	,
10_1101-2021_01_05_425508	347	229	who	who	WP
10_1101-2021_01_05_425508	347	230	has	have	VBZ
10_1101-2021_01_05_425508	347	231	granted	grant	VBN
10_1101-2021_01_05_425508	347	232	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	347	233	a	a	DT
10_1101-2021_01_05_425508	347	234	license	license	NN
10_1101-2021_01_05_425508	347	235	to	to	TO
10_1101-2021_01_05_425508	347	236	display	display	VB
10_1101-2021_01_05_425508	347	237	the	the	DT
10_1101-2021_01_05_425508	347	238	preprint	preprint	NN
10_1101-2021_01_05_425508	347	239	in	in	IN
10_1101-2021_01_05_425508	347	240	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	347	241	.	.	.
10_1101-2021_01_05_425508	348	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	348	2	is	be	VBZ
10_1101-2021_01_05_425508	348	3	The	the	DT
10_1101-2021_01_05_425508	348	4	copyright	copyright	NN
10_1101-2021_01_05_425508	348	5	holder	holder	NN
10_1101-2021_01_05_425508	348	6	for	for	IN
10_1101-2021_01_05_425508	348	7	this	this	DT
10_1101-2021_01_05_425508	348	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	348	9	version	version	NN
10_1101-2021_01_05_425508	348	10	posted	post	VBD
10_1101-2021_01_05_425508	348	11	January	January	NNP
10_1101-2021_01_05_425508	348	12	6	6	CD
10_1101-2021_01_05_425508	348	13	,	,	,
10_1101-2021_01_05_425508	348	14	2021	2021	CD
10_1101-2021_01_05_425508	348	15	.	.	.
10_1101-2021_01_05_425508	348	16	;	;	:
10_1101-2021_01_05_425508	348	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	348	18	:	:	:
10_1101-2021_01_05_425508	348	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	348	20	preprint	preprint	NN
10_1101-2021_01_05_425508	348	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	POS
10_1101-2021_01_05_425508	348	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NN
10_1101-2021_01_05_425508	348	23	22	22	CD
10_1101-2021_01_05_425508	348	24	Table	table	NN
10_1101-2021_01_05_425508	348	25	3	3	CD
10_1101-2021_01_05_425508	348	26	539	539	CD
10_1101-2021_01_05_425508	348	27	Clade	clade	NN
10_1101-2021_01_05_425508	348	28	G	G	NNP
10_1101-2021_01_05_425508	348	29	Clade	Clade	NNP
10_1101-2021_01_05_425508	348	30	GH	GH	NNP
10_1101-2021_01_05_425508	348	31	Clade	Clade	NNP
10_1101-2021_01_05_425508	348	32	GR	GR	NNP
10_1101-2021_01_05_425508	348	33	Clade	Clade	NNP
10_1101-2021_01_05_425508	348	34	L	L	NNP
10_1101-2021_01_05_425508	348	35	Clade	Clade	NNP
10_1101-2021_01_05_425508	348	36	V	V	NNP
10_1101-2021_01_05_425508	348	37	Clade	Clade	NNP
10_1101-2021_01_05_425508	348	38	S	S	NNP
10_1101-2021_01_05_425508	348	39	PTBP1	PTBP1	''
10_1101-2021_01_05_425508	348	40	-2.81	-2.81	CD
10_1101-2021_01_05_425508	348	41	-3.46	-3.46	CD
10_1101-2021_01_05_425508	348	42	-4.92	-4.92	CD
10_1101-2021_01_05_425508	348	43	-13.50	-13.50	NFP
10_1101-2021_01_05_425508	348	44	-11.66	-11.66	NFP
10_1101-2021_01_05_425508	348	45	3.95	3.95	CD
10_1101-2021_01_05_425508	348	46	HNRNPL	hnrnpl	NN
10_1101-2021_01_05_425508	348	47	-3.03	-3.03	CD
10_1101-2021_01_05_425508	348	48	-1.78	-1.78	CD
10_1101-2021_01_05_425508	348	49	-0.52	-0.52	CD
10_1101-2021_01_05_425508	348	50	-3.62	-3.62	CD
10_1101-2021_01_05_425508	348	51	-6.48	-6.48	CD
10_1101-2021_01_05_425508	348	52	0.71	0.71	CD
10_1101-2021_01_05_425508	348	53	NOVA1	nova1	NN
10_1101-2021_01_05_425508	348	54	-0.04	-0.04	CD
10_1101-2021_01_05_425508	348	55	-2.77	-2.77	CD
10_1101-2021_01_05_425508	348	56	-0.70	-0.70	CD
10_1101-2021_01_05_425508	348	57	-3.37	-3.37	CD
10_1101-2021_01_05_425508	348	58	-5.04	-5.04	CD
10_1101-2021_01_05_425508	348	59	1.09	1.09	CD
10_1101-2021_01_05_425508	348	60	SRSF2	SRSF2	VBN
10_1101-2021_01_05_425508	348	61	-1.17	-1.17	CD
10_1101-2021_01_05_425508	348	62	-3.02	-3.02	CD
10_1101-2021_01_05_425508	348	63	-1.09	-1.09	CD
10_1101-2021_01_05_425508	348	64	-3.10	-3.10	CD
10_1101-2021_01_05_425508	348	65	-3.10	-3.10	CD
10_1101-2021_01_05_425508	348	66	0.78	0.78	CD
10_1101-2021_01_05_425508	348	67	ZFP36	ZFP36	NNP
10_1101-2021_01_05_425508	348	68	1.67	1.67	CD
10_1101-2021_01_05_425508	348	69	-3.50	-3.50	CD
10_1101-2021_01_05_425508	348	70	-1.98	-1.98	CD
10_1101-2021_01_05_425508	348	71	-3.48	-3.48	CD
10_1101-2021_01_05_425508	348	72	-4.78	-4.78	CD
10_1101-2021_01_05_425508	348	73	1.86	1.86	CD
10_1101-2021_01_05_425508	348	74	HNRNPA1	hnrnpa1	CD
10_1101-2021_01_05_425508	348	75	-0.16	-0.16	CD
10_1101-2021_01_05_425508	348	76	-2.50	-2.50	CD
10_1101-2021_01_05_425508	348	77	-0.50	-0.50	CD
10_1101-2021_01_05_425508	348	78	-2.64	-2.64	CD
10_1101-2021_01_05_425508	348	79	-3.93	-3.93	CD
10_1101-2021_01_05_425508	348	80	0.44	0.44	CD
10_1101-2021_01_05_425508	348	81	ELAVL1	elavl1	CD
10_1101-2021_01_05_425508	348	82	2.82	2.82	CD
10_1101-2021_01_05_425508	348	83	0.47	0.47	CD
10_1101-2021_01_05_425508	348	84	2.87	2.87	CD
10_1101-2021_01_05_425508	348	85	0.59	0.59	CD
10_1101-2021_01_05_425508	348	86	0.03	0.03	CD
10_1101-2021_01_05_425508	348	87	2.39	2.39	CD
10_1101-2021_01_05_425508	348	88	TIA1	TIA1	NNP
10_1101-2021_01_05_425508	348	89	-0.82	-0.82	CD
10_1101-2021_01_05_425508	348	90	-2.05	-2.05	CD
10_1101-2021_01_05_425508	348	91	-1.20	-1.20	CD
10_1101-2021_01_05_425508	348	92	-1.72	-1.72	CD
10_1101-2021_01_05_425508	348	93	-4.41	-4.41	CD
10_1101-2021_01_05_425508	348	94	1.67	1.67	CD
10_1101-2021_01_05_425508	348	95	PCBP2	pcbp2	CD
10_1101-2021_01_05_425508	348	96	-0.37	-0.37	CD
10_1101-2021_01_05_425508	348	97	-2.50	-2.50	CD
10_1101-2021_01_05_425508	348	98	-1.03	-1.03	CD
10_1101-2021_01_05_425508	348	99	-2.28	-2.28	CD
10_1101-2021_01_05_425508	348	100	-2.35	-2.35	CD
10_1101-2021_01_05_425508	348	101	0.11	0.11	CD
10_1101-2021_01_05_425508	348	102	SRSF1	SRSF1	NNS
10_1101-2021_01_05_425508	348	103	-0.63	-0.63	CD
10_1101-2021_01_05_425508	348	104	-2.29	-2.29	CD
10_1101-2021_01_05_425508	348	105	-1.26	-1.26	CD
10_1101-2021_01_05_425508	348	106	-2.55	-2.55	CD
10_1101-2021_01_05_425508	348	107	-1.84	-1.84	CD
10_1101-2021_01_05_425508	348	108	0.36	0.36	CD
10_1101-2021_01_05_425508	348	109	540	540	CD
10_1101-2021_01_05_425508	348	110	541	541	CD
10_1101-2021_01_05_425508	348	111	542	542	CD
10_1101-2021_01_05_425508	348	112	543	543	CD
10_1101-2021_01_05_425508	348	113	.CC	.CC	:
10_1101-2021_01_05_425508	348	114	-	-	HYPH
10_1101-2021_01_05_425508	348	115	BY	BY	NNP
10_1101-2021_01_05_425508	348	116	-	-	HYPH
10_1101-2021_01_05_425508	348	117	NC	NC	NNP
10_1101-2021_01_05_425508	348	118	4.0	4.0	CD
10_1101-2021_01_05_425508	348	119	International	international	JJ
10_1101-2021_01_05_425508	348	120	licensemade	licensemade	NN
10_1101-2021_01_05_425508	348	121	available	available	JJ
10_1101-2021_01_05_425508	348	122	under	under	IN
10_1101-2021_01_05_425508	348	123	a	a	DT
10_1101-2021_01_05_425508	348	124	(	(	-LRB-
10_1101-2021_01_05_425508	348	125	which	which	WDT
10_1101-2021_01_05_425508	348	126	was	be	VBD
10_1101-2021_01_05_425508	348	127	not	not	RB
10_1101-2021_01_05_425508	348	128	certified	certify	VBN
10_1101-2021_01_05_425508	348	129	by	by	IN
10_1101-2021_01_05_425508	348	130	peer	peer	NN
10_1101-2021_01_05_425508	348	131	review	review	NN
10_1101-2021_01_05_425508	348	132	)	)	-RRB-
10_1101-2021_01_05_425508	348	133	is	be	VBZ
10_1101-2021_01_05_425508	348	134	the	the	DT
10_1101-2021_01_05_425508	348	135	author	author	NN
10_1101-2021_01_05_425508	348	136	/	/	SYM
10_1101-2021_01_05_425508	348	137	funder	funder	NN
10_1101-2021_01_05_425508	348	138	,	,	,
10_1101-2021_01_05_425508	348	139	who	who	WP
10_1101-2021_01_05_425508	348	140	has	have	VBZ
10_1101-2021_01_05_425508	348	141	granted	grant	VBN
10_1101-2021_01_05_425508	348	142	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	348	143	a	a	DT
10_1101-2021_01_05_425508	348	144	license	license	NN
10_1101-2021_01_05_425508	348	145	to	to	TO
10_1101-2021_01_05_425508	348	146	display	display	VB
10_1101-2021_01_05_425508	348	147	the	the	DT
10_1101-2021_01_05_425508	348	148	preprint	preprint	NN
10_1101-2021_01_05_425508	348	149	in	in	IN
10_1101-2021_01_05_425508	348	150	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	348	151	.	.	.
10_1101-2021_01_05_425508	349	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	349	2	is	be	VBZ
10_1101-2021_01_05_425508	349	3	The	the	DT
10_1101-2021_01_05_425508	349	4	copyright	copyright	NN
10_1101-2021_01_05_425508	349	5	holder	holder	NN
10_1101-2021_01_05_425508	349	6	for	for	IN
10_1101-2021_01_05_425508	349	7	this	this	DT
10_1101-2021_01_05_425508	349	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	349	9	version	version	NN
10_1101-2021_01_05_425508	349	10	posted	post	VBD
10_1101-2021_01_05_425508	349	11	January	January	NNP
10_1101-2021_01_05_425508	349	12	6	6	CD
10_1101-2021_01_05_425508	349	13	,	,	,
10_1101-2021_01_05_425508	349	14	2021	2021	CD
10_1101-2021_01_05_425508	349	15	.	.	.
10_1101-2021_01_05_425508	349	16	;	;	:
10_1101-2021_01_05_425508	349	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	349	18	:	:	:
10_1101-2021_01_05_425508	349	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	349	20	preprint	preprint	NN
10_1101-2021_01_05_425508	349	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	349	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	349	23	23	23	CD
10_1101-2021_01_05_425508	349	24	544	544	CD
10_1101-2021_01_05_425508	349	25	545	545	CD
10_1101-2021_01_05_425508	349	26	546	546	CD
10_1101-2021_01_05_425508	349	27	.CC	.CC	:
10_1101-2021_01_05_425508	349	28	-	-	HYPH
10_1101-2021_01_05_425508	349	29	BY	BY	NNP
10_1101-2021_01_05_425508	349	30	-	-	HYPH
10_1101-2021_01_05_425508	349	31	NC	NC	NNP
10_1101-2021_01_05_425508	349	32	4.0	4.0	CD
10_1101-2021_01_05_425508	349	33	International	international	JJ
10_1101-2021_01_05_425508	349	34	licensemade	licensemade	NN
10_1101-2021_01_05_425508	349	35	available	available	JJ
10_1101-2021_01_05_425508	349	36	under	under	IN
10_1101-2021_01_05_425508	349	37	a	a	DT
10_1101-2021_01_05_425508	349	38	(	(	-LRB-
10_1101-2021_01_05_425508	349	39	which	which	WDT
10_1101-2021_01_05_425508	349	40	was	be	VBD
10_1101-2021_01_05_425508	349	41	not	not	RB
10_1101-2021_01_05_425508	349	42	certified	certify	VBN
10_1101-2021_01_05_425508	349	43	by	by	IN
10_1101-2021_01_05_425508	349	44	peer	peer	NN
10_1101-2021_01_05_425508	349	45	review	review	NN
10_1101-2021_01_05_425508	349	46	)	)	-RRB-
10_1101-2021_01_05_425508	349	47	is	be	VBZ
10_1101-2021_01_05_425508	349	48	the	the	DT
10_1101-2021_01_05_425508	349	49	author	author	NN
10_1101-2021_01_05_425508	349	50	/	/	SYM
10_1101-2021_01_05_425508	349	51	funder	funder	NN
10_1101-2021_01_05_425508	349	52	,	,	,
10_1101-2021_01_05_425508	349	53	who	who	WP
10_1101-2021_01_05_425508	349	54	has	have	VBZ
10_1101-2021_01_05_425508	349	55	granted	grant	VBN
10_1101-2021_01_05_425508	349	56	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	349	57	a	a	DT
10_1101-2021_01_05_425508	349	58	license	license	NN
10_1101-2021_01_05_425508	349	59	to	to	TO
10_1101-2021_01_05_425508	349	60	display	display	VB
10_1101-2021_01_05_425508	349	61	the	the	DT
10_1101-2021_01_05_425508	349	62	preprint	preprint	NN
10_1101-2021_01_05_425508	349	63	in	in	IN
10_1101-2021_01_05_425508	349	64	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	349	65	.	.	.
10_1101-2021_01_05_425508	350	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	350	2	is	be	VBZ
10_1101-2021_01_05_425508	350	3	The	the	DT
10_1101-2021_01_05_425508	350	4	copyright	copyright	NN
10_1101-2021_01_05_425508	350	5	holder	holder	NN
10_1101-2021_01_05_425508	350	6	for	for	IN
10_1101-2021_01_05_425508	350	7	this	this	DT
10_1101-2021_01_05_425508	350	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	350	9	version	version	NN
10_1101-2021_01_05_425508	350	10	posted	post	VBD
10_1101-2021_01_05_425508	350	11	January	January	NNP
10_1101-2021_01_05_425508	350	12	6	6	CD
10_1101-2021_01_05_425508	350	13	,	,	,
10_1101-2021_01_05_425508	350	14	2021	2021	CD
10_1101-2021_01_05_425508	350	15	.	.	.
10_1101-2021_01_05_425508	350	16	;	;	:
10_1101-2021_01_05_425508	350	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	350	18	:	:	:
10_1101-2021_01_05_425508	350	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	350	20	preprint	preprint	NN
10_1101-2021_01_05_425508	350	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	350	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	350	23	24	24	CD
10_1101-2021_01_05_425508	350	24	547	547	CD
10_1101-2021_01_05_425508	350	25	548	548	CD
10_1101-2021_01_05_425508	350	26	.CC	.CC	:
10_1101-2021_01_05_425508	350	27	-	-	HYPH
10_1101-2021_01_05_425508	350	28	BY	BY	NNP
10_1101-2021_01_05_425508	350	29	-	-	HYPH
10_1101-2021_01_05_425508	350	30	NC	NC	NNP
10_1101-2021_01_05_425508	350	31	4.0	4.0	CD
10_1101-2021_01_05_425508	350	32	International	international	JJ
10_1101-2021_01_05_425508	350	33	licensemade	licensemade	NN
10_1101-2021_01_05_425508	350	34	available	available	JJ
10_1101-2021_01_05_425508	350	35	under	under	IN
10_1101-2021_01_05_425508	350	36	a	a	DT
10_1101-2021_01_05_425508	350	37	(	(	-LRB-
10_1101-2021_01_05_425508	350	38	which	which	WDT
10_1101-2021_01_05_425508	350	39	was	be	VBD
10_1101-2021_01_05_425508	350	40	not	not	RB
10_1101-2021_01_05_425508	350	41	certified	certify	VBN
10_1101-2021_01_05_425508	350	42	by	by	IN
10_1101-2021_01_05_425508	350	43	peer	peer	NN
10_1101-2021_01_05_425508	350	44	review	review	NN
10_1101-2021_01_05_425508	350	45	)	)	-RRB-
10_1101-2021_01_05_425508	350	46	is	be	VBZ
10_1101-2021_01_05_425508	350	47	the	the	DT
10_1101-2021_01_05_425508	350	48	author	author	NN
10_1101-2021_01_05_425508	350	49	/	/	SYM
10_1101-2021_01_05_425508	350	50	funder	funder	NN
10_1101-2021_01_05_425508	350	51	,	,	,
10_1101-2021_01_05_425508	350	52	who	who	WP
10_1101-2021_01_05_425508	350	53	has	have	VBZ
10_1101-2021_01_05_425508	350	54	granted	grant	VBN
10_1101-2021_01_05_425508	350	55	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	350	56	a	a	DT
10_1101-2021_01_05_425508	350	57	license	license	NN
10_1101-2021_01_05_425508	350	58	to	to	TO
10_1101-2021_01_05_425508	350	59	display	display	VB
10_1101-2021_01_05_425508	350	60	the	the	DT
10_1101-2021_01_05_425508	350	61	preprint	preprint	NN
10_1101-2021_01_05_425508	350	62	in	in	IN
10_1101-2021_01_05_425508	350	63	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	350	64	.	.	.
10_1101-2021_01_05_425508	351	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	351	2	is	be	VBZ
10_1101-2021_01_05_425508	351	3	The	the	DT
10_1101-2021_01_05_425508	351	4	copyright	copyright	NN
10_1101-2021_01_05_425508	351	5	holder	holder	NN
10_1101-2021_01_05_425508	351	6	for	for	IN
10_1101-2021_01_05_425508	351	7	this	this	DT
10_1101-2021_01_05_425508	351	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	351	9	version	version	NN
10_1101-2021_01_05_425508	351	10	posted	post	VBD
10_1101-2021_01_05_425508	351	11	January	January	NNP
10_1101-2021_01_05_425508	351	12	6	6	CD
10_1101-2021_01_05_425508	351	13	,	,	,
10_1101-2021_01_05_425508	351	14	2021	2021	CD
10_1101-2021_01_05_425508	351	15	.	.	.
10_1101-2021_01_05_425508	351	16	;	;	:
10_1101-2021_01_05_425508	351	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	351	18	:	:	:
10_1101-2021_01_05_425508	351	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	351	20	preprint	preprint	NN
10_1101-2021_01_05_425508	351	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NN
10_1101-2021_01_05_425508	351	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	351	23	25	25	CD
10_1101-2021_01_05_425508	351	24	549	549	CD
10_1101-2021_01_05_425508	351	25	550	550	CD
10_1101-2021_01_05_425508	351	26	.CC	.CC	:
10_1101-2021_01_05_425508	351	27	-	-	HYPH
10_1101-2021_01_05_425508	351	28	BY	BY	NNP
10_1101-2021_01_05_425508	351	29	-	-	HYPH
10_1101-2021_01_05_425508	351	30	NC	NC	NNP
10_1101-2021_01_05_425508	351	31	4.0	4.0	CD
10_1101-2021_01_05_425508	351	32	International	international	JJ
10_1101-2021_01_05_425508	351	33	licensemade	licensemade	NN
10_1101-2021_01_05_425508	351	34	available	available	JJ
10_1101-2021_01_05_425508	351	35	under	under	IN
10_1101-2021_01_05_425508	351	36	a	a	DT
10_1101-2021_01_05_425508	351	37	(	(	-LRB-
10_1101-2021_01_05_425508	351	38	which	which	WDT
10_1101-2021_01_05_425508	351	39	was	be	VBD
10_1101-2021_01_05_425508	351	40	not	not	RB
10_1101-2021_01_05_425508	351	41	certified	certify	VBN
10_1101-2021_01_05_425508	351	42	by	by	IN
10_1101-2021_01_05_425508	351	43	peer	peer	NN
10_1101-2021_01_05_425508	351	44	review	review	NN
10_1101-2021_01_05_425508	351	45	)	)	-RRB-
10_1101-2021_01_05_425508	351	46	is	be	VBZ
10_1101-2021_01_05_425508	351	47	the	the	DT
10_1101-2021_01_05_425508	351	48	author	author	NN
10_1101-2021_01_05_425508	351	49	/	/	SYM
10_1101-2021_01_05_425508	351	50	funder	funder	NN
10_1101-2021_01_05_425508	351	51	,	,	,
10_1101-2021_01_05_425508	351	52	who	who	WP
10_1101-2021_01_05_425508	351	53	has	have	VBZ
10_1101-2021_01_05_425508	351	54	granted	grant	VBN
10_1101-2021_01_05_425508	351	55	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	351	56	a	a	DT
10_1101-2021_01_05_425508	351	57	license	license	NN
10_1101-2021_01_05_425508	351	58	to	to	TO
10_1101-2021_01_05_425508	351	59	display	display	VB
10_1101-2021_01_05_425508	351	60	the	the	DT
10_1101-2021_01_05_425508	351	61	preprint	preprint	NN
10_1101-2021_01_05_425508	351	62	in	in	IN
10_1101-2021_01_05_425508	351	63	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	351	64	.	.	.
10_1101-2021_01_05_425508	352	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	352	2	is	be	VBZ
10_1101-2021_01_05_425508	352	3	The	the	DT
10_1101-2021_01_05_425508	352	4	copyright	copyright	NN
10_1101-2021_01_05_425508	352	5	holder	holder	NN
10_1101-2021_01_05_425508	352	6	for	for	IN
10_1101-2021_01_05_425508	352	7	this	this	DT
10_1101-2021_01_05_425508	352	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	352	9	version	version	NN
10_1101-2021_01_05_425508	352	10	posted	post	VBD
10_1101-2021_01_05_425508	352	11	January	January	NNP
10_1101-2021_01_05_425508	352	12	6	6	CD
10_1101-2021_01_05_425508	352	13	,	,	,
10_1101-2021_01_05_425508	352	14	2021	2021	CD
10_1101-2021_01_05_425508	352	15	.	.	.
10_1101-2021_01_05_425508	352	16	;	;	:
10_1101-2021_01_05_425508	352	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	352	18	:	:	:
10_1101-2021_01_05_425508	352	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	352	20	preprint	preprint	NN
10_1101-2021_01_05_425508	352	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NNP
10_1101-2021_01_05_425508	352	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	352	23	26	26	CD
10_1101-2021_01_05_425508	352	24	551	551	CD
10_1101-2021_01_05_425508	352	25	552	552	CD
10_1101-2021_01_05_425508	352	26	553	553	CD
10_1101-2021_01_05_425508	352	27	.CC	.CC	:
10_1101-2021_01_05_425508	352	28	-	-	HYPH
10_1101-2021_01_05_425508	352	29	BY	BY	NNP
10_1101-2021_01_05_425508	352	30	-	-	HYPH
10_1101-2021_01_05_425508	352	31	NC	NC	NNP
10_1101-2021_01_05_425508	352	32	4.0	4.0	CD
10_1101-2021_01_05_425508	352	33	International	international	JJ
10_1101-2021_01_05_425508	352	34	licensemade	licensemade	NN
10_1101-2021_01_05_425508	352	35	available	available	JJ
10_1101-2021_01_05_425508	352	36	under	under	IN
10_1101-2021_01_05_425508	352	37	a	a	DT
10_1101-2021_01_05_425508	352	38	(	(	-LRB-
10_1101-2021_01_05_425508	352	39	which	which	WDT
10_1101-2021_01_05_425508	352	40	was	be	VBD
10_1101-2021_01_05_425508	352	41	not	not	RB
10_1101-2021_01_05_425508	352	42	certified	certify	VBN
10_1101-2021_01_05_425508	352	43	by	by	IN
10_1101-2021_01_05_425508	352	44	peer	peer	NN
10_1101-2021_01_05_425508	352	45	review	review	NN
10_1101-2021_01_05_425508	352	46	)	)	-RRB-
10_1101-2021_01_05_425508	352	47	is	be	VBZ
10_1101-2021_01_05_425508	352	48	the	the	DT
10_1101-2021_01_05_425508	352	49	author	author	NN
10_1101-2021_01_05_425508	352	50	/	/	SYM
10_1101-2021_01_05_425508	352	51	funder	funder	NN
10_1101-2021_01_05_425508	352	52	,	,	,
10_1101-2021_01_05_425508	352	53	who	who	WP
10_1101-2021_01_05_425508	352	54	has	have	VBZ
10_1101-2021_01_05_425508	352	55	granted	grant	VBN
10_1101-2021_01_05_425508	352	56	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	352	57	a	a	DT
10_1101-2021_01_05_425508	352	58	license	license	NN
10_1101-2021_01_05_425508	352	59	to	to	TO
10_1101-2021_01_05_425508	352	60	display	display	VB
10_1101-2021_01_05_425508	352	61	the	the	DT
10_1101-2021_01_05_425508	352	62	preprint	preprint	NN
10_1101-2021_01_05_425508	352	63	in	in	IN
10_1101-2021_01_05_425508	352	64	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	352	65	.	.	.
10_1101-2021_01_05_425508	353	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	353	2	is	be	VBZ
10_1101-2021_01_05_425508	353	3	The	the	DT
10_1101-2021_01_05_425508	353	4	copyright	copyright	NN
10_1101-2021_01_05_425508	353	5	holder	holder	NN
10_1101-2021_01_05_425508	353	6	for	for	IN
10_1101-2021_01_05_425508	353	7	this	this	DT
10_1101-2021_01_05_425508	353	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	353	9	version	version	NN
10_1101-2021_01_05_425508	353	10	posted	post	VBD
10_1101-2021_01_05_425508	353	11	January	January	NNP
10_1101-2021_01_05_425508	353	12	6	6	CD
10_1101-2021_01_05_425508	353	13	,	,	,
10_1101-2021_01_05_425508	353	14	2021	2021	CD
10_1101-2021_01_05_425508	353	15	.	.	.
10_1101-2021_01_05_425508	353	16	;	;	:
10_1101-2021_01_05_425508	353	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	353	18	:	:	:
10_1101-2021_01_05_425508	353	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	353	20	preprint	preprint	NN
10_1101-2021_01_05_425508	353	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	NN
10_1101-2021_01_05_425508	353	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP
10_1101-2021_01_05_425508	353	23	27	27	CD
10_1101-2021_01_05_425508	353	24	554	554	CD
10_1101-2021_01_05_425508	353	25	.CC	.CC	:
10_1101-2021_01_05_425508	353	26	-	-	HYPH
10_1101-2021_01_05_425508	353	27	BY	BY	NNP
10_1101-2021_01_05_425508	353	28	-	-	HYPH
10_1101-2021_01_05_425508	353	29	NC	NC	NNP
10_1101-2021_01_05_425508	353	30	4.0	4.0	CD
10_1101-2021_01_05_425508	353	31	International	international	JJ
10_1101-2021_01_05_425508	353	32	licensemade	licensemade	NN
10_1101-2021_01_05_425508	353	33	available	available	JJ
10_1101-2021_01_05_425508	353	34	under	under	IN
10_1101-2021_01_05_425508	353	35	a	a	DT
10_1101-2021_01_05_425508	353	36	(	(	-LRB-
10_1101-2021_01_05_425508	353	37	which	which	WDT
10_1101-2021_01_05_425508	353	38	was	be	VBD
10_1101-2021_01_05_425508	353	39	not	not	RB
10_1101-2021_01_05_425508	353	40	certified	certify	VBN
10_1101-2021_01_05_425508	353	41	by	by	IN
10_1101-2021_01_05_425508	353	42	peer	peer	NN
10_1101-2021_01_05_425508	353	43	review	review	NN
10_1101-2021_01_05_425508	353	44	)	)	-RRB-
10_1101-2021_01_05_425508	353	45	is	be	VBZ
10_1101-2021_01_05_425508	353	46	the	the	DT
10_1101-2021_01_05_425508	353	47	author	author	NN
10_1101-2021_01_05_425508	353	48	/	/	SYM
10_1101-2021_01_05_425508	353	49	funder	funder	NN
10_1101-2021_01_05_425508	353	50	,	,	,
10_1101-2021_01_05_425508	353	51	who	who	WP
10_1101-2021_01_05_425508	353	52	has	have	VBZ
10_1101-2021_01_05_425508	353	53	granted	grant	VBN
10_1101-2021_01_05_425508	353	54	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	353	55	a	a	DT
10_1101-2021_01_05_425508	353	56	license	license	NN
10_1101-2021_01_05_425508	353	57	to	to	TO
10_1101-2021_01_05_425508	353	58	display	display	VB
10_1101-2021_01_05_425508	353	59	the	the	DT
10_1101-2021_01_05_425508	353	60	preprint	preprint	NN
10_1101-2021_01_05_425508	353	61	in	in	IN
10_1101-2021_01_05_425508	353	62	perpetuity	perpetuity	NN
10_1101-2021_01_05_425508	353	63	.	.	.
10_1101-2021_01_05_425508	354	1	It	-PRON-	PRP
10_1101-2021_01_05_425508	354	2	is	be	VBZ
10_1101-2021_01_05_425508	354	3	The	the	DT
10_1101-2021_01_05_425508	354	4	copyright	copyright	NN
10_1101-2021_01_05_425508	354	5	holder	holder	NN
10_1101-2021_01_05_425508	354	6	for	for	IN
10_1101-2021_01_05_425508	354	7	this	this	DT
10_1101-2021_01_05_425508	354	8	preprintthis	preprintthis	NN
10_1101-2021_01_05_425508	354	9	version	version	NN
10_1101-2021_01_05_425508	354	10	posted	post	VBD
10_1101-2021_01_05_425508	354	11	January	January	NNP
10_1101-2021_01_05_425508	354	12	6	6	CD
10_1101-2021_01_05_425508	354	13	,	,	,
10_1101-2021_01_05_425508	354	14	2021	2021	CD
10_1101-2021_01_05_425508	354	15	.	.	.
10_1101-2021_01_05_425508	354	16	;	;	:
10_1101-2021_01_05_425508	354	17	https://doi.org/10.1101/2021.01.05.425508doi	https://doi.org/10.1101/2021.01.05.425508doi	LS
10_1101-2021_01_05_425508	354	18	:	:	:
10_1101-2021_01_05_425508	354	19	bioRxiv	biorxiv	IN
10_1101-2021_01_05_425508	354	20	preprint	preprint	NN
10_1101-2021_01_05_425508	354	21	https://doi.org/10.1101/2021.01.05.425508	https://doi.org/10.1101/2021.01.05.425508	POS
10_1101-2021_01_05_425508	354	22	http://creativecommons.org/licenses/by-nc/4.0/	http://creativecommons.org/licenses/by-nc/4.0/	NNP